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ABSTRACT 
Various chromone derivatives have been used in asthma therapy, and their 
biological activity is apparently related to certain chemical features 
which include conformation and acidity. In the present study, 
substituent effects on conformation and acidity have been explored in 
chromone systems with potential biological activity. A range of 
variously substituted symmetrical chromone-2-carboxamides (including a 
series of N,N-dimethylchromone-2-carboxamides) have been prepared via 
chromone-2-carboxylic acids, which, in turn, were prepared from the 
corresponding o-hydroxyacetophenones. The N,N-dimethylchromone-2-
carboxamides were prepared by reacting the appropriate chromone-2-
carbonyl chlorides with dimethylammonium chloride in pyridine, in an 
approach which resolved various problems encountered in the preparation 
of these compounds. Substituent effects on the conformation of 
chromone-2-carboxamides have been explored using dynamic NMR 
spectroscopy, and the observed splitting of the N-alkyl signals has been 
attributed to slow site-exchange of the N-alkyl substituents. Dynamic 
NMR frequency separations and coalescence temperatures have been used to 
calculate rotational energy barriers, and substituent effects on these 
rotational energy barriers have been analysed. 
The possible implication of ring-opening of chromones in chromone 
pharmacology has also been examined. A range of 3-(2-hydroxybenzoyl)-
acrylamides has been prepared via the dimethylamine-mediated ring-
opening of N,N-dimethylchromone-2-carboxamides and the E-double-bond 
configuration of the ring-opened products has been unambiguously 
established by single crystal analysis of the parent system. The 
configuration and conformation of the crystal structure of the parent 
ii 
system have been shown, using IR and NMR spectroscopic, and molecular 
graphics techniques, to be maintained in solution and to characterise 
the whole series. IH and 13C NMR spectroscopy have also been used to 
study the dimethylamine-mediated ring-opening of disodium cromoglycate. 
The kinetics of the dimethylamine-mediated ring-opening of 
N,N-dimethylchromone-2-carboxamides have been studied using UV 
spectroscopy. These reactions have been shown to follow third-order 
kinetics overall and a mechanism accommodating the observed third-order 
kinetics has been proposed. 
Substituent effects have been further investigated by the potentiometric 
determination of the pKa values for a series of chromone-2-carboxylic 
acids. The relationship between acidity and the observed rate 
constants has been explored and has verified that the observed rate 
constants are sensitive to the influence of meta-substituents on the 
stability of the phenoxide ion "leaving group" rather than C-2 
electrophilicity. 
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1. INTRODUCTION 
The name "chromone" , first used by Bloch and Kostanecki in 1900, was 
chosen to describe coloured, naturally occurring compounds known to 
contain the benzo-4H-pyran-4-one structure 1.1 The chemistry of 
chromones has been extensively reviewed. 1-3 Chromones are benzanulated 
analogues of ~-pyrone 2n and their systematic nomenclature originates 
from the pyran analogues 3 and 4.4 The chromone structure will be 
denoted simply as chromone rather than 4-oxo-4H-chromene. Many 
chromones occur naturally in plants and exhibit biological activity.5 
Potentially active structural chromone analogues have been synthesised 
in attempts to improve potency or reduce unwanted side effects. Another 
related family of compounds are the flavanoids, which are derivatives of 
the 2- and 3-arylchromones respectively4 and which are widely 
distributed in plants. 6 
o 
3 
2 
1 
Chromone 
(Benzo-4H-pyran-4-one) 
(4-0xo-4H-l-benzopyran) 
(4-0xo-4H-chromene) 
4 
0: o 
1 
3 
4H-pyran 
o 6: .-,.... Jo 
o 
1 
2a 
.., -Pyrone 
(4H-pyran-4-one) 
5 4 
6(X)1 1 3 
7 ~ 0 2 
8 1 
4 
4H-1-Benzopyran 
(4H-Chromene) 
(.., -Chromone) 
2b 
1.1 CHROMONE CHEMISTRY 
1 . 1 . 1 PROPERTIES OF THE CHROMONE NUCLEUS. 
Most properties of ~-pyrones, and hence chromones, are attributable to 
the aliphatic dienone system 2a, although some properties, such as the 
lack of normal ketonic activity and the exceptional reactivity of the 
carbonyl oxygen, may be attributed to substantial ~-electron 
delocalization consistent with the aromatic pyrylium betaine structure 
2b. The electronic interaction of the ether oxygen with the carbonyl 
group was first proposed by Arndt in 1924. 4 
1 . 1 . 1 . 1 PHYSICAL AND SPECTRAL PROPERTIES. 
2 
The great propensity of ~-pyrone and chromone to form salts with acids 
results from their observed basicity, which has been rationalised in 
terms of the betaine structure 2b.7 Although the pKa value of ~ -pyrone 
(0.1) is comparable to nitrogen bases with very low basic strength, e.g. 
urea (pKa 0.1) and p-nitroaniline (pKa 1.0), it is nevertheless 
remarkably high compared to other oxygen bases, e.g. acetone (pKa -7.2). 
The pKa of chromone (2.0) is significantly higher than ~-pyrone.7 
Spectroscopic properties are rationalised in terms of an aliphatic 
dienone system 2a. The IR carbonyl stretching frequency of chromone 
occurs at ca. 1660 em-I, the exact value depending on the solvent 
used. 4,8 This value is lower than the carbonyl stretching frequency of 
coumarin 5 (ll max 1710 cm-1) and IR spectroscopy may thus be used to 
distinguish chromones from coumarins. The UV spectra of chromone9 and 
many of its derivatives are characterised by four bands centred at 205, 
3 
225, 240 and 300 nm, the last two being major absorption peaks. Solvent 
studies have shown that the lowest wavelength band is probably a 
~~ a* transition involving the heteroatom lone-pair electrons, while 
the three higher wavelength bands arise from ~~ ~* transitions." The 
latter wavelength bands are generally red-shifted by C-2 electron 
withdrawing groups or blue-shifted by a C-2 methyl group. Introduction 
~ ~oAo 
5 
of NHC02Et at C-2 causes pronounced spectral changes which are 
associated with the charge transfer species 6. In mass spectrometric 
analysis,lO the chromone molecular ion fragments via two pathways 
involving either the loss of carbon monoxide or ring cleavage by a 
retro-Diels-Alder reaction (Scheme 1). 
-co 
.. 
m/z 92 
m/z 64 
m/z 118 
SCHEME 1 
4 
A detailed IH NMR study of chromone has been published by Mathis and 
Goldstein. l ! The benzenoid proton signals in chromone are shifted down-
field, relative to those of the isomeric coumarin, as a result of the 
close proximity of the carbonyl group to the benzene ring. This effect 
is greatest at C-5 and the separation of this signal from the other 
benzenoid signals is characteristic of chromones and is not shown in 
coumarins. The 13C NMR spectra of chromones 11 are characterised by a 
number of general features : (i) the carbonyl carbon signal is always at 
the lowest field and is essentially unaffected by substitution in the 
system; (ii) the C-3 signal is at a higher frequency than all the other 
methine carbon signals; and (iii) the ring junction signals are largely 
unaffected by substitution in either ring. 
1 .1 . 1 . 2 CHEMICAL PROPERTIES. 
( i ) Salt Formation. 
Both ~-pyrone and chromone form oxonium or benzopyrylium salts, e.g. 
chromone forms the hydrochloride 7, methoxonium 8, or 
4-siloxybenzopyrylium salt 9 when treated with hydrochloric acid, methyl 
o-nitrobenzenesulphonate, or t-butyldimethylsilyl triflate 
respectively.4.12.13 These reactions all reflect the latent aromaticity 
of the heterocyclic ring.4 
+OR 
~ UoJ .. 
7 (R a H) 
8 (R co Me) 
OR 
~ U o) 
+ 
9 [R = S!(Me)2But) 
5 
( i i ) Ring-opening Reactions. 
Chromones readily undergo C-2 nucleophilic cleavage of the heterocyclic 
ring.4 Consequently, there are few synthetic methods for introducing 
nucleophiles at this position without ring-opening or ring-
transformation. 13 A variety of nitrogen, oxygen and carbon nucleophiles 
have been used in the ring-opening of chromones, and only selected 
examples will be discussed. 
( a ) Reactions with nitrogen nucleophiles. 
Kostka14 showed that chromones react with primary and secondary amines 
to produce ~-aminovinylketones 10 having either E- or Z-double-bond 
configurations (Scheme 2). Zagorevskii et a1. 15•16 used 1H NMR 
spectroscopy to study the detailed structure of the ~-aminovinylketone 
products (Section 2.3) and proposed a feasible reaction mechanism using 
1H NMR spectroscopic and deuterium labelling techniques (Section 2.5). 
o 
~ UoJ i 
SCHEME 2 
Reagents : i) RIR2NH, 80-85°C, 2h. 
6 
Chromone-2-carboxylate esters (e.g. 11) react with amine or ammonia to 
give different products occording to the nature and quantity of the 
amine, and the reaction conditions (Scheme 3); secondary and tertiary 
carboxamides (e.g. 12) are produced under very mild, anhydrous 
conditions while an excess of amine or prolonged reaction affords 
coloured acrylamides 13.15,17-20 The latter reaction is presumed to 
proceed via the carboxamide with a second mole of amine cleaving the 
ring, since treatment of the preformed carboxamide (12; R=CH2Ph) with 
benzyl amine afforded the corresponding acrylamide. 21 
0 0 
cCt i oa »-~ 0 C02Et ~ 0 ~ CONHR 
11 12 .. 
NH2R 
~ liB 
CONHR 
NHR 
0 
-
-
13 
SCHEME 3 
Reagents : i) RNH2 (1 Molar eq.); 
ii) RNH2 (2 Molar eq. ); 
iii) RNH2 (1 Molar eq. ). 
7 
Reaction of chromones with ambident nucleophiles or those containing an 
N-C-N group results in ring cleavage and subsequent cyclization to other 
heterocyclic systems. Reactions with hydroxylamine, for example, afford 
isomeric isoxazole derivatives 14 and 15, and the oxime derivative 16 is 
only obtained under anhydrous conditions (Scheme 4).22 Base catalysed 
reaction of 3-nitrochromone 17 with a series of nucleophiles affords 
heteroaromatic nitro compounds,23 e.g. reaction with glycine ethyl ester 
hydrochloride or benzamidine affords the pyrrolyl- or pyrimidyl-
derivatives 18 and 19 respectively (Scheme 5). Analogous reactions 
occur with 2-carbonyloxychromones, e.g. ethyl chromone-2-carboxylate has 
been cleaved by hydrazine, diaminoethane and 1,2-diaminobenzene,24,25 
while chromone-2-carboxylic acid reacts with hydrazine to produce 
pyrazole derivatives. 20 
( b) Reactions with oxygen nucleophiles. 
Chromones undergo ring opening when treated with aqueous alkali;4 
cyclization of the resultant salt of the ~-diketone 20 to the chromone 
on acidification often prevents isolation of the free ~-diketone 20 
(Scheme 6). Hydrolytic carbon-carbon cleavage of the ~-diketone 20 
occurs under vigorous, prolonged treatment with aqueous alkali to afford 
a mixture of products and this reaction has been widely used in chromone 
structural analysis. Szabo et al. have studied the kinetics of this 
reaction of chromones 26 and isoflavanoids27 ,28 and have proposed a 
mechanism in which C-2 nucleophilic attack occurs in the rate-
determining step whose rate constant varies with electron density at C-2 
(Section 2.5). Treatment of chromones with sodium alkoxide may also 
result in ring cleavage, e.g. 2-methylchromone 21 affords the dimeric 
product 22 which, on treatment with acid, is reconverted to 
2-methylchromone (Scheme 7) .22 
8 
o 
~ U O) ~ U OH i + .. 
14 
NOH 
~ UOJ 
16 
SCHEME 4 
Reagents: i) NH20H.HCl; ii) anhydrous NH20H.HCl. 
0 NH OCrNO• i 0 l.C02 Et ~ I I .. --
0 
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iii 1 
~ N 
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N Ph 
0 
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SCHEME 5 
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0 0 
(xJ(' i ~ I I .. ~ b 
::::::.--. 0 RZ ii 
RI 
20 
~ 1· 0 
~R' (XCO'H RZ I R1C02 H I + 
OiR' ::::::.--. OH + ::::::.--. OH 
SCHEME 6 
o 
~ OOH ~O)lCH=CM.CH' ~ 
SCHEME 7 
Reagents: i) OEt-, laoe; ii) U+. 
10 
( c ) Reactions with carbon nucleophiles. 
Carbon nucleophiles attack either the C-2 or C-4 positions of chromones 
resulting in ring cleavage or ring transformation. Ring-opening 
reactions of chromones with an active methylene species,29 in the 
presence of DBN or DBU, occur at room temperature, e.g. reaction of 
3-bromochromone 23 affords the furan derivative 24 (Scheme 8). Some 
heterocyclic quaternary compounds (e.g. N-ethyl-2-methy1benzothiazolium 
tosylate 25) cleave chromones to form compounds (e.g. 26) which are 
potentially useful as dyes (Scheme 9).30 Nucleophilic attack on the 
carbonyl group of chromones by Grignard reagents followed by 
acidification affords benzopyrylium salts (e.g. 27) (Scheme 10), 
although the Grignard reaction of isoflavone 28 in the presence of 
copper (I) chloride, affords the ring-opened product 29. 29 
C-2 Nucleophilic attack may not always result in ring cleavage. The 
reaction of 3-nitrochromone 30 with diazomethane or diazopropane affords 
a cyclopropabenzopyran 31 or the homologous dimethy1cyclopropane 32 
respectively (Scheme 11).29 Akiba et al. 13 recently reported reactions 
of the siloxybenzopyrylium salts 33 (generated from chromone using 
t-buty1dimethy1si1y1 trif1ate) with si1yl enol ethers or alkyl 
organometallic reagents in the presence of 2,6-lutidine. For example, 
reaction with the ketene silyl acetyl 34 affords 4-siloxybenzopyran 35, 
while reaction with 3-(trimethylsilyl)-1-butene 36 affords the 
unexpected cyclopentane annulation product 37 (Scheme 12). A second 
substituent may be introduced at the C-3 position of the 2-substituted 
4-si1oxybenzopyrans via reaction with electrophiles, e.g. reaction of 
compound 35 with the appropriate iminium salt affords the 
3-methylenechromone derivative 38. 
11 
o 
24 
SCHEME 8 
Reagents : i) CHZAcZ' DBN, 180C. 
o 
~ U O) 
Ts· 
+ 0"N~M. ~S 
o Et 
i ~ YCH=CHCH=(JO U OH 
25 26 
SCHEME 9 
Reagents : i) AcONa, EtOH. 
o Ph 
ro-OMe mPh OMgBr ro ,... i -:P' OMe ii -:P' . ~ OMe ,I I -+~ I I --... I 
.............. ~ ~ h MeO 0 Me MeO _ 0 Me MeO 0 Me 
+ 
27 FeCI 4 -
OMe 0 OMe 0 MaoroAr MeO Ar iii 
• 
MeO ~ 0 MeO 
28 Me 
29 
SCHEME 10 
Reagents: i) PhMgBr; ii) HCl, FeCI3; iii) MeMgI, CuZCIZ. 
o 
~ lv!lO) 
0 o(rNO, i ~ I I .. 
~ 0 
30 
i 
~SiMe3 
Me 
36 
33 
SCHEME 11 
+ 
-OTf 
37 
0 
31 (R ... H) 
32 (R ... Me) 
OSiMe 3 
~OEt 
34 
ii 
SCHEME 12 
Reagents: i) But(Me)2SiOTf, SO°C, 1 h; 
ii) 2,6-1utidine, CH2C12' rt, 1 h; 
R 
35 
38 
iv) 2,6-1utidine, CH2C12, rt, 4.5 h; Na2C03' 
12 
1 iii 
o 
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iii) Electrophillc Addition and Substitution Reactions. 
Both chromone rings are relatively resistant to electrophilic attack31 
since strongly acidic electrophilic reagents (e.g. sulphuric acid or 
nitric-sulphuric acid mixtures) or strong acids (i.e. halogen acids) 
produced during the reaction, may result in protonation of the pyran 
ring thus inhibiting further electrophilic attack. 29 Nitration,31,32 
under forcing conditions, is the most readily achieved electrophilic 
substitution reaction and affords mainly the 6-nitrochromone derivative, 
while bromination,29,32 using bromine in carbon disulphide, affords a 
2,3-dibromo adduct which on treatment with a secondary amine gives 
3-bromochromone. The less acidic conditions of the Mannich reaction 
afford salts of 3-aminomethylchromone 39 (Scheme 13), the reaction 
probably proceding via electrophilic attack on a ~-diketone 
intermediate produced by heterolytic cleavage of the chromone 
system. 29 ,31 
Treatment of hydroxylated or methylated chromones with hydroiodic acid 
induces an interesting and occasionally useful rearrangement 
(Scheme 14).29 Demethylation of the flavone dimethyl ether 40 with 
hydroiodic acid proceeds via the Wessely-Moser rearrangement of the 
ring-opened diketone 41 which cyclises to the flavone scutellarein 42 
which has a different trihydroxy substitution pattern. 
HO 
o 
~ yO} i 
OMe 
SCHEME 13 
OMe 
39 
Reagents: i) HZCO, MeZNH, AcOH. 
OMe 0 OH 
i 
,. 
Ar HO 
OMe OH 
40 41 
CAr = 4-0HC6H4) 1 
OH 0 OHm SCHEME 14 
HO :::::.... I 0 I Ar 
Reagents : i) HI. 
42 
14 
Ar 
15 
( i v) Other Reactions of Chromones. 
The oxidation of chromones using permanganate or dichromate results in 
ring-opening and the formation of salicylic acid. 29 Catalytic reduction 
of chromones, on the other hand, may produce several products. Thus 
conditions favourable for the production of a specific product from a 
particular substrate may be selected. For example, hydrogenation of 
6-chlorochromone-2-carboxylic acid with palladium-charcoal in acetic 
acid at 70°C at low pressure results in the loss of the 2,3-double bond, 
ketone carbonyl and chlorine functions, while the use of Raney nickel at 
low pressure. or at high pressure and temperature over copper chromate. 
failed to effect reduction. 22 Chromones also react with free radicals, 
and undergo thermal and photochemical reactions .22,31 
16 
1 . 1 .2. SYNTHESIS OF CHROMONES. 
Preparative methods for chromones have been extensively reviewed. 1- 3 
Although chromones may be synthesised from a variety of substrates, the 
two most common precursors are o-hydroxyacetophenones and phenols. In 
both instances, a side-chain is linked to the substrate, followed by 
cyclisation. The source of the side-chain differentiates each synthetic 
route33 and aromatic substituents may be introduced without any 
substantial changes in synthetic methodology.34 
The Claisen condensation34 of an o-hydroxyacetophenone with an ester 
(Scheme 15) is one of most frequently used synthetic methods, and was 
first described by Kostanecki et al. in 1901. Condensation with an 
ester, e.g. diethyl oxalate (R=C02Et ), in the presence of strong base, 
usually sodium ethoxide, affords a 1,3-diketone 43 which readily 
cyclises in acidic solution. 
An alternative route to the 1,3-diketones involves the O-acylation of an 
o-hydroxyacetophenone to afford an acyloxybenzene 44 which, on treatment 
with potassium carbonate, undergoes an intramolecular Baker-Venkataraman 
rearrangement to the 1,3-diketone 45 (Scheme 16).33 In the Kostanecki-
Robinson35 synthesis of chromones an o-hydroxyacetophenone is reacted 
with an aliphatic anhydride and the sodium salt of the corresponding 
acid (Scheme 17). This reaction may produce a mixture of products and 
alkaline cleavage of the 3-acyl group may occur during isolation of the 
product. 
17 
~ U OH 
o 
i,ii 
o o 
~ UOJlR iii R iii ~ 
43 
SCHEME 15 
Reagents: i) base (NaOEt); ii) RC02Et; iii) H+. 
o 
~ U OH i 
44 
o o o 
~ UoJlMe iii 
45 
SCHEME 16 
Reagents: i) MeCOCl, pyridine; ii) KOH, pyridine or K2C03; iii) H+. 
o 
~ U OH 
o 
i 
o o 
~. UOJlMe H 
SCHEME 17 
Reagents: i) AcZO, NaOAc; ii) aq. NaHC03' 
18 
The reaction of an o-hydroxyacetophenone with dimethylformamide (DMF) 
under Vilsmeier conditions is used for the synthesis of 2-unsubstituted 
chromones (Scheme 18).36,37 Reactions with DMF or its dimethyl acetal in 
the absence of phosphorous oxychloride afford chromone itself via 
cyclization of the ~-aminovinylketone 46. 
The Simonis reaction31 ,38 is also widely used and involves the 
condensation of a phenol with a ~-keto ester 47 (Scheme 19). The 
reaction may produce a chromone 48, or a coumarin 49 (the Pechmann 
reaction), or a mixture of both. Chromone formation predominates with 
the use of phosphorous pentoxide while sulphuric acid effects 
cyclisation to the coumarin; complete selectivity is, however, not 
always observed. 
The reaction of a phenol with an unsaturated ester, e.g. diethyl 
acetylene dicarboxylate 50 or diethyl chlorofumarate38 is widely used in 
the synthesis of chromone-2-carboxylic acids 53 (Scheme 20) and was 
developed by Ruhemann et ai. between 1900 and 1921. 39 Readily available 
substituted phenols may be used, and yields are reasonable, e.g. 
o-iodophenol is converted into 8-iodochromone-2-carboxylic acid in about 
33% yield. 40 Cyclization of the aryloxyalkenoic acid 51 or ester 52 
intermediates is effected by treatment with a mineral acid or acetyl 
chloride. 
19 
o 
~;CHNMe:i . 
UO/H 
o 
~ UoJ 
~R ~I  OH 48 
o 
ro CHO ~ I I o 
o TIMe 
~oJ 
SCHEME 18 
iii) R=H, DMF, POCl3; iv) R=Me, DMF, POCl3-
0 0 Me RO~ Cl i ro+ ro .. ~ OH+ ~ 0 Me ~ 0 0 
47 48 49 
SCHEME 19 
Reagents: i) H+ (H2S04 or P205)-
0 
C02Et 
Cl II i Cl CHR i1 ro .. ,. ~ OH+ ~ OAR ~ 0 R 
C02Et 
50 51 (R = C02H) 53 (R =0 C02H) 
52 (R .. C02Et) 54 (R = C02Et) 
SCHEME 20 
Reagents: i) base; ii) R=C02Et, MeCOCl, or R=C02H, H2S04-
20 
Chroman-4-ones are also used in chromone synthesis although their poor 
availability and low yields reduce their preparative value. 41 Conversion 
to chromones is effected by dehydrogenation or oxidation using selenium 
dioxide or palladium on charcoal. A more reliable conversion is the 
dehydrobromination of 3-bromochroman-4-one 55 using an amine 
(Scheme 21). The p-aminovinylketone 56, isolated in some instances, is 
subsequently cyclized on acidification to chromone. The 
2,3-dibromochroman-4-one 57 affords chromone on treatment with zinc dust 
and is dehydrobrominated to 3-bromochromone S8 in pyridine. 38 
Chromones are also synthesised from salicylic acid derivatives,36 
enamines,42 coumarins, benzopyrylium salts, chroman-4-ols, furans, and 
benzofurans .38 
0 ci;CHNR, roa, i -9'1 .-
~ 0 ~ O",H 
55 56 
~ iil 
0 0 
ol:(' iv oJ -9'1 .-... ~ 0 8r v ~ 0 
57 
iv! 
0 roa, 
-9' 1 I 
~ 0 
58 
SCHEME 21 
Reagents : i) R2NH, 20 oC; ii) Er; iii) Me2NPh; 
iv) Zn; v) Br2; vi) pyridine. 
21 
1.2 CONFORMATIONAL ANALYSIS 
The energetics and origins of conformational preferences may be studied 
using various techniques43 including (i) IR. NMR. Raman. and microwave 
spectroscopy; (ii) dipole moment measurements; and (iii) electron 
diffraction and x-ray diffraction studies. Isomeric. stable conformers 
in dynamic equilibrium may be separately observed provided the time-
scale of the spectroscopic detection method is sufficiently fast 
relative to the interconversion rate of the isomers, i.e. the average 
lifetime of the species must be greater than the (inverse) frequency of 
the absorbed radiation. 44 Each isomer must also possess different 
absorption characteristics and be present within the concentration 
detection limits. 
1 .2 .1 NMR SPECTROSCOPIC STUDIES OF AMIDES. 
Rotational isomerism of amides bas largely been studied using variable-
temperature dynamic NMR spectroscopy. 44,45 The partial double-bond 
character of the amide N-CO bond arising from nitrogen lone-pair 
delocalization (Figure 1) has the following consequences : 
(i) a large rotational barrier about the amide N-CO bond ranging 
between 50-100 kJ mol-1 ;44 
(ii) a rigid planar amide framework; 
(iii) the non-equivalence of the nitrogen substituents. even when 
(iv) the possibility of long-range spin-coupling,from R to Rl and R2 . 
.. 
FIGURE 1. 
Since the rotational barriers of amides are large, N,N-dialkyl amides 
often show splitting of the IH N-alkyl signals at ambient temperature. 
The separate chemical shifts for identical N-alkyl protons of 
N,N-dialkyl amides (under coriditions of slow site-exchange relative to 
the NMR time-scale) have been attributed to the anisotropy of the 
diamagnetic susceptibility of the amide carbonyl group.45 
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The heights of rotational barriers are measured using various 
methods,44,45 which include lineshape analysis, approximate methods, and 
the spin-echo method. For example, using approximate methods, the site-
exchange rate constant (k; Equation 1) for equivalent populations at 
coalescence tempera"ture (Tc) may be calculated from the chemical shift 
difference at infinitely slow site-exchange (8vco ). 44,45 Alternatively, 
the energy of activation CAG*; Equation 2) and hence the first-order 
rate constant (k; Equation 3) may be calculated from the coalescence 
temperature (Tc) and the chemical shift difference at coalescence 
CAv c) .46 
k = 7f8vco / V'E 
AG* = RTc (22.96 + In Tc/Avc) 
In k = In (kbT/h) - AG* /RT 
where R = Gas constant 
kb = Boltzmann constant 
h = Planck constant 
T = 298 K 
(1) 
(2) 
(3) 
Interpretation of variable-temperature spectra may be complicated by 
factors such as the non-equivalence of conformers which may require 
application of the Winstein-Holness principle. 44 Simultaneous rotation 
may also occur about two separate bonds, and individual rotational 
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barriers may be determined provided that both site-exchange processes 
are sufficiently slow, as shown in two recent dynamic NMR studies. 46,47 
In heterocyclic amides, nitrogen inversion and ring reversal 
conformational changes may also establish additional rotational 
equilibria, although these processes are considered to be faster than 
N-CO rotation. 48 For example,48 rotational barriers about the N-CO bond 
of N-substituted benzamides are generally larger than 60 kJ mol-I. 
Ring-reversal rotational barriers of piperidines are smaller 
(40-44 kJ mol-I) and those of pyrrolidines are expected to be even 
lower. Rotational barriers due to nitrogen inversion in heterocyclic 
amides are generally too small to be detected by NMR spectroscopy. 
The energy minima of amides correspond to conformations which favour a 
planar amide function. 44 In symmetrically substituted 
N,N-dialkylbenzamides, steric interactions between the o-hydrogen and 
the N-alkyl substituents apparently disrupt the co-planarity of the 
N-alkyl substituents in the near planar amide group, and may increase 
the torsion angle between the planar amide and aromatic functions. 49 
(In the crystal structure of p-bromo-N,N-dimethylbenzamide, the N-methyl 
substituents are twisted out of plane by 9° and the torsion angle 
between the amide and aromatic planes is 45°.) Site-exchange of the 
N-alkyl substituents apparently involves a rotational equilibrium 
between two quasi-planar conformers. 49 Rotational barriers of 
N,N-dialkylbenzamides are reduced relative to N,N-dialkylacetamides, for 
example, since competitive delocalization stabilises the activated state 
(Figure 2), thus reducing the .rotational barriers. 45 The lower 
FIGURE 2. 
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rotational barriers obtained in piperidides50 relative to 
N,N-dimethylamides50 have been attributed to repulsions, between the 
N-acyl group and the vicinal equatorial hydrogens, which impart more sp3 
character to the nitrogen inpiperidines than in acyclic analogues. In 
simple piperidine and pyrrolidine amides,45 rotational barriers for the 
five-membered ring systems have been shown to be consistently larger 
(8-12 kJ mol-I) than those of the six-membered ring systems. In 
general, larger N-alkyl groups tend to result in smaller rotational 
energy barriers. 45 However, reasons for this trend are not clearly 
understood and there are exceptions to the trend. 
The rigidity of the planar (or near planar) amide framework may also 
result in additional slow rotations about bonds other than the N-CO 
amide bond. 45 For example. in o-substituted benzamides. rotation about 
the C(1)-CO bond involves site-exchange between conformers in which the 
aromatic group is rotated out-of-plane relative to the planar amide 
group. Such rotational barriers range between 32-56 kJ mol-I •45 
1.2.2 IR SPECTROSCOPIC STUDIES OF CHROMONE-2-CARBOXYLATE ESTERS. 
Rapid internal rotations involving carbonyl systems may be studied using 
IR spectroscopy since IR carbonyl absorption bands are sensitive to 
conformational change and this detection method has a much shorter time-
scale than that required for NMR spectroscopic detection. In an IR 
study of solvent, substituent and temperature effects on rotational 
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isomerism in a series of chromone-2-carboxylate esters, Drews and Kaye51 
rationalised the observed doubling of the carboxylate carbonyl 
absorption bands in terms of a rotational equilibrium between 
syn- s- trans II and anti- s- trans I conformers (Scheme 22). The absence of 
splitting of the carboxylate carbonyl bands for the 3-methyl-, 
3-chloro-, and 3-bromochromone-2-carboxylate esters was rationalised in 
terms of unfavourable steric and dipolar interactions which disrupted 
the co-planarity of the chromone and carboxylate functions. 
0 0 
~ 
0 O .... R3 R' R' 
O .... R3 0 
anti-s- trans (I) syn-s- trans (II) 
SCHEME 22 
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1.3 BIOLOGICALLY ACTIVE CHROMONES 
1. 3.1 NATURALLY OCCURRING CHROMONES 
By 1975, the number of isolated naturally occurring chromones exceeded 
fifty five. 52 The present discussion, however. will be confined to a 
limited number of examples which illustrate their diversity of location, 
structure, and biological or pharmacological activity. 
Many natural chromones contain hydroxy, methyl and/or prenyl 
substituents. 53 Thus, eugenin 59, one of the simplest chromones, and 
eugenitin 60 are both constituents of the Javan wild clove E~enis 
csryophyllsts L. Thunbg., while peucenin 61 is found in the rhizome of 
the masterwort Imperstoris ostruthium and the South African sneezewood 
tree. 54 The halogenated hydroxychromone rupicolon 62 has been isolated 
from extracts of lichens, while siphulin 63, the only natural chromone 
carboxylic acid, occurs in a Scandinavian lichen, Siphuls ceretites. A 
OH 0 OH 0 
)~X~ -7 I I MeO ~ 0 Me 61 Me 59 (R .. H) 
60 (R ... Me) 
CI 0 OH 
HO 
Me Me HO OH 
OH COzH 63 
62 
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rare C-glycosylchromone, aloesin 64, has been identified in several 
species of bitter aloes. 55 Natural 3-methylchromones are also rare and 
hormothamnione 65, isolated by Gerwick et.a156•57 in small quantities 
from the marine cyanophyte Hormothamnion enteromorphoides or from the 
marine cryptophyte Chrysophaeum taylori, was the first reported 
styrylchromone. Hormothamnione is a potent cytotoxin to cancer cells in 
vitro and, although the mechanism for its cytotoxic activity has not 
been completely established, it appears to selectively inhibit RNA 
synthesis. 56 
OH 
0 MeO 
Me MeO OH 
OMe 
HO OH 
65 
64 
The natural furochromone, khellin 66,58.59 was isolated by Mustapha in 
1897 from the seeds and fruit of a Middle Eastern plant ~ Visnaga. 
Khellin induces relaxation of the bronchial musculature (anti-spasmodic 
activity) thereby alleviating the symptoms of bronchial asthma; a direct 
action on heart muscle causes vasodilation thus offering relief for 
angina pains. Khellin also exhibits lipid-altering, anti-
atherosclerotic activity60 and may thus provide a valuable therapy for 
reducing the risk of cardiovascular disease. Extracts of this plant 
have been used since ancient times for the treatment of colics, and more 
recently, in asthma therapy but unpleasant side effects, such as nausea 
and vomiting, have limited its clinical use. 
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The flavanoid, baicalein 67,51,59 a constituent of the dried radix of 
Scutellaria baicalensis Georg which was used in ancient Chinese medicine 
as a diuretic and anti-allergic drug, has been shown by Koda et al. to 
exhibit anti-allergic activity. 
OMe 0 OH 0 
HO 
OMe HO 
OMe 
66 67 
1.3.2 SYNTHETIC CHROMONE DERIVATIVES 
Some chromonecarboxamides have an effect on the central nervous system52 
(e.g. N,N-diethylchromone-2-carboxamide exhibits sedative and hypnotic 
activity) while analgesic properties are exhibited by several N-
arylamides of which the sulphonamide 68 was found to be the most potent. 
The amide 69 exibits anti-histaminic activity and N-arylchromone-3-
carboxamides 70 show anti-bacterial activity.52 Anti-inflammatory 
o 
CI~ 
UOJlCONH-o-SO,NH' 
68 
o 
~ ~~~ UO~CONH~S~ 
o 
roCONHR ~ I I o 
69 70 
activity is exhibited by the substituted chromone-2- or 3-carboxamides 
of which the flavone 71 was found to be the most potent. 63 Several 
chromonecarboxamides64 [e.g. substituted N-Ctetrazol-5-yl)chromone-2-
carboxamides 72] also exhibit anti-allergic activity and will be 
discussed in Section 1.3.3 (i). 
~co<~}-o 
UO~Ph 
71 
o 
R~ -UO~CONH 
72 N~NH 
\ I 
N=N 
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The biological properties of various chromone-2-carboxylic acids58 have 
been explored in the search for a khellin (66) replacement which is more 
soluble and which has improved muscle relaxing properties, but none of 
the unwanted side-effects of khellin. The search for a more specific 
treatment for bronchial asthma began in 1956 with the synthesis of the 
hydrophylic 2-carboxychromones by Cox et ai. 58 They established that 
these compounds exhibit anti-allergic activity rather than the anti-
spasmodic activity of khellin. However, since the duration of their 
prophylactic action was short, it was concluded that mono-chromone-2-
carboxylic acids were unlikely to be of any clinical use. Consequently, 
research was directed towards the synthesis of novel bischromones. 
The discovery of disodium cromoglycate (DSCG) 7358 in 1965 undoubtedly 
provided a major advance in the treatment and prophylaxis of bronchial 
asthma and other allergic diseases. 65 DSCG is widely used in asthma 
therapy66 under commercial names of Intal or Lomudal. 40 In 1967, 
Altouyan58 showed that DSCG exhibits anti-allergic activity. This 
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protective effect lasts several hours and long-term use of the drug can 
reduce the number and frequency of exacerbations in the clinical course 
of asthma. 66 Partly due to its size and the acidity of the two 
carboxylic acid groups, DSCG is poorly absorbed and is thus administered 
by inhalation as a fine powder or as an aqueous aerosol. 59 Many other 
anti-allergic compounds,67 such as ketotifen 74 and doxantrazole 75, have 
subsequently been developed in the search for an orally active successor 
to DSCG with an improved clinical profile. 59 By 1985, little success 
had been achieved and tranilast (N-5' ) 76, an orally active oxanilic 
acid derivative, was the only such drug to have been marketed. 59 
OH 
J 
/' CH 2CHCH 2, 
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A novel pyranoquinoline dicarboxylic acid, nedocromil sodium (Tilade®) 
77, has recently been used as an ant~-inflammatory, effective in the 
treatment of mild asthma.6~,69 It is also interesting to note that 
cromakalim BRL 34915, 78 is an effective bronchodilator. 70 ,ll The 
mechanism of this action involves the opening and activation of 
potassium channels in the cytosol of the smooth muscle cells. The 
potential of such potassium channel activators in asthma therapy is 
currently being investigated. 
o o ~O Ncm",OH I Me 
~ 0 Me 
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1.3 . 3 THE MODE OF ACTION OF ANTI-ALLERGIC CHROMONES 
( i) Structure-activity Relationships of Anti-allergic Chromones. 
The chemical structure of a drug determines its affinity for a specific 
receptor and hence the intrinsic activity of the drug. The correlation 
of the action of drugs with their chemical structure is an integral link 
in the analysis of drug action, and an exploitation of these 
relationships has often resulted in the development of better drugs. 72 
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Common structural features of anti-allergic compounds include 
(Figure 3.) 73 : 
(i) a planar system with extended v-bonding; 
(ii) a benzene ring; 
(iii) an attached oxygen or nitrogen atom; and 
(iv) an sp2-hybridised carbon atom (designated by the incomplete double 
bond) separating the heteroatom and the carboxylic acid, or its 
equivalent. 
Charge delocalisation and acidity may thus be important contributing 
features for significant activity. 
UxfyOH 
o 
X = 0 or NH 
FIGURE 3. Structural requirements for anti-allergic activity. 
Structure-activity studies40 of a number of bischromone DSCG analogues 
79 suggest that co-planarity of the two chromone rings is an important 
property as shown : 
(i) by the higher activity of the planar compound 80 and 
(ii) by the reduced potency of compounds (79; R = H) with a bridging 
alkylenedioxy chain [79; X = 5,5' -O(CH2)nOJ comprising more than 
six atoms or a single methylene bridging group (79; X = 6,6' -CH2) 
which, in either case, reduces co-planarity of the two nuclei. 
The presence of terminal oxygen atoms in the bridging chain is not 
essential for activity, and the position of attachment of the chromone 
rings to the bridging chain [79; X = OCH2CHOHCH20 or O(CH2}50] is 
unimportant, with the exception of the 8,8' positions which produce 
compounds with little or no activity. Introduction of alkoxy groups 
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generally maintains or enhances activity, although the disubstituted 
methoxyanalogue (79; R = 7,7' di-OMe, X=OCH2CHOHCH20) is less active 
than DSCG. 
79 [X = OCH2CHOHCH20; or 
X 5,5' 0(CH2)nO n = 2-6,8-10; or 
X = 6,6' (CH2)n n 1,3,5,6; or 
X = 6,6' 0, C=O, NH.) 
o o 
80 
Many mono-chromones have proven to be orally active, a result partly due 
to increased lipophilicity and decreased polarity.59 Proxicromil 81 
(FPL-57787)59 was, perhaps, the most promising orally active chromone in 
clinical trials but toxicity prevented further development. Chromone-3-
carboxylic acid 82 is inactive, perhaps due to the loss of acidity 
resulting from intra-molecular hydrogen bonding. Structure-activity 
OH 0 
H 
0" '0 
~o VloJ 
82 
81 
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studies of chromone-3-acrylic acids 83,61 in which intra-molecular 
hydrogen bonding between the carboxylic acid and the carbonyl oxygen is 
sterically impossible, have established that 
(i) only the trans isomers are active; 
(ii) introduction of an alkyl or alkoxy group at C-6 or C-8 leads to 
the greatest enhancement of activity; and 
(iii) activity is destroyed by moving the acrylic group to C-2, or by 
modifying it by introducing an a-substituent or saturating the 
double bond. 
o 
R 
83 
The carboxylic acid group of biologically active chromones has often 
been replaced by the 1H-tetrazole moiety. which exhibits comparable 
acidi ty74 (pKa ca. 3).75 Such replacement has often resulted in 
compounds with increased activity.64 Structure-activity studies74 of 3-
(lH-tetrazol-S-yl)chromone AA-344 (84;R = 6-Et), modelled on the anti-
allergic flavanoid baicalein (67) ,59 have established that : 
(i) the analogues (84; R = 6-Et, 6-Cl, 6,8-di-Me, 6-N02. and 6-0H) are 
all ca. 4-10 times more active then DSCG; and 
(ii) the parent compound is at least 2.S times as active as the 
isomeric 2-(lH-tetrazol-5-yl)chromone. 
o 
R 
84 
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The N-(tetrazol-5-yl)chromone-2-carboxamides 72 are ca. 80 times more 
active than DSCG with a longer duration of action75 and structure-
activity studies64 have established that : 
(i) a source of acidity near the pyran ring is desirable; 
(ii) the analogues (72; R = 7-0Me or 6-Me) are more potent than the 
parent compound; 
(iii) introduction of a C-3 chloro or methyl group lowers the activity, 
although a basic C-3 side chain [e.g. 3-NH(CH2)20H or 3-NHMe] 
retained high activity; and 
(iv) replacement of either hydrogen of the N-tetrazolylcarboxamido group 
by a methyl group resulted in loss of activity. 
o 
R~ 
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72 A N~ NH 
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( ii ) Mechanisms of Anti-asthmatic Drugs. 
The word asthma was derived from a Greek word which means "to pant. ,,76 
In 1984, Scanlon77 described bronchial asthma as "a generalised 
condition of the lung characterised by bronchospasm, mucosal edema" (an 
abnormal accummulation of fluid in the tissues causing puffiness), "and 
thick mucus that can lead to ventilatory insufficiency." A cyclic 
nucleotide imbalance in airway smooth muscle appears to modulate 
bronchospasm. Factors causing this imbalance include nervous system 
imbalances, diminished response(s) of beta-receptors located in the 
lung, or the effects of histamine. Involvement of the nervous system, 
including beta receptor malfunction, is referred to as the "intrinsic 
defect", while external influence, especially allergy, is referred to as 
the "extrinsic component" of bronchial asthma. 
When considering the mechanisms of asthma Salter78 wrote in 1868, " ... 
it is clear that the vice of asthma is not in the production of any 
special irritant, but in the irritability of the part irritated." 
Persson80 relates this to the present "difficulty in finding a mediator 
that is peculiar to asthma or a type of cell of the airway in asthma 
that is abnormally prone to release mediators." There is a resurging 
interest in the inflammation aspects of asthma68•80 with a major emphasis 
on : 
(i) plasma exudation; 
(ii) the nerve axon mechanism (a neural locus); 
(iii) primary effector cells (e.g. epithelial cells, mast 
cells, macrophages, eosinophils, neutrophils, and platelets); or 
(iv) mediators from these sources. 
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Most asthmatic patients suffer with allergy; the allergen may vary but 
common ones include pollen, feathers and house dust mites (Figure 4).81 
The allergic reaction, or so-called anaphylactic reaction, is mediated 
by the binding of IgE-antibodiesa to receptors on the surface of mast 
cells. 82 Mast cells are located within the muscular wall of the lower 
airways or bronchioles, among other places, and they contain granules 
which store a number of potent mediators, including histamine. 81 Mast 
cell activation is initiated by the bridging of two IgE-molecules by the 
inhaled allergen or antigen. 83 Activation of mast cells causes 
degranulation and the release of mediators into the surrounding smooth 
IgE-antibody 
Granules containing mediators 
I Allergen 
- >< ~ I Released mediators I 
Mast cell stabiliser 
Mast cell 
n + AntHofiammato'll 
iii 
18ronchoconstriction I >< I Inflammation 
Bronchodilator 
FIGURE 4. A schematic representation of the 'asthmatic response' 
in humans. 81 
a Anti-bodies are termed immunoglobins (abbrev. Ig) since they are 
globular proteins with an immune function. IgE-antibodies, one of the 
five classes of immunoglobins, are responsible for allergic reactions. 82 
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muscle. This initiates an inflammatory responsea which causes bronchial 
smooth muscle contraction, thereby inducing an asthmatic attack. M 
Consideration of these events suggests three possible mechanisms for an 
anti-asthmatic drug (Figure 4).81 (i) The drug should stabilise mast 
cells and prevent mediator release after allergen challenge. (ii) The 
drug should block the action of the released mediators thereby 
functioning as antagonists, or alternatively, it should act as an anti-
inflammatory. [Anti-inflammatory steroids introduced directly into the 
lung using inhalers are an accepted first-line treatment.] (iii) The 
drug should relax the contracted airway's smooth muscle thus functioning 
as a bronchodilator. 
Disodium cromolycate (DSCG 73) is generally believed to act on pulmonary 
mast cells to suppress the secretory response, thus stabilising the 
membrane. 77 It is used prophylactically as a preventative drug which 
over time preserves mast cell membrane integrity.77 DSCG has also been 
shown to block the late asthmatic response which occurs 3-4 hours after 
mast cell degranulation and lasts for 10 hours. This response may be 
caused by mast cell degranulation and increased inflammation, and 
subsequent non-allergic bronchial hyper-responsiveness lasting up to 10 
days can also occur. (This action explains the use of DSCG by seasonal 
asthmatics). Two additional actions include the ability to modulate 
a Inflammation85 is a defensive reaction of the tissues to injury or 
infection; the blood vessels in the effected area swell and allow their 
contents to ooze out. Many protective substances, including white blood 
cells, are released which destroy the foreign particles and bacteria. 
This process is often referred to as plasma exudation or edema. 
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bronchoconstrictor response to cooling and the inhibition of irritant 
receptors; DSCG is thus effective in exercise-induced asthma and in 
periods of high air pollution. 77 DSCG does not, however, relax 
bronchial smooth muscle or antagonise any of the known mediators, e.g. 
histamine. 65,72 Since the mode of action of DSCG appears to be limited 
to mast cell stabilisation and anti-inflammation, only these two aspects 
will be discussed shortly in detail. 
The prophylactic action of DSCG and consideration of the events outlined 
in Figure 4, both suggest the use of a combination of anti-asthmatic 
drugs, either including or excluding DSCG. Alternative asthma therapy 
involves the use of effective bronchodi1ators e.g. glucocorticoids, 
sympathomimetic drugs, and xanthines. 77 G1ucocorticoids (e.g. cortisol 
85) often reverse a difficult asthmatic condition when other medications 
fail and are thus, in a sense, the ultimate drug for bronchial asthma. 
Peak action only occurs 4-6 hours after administration and adverse side 
effects have limited their use to the difficu1t-to-control patients with 
chronic asthma. Glucocorticoids also function as anti-inflammatories. 
The fundamental structure of sympathomimetic drugs is derived from 
adrenaline, the body's natural bronchQ.dilator, and salbutamol 86 is the 
most widely used bronchodilator in the world. 81 Theophylline 87, a 
xanthene. is generally considered to be the first line of defence in the 
United States. 77 
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( iii) Mast Cell Activation and Histamine Secretion. 
The biochemical changes accompanying mast cell activation and the 
subsquent secretion of histamine were reviewed by Siraganian83 in 1983. 
These changes include : (i) receptor cross-linking; (ii) proteolytic 
enzyme activation; (iii) increased phospholipid methylation; (iv) 
increased intracellular cAMPa levels; (v) increased phosphorylation of 
membrane lipids; (vi) Ca2+ influx; (vii) phospholipase activation and 
release of arachidonic acid; (viii) protein phosphorylation; and 
finally, (ix) secretion of histamine. However, molecular events that 
terminate the secretory response are not well defined and an 
understanding of the mode of action of DSCG may provide some of the 
answers .86 In the following survey attention will be drawn to those 
molecular events implicated in the mode of action of DSCG, viz., the 
increased intracellular cAMP levels, protein phosophorylation, and 
calcium influx. The role of the mediators of mast cell secretion will 
then be discussed. 
Mast cell activation results in changes in intracellular cAMP levels. 83 
The generation of cAMP in localised intracellular compartments67 by the 
activation of specific adenylate cyclase complexes or the inhibition of 
particular phosphodiesterases (enzymes converting cAMP to AMP) may lead 
a Cyclic adenosine monophosphate (cAMP)87.88 is a nucleotide which, in 
the presence of a hormone at the cell membrane, breaks down adenosine 
triphosphate (ATP) to cAMP, which then acts in the cell to bring about a 
functional change. Additional functions include an involvement in 
controlling gene expression, in immune responses, and in nerve 
transmission. 
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to preferential activation of protein kinases and subsequent 
phosphorylation of proteins involved in either the activation or 
inhibition of the release mechanism. The former kinases may facilitate 
calcium influx and/or the mobilization of intracellular stores of 
calcium, the latter activating the calcium pumps leading to the 
extrusion of calcium from the cytosol. Selective phosphorylation of 
three proteins83 with molecular weights of 42 ODD, 59 ODD, and 68 000 
occurs rapidly after mast cell activation with Ca2+ ionophore. DSCG 
apparently enhances the selective phosphorylation of a molecular weight 
78 000 protein, thus terminating or inhibiting secretion. 
The role of Ca2+ in the secretory process was reviewed by Pearce89 in 
1982. Although the precise role of Ca2+ in histamine secretion is still 
unclear, several possibilities have been proposed. Mast cell secretion 
is triggered by an increase in the level of Ca2+ ions in the cytosol and 
this event links the activation to the secretion process. Ca2+ ions are 
obtained from the external environment or by the mobilization of 
intracellular or membranous stores. The former route may involve the 
binding of calcium ions to superficial membrane receptors. The 
polypeptide, calmodulin, has been proposed as a universal receptor for 
calcium and the major physiological effector for a wide range of 
cellular responses evoked by the cation. The disodium cromoglycate 
binding protein [discussed later in Section 1.3.3 (iv)] is a possible 
site of action for calcium channel antagonists. 90 Several receptor-
mediated changes in membrane metabolism have been implicated in the 
regulation of Ca2+ channels and Ca2+ mobilization, although their 
specific roles have not yet been determined. 
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Calcium influx into the mast cell also activates phospholipase A2' an 
enzyme which cleaves phosphatidylcholine to produce arachidonic acid. 83 
Released arachidonic acid is metabolised by either the cyclo-oxygenase 
or the lipoxygenase pathways~ The former pathway results in the 
production of prostaglandins and thromboxanes, while leucotrienes. 
commonly referred to as the slow reacting substance of anaphylaxis 
(SRS-A), are produced via the latter pathway. 
The final steps of secretion are regulated by the influx of calcium and 
changes in cAMP and cGMP,a while phosphorylation of proteins may be 
important at this stage. Aggregation of microtubules then occurs. 
allowing granules to open to the extracellular space. resulting in 
mediator release. 83 Important biogenetic substances or mediators 
released77 include vasoactive amines (e.g. leukotrienes and histamine), 
prostaglandins and thromboxanes. The leukotrienes, thromboxanes and 
some of the prostaglandins (PGF2 and PGD2) are potent 
bronchoconstrictors. However, some of the prostaglandins (PGE2 and 
PGI2) are bronchodilators. Other important mediators released include 
heparin, platelet activating factor (PAF), enzymes and chemotactic 
factors. 91 Triptic enzymes activate the kinogenase responsible for the 
release of bradykinin. an extremely potent vasoactive mediator. 
Chemotactic factors attract eosinophils which modulate the reactions 
consequent to mast cell activation by neutralising the effects of the 
released mediators. 
a Cyclic guanosine monophosphate (cGMP), a nucleotide with regulatory 
functions. 
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( i v) A Molecular Basis for the Mode of Action of Disodium Cromoglycate. 
An understanding of the mode of action of DSCG at a molecular level 
would not only facilitate the rational development of new and more 
potent anti-allergic drugs,92 but would also provide some of the answers 
to the molecular events that terminate the secretory response. 86 The 
pharmacological implications of DSCG action have, in fact, prompted 
extensive research, but still remain the subject of debate and 
controversy.66,68,93,94 
An initially proposed, clearly defined and novel mode of action for DSCG 
involves direct action on mast cells, thereby supressing the secretion 
process. This mechanism has received the most attention but is not 
directly involved in many aspects of asthma, e.g. exercise induced 
asthma or that induced by pollution. The drug exhibits additional anti-
inflammatory action, involving multiple sites of action65 ,93 and other 
additional cells. 94 In the following survey attention will be drawn to 
(a) mast cell stabilization and (b) the alternative modes of action of 
DSCG. 
( a) Mast cell stabilization. 
DSCG does not inhibit the binding of the IgE molecules or their 
interaction and crosslinking with specific antigens; it rather supresses 
the response to this reaction, although how it does so is uncertain. 72 
It has become evident that there are either two receptors for DSCG, or 
the receptor is multifunctional. 94 Three major explanations include 
(i) phosphodiesterase inhibition which affects cyclic nucleotide 
levels; 
(ii) the blocking of calcium channels; and 
(iii) the promotion of the phosphorylation of a single mast cell 
protein. 
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Initial studies indicated that DSCG inhibited cAMP phosphodiesterase67 
and, considering the importance of this nucleotide (cAMP) in the 
modulation of histamine secretion, seemed to thus provide an explanation 
for the drug's activity. Studies discrediting this activity established 
that, among other things, DSCG concentrations required to inhibit mast 
cell phosphodiesterase were considerably greater than those required to 
prevent secretion, and there was no correllation between secretion 
supression and phosphodiesterase inhibition in a variety of other anti-
allergic drugs. 
Foreman et al. 93 showed that the uptake of radioactive Ca2+ by, and 
histamine secretion of mast cells were both inhibited by DSCG in those 
cells activated by antigen or similar agonists; neither parameter was 
affected when the cells were activated by calcium ionophore A23187. It 
was thus argued that DSCG inhibited the opening of calcium channels 
since this was the only difference between the two processes. (Ca2+ 
ionophores89 are organic compounds which activate mast cells by 
complexing with Ca2+ and transfering the cation across the cell 
membrane, hence bypassing the receptor gating mechanism). Studies93 
contradicting this hypothesis have shown that (i) secretion is inhibited 
by DSCG in the absence of calcium and that DSCG is at least equipotent 
and generally more active under conditions of calcium deprivation. (ii) 
The drug also blocks the mobilization of internal stores and inhibits 
the secretion induced by a diversity of other ionophores. (iii) The 
uptake of radioactive Ca2+ may also be a consequence and not a cause of 
the release process since the isotope may possibly bind to new membrane 
sites which are revealed during the degranulation process. 
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Despite these problems, Pecht et sl. 95 have shown, using fluorescence 
microscopy, that the chromone binds to a specific binding protein, 
located on the mast cell membrane, which constitutes the Ca2+ channel 
and that it acts by blocking simulated Ca2+ fluxes. The drug was 
coupled or covalently conjugated to an insoluble support of fluorescent 
polyacrylamide and glutaraldehyde beads, which prevented the penetration 
of the drug into the cell without reducing its ability to inhibit 
secretion. This specific DSCG-binding protein was then isolated from 
rat basophil leukaemic cells using affinity chromatography.96 IgE 
mediated challenge of varients of this cell-line lacking in the binding-
protein did not result in Ca2+ influx or degranulation; however, the 
action of Ca2+ ionophore A 23187 lead to histamine secretion, which 
indicated that the secretory process distal to Ca2+ influx was 
uneffected. These two findings suggested the involvement of the DSCG-
binding protein in transmembrane calcium influx. The responsitivity to 
immunologic challenge was restored with the implantation of binding 
proteins into the cells. Moreover. exogenous DSCG blocked the Ca2+ 
influx induced by monoclonal antibodies to the binding protein in 
synthetic planar lipid bilayers. 
The relevance of this work to the mode of action of DSCG93 has been 
questioned since interaction of the drug and binding protein is 
absolutely Ca2+ dependent and contradicts the enhanced inhibitory effect 
of the drug in the absence of Ca2+. In addition, rat basophil leukaemic 
cells are considered to be resistant to the inhibitory effects of DCSG. 
It was concluded that the work needed to be confirmed and extended to 
cells fully active to the drug, since this would prevent the isolation 
of the binding protein under conditions different from those required to 
demonstrate the drugs functional activity. Other agents, e.g. 
doxantrazole, claimed to function by inhibition of Ca2+ gating, 
46 
presumably could not interact with the binding protein, unless it showed 
remarkable specificity. 
The phosphorylation of a specific protein (mol. wt. 78 000) occurs in 
the final stages of secretion and has been associated with the natural 
termination of the process. 93 DSCG induces the phosphorylation of this 
protein and may thus have the unique action of stimulating an endogenous 
control mechanism. The detailed basis for this effect remains obscure 
but could involve an interaction with protein kinase C, as suggested by 
Sagi-Eisenberg. 94 This interaction was proposed since protein kinase C 
requires Ca2+ and phosphatidylserine for optimum activity, and DSCG 
binding is associated with Ca2+, phosphatidylserine and a membrane 
protein. The mechanism whereby phosphorylation modulates secretion 
remains open and could involve an effect on Ca2+ gating, i.e. they may 
be regulated by the degree of their phosphorylation, which is controlled 
by protein kinase C. However, Foreman et al. 93 demonstrated that the 
Ca2+ gates remain open for a considerable period after the termination 
of secretion. 
Sagi-Eisenberg94 also demonstrated that this protein kinase C has an 
additional role in the activation of secretion and involves the 
mechanism of secretion distal to Ca2+ influx. Additional interaction of 
DSCG with this protein kinase C would then account for its dual 
inhibition action, although this hypothesis requires verification. They 
thus proposed the existence of two forms of protein kinase C, one 
responsible for Ca2+ regulation, the other involved in the activation of 
secretion. Activation of protein kinase C by itself was insufficient to 
cause secretion, and they concluded that "receptor aggregation elicits 
an aditional, as yet unknown, signal, which together with kinase C 
activation, yields a cellular response." Inhibition activity of DSCG 
thus requires the interaction with kinase C which (i) promotes 
phosphorylation in Ca2+ gating, and (ii) inhibits the phosphorylation 
that stimulates secretion. 
( b ) Alternative modes of action of DSCG. 
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In 1985, Pearce93 concluded, however, that the mode of action of DSCG 
was still an enigma since not all the effects of DSCG can be explained 
by its mast cell stabilizing activi ty55 and premedication with the drug 
inhibits bronchospasm produced by a diversity of stimuli. including 
histamine, cold air, aspirin, fog, and exercise, thus implicating at 
least two different receptors in the lung for the drug. Pretreatment 
with the drug, in a variety of models of mediator release, has been 
shown to abolish the inhibitory effect of subsequent doses i.e. DSCG 
exhibits tachyphylaxis92 which completely contrasts with its regular and 
prophylactic clinical use in asthma therapy. The drug also shows a high 
degree of tissue and species selectivity in its action. 55 Many other 
novel anti-allergic drugs are far more potent than DSCG in mast cell-
mediated animal models but have demonstrated little or no efficacy when 
clinically tested. 97 A more detailed mode of action is thus required. 65 
In 1987 Persson98 reviewed three alternative modes of action for DSCG 
which include : 
(i) an anti-plasma leakage effect; 
(ii) inhibition of an axon reflex mechanism (a neural locus effect); 
and 
(iii) PAF-acethera inhibition. 
a Platelet activating factor, an ether-linked phospholipid 
(abbrev. PAF-acether).M 
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DSCG is now also thought to affect a variety of inflammatory cells, such 
as platelets and macrophages. 
In inflamed airways, plasma molecules may readily pass through a 
microvascular or epithelial barrier. 80,98 Plasma exudation in the lumen 
and airway wall from tracheobronchial microvessels is regulated by the 
venular endothelium. This process is induced by many cellular and 
humoral mediators including bronchoconstrictory mediators (amines, 
peptides, lipid products, e.g. PAF-acether, etc.). Exudation in the 
airway wall contributes to bronchial hyper-responsiveness and damage of 
airway epithelium, while activation of potent mediators and 
chemoattractants for effector cells may amplify the inflammatory 
process. DSCG has a potent ability to reduce and normalise mediator-
induced plasma leakage or exudation. It is also "effective against 
agents such as histamine that increase endothelial-epithelial 
permeability to macromolecules by direct action without the involvement 
of neurogenic or mast cell mechanisms." 
Asthma provoked by non pharmacological stimulus such as exercise 
(inhaling dry air) may be associated with plasma exudation in asthmatic 
airways, the characteristic feature of which, may be vascular 
leakiness. 98 In inflamed airways it is vessel fluid that humidifies 
incoming air whereas other sources are used under normal conditions. 
Thus the effectiveness of DSCG in exercise-induced asthma could be 
attributed to its anti-plasma-leakage effect. 
Damage of the airway epithelium exposes C-fibre afferent nerve 
endings,79 and the stimulation of these superficial nerve endings by 
inflammatory mediators (e.g. bradykinin) may result in an axon (local) 
reflex and the release of sensory neuropeptides which induce 
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bronchoconstriction, edema, plasma exudation, mucus hypersecretion, and 
possible inflammatory cell infiltration and secretion. DSCG inhibits 
bronchial C-fibre reflex activity98 and preliminary studies show that it 
reduces bradykinin-induced bronchoconstriction. However this has only 
been shown in animal models and requires further elucidation. Several 
factors opposing a neural locus for the drug's effect have also been 
presented. 
The ether-linked phospholipid, PAF-acether,M is released from a number 
of inflammatory cells in the lung (e.g. alveolar macrophages) and 
induces plasma exudation and the activation of platelets. Both the 
production and action of PAF-acether could be inhibited by DSCG since it 
also inhibits the late response to PAF-acether in human skin and the IgE 
activation of human macrophages. 99 Recent work, however, has not 
provided confirmation of these findings. 98 
The involvement of platlets in inflammation and allergen-induced asthma 
was reviewed by Page84 in 1988. Platelets are the smallest blood 
element and, despite being devoid of a nucleus, they still possess many 
features of classical inflammatory cells. Their biological 'activities 
include chemotaxis, i.e. the release of a variety of mediators which 
augment inflammatory cell recruitment. Furthermore, they possess IgE 
receptors and their activation. by PAF-acether, results in the 
generation of free radical species. Platelet aggregation and platelet 
activation have different pharmacological profiles and this distinction 
is important in the search for new anti-allergic drugs, e.g. DSCG can 
inhibit IgE dependent release of free radicals, but has no effect on 
platelet aggregation. 
1.4 AIMS OF THE INVESTIGATION 
The preceding introduction illustrates the various properties of the 
chromone nucleus. preparative methods used in chromone synthesis. and 
the susceptibility of chromones to C-2 nucleophilic attack. with 
consequent ring opening. by nitrogen and oxygen nucleophiles 
(Section 1.1). The conformational analysis of amides and chromone-2-
carboxylate esters. using variable temperature dynamic NMR and IR 
spectroscopic techniques respectively. were also presented 
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(Section 1.2). Furthermore, the well established potential of chromone 
systems in asthma therapy has been discussed. with particular emphasis 
on two chromone derivatives, viz., the naturally occuring furochromone, 
khellin 66 (Section 1.3.1), and the widely used anti-allergic drug 
disodium cromoglycate (DSCG) 73 (Section 1.3.2). 'While 
chromonecarboxamides exhibit a wide diversity of biological activities, 
their anti-allergic activity [e.g exhibited by N-(tetrazol-5-
yl)chromone-2-carboxamides 72] is of particular interest 
(Section 1.3.2). The essential structural features apparently required 
for anti-allergic activity include a planar conformation with extended 
~-bonding and a source of acidity near the heteroatom attached to the 
benzene ring. Thus, biological activity is enhanced in rigid planar 
structures and inhibited by a loss of acidity, while electronic effects 
of ring substituents and the effect of their positions appear to vary 
according to the nature of the parent structure [Section 1.3.3 (i)]. In 
asthma therapy. DSCG stabilises mast cells in the bronchial mucosa, 
thereby preventing the secretion of histamine and other inflammatory 
mediators. Furthermore, this action may be associated with the binding 
of DSCG to a specific protein located on the mast cell membrane [Section 
1.3.3 (iv»). 
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In anti-allergic chromones, biological activity is thus influenced by 
conformation, acidity, steric effects, and substituent effeGts. 
Consequently, similar electronic and steric effects on the conformation 
and acidity in chromone systems with medicinal potential were 
investigated. The mode of action of DSCG may involve an in vivo 
interaction with various biological amines or proteins. Furthermore, 
since ring-opening reactions of chomones may well be implicated in 
molecular-level chromone pharmacology, the ring-opening of variously 
substituted chromone-2-carboxamides with dimethylamine was also 
investigated, and extended to include DSCG. The investigation thus 
involved the following : 
(i) The synthesis of conformationally-mobile, substituted, symmetrical 
chromone-2-carboxamides with potential anti-allergic activity. 
(ii) The conformational analysis of these chromone-2-carboxamides using 
IH dynamic NMR spectroscopic and molecular graphics techniques. 
(iii) A structural analysis of the ring-opened products of reactions of 
N,N-dimethylchromone-2-carboxamides with dimethylamine. 
(iv) An extension of these studies to DSCG. 
(v) A kinetic study of substituent effects on the ring-opening 
reactions and a determination of the mechanism. 
(vi) A potentiometric study of substituent effects on the dissociation 
constants of substituted chromone-2-carboxylic acids. 
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2. DISCUSSION 
2.1 PREPARATION OF CHROMONE DERIVATIVES 
An investigation of conformation in chromone-2-carboxamides III required 
the preparation of two major intermediates, viz., the substituted 
o-hydroxyacetophenones I and chromone-2-carboxylic acids II, while 
structural and kinetic studies required the preparation of acrylamides 
TV from the respective chromone-2-carboxamides III (Scheme 23 p.53). 
Thus, the o-hydroxyacetophenones 93-98, required for the synthesis of 
the chromone-2-carboxylic acids 112-118, were prepared from the 
corresponding phenyl acetates 88-92, which, in turn, were prepared from 
m-phenols or p-chlorophenol; or in the case of the methoxy analogue 93, 
via methylation of resacetophenone (Schemes 24 and 25 p.54 and p.55). 
The chromone-2-carboxylic acids 112-118 were prepared from the respective 
o-hydroxyacetophenones 93-98 via, in some cases, chromone-2-carboxylate 
esters 110 and 111 (Schemes 26 and 27 p.56). 3-Methylchromone-2-
carboxylic acid 120 was similarly prepared from o-hydroxypropiophenone 
via the ethyl carboxylate ester 119 (Scheme 28 p.57). The chromone-2-
carboxamides 129-139 were prepared from the corresponding chromone-2-
carboxylic acids 112-117 and 120 via the chromone-2-carbonyl chloride 
intermediates 121-127 (Scheme 29 p.61). The acrylamides 140,142-151, and 
153 were prepared via amine-mediated ring-opening of the chromone-2-
carboxamides 129-134 (Schemes 30-33 p.69 and p.73) or, in some cases (140 
and 141), of chromone-2-carbonyl chloride 121 (Scheme 29 p.61). 
SCHEME 23 
i,ii 
,. 
o 
roR2 ?" I I R' ~ 0 COR~ 
III 
R' 
IV 
Reagents: i) NaOEt - EtOH, (C02Et)2' J1, 
ii) HCl - AcOH (1: 1). J1 ; 
iii) SOC12 - DMF - C1CH2CH2Cl. J1; 
iv) Me2NH2Cl - pyridine. OOC or 
R3H - aq.NaHC03 or 
R3H - pyridine; 
v) Ethanolic Me2NH - EtOH. 350C. 
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2 • 1 ( i) • Preparation of o-hydroxyacetophenones. 
2-Hydroxy-4-methoxyacetophenone 93 was prepared via methylation of 
resacetophenone (Scheme 24).100 The series of o-hydroxyacetophenones 
94-97 were prepared using standard literature procedures101 involving 
Fries rearrangement102 of the corresponding phenyl acetates 88-91, 
generated, in turn, by acetylation of the respective m-phenols 
(Scheme 24), as described by Bryan et al. I03 The acetates were heated 
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with aluminium trichloride at high temperatures (ca. 175°C) which favour 
o-substitution.101 ,102 The Fries rearrangement of 3-nitrophenylacetate 
88, using nitrobenzene as a solvent,101,104 afforded moderate yields (ca. 
40%) of 2-hydroxy-4-nitroacetophenone 94. Extended steam distillation 
was necessary, since the initial fractions were predominantly solvent. 
o 
~ HO~OH 
N02' F, CI, Br. 1 iii 
ii 
RI 
OMe 93 
88 N02 94 
89 F 95 
90 CI 96 
91 Br 97 
SCHEME 24 
Reagents: i) 
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5-Chloro-2-hydroxyacetophenone 98 was similarly prepared from 
4-chlorophenyl acetate 92 which, in turn, was prepared from 
4-chlorophenol (Scheme 25) • 
0 CI'0 i CI'0 0 H CI'Q: 
• ~ I O~ • ~ OH ~ OH 
92 98 
SCHEME 25 
Reagents: i) Aq.NaOH - AC20, OoC; ii) AlCl3' 1::.. 
2 • 2 (ii). Preparation of chromone-2-carboxylate esters and chromone-2-
carboxylic acids. 
The chromone-2-carboxylic acids 112-117 and 120 (Schemes 26 and 28) were 
required for the preparation of the chromone-2-carboxamides 129-139, 
while, in an investigation of the acidity in the chromone-2-carboxylic 
acids 112-118 (Schemes 26 and 27), the C-7 and 6-chloro ring substituents 
CR1) were chosen to illustrate substituent effects on acidity. The 
chromone-2-carboxylate esters 110 and 111 and chromone-2-carboxylic acids 
112-117 were prepared via Claisen acylation of the o-hydroxyacetophenones 
93-97 with diethyl oxalate in the presence of sodium ethoxide, as 
described by Fitton and Smalley,105 and Bryan et a1. 103 (Scheme 26). 
Cyclization of the resultant dike to esters using traces of hydrochloric 
acid in acetic acid afforded the chromone-2-carboxylate esters 110 and 
111,106,107 while chromone-2-carboxylic acids 112-117 were obtained by 
using a mixture (1:1) of hydrochloric acid and acetic acid. In both 
approaches, two reaction intermediates were generally detected by IH NMR 
spectroscopy, viz., a dike tone and a 2-hydroxychromanone. The chemical 
shifts of the methylene protons of the dike tone occur at low field 
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0 OMe 93 
« 
N02 94 
F 95 
R':::::-'" OH CI 96 
0 
Rl ro iii H 110 ~ R':::::-'" 0 COzEt 
N0 2 111 
Sr 97 
it 
o o 
ii 
+ 
Rl 
H 99 (100%)a 112 
OMe 100 (68%)a 105 (32%)a 113 
N02 101 (78%)a 106 (22%)a 114 
F 102 (62%)a 107 (38%)a 115 
CI 103 (37%)a 108 (63%)a 116 
Sr 104 (45%)a 109 (55% )a 117 
SCHEME 26 
Reagents: i) NaOEt - EtOH, (C02Et)2; ii) HCI - AcOH (1:1), a; 
iii) HCI(trace) - AcOH, a (Rl = H, N02); 
iv) H2S04 - AcOH, a or HBr - AcOH (45%), a (Rl = H, N02). 
o 
CI~ 
U OH 
98 
SCHEME 27 
i,!! 
.. 
o 
CI~ 
lJloJlCOzH 
118 
Reagents: i) NaOEt - EtOH, (C02Et)2; ii) HCI - AcOH (1:1), a. 
a Calculated from IH spectrum of crude intermediate mixtures. 
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(ca. 7.1 ppm), while the diastereotopic (C-3) methylene protons of the 
2-hydroxychromanone appear as a doublet of doublets at higher field 
(ca. 2.9 and 3.3 ppm). In the synthesis of chromone-2-carboxylic 
acid 112, only the dike tone intermediate 99 was formed, while in the 
synthesis of the substituted chromones 111, 113 and 115-117, mixtures of 
the corresponding intermediates were obtained. In some cases the 
dike tone intermediates 100-102 predominated, while in others, the 
2-hydroxychromanones 108-109 were the major isomers (Scheme 26). In all 
cases the crude intermediate mixtures were used without further 
purification. 
Chromone-2-carboxylic acid 112 was alternately prepared by acid 
hydrolysis of the ethyl carboxylate ester 110. 107 7-Nitrochromone-2-
carboxylic acid 114 was similarly prepared from the carboxylate ester 111 
(Scheme 26) using sulphuric acid and acetic acid,107 since the use of 
45% hydrobromic acid in acetic acid following the literature 
procedure106 gave the acid in low yield (ca. 33%). 6-Chlorochromone-2-
carboxylic acid 118 was prepared via Claisen acylation of 5-chloro-2-
hydroxyacetophenone 98 (Scheme 27 p.56).103 3-Methylchromone-2-
carboxylic acid 120 was prepared by acid hydrolysis of the carboxylate 
ester 119, which in turn, was prepared by Claisen acylation of 
o-hydroxypropiophenone and diethyl oxalate with sodium hydride 
(Scheme 28) .107 
o 
~Et ~OH 
SCHEME 28 
i,U 
,. 
o 
~Me 
UOJlC02Et 
119 
iii 
o 
~Me 
UOJlC02H 
120 
Reagents: i) NaH, (COzEt)2, EtOZ; ii) H+, A; iii) H+, A. 
Repeatedrecrystallisation of the acids did not improve the melting 
points which, in some cases, were well below the literature values. 
Other methods, such as sublimation and extraction with ethyl acetate, 
were used in attempts to obtain analytically pure samples. 
The 1H chemical shifts of the chromone-2-carboxylic acids and 
carboxylate esters were assigned using reported values ,51,108 while IH 
and I3C signals of the fluoro analogue 115 were assigned using 1H_F and 
13C_F coupling constantsI09 (Figure 5). The 1H NMR spectra of the 
58 
chromone-2-carboxylic acids and carboxylate esters are characterised by 
the vinyl proton (3-H) singlet at ca. 7.00 ppm or 7.15 ppm respectively 
(Table 1). C-7 substituents produce small variations in the (3-H) 
chemical shift, while changing the chloro substituent position did not 
affect the (3-H) chemical shift, as illustrated in Table 1. The IR 
carbonyl absorption bands (ca. 1740 em-I) of the chromone-2-carboxylic 
acids and carboxylate esters are well separated from the ketone carbonyl 
absorption bands occuring at ca. 1650 em-I. 
Table 1. Selected spectral data for chromone-2-carboxylic 
acids and chromone-2-carboxylate esters. 
Compound 3-H CO.OH CO Compound 3-H CO.OR CO 
Acid (ppm) (em-I) (em-I) Ester (ppm) (em-I) (em-I) 
112 7.00 1740 1630 23 7.15 1740 1650 
113 6.90 1735 1625 
114 7.20 1730 1640 24 7.25 1745 1660 
115 6.84 1740 1630 
116 7.00 1710 1650 7.09 1740 1655 
117 7.00 1720 1630 
118 7.00 1735 1630 
120 2.30a 1730 1615 31 2.35a 1730 1645 
a (3-Me) IH chemical shift. 
N ~ .., N .., 0'1 0'1 N .... ~ ...... .... 0'1 .., .... .., .... ~ ~ N 0 c:c 
'" .... 
N ~ ......... c:c'" ..... .., ~ .., .... c:c c:c 
'" 
~ ~ .... ~ ~ '" 0'10'1 ::z:: .., N N N ........ .... 0'1 0'1 0'1 C:CC:C0'l ........ .... .... .... .... .... .... 
I I V I Y ~I V 
C-3 
\ 
3JCF 11 Hz ZJCF 26 Hz COzH 
ZJCF 23 Hz C-8 8 1 C-5 \ \ C-6 
" I 
IJCF 253 Hz 
C-4 C-7 COzB / \ /\ 3JCF 14 Hz I C-4a ~ C-8a I ..... C-2 
\ 
~I I 
.-.--., '~ ", , , ", "'" , I ", I I I ,~ 
PS I'll !SS :tta !SS :50 :45 :'11 !5; 130 12S 1211 !IS 1111 !IlS 
PPM 
FIGURE 5. 75 MHz 13c spectrum of 7-fluorochromone-2-carboxylic acid 115. 
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2.1 (iii). Preparation of chromone-2-carboxamides. 
An NMR study of rotational isomerism in the chromone-2-carboxamides 
129-138 (Scheme 29) required the synthesis of a range of substituted 
N,N-dialkyl amides; the ring and N-alkyl substituents were chosen to 
illustrate the influence of electronic and steric effects on rotational 
barriers. Symmetrically substituted amides were chosen to simplify 
interpretation of the dynamic NMR spectra. The chromone-2-carboxamides 
129-139 were prepared from the corresponding chromone-2-carbonyl 
chlorides 121-127 generated, in turn, from the respective chromone-2-
carboxylic acids 112-117 and 120 using thionyl chloride (Scheme 29).64 In 
all cases, yields of the carboxamides were calculated from the 
corresponding carboxylic acids (Table 2). The crude chromone-2-carbonyl 
chlorides were reacted, following a literature procedure,54 with one 
molar equivalent of primary or secondary amine in aqueous sodium 
bicarbonate, or in pyridine. An equimolar quantity of amine was used, 
since C-2 nucleophilic attack by excess amine with consequent ring-
opening afforded acrylamides, e.g. reaction of chromone-2-carbonyl 
chloride 121 with excess aqueous dimethylamine afforded the acrylamide 
140. It is interesting to note that in related studies, Jerzmanowska 
and Kostka17 have reported the ammonolysis of chromone-2-carboxylate 
esters using one molar equivalent of amine; while ring-opening of 
chromone-2-carboxylate esters with two molar equivalents of amine, and 
subsequent cyclisation of the resulting acrylamides (e.g. 140), afforded 
chromone-2-carboxamides (e.g. 129). The analogous preparation of 
N,N-dimethylchromone-2-carboxamide 129 via ammonolysis of the ethyl 
carboxylate ester 110 with one molar equivalent of ethanolic 
dimethylamine in ethanol was unsuccessful. 
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Rl R2 RI R2 R3 
112 H H 121 H H NMe2 129 
113 OMe H 122 OMe H NMe2 130 
114 N0 2 H 123 N02 H NMe2 131 
115 F H 124 F H NMe2 132 
116 CI H 125 CI H NMe2 133 
117 Sr H 126 Sr H NMe2 134 
120 H Me 127 H Me NMe2 135 
H H NPri2 136 
H H {) 137 
H H NJ 138 
H H NH2 139 
SCHEME 29 
Reagents: i) SOC12 - DMF - ClCH2CH2Cl, fl; 
ii) Me2NH2Cl (128) - pyridine, DoC, or 
R3H - aq.NaHC03, or 
R3H - pyridine; 
iii) R3H (2 Molar eq.) 
- H20 (RI = R2 = H); 
iv) Ethanolic Me2NH - EtOH (RI = R2 = H); 
v) Ethanolic Me2NH - pyridine (RI = R2 = H). 
TABLE 2. Preparation of chromone-2-carboxamides 129-138. 
129 H H NMe2 
130 OMe H NMe2 
131 N02 H NMe2 
132 F H NMe2 
133 Cl H NMe2 
134 Br H NMe2 
135 H Me NMe2 
136 H H NPri2 
137 H H {) 
138 H H NJ 
Anhydrous reactions Aqueous Reactions 
Crude Chromo 
Yielda Yieldb 
(%) (%) 
76 62 
92 83 
68 66 
76 64 
80 72 
96 77 
84 71 
-
f 40 
_f 75 
Crude Chromo 
Yielda Yieldb 
(%) (%) 
109 5h 
54 43 
61 41 
32 21 
52 24 
6 
22 
Melting 
Point 
115-116d 
120-122c 
152-153c 
144-146c 
146-147c 
143-145c 
74-76c 
95-96c 
103-105c 
66-67e 
a Overall yield from the corresponding acid. material essentially clean by IH NMR spectroscopy. 
b Overall yield from corresponding acid after flash chromatography. c New compound with 
satisfactory spectroscopic analyses. d Lit.17 115-116DC. e Lit.17 90.5-92°C. f Crude oil. 
g Recrystallised yield. h Flash chromatography of crude motherliquors. i Crude mixture of 
acid and amide. 
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The N,N-dimethylchromone-2-carboxamides 129 and 132-135 were initially 
prepared in variable yields (15-61%; Table 2 p.62) from the chromone-2-
carbonyl chlorides 121 and 124-127 using equimolar quantities of aqueous 
dimethylamine (40% w/w) , and applying the procedure reported by Ellis 
et al. 64 [Low yields were also obtained in the preparation of chromone-
2-carboxamides 136 and 137 in aqeuous media (Table 2).] Such low yields 
may be attributed to factors such as the insolubility of both starting 
materials and products in aqueous media and the possible hydrolysis of 
the chromone-2-carbonyl chloride intermediates. The synthesis of 
chromone-2-carboxamide 138 in higher yield (75%) using dry pyridine as 
solvent illustrated the advantages of using anhydrous conditions, and 
this approach was consequently explored for the synthesis of the 
N,N-dimethylchromone-2-carboxamides 129-135. 110 However, the use of 
ethanolic dimethylamine (33% w/w) afforded a mixture (1:2) of the 
carboxamide 129, in low yield (ca. 28%), and the corresponding ethyl 
carboxylate ester 110. The use of pure dimethylamine was not considered 
a viable proposition in view of its volatility (b.p. 7°C), which 
complicates both handling and measuring of the compressed liquid at room 
temperature. [An alternative procedure which does not require the "use 
of the somewhat objectionable dimethylamine", has been reported by 
Coppinger. lll This procedure involves the reaction of an acid chloride 
or anhydride in N,N-dimethylformamide at high temperatures (150°C) to 
afford N,N-dimethylcarboxamides.] 
The use of dimethylammonium chloride 128 in anhydrous pyridine at OOC, 
eliminated the problems associated with the use of aqueous/ethanolic or 
neat dimethylamine, and afforded the required N,N-dimethylchromone-2-
carboxamides 129-135 in high yield (68-98%; Table 2).110 Various 
quantities of amine hydrochloride were used in the preparation of the 
unsubstituted analogue 129, and optimum yields were obtained using two 
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molar equivalents of the amine hydrochloride. Free dimethylamine is 
thus generated in situ via neutralisation with pyridine, the reaction 
solvent. Furthermore, acyl substitutionl12 is enhanced by the formation 
of an acylammonium salt,l13 via nucleophilic attack of pyridine on the 
carbonyl chloride intermediate, and the hydrochloric acid produced is 
neutralised by pyridine. [Ammonium salts have previously been used in 
the reported acid catalysed ammonolysis of ethyl benzoate;114 the 
acylation of amines by carboxamides;115 and the Schotten-Baumann 
acylationl16 of l,3,5-tris(aminomethyl)benzene trihydrochloride. 117 ) 
Chromone-2-carboxamide 139 was prepared from the carbonyl chloride 121 
using a large excess of aqueous ammonia, or two molar equivalents of 
ammonium chloride in pyridine; the latter preparation represents an 
extension of the use of ammonium salts in the synthesis of chromone-2-
carboxamides. However, in both preparations, impurities were detected 
in the IH and 13C NMR spectra. 
The IH NMR chemical shifts of the chromone-2-carboxamides 129-139 were 
assigned using the literature values for chromone,ll and correlation 
data from COSY experiments. Non-quaternary 13C chemical shifts were 
assigned from HETCOR experiments (Figure 6), while the benzenoid signals 
were also confirmed by calculation using correlation tables109 and, in 
the case of the fluoro-analogue 132, using 13C_F coupling constants109 
(Figure 7). In general, the C-5 and C-6 13C chemical shifts are too 
similar to assign by calculation (in the case of the 
N,N-dimethylchromone-2-carboxamide 129 these signals actually coincide). 
The quaternary carbons, C-4a and C-8a, and the ketone carbonyl carbon 
(C-4) signals correlate with reported values for chromone,ll while C-2 
chemical shifts were assigned by comparison with reported values of the 
corresponding chromone-2-carboxylic acids and carboxylate esters. 51 ,108 
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The IH NMR spectra of chromone-2-carboxamides 129-139 are characterised 
by the vinyl proton (3-H) singlet at ca. 6.45 ppm. The observed 
splitting of the N-a1ky1 signals at ambient temperature in all the 13C 
NMR spectra and, with the exception of the N,N-dimethy1chromone-2-
carboxamides 129,132 and 133 in all the ambient IH NMR spectra, reflects 
slow site-exchange of the N-a1ky1 substituents. The C-7 substituents 
produce wide variations in the C-7 13C chemical shifts relative to the 
parent system 129, as illustrated in Table 3. This effect gradually 
decreases with distance from C-7, and produces small chemical shift 
variations of the ~-pyrone carbons, particularly the remote C-2. The 
largest variations were generally due to 7-methoxy-, 7-nitro-, and 
7-f1uoro- substitue~ts. Variation of the 7-substituent also effected 
small variations in the vinyl (3-H) IH chemical shifts. In the IR 
spectra of the chromone-2-carboxamides 129-139, the ketone carbonyl 
absorption band occurs in the typical chromone carbonyl region 
(ca. 1650 cm-I ) , and the overlapping of the amide carbonyl absorption 
band in this region is attributable to de10ca1isation of the nitrogen 
lone-pair, which increases the single-bond character of the amide 
carbonyl. 
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Table 3. Comparative 1H and 13C NMR data for the 
N.N-dimethylchromone-2-carboxamides 129-134. 
13C Nucleus 8 129 ~8a 
(ppm) (ppm) 
CON 162.27 0.94 
C-2 158.20 1.08 
C-3 111.58 0.83 
C-4 177.42 1.61 
C-4a 124.20 6.15 
C-5 125.73 3.66 
C-6 125.73 11.33 
C-7 134.25 31.41 
C-8 118.13 17.74 
C-8a 155.66 1.77 
3_Hb 6.45 0.16 
a Maximum variation from compound 129. 
b IH nucleus. 
2.1 (i v) • Preparation of 2-amino-3-{2-hydroxybenzoyl)acrylamides. 
A prerequisite for the proposed kinetic study of the dimethylamine-
mediated ring-opening of the chromone-2-carboxamides 129-133 was the 
unambiguous structural analysis of the N,N-dimethylaminoacrylamide 
68 
products 140 and 142-146. The synthesis of these compounds is 
illustrated in Scheme 30 (p.69). Ring substituents (Rl) were chosen to 
illustrate electronic effects on the reaction rates. which. in turn. 
were used to determine the reaction mechanism. The N,N-dimethyl-2-
pyrrolidinoacrylamide 151 (Scheme 32 p.72) was prepared to facilitate 
assignment of the N-methyl NMR signals of the substituted 
N.N-dimethylacrylamides 140.142-150. and 153. The acrylamide 153 was 
prepared in order to show the interaction of N.N-dimethylchromone-2-
carboxamide 129 with glycine (Scheme 33 p.72). The acrylamides 140. 142-151 
and 153 were generally prepared via amine-mediated ring-opening of the 
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corresponding chromone-2-carboxamides (129-134) in ethanol at 35°C, or, 
in some cases, at ambient temperature (Schemes 30-33). The acrylamides 
140 and 141 were obtained by reacting the chromone-2-carbonyl chloride 
121 with two molar equivalents of secondary amine in water 
(Scheme 29 p.61). 
Isolation of the substituted N-methylaminoacrylamides (147-150; 
Scheme 30), as minor products in the preparation of the substituted 
N,N-dimethylaminoacrylamides 143-146. is attributed to contamination of 
the ethanolic dimethylamine (25% w/w) with traces of methylamine. [GLC 
analysis of ethanolic dimethylamine (25% w/w) showed an additional peak 
with a retention time corresponding to ethanolic methylamine (5% w/w).) 
0 ro i 
R' ~ 0 CON(CHJh 
Rl 
H 129 
OMe 130 
N0 2 131 
F 132 
CI 133 
Sr 134 
SCHEME 30 
~ 
R' 
140 
142 
143 
144 
145 
146 
+ 
147 
148 
149 
150 
Reagents: i) Ethanolic Me2NH - EtOH, 35°C (130-134), or rt (129). 
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The bromo-analogue 150 was also prepared using ethano1ic methylamine 
(Scheme 31 p.72), thus providing an alternative preparation and evidence 
for the characterisation of the N-methy1aminoacry1amides 147-150. The 
acrylamide 153 was prepared using glycine ethyl ester, generated in situ 
by neutra1ising the hydrochloride salt 152 with an equimo1ar quantity of 
potassium hydroxide using ethanol as solvent (Scheme 33 p.72). [Excess 
base may catalyse cyc1isation of the acry1amide 153 to afford a pyrro1y1 
derivative23 (e.g. 18; Scheme 5 p.8), as described previously in 
Section 1.1.1.2 (ii)]. 
The IH and I3C N-methy1 signals of the N,N-dimethylacrylamides 140, 
142-150 and 153 were assigned by comparison with the NMR spectra of 
N,N-dimethyl-2-pyrro1idinoacrylamide 151, and correlation data from 
HETCOR experiments on the acry1amide 153 (Figure 8 p.73). The benzenoid I3C 
chemical shifts were assigned by calculation using correlation tab1es I09 
and, in the case of the fluoro analogue 144, by I3C_F coupling 
constantsI09 (Figure 10 p.75), while correlation data from HETCOR and COSY 
-experiments were used to establish the IH chemical shifts (Figures 8 
and 9 p.73 and p.74). 
The acry1amides 140-151 and 153 (Schemes 29-33) are differentiated from 
the chromone-2-carboxamides 129-134 and 137 by the vinyl proton (3-H) 
singlet which occurs at 5.63 - 5.80 ppm in the acrylamides (Tables 4 and 
5), and at lower field, viz., 6.45 - 6.62 ppm in chromone-2-
carboxamides. The acrylamides are also characterised by the phenolic 
proton singlet which occurs at low field, ca. 13 - 14 ppm due to intra-
molecular hydrogen bonding between the phenolic proton and ketone 
carbonyl group.15 Determination of the E-double bond configurational 
and the conformational preferences of the N,N-dimethylacrylamides 
140,142-146 and 151 will be discussed in Section 2.3. Although, the vinyl 
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proton (3-H) chemical shifts of the N-methylaminoacrylamides 147-150 are 
almost identical to those of the corresponding 
(E)-N,N-dimethylaminoacrylamides 143-146 (Tables 4 and 5 p.76), the 
Z-double-bond configuration is presumably favoured in the 
N-methylaminoacrylamides 147-150 and the acrylamide 153 due to 
additional intra-molecular hydrogen bonding between the amino proton and 
the ketone carbonyl group (Schemes 30 and 33).15 The N-alkylamino 
acrylamides (147-150 and 153; Schemes 30 and 33) are characterised by 
amino and phenolic proton chemical shift singlets at ca. 10 and 13 ppm 
respectively, and the IR N-H absorption band of the amino group at ca. 
3200 cm-1 (Table 5 and Figure 11 p. 76 and p.77). These values 
correlate with data reported by Zagorevskii et a1. 15 in related studies. 
In the N,N-dimethylaminoacrylamides (140, 142-146, and 151) the IR 
hydroxyl stretching band is shifted below 3000 cm-1 due to 
intramolecular hydrogen bonding, and similar effects are presumed to 
obtain in the N-methylaminoacrylamides (147-150 and 153; Figure 11). 
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Table 4. Characteristic spectroscopic data for the 
N,N-dialkylamino acrylamides 140-146 and 151. 
Compound 3-H/ppm DH/ppm 
140 5.75 13.60 
141 5.57 13.61 
142 5.65 14.10 
143 5.71 13.85 
144 5.63 14.00 
145 5.66 13.85 
146 5.65 13.70 
151 5.72 13.70 
Table 5. Characteristic spectroscopic data for the N-alkylamino 
acrylamides 147-150 and 153. 
Compound 
147 
148 
149 
150 
153 
3-H/ppm NH/ppm 
5.76 10.56 
5.62 10.10 
5.65 10.30 
5.65 10.30 
5.80 10.50 
DH/ppm 
13.52 
13.57 
13.41 
13.36 
13.01 
3235 
3230 
3200 
3200 
3230 
a Assigned by comparison with OH absorption bands 
of N,N-dialkylamino acrylamides and reported values 
for N-monosubstituted~-aminovinylketones (e.g. 3310cm-1).15 
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FIGURE 11. Solid-state IR spectra of compounds 146 and 150. 
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2.1 (v). Preparation of disodium cromoglycate. 
As part of an investigation of the significance of ring-opening 
reactions in molecular-level chromone pharmacology, the dimethylamine-
mediated ring-opening reactions were extended to include DSCG 158. DSCG 
158 was prepared following the procedures reported by King et a1. 40 
(Schemes 34 and 35). Thus, the bis(o-hydroxyacetophenone) 155 was 
prepared by condensation of two molar equivalents of 
2,6-dihydroxyacetophenone with single molar equivalents of 
epichlorohydrin and potassium hydroxide (Scheme 34). King et a1. 40 
found that alkylation of the second phenolic group of the monoalkylated 
intermediate species 154 was prevented by strong intra-molecular 
hydrogen bonding between the phenolic proton and ketone carbonyl group. 
Diethyl cromoglycate 156 was prepared via Claisen acylation of the 
bis(o-hydroxyacetophenone) 155 with excess diethyl oxalate and sodium 
ethoxide. Three products, viz., the required diethyl carboxylate ester 
156, starting material 155, and the major component, 3-(2-acetyl-3-
hydroxyphenoxy)-1-(2-ethoxycarbonylchromon-5-yloxy)-2-hydroxypropane 
157, were isolated in yields well below the reported values. Disodium 
cromoglycate 158 was prepared by hydrolysis of the diethyl carboxylate 
ester 156. The quantity of sodium hydroxide used was limited to 2 molar 
equivalents in order to control contamination by the ring-opened 
product. IIB The dimethylamine-mediated ring-opening of DSCG 158 
(Scheme 35) was performed in an NMR tube, and the reaction was followed 
by NMR spectroscopy, as described in Section 2.4. 
i,il 
,. 
156 
SCHEME 34 
f. iv. v 
157 
Reagents : i) Epichlorohydrin, i-PrOH; 
ii) KOH, i-PrOH, H20, a; 
iii) NaOEt - EtOH, Et20, a; 
Iv) (C02Et)2 - EtOH - C6H6' a; 
v) H+/H20; EtOH - C6H6' a. 
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The IH and l3C NMR chemical shifts of the 2-hydroxypropane analogues 155-
159 were assigned using correlation data from COSY and HETCOR 
experiments on compound 157 (Figures 12 and 13); the 13C benzenoid 
signals were assigned by calculation using correlation tables. 109 In 
diethyl cromoglycate 156. the aromatic and 2-hydroxypropane proton 
chemical shifts correlate with the literature values for dimethyl 
cromoglycate,l19 and the C-2 signal was assigned using the value for 
ethyl chromone-2-carboxylate 110. 108 
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2.2 NMR ANALYSIS OF ROTATIONAL ISOMERISM IN 
CHROMONE-2-CARBOXAMIDESI20 
The chromone-2-carboxamides (129-138; Table 6 p.8S) were prepared from 
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the corresponding acids via an acid chloride intermediate, as described 
previously in Section 2.1 (iii). The ring and N-alkyl substituents were 
chosen to determine electronic and steric effects on the rotational 
equilibria. Symmetrically substituted N,N-dialkyl amides were chosen to 
simplify interpretation of the variable-temperature IH NMR spectra. The 
rotational energy barriers ~G*; Table 6) of the chromone-2-carboxamides 
were determined from variable-temperature IH spectra (e.g. Figure 14), 
in which the observed splitting of the N-alkyl signals was attributed to 
slow site-exchange of the N-alkyl substituents. 
335K~ 
325 K 
305 K A ___ _ 
320K~ 
315K~ ~ 
305K~ 285 K It. 
---
296 K 296 275 K i ... __ 
3.7 3.4 3.8 3.6 3.2 3.0 6 
138 137 130 
FIGURE 14. Variable temperature IH NMR spectra showing N-alkyl 
signals for selected chromone-2-carboxamides (129-138). 
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TABLE 6. Data from dynamic NMR study of chromone-2-carboxamides 129-138.a 
130 OMe H NMe2 302 2.5 ± 0.7 69.7 ± 1.5 4 
131 H02 H NMe2 305 1.8± 0.6 71.2 ± 1.9 2 
132 F H NMe2 270 1.0 ± 0.5 64.1 ± 2.3 36 
133 Cl H NMe2 < 255f 
134 Sr H NMe2 290 1.0± 0.3 69.0± 1.6 5 
135 H Me NMe2 > 345g > 72.3 ± 0.2 < 1 
129 H H NMe2 270 O.B± 0.3 64.6± 1.9 
136 H H NPr12 315 87.2 ± 2.2 63.5± 0.7 
137 H H {) 332 13.6± 1.1 72.2 ± 0.9 
138 H H NJ 325 61.6 ± 1.6 66.5 ± 0.9 
aVariable temperature 300 MHz 1H NMR spectra recorded using solutions in CDC13' 
bCoalescence temperature ~ 3 K). CFrequency separation at coalescence. 
29 
46 
1 
14 
dFree energy of activation for H-CO rotation; aG* 0 RTc (22.96 + ln Tc/av c), 
eFirst-order rate constant at 298 K for N-CO rotation; ln k a ln (kbT/h) -aG*/RT. 
fNo splitting of NMe2 Signal observed. gNo coalescence of the NMe signals observed; 
av at 345K = 36.5 ± 0.5 Hz. 
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In chromone-2-carboxamides (Scheme 36 p.87; where R* = R) simultaneous 
rotation about two bonds, viz., the N-CO and C(2)-CO bonds implies a 
rotational equilibrium between two equivalent pairs of quasi-planar, 
resonance-stabilised conformers [CIa == IIa) and (lb == lIb)]. [In 
analogous benzamides the amide and aromatic planes are apparently 
twisted slighly out of plane relative to each other due to steric 
interactions and the rotational equilibrium apparently comprises two 
quasi-planar conformers,49 as discussed in Section 1.2.1.] Site-
exchange about the C(2)-CO bond at ambient temperature is expected to be 
too rapid for dynamic NMR spectroscopic analysis. This expectation may 
be rationalised by analogous rotational barriers about the C(1)-CO bond 
in sterically hindered ortho-substituted benzamides which have been 
reported to be less than 60 kJ mol- l . 45 Since IR spectroscopy has a very 
much shorter time-scale, the rapid C(2)-CO rotation may have been 
analysed using this alternative detection method. Successful analysis 
of rapid C(2)-CO rotations have been shown by the IR study of rotational 
isomerism in chromone-2-carboxylate esters,51 previously discussed in 
Section 1.2.2. In chromone-2-carboxamides, however, the infrared ketone 
and amide carbonyl absorption bands partially coincide at ca. 1650 em-I, 
which prevented IR analysis of the C(2)-CO rotational barrier. However, 
rotation about the N-CO bond is expected to be hindered by 
delocalization of the nitrogen lone-pair (Figure 15 p. 87), and in the 
rotational equilibria, ka' ka l «Rb. Rb' (Scheme 36). Consequently, 
site-exchange of the N-alkyl substituents is likely to be sufficiently 
slow for NMR analysis. Since the rotational equilibria comprise two 
non-equivalent rotamer types (a) and (b), the measured rate constants 
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for site-exchange are weighted combinations of the individual rate 
constants. Use of the Winstein-Holness principle44 then affords 
equation 4. 
kobs ka [Ia) + ka' [Ib] (4) 
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In the series 129-138, the IH NMR frequency separations measured at slow 
site-exchange (Avo) range between 1-99 Hz, and are smallest for the 
N,N-dimethylcarboxamides (129-132 and 134). Such frequency separations 
(Avo) reflect the difference in the average magnetic environment of each 
N-alkyl substituent in each compound, and more specifically, their 
. 
average position relative to the magnetically anisotropic chromone and 
amide45 functions. The positions of the relevant nuclei relative to the 
amide function are determined by : dipole-dipole and steric49 
interactions; ngear_meshing n121 of the isopropyl groups in compound 136; 
and ring-conformational constraints in the heterocyclic analogues 137 
and 138. Similar deshielding of the N-methyl groups in the 
N,N-dimethylcarboxamides (129-132 and 134) may thus account for the small 
~vo values. In the 7-chloro analogue 133, the IH NMR N-methyl signal did 
not split, the material precipitating below 255K. This observation 
is probably due to identical deshielding of the N-methyl groups at slow 
site-exchange, rather than an unusually low rotational barrier. This 
argument is also substantiated by the observed splitting of N-alkyl 
13C signals at ambient temperature for all the chromone-2-carboxamides 
129-138, including the 7-chloro compound 133. 
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Rotational energy barriers caG*; Table 6 p.85), were determined for the 
chromone-2-carboxamides (129-132,134,136-138) from the coalescence 
temperatures (Te> and the frequency separations at coalescence cave)' 
using equation 2. 46 The latter aVe values were determined by linear 
extrapolation (Section 3.3), as described by Lai and Chen. 122 Site-
exchange rate constants (k) were then determined from the aG* values 
using equation 3. 
AG* ... RTe (22.96 + In Te/ave) 
In k = In (kbT/h) - AG*/RT 
(2) 
(3) 
The rotational energy barriers caG*) range between 64-72 kJ mol-I 
correlating with typical amide ~otational barriers (50-100 kJ mol-I) 
and, more importantly, with reportedAG* data for comparable 
N,N-dialkylbenzamides .123,124 The slightly higher rotational barriers 
determined for the chromone analogues, relative to the 
N,N-dialkylbenzamides, may reflect a reduction in competitive 
delocalisation45 due to the electron-withdrawing chromone system 
. 
(Figure 16 p.92). This electron-withdrawing effect consequently increases 
the double-bond character of the N-CO bond, which effectively increases 
the magnitude of the chromone-2-carboxamide rotational barriers. In the 
substituted N,N-dimethylcarboxamides, the increasing net electron-
withdrawing effects of the substituent Rl result in decreasing 
competitive delocalization, and such effects may account for the gradual 
increase in aG* values in the series RI ... F (132) < Br (134) < N02 (131). 
This trend also correlates with reportedAG* data for the corresponding 
para-substituted N,N-dimethylbenzamides. l23 Changing conformer 
populations may influence the overall rate of rotation and could explain 
the apparently anomalous result for the 7-methoxy analogue 130. 
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The rotational barriers for the pyrrolidine derivative 137, and to a 
lesser extent, for the piperidine analogue 138 are both higher than that 
of the N,N-dimethyl compound 129. This may illustrate the influence of 
electron-releasing inductive effects on nitrogen lo~e-pair 
delocalisation (Figure 15 p.87). Ring conformational contraints are 
expected to allow the pyrrolidine nitrogen to adopt the planar sp2 
arrangement more easily than the piperidine nitrogen. The pyrrolidine 
nitrogen thus has more sp2 character and hence more effective nitrogen 
lone-pair delocalization. This effect may account for higher rotational 
barrier for the pyrrolidine derivative 137 than for the piperidine 
analogue 138. This trend correlates with reportedaG* data for simple 
piperidine and pyrrolidine compounds,45 as discussed in Section 1.2.1. 
The electron-releasing inductive effect may be opposed by steric 
destabilisation of the carboxamide ground-state125 which inhibits 
de10calisation, and this effect presumably occurs in the 
N,N-diisopropylchromone-2-carboxamide 136. An analogous trend occurs in 
the reportedaG* data for benzamide analogues, viz., 
N,N-diisopropylbenzamide s N,N-dimethylbenzamide124 = I-benzoyl-
piperidine. 50 
As discussed previously in Section 1.2.2, an IR study of rotational 
isomerism in chromone-2-carboxylate esters has shown that bulky 
3-substituents appear to prevent co-planarity of the ester and chromone 
planes. 51 Similar steric effects were thus expected to occur in 
3-methylchromone-2-carboxamide 135 and this expectation is supported 
both by computer modelling and by earlier studies of benz amide 
analogues. 49 Steric effects of the bulky 3-methyl substituent are 
expected to inhibit rotation about both the C(2)-CO and N-CO bonds. 
This expectation was confirmed by the well separated 1H NMR N-methyl 
signals (37 Hz) which did not coalescence even at 345 K. The proposed 
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conformation illustrated in Figure 17 (p.92) rationalises both the 
failure to achieve coalescence of the IH N-methyl signals and the 
expected steric constraints. In the proposed conformation, the 
essentially planar N,N-dimethylcarboxamide group lies perpendicular or 
nearly perpendicular to the chromone plane, the N-methyl groups are 
diastereotopic, and rotation about both the C(2)-CO and N-CO bonds is 
significantly hindered due to steric effects of the 3-methyl 
substituent. These steric interactions were further investigated using 
nuclear Overhauser enhancement (n.O.e.) experiments, involving the 
separate irradiation of the 3-methyl group and each of the N-methyl 
groups (Figure 18 p.93). In each case, small enhancements of both non-
irradiated methyl groups occur in the n.O.e difference spectra 
(Figure 19 p.92). [Calculation of the n.O.e. enhancements is described 
in Section 3.3] These findings suggest that all three methyl groups are 
closely situated to each other, thus substantiating the proposed 
conformation (Figure 17). However, in view the small magnitude of the 
intensity enhancements and the complexity of the internal rotations, 
arguments based on the n.O.e data cannot be considered conclusive. 
o 
R' 
FIGURE 16. a) competitive delocalization; 
b) nitrogen lone-pair delocalization. 
carboxamide 
plane 
I 
chromone 
plane 
N-methyl 
groups 
(i) (ii) 
FIGURE 17. Proposed conformation of compound 135 based on 
computer-modelled structure; (i) "wire-frame" 
and (ii) "spacefill" representations. 
o D~~ ye0' 
o 
N, u·!I))1.4 
Me 
FIGURE 19. Percentage n.O.e. enhancements of compound 135. 
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3-methyl 
group 
(a) 
(b) 
(c) 
(d) 
FIGURE 18. IH N.m.r. spectra of methyl signals from n.O.e. 
experiments on chromone-2-carboxamide 135 :-
a) irradiation at frequency, vI; b) irradiation 
at frequency v2; c) irradiation at frequency, v3; 
and d) reference spectrum. 
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2.3 STRUCTURAL ANALYSIS OF CHROMONE-DERIVED 
2-AMINO-3-(2-HYDROXYBENZOYL)ACRYLAMIDES126 
As previously discussed in Section 1.3.3 (iv), many different modes of 
action for DSCG in asthma therapy have been proposed. The mast cell 
stabilising action72•93 of DSCG has received the most attention, 
although. the molecular basis for this action (and all the other 
proposed modes of action) has not been elucidated. 66 •72 ,93.98 Chromones 
94 
are susceptible to C-2 nucleophilic attack and are consequently ring-
opened by various nitrogen21 and oxygen nucleophiles. 26 The implications 
of such reactions in molecular-level chromone pharmacology have thus 
been explored in the present study. DSCG may interact with biogenetic 
nucleophiles via the ring-opening reaction. Such reactions thus provide 
a mechanism for the C-2 covalent binding of the drug to mast cell 
receptor sites such as the DSCG-binding protein (Figure 20).94.95 The 
drug may similarly block or antagonise the effects of anti-inflammatory 
mediators such as histamine. The reactions of the chromone-2-
carboxamides with amines as models for in vivo nucleophiles were thus 
investigated (Scheme 37 p.95), The configurational and conformational 
preferences of the ring-opened 2-amino-3-(2-hydroxybenzoyl)acrylamides 
140, 142-146, and 151 were determined using a combination of x-ray 
crystallographic, 1H, 13C NMR and IR spectroscopic, and computer 
modelling techniques .126 
a ~ 3 roll 0 .. Ilr·· ,~ 9' R A~ 
FIGURE 20. Putative interaction of biogenetic nucleophiles 
(e.g. X = N.O.S) with chromone systems. 
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/ 
IV 
RI RZ R3 
129 H Me Me 140 
130 OMe Me Me 142 
131 NOZ Me Me 143 
132 F Me Me 144 
133 CI Me Me 145 
134 Sr Me Me 146 
129 H -(CH2)4- 151 
SCHEME 37 
Chromones are ring-opened to produce products with either E- or 
Z-double-bond configurations. Zagorevskii et al. 15 have investigated 
J3 -aminovinylketone systems using 1HJl,3 vinyl coupling constants to 
determine the E-configuration of N. N-disubstituted J3 -aminovinylketones 
96 
160 and the Z-configuration of N-monosubstituted analogues 161. However. 
they failed to deter.mine the double-bond configuration in the products 
of reactions of 2-substituted chromones with secondary amines. NMR and 
IR spectroscopy have also been usedlS to determine the significance of 
intra-molecular hydrogen-bonding in both series. 
NRa H 
H N ..... R 
I 
0 0" 
H 
-
160 161 
The E-double-bond configuration of the parent system 140 was 
unambiguously determined by single crystal x-ray diffraction analysis. 
The crystal structure and packing diagrams of this compound (140) are 
shown in Figures 21 and 22 (p.97 and 98). The crystal stucture also 
indicates intra-molecular hydrogen-bonding between the phenolic proton 
and the syn-orientated ketone carbonyl group. The amide group is planar 
with a maximum deviation from the least-square plane of 0.0820 1, and 
lies perpendicular (ca. 85°) to the rest of the molecule. The remaining 
crystallographically determined atoms are co-planar, with a maximum 
deviation from the least-square plane of 0.0796 1. The planarity of the 
J3-amino-vinyl ketone system implies significant delocalisation of the 
dimethylamino nitrogen lone pair into the extended conjugated system 
(Figure 23 p.99). This delocalisation effect is also enhanced by 
intra-molecular hydrogen-bonding chelation which also encourages the 
co-plan~rity of the aryl and J3-amino-vinylketone systems. 
FIGURE 21. X-Ray crystal structure of (E)-2-(dimethylamino)-3-
(2-hydroxybenzoyl)-N,N-dimethylacrylamide 140, 
showing the crystallographic numbering. 
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FIGURE 22. Packing diagram of lEl_2_ldimethylamiUO)-3-
(Z_hYdrOXYbenZOY1)_N.N-dimethYlaCrYlamide 140. 
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(b) 
FIGURE 23. (a) Favoured E-configuration of compounds 140,142-146 and 
151 illustrating delocalisation and hydrogen-bonded 
chelation. (b) Unfavourable steric interaction in the 
alternative conformer of the E-diastereomer. 
III 
(a) 
(c) Unfavourable steric interaction in a planar conformation 
of the Z-diastereomer. 
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NMR and IR data may be used to argue that the solid state (crystal) 
conformation of the parent system is essentially maintained in solution 
i.e. in chloroform; and the same configurational and conformational 
preferences are present in all of the 2-amino-3-(2-hydroxybenzoyl)-
acrylamides 140, 142-146, and 151. The E-double-bond configuration in 
each of the 2-amino-3-(2-hydroxybenzoyl)acrylamides is substantiated by 
the following NMR data, obtained for CDCl3 solutions. In the series 
(Table 7; Figure 24 p.101), the chemical shifts for the vinyl (3-H) 
protons and the non-aromatic carbons show only small differences and the 
vinyl 3-H proton chemical shifts correlate more closely to the 
calculated value for the E-isomer (5.51 ppm) than for the Z-isomer 
(6.08 ppm). These calculated values were determined using the method of 
additive increments described by Matter et 81. 127 Furthermore, in each 
of the compounds, the 13C N-methylamino and N-methylcarboxamido signals 
are both split at ambient temperature. The corresponding 1H 
N-methylcarboxamido signals are clearly split, while the 1H 
N-methylamino signals form broad, post-coalescence singlets at ambient 
temperature (Figure 24). N,N-disubstituted amides usually exhibit slow 
site-exchange of N-alkyl groups at ambient temperature. However, the 
analogous splitting of the 13C N,N-dimethylamino signals is significant 
and implies a rotational equilibrium between resonance-stabilised planar 
conformers due to slow site-exchange of diastereotopic N-methyl groups. 
These conformational options are only possible in the E-double-bond 
configuration of the acrylamide illustrated in Figure 23a (p.99), since 
molecular modelling studies show that in the Z-diastereomer 
(Figure 23c). unfavourable steric interactions prevent co-planarity of 
the dimethylamino- and vinyl ketone moieties. The alternative planar 
conformer (Figure 23b) is destabilised by unfavourable steric 
interactions even when the planar amide moiety is perpendicular to the 
rest of the molecule. [The planar arrangements illustrated in Figure 23 
Table 7. Comparative IH and 13C NMR chemical shifts for 
dimethylamino-N,N-acrylamides 140,142-146, and 151. 
13C Nucleus 8 140 a8 a 
(ppm) (ppm) 
CO.NM~ 34.06 0.44 
36.84 0.46 
NMe2 39.38 0.52 
40.11 0.82 
C-1 166.44 1.52 
C-2 158.76 1.54 
C-3 88.81 0.31 
C-4 189.74 1.72 
3_Hb 5.75 0.12 
a Maximum deviation from compound 140. 
b IH nucleus. 
(a) 
IV 
3.2 
CON(CH,,). 
1 
(b) 
2.8 I) 50 
(c) 
20 I) 
101 
FIGURE 24. (a) Compounds IV with numbering (see Table 7 for NMR data). 
(b) Partial IH NMR spectrum for compound (144; RI = F). 
ec) Partial I3C NMR spectrum for compound (14.4; Rl = F). 
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were obtained by changing the relevant torsion angles of energy 
minimised structures.] The perpendicular arrangement of the amide group 
illustrated in the crystal structure of the parent system is likely to 
be maintained in solution, and eliminates unfavourable steric 
interaction with the vinyl ketone oxygen, while still allowing 
uninhibited delocalisation of the nitrogen lone-pair in the 
independently planar amide group. 
In the IR spectra of the compounds obtained using KBr discs and 
chloroform solutions, the carbonyl absorption bands differ only by 
ca. ± 10 cm-I . This observation is significant since IR carbonyl band 
frequencies are sensitive to structural change. Furthermore, in the 
systems examined, both ketone and amide carbonyl absorption bands are 
generally superimposed at low frequencies, viz., ca. 1650 cm-I 
[Figure 11 p. 77, Section 2.1 (iv)]. This observation reflects a 
reduction in the double-bond character of both carbonyl groups due to 
effective delocalisation. While such frequency shifts are 
characteristic of planar amide systems, they also independently 
substantiate the essential co-planarity of the dimethylamino and aryl 
vinyl ketone systems. The hydroxyl stretching band is shifted below 
3000 cm- I in both the solid state and solution IR spectra of each 
compound, while the phenolic proton chemical shifts occur at low field 
(ca. 14 ppm) in the 60 MHz IH NMR spectrum of each compound. Both these 
observations substantiate48 the strongly hydrogen-bonded chelate 
conformation illustrated in Figure 23a (p.99). 
C-2 nucleophilic attack may occur at either face of the planar chromone-
2-carboxamide (I, Scheme 37 p.95) and ring-opening proceeds via racencic, 
dipolar intermediates III (see mechanistic study in Section 2.5.) 
Product development control may be responsible for the preferential 
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formation of the corresponding (E)-dimethylaminoacrylamides rv. 
Alternatively, the predominance of the more stable isomer may result 
from equilibration to the E-product, as a result of the configurational 
lability of the dimethylaminoacrylamides rv. Analogous configurational 
labilty has been reported by Shvo and Shanan-Aridi128 in related 
systems, and has been rationalised by amino nitrogen lone-pair 
delocalisation which effectively increases the single-bond character of 
the double-bond. The essentially planar, conjugated E-products rv are 
the more stable isomers due to effective delocalisation of the 
dimethylamino nitrogen lone-pair, an effect which is not possible in the 
Z-diastereomers due to steric inhibition of resonance. In the mono-
substituted amino analogues 161 (p.96) examined by Zagorevskii et a1.,15 
however, co-planarity of the syn-orientated amino- and vinyl ketone 
groups may be achieved in the Z-isomer without steric strain. The 
Z-double-bond configuration in these compounds is apparently favoured 
due to stabilisation by additional intra-molecular hydrogen bonding 
between the amino hydrogen and the ketone carbonyl group. 
2.4 NMR ANALYSIS OF THE REACTION OF DISODIUM CROMOGLYCATE WITH 
DIMETHYLAMINE 
104 
The dimethylamine-mediated ring-opening of DSCG 158 (Scheme 35 p.SO) was 
performed in an NMR tube, and the reaction was followed by NMR 
spectroscopy. IH and 13C spectra of the starting material, and the 
reaction mixture after 0.5 h are shown in Figures 25 and 26. The IH NMR 
spectrum of the reaction mixture taken after 0.5 h shows the complete 
disappearance of the vinyl (3-H) proton singlet and the shifting of the 
benzenoid protons to higher field with chemical shifts comparable to 
those observed for bis(o-hydroxyacetophenone) 155; the benzenoid proton 
triplet and doublets are also shifted further apart. In the 13C NMR 
spectrum, taken after 0.5 h, the vinyl ketone (C-4) chemical shift 
occurs at lower field (ca. 193 ppm) and the benzenoid chemical shifts 
are comparable to those observed for bis(o-hydroxyacetophenone) 155. 
The N-methylamino 13C signals presumably coincide with those of 
dimethylamine. The spectra of the reaction mixture after 0.5 h thus 
show significant differences from the starting material and differences 
are consistent with formation of the ring-opened product 159. Isolation 
of the ring-opened product 159 was then attempted. Surprisingly, 
however, the IH and 13C spectra of the crude isolated product (obtained 
in quantitative yield) correlate with DSCG 158 rather than the ring-
opened product 159 [as illustrated in the DEPT spectra (Figure 27)]. 
While there is clear evidence that ring-opening of DSCG occurs in the 
reaction solution, the reaction appears to be reversible since the 
starting material was isolated. This interesting reaction still 
requires further investigation. 
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FIGURE 25. 400 MHz IH spectra of 
a) reaction mixture after 0.5 h. 
b) DSCG IS8 (starting material). 
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FIGURE 27. 100 MHz DEPT spectra of 
a) reaction mixture after 24 h. 
b) DSCG 158 (isolated product). 
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2. 5 KINETICS AND MECHANISM OF THE REACTION OF CHROMONE-2-
CARBOXAMIDES WITH DIMETHVLAMINEl29 
108 
Further investigation of the implications of the ring-opening reactions 
of chromones in molecular-level chromone pharmacology involved a kinetic 
study of the dimethylamine-mediated ring-opening of the 
N,N-dimethylchromone-2-carboxamides 129-133 to the corresponding 
(E)-2-(N,N-dimethylamino)-3-(2-hydroxybenzoyl)acrylamides 140 and 142-145 
(Scheme 38). 
0- ~ CONMea 0 m Kl kJ NMez I CONMez ~ I c.-=: CONMez 0;;- -R' ~ 0 + NMez R' ~ ~ NMez rds R' 
II (,8 III IV G :NHMez 
1~ K, lW 
(0 0 CONMea 
d): NMez 
R' R' ~ 0) CONMez 
V I .. 
NHMez 
RI 
129 H 140 
130 OMe 142 
131 N02 143 
132 F 144 
133 CI 145 
SCHEME 38 
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The ring-opening reactions were followed by ultraviolet spectroscopy. 
The absorption maxima of the reactants and products were well separated 
(e.g. Figure 28 p.1I0), in all cases, and the reactions were followed by 
monitoring the rate of formation of the acrylamides. In each case, the 
absorbance changes were measured at the wavelength corresponding to the 
absorption maximum of the particular acrylamide (e.g. Figures 29 and 30 
p.110 and p.111). The cuvette chamber, reaction flask, and reagent 
solutions were maintained at 30 (± 0.2)OC. Other reaction parameters 
such as the wave-length, initial chromone-2-carboxamide- and 
dimethylamine concentrations, and the duration of each reaction are 
summarised in Table 8. Initial chromone-2-carboxamide concentrations 
were chosen to produce maximum acrylamide absorbances of ca. 1.0 - 1.2 
absorbance units, and dimethylamine concentrations were chosen to ensure 
ca. 80% completion of the reactions within 1-1.5 h. The final 
absorbance readings (lim t- 00 At) were taken after 15-24 h. All 
determinations were duplicated. The linear (Beer's Law) relationship 
between acrylamide concentration and absorbance (e.g. Figure 31 p.111) 
was confirmed over the corresponding ranges used for each system. 
·0 
TABLE 8. Reaction parameters. 
R1 A. [Amide] [Me2NH] Completion Reaction time 
(nm) (mo1.dm- 3 x 105 ) (mo1.dm- 3) (%) (min) 
H 357 3.5 LO - L8 80 - 85 40 - 120 
OMe 361 3.0 L8 - 2.6 65 - 76 32 - 80 
N02 388 5.5 0.059 - 0.099 80 - 82 35 - 70 
F 353 3.5 0.4 - 0.8 74 - 85 19 - 70 
Cl 358 3.5 0.2 - 0.6 80 - 87 17.5 - 130 
~ 
c 
ca 
.D 
1.0 
6 0.5 
II) 
.D 
« 
At 
0.0 
1.0 
0.5 
200 300 I 400 A nm 
FIGURE 28. UV Spectra of ethanolic 
solutions of 7-chloro-N,N-dimethyl-
chromone-2-carboxamide 133 and the 
corresponding acrylamide 145. 
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FIGURE 29. UV Spectra showing absorbance 
changes during the reaction of 7-fluoro-
N.N-dimethylchromone-2-carboxamide 132 
with 0.5~-dimethylamine at 30°C. 
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FIGURE 30. Plots of absorbance VB. time 
for reactions at 30 De of N,N-dimethyl-
chromone-2-carboxamide 129 with 
(a) l.OM-Me2NH; (b) 1.2M-MelNH; 
(c) 1.4M-MelNH; Cd) 1.6M-MelNH; 
and (e) 1.8M-Me2NH. 
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FIGURE 31. Beer's Law plot of absorbance 
VB. concentration of the acrylamide 140. 
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Large excesses of dimethylamine { > l03x [chromone-2-carboxamide I]} were 
used to produce pseudo first-order reaction ~onditions (Equation 7). 
The pseudo first-order rate constants (ka) at different dimethylamine 
concentrations were determined from linear plots (e.g. Figure 32 p.113) 
of In (A-At) against time using equation 5. The ring-opening reactions 
were shown to be third-order overall, consistent with equation 6. The 
rate constants (kobs) were determined from plots of pseudo first-order 
rate constants (ka) against the square of the dimethylamine 
concentration {[Me2NH)2} (e.g. Figure 33 p.113). The relevant data are 
summarised in Tables 9 and 10 (p.114 and 117). Linear regression 
analysis of the experimental data afforded best straight line fits 
(Section 3.5). 
In (A - At> -kat + In (A - Ao) 
where Ao initial absorbance 
At absorbance at time, t 
A = limt_ coAt 
Rate = kobs [chromone-2-carboxamide I] [Me2NH)2 
ka [chromone-2-carboxamide I) 
where ka = kobs[Me2NH)2 
(5) 
(6) 
(7) 
-1.5 
-2~--L---~---~--~----~--~--~ 
o 5 10 15 20 25 30 35 
time/min 
FIGURE 32. Pseudo first-order kinetic 
plot for the reaction of 7-fluoro-N,N-
dimethylchromone-2-carboxamide 132 
with O.7~-dimethylamine at 30 DC. 
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(dimethylamine concentration)2/mol.2dm-6 
FIGURE 33. Plot of pseudo first-order 
rate constants (ka> VB. [Me2NH]2 for the 
reaction of N,N-dimethylchromone-2-
carboxamide 129 with dimethylamine 
at 30 DC. 
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TABLE 9. Pseudo first-order rate constants (ka ) for the ring-opening of 
N,N-dimethylchromone-2-carboxamides 129-133 by dimethylamine 
at 30°C. 
R1 [Amide] [Me2NH ] k a a 
(mol.dm- 3 x 105) (mol.dm- 3 ) (s-l x 104 ) 
H 3.5 1.00 2.40 ± 0.02 
1.20 3.45 ± 0.15 
1.40 4.53 ± 0.03 
1.60 5.90 ± 0.38 
1.80 7.10 ± 0.12 
OMe 3.0 1.80 3.97 ± 0.05 
2.00 4.98 ± 0.22 
2.10 5.73 ± 0.18 
2.40 6.87 ± 0.25 
2.60 7.97 ± 0.15 
N02 5.5 0.059 2.53 ± 0.12 
0.069 3.35 ± 0.05 
0.079 4.33 ± 0.10 
0.089 5.67 ± 0.18 
0.099 6.50 ± 0.02 
F 3.5 0.40 3.33 ± 0.05 
0.50 4.70 ± 0.20 
0.60 7.23 ± 0.72 
0.70 9.18 ± 0.48 
0.80 12.22 ± 0.65 
Cl 3.5 0.20 2.22 ± 0.02 
0.30 4.75 ± 0.03 
0.40 7.05 ± 0.42 
0.50 10.72 ± 0.40 
0.60 15.53 ± 0.65 
a Mean value from duplicate runs. 
115 
Szabo et al. have studied the kinetics of hydroxide ion induced ring-
opening reactions of chromone-26 and isoflavonoid derivatives. 27 ,28 They 
established that the reactions follow second-order kinetics, in which 
the rate is directly proportional to the product of the substrate and 
hydroxide ion concentrations. In their proposed mechanism (Scheme 39), 
the rate-determining step is considered to be the first step (162 -+ 163) 
involving C-2 nucleophilic attack by the hydroxide ion. They 
suggested26 that the measured rate constants could be used to quantify 
the electron density at C-2 and, hence, the susceptibility of chromone 
derivatives to C-2 nucleophilic attack. 
0 0 o(ylR' 0:)( OH- 0(:( ~ I I ~ ~ I 2 - I R' ~ 0 ~H ~ 0 R2 ~ OH 
162 163 164 
1~ 
o(iR' ~ I 2 ~ 0 ~H 
165 
SCHEME 39 
Consequently. the reactions of the N,N-dimethylchromone-2-carboxamides 
with dimethylamine were expected to follow second-order kinetics with 
the rate-determining step involving C-2 nucleophilic attack by 
dimethylamine. However, the kinetic data show that ring-opening of 
chromone-2-carboxamides follow third-order (rather than second-order) 
kinetics overall corresponding to the rate equation 6 (p.112). The 
proposed mechanism is detailed in Scheme 38 (p.108). The rate 
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expression (Equation 8) is consistent with the proposed mechanism, and 
is equivalent to the experimentally determined relationship 
(Equa tion 6 p .112) when kJKIK2 = kobs' 
(8) 
In the proposed mechanism, two consecutive equilibria are followed by a 
rate-determining ring-opening step. The first equilibrium involves 
readily reversible nucleophilic attack by the amine at C-2 of the 
chromone-2-carboxamide I. The resultant dipolar species II then 
eliminates the neutral amine (II -+ I; Figure 34 p.119) more readily than 
it undergoes ring-cleavage (II -+ rv). In the second acid-base 
equilibrium, a second molecule of amine abstracts a proton from the 
dipolar species II thus acting as a base, rather than a nucleophile. 
[It is presumably this additional step which is responsible for the 
overall third-order kinetics, since in the hydroxide mediated reactions, 
(which follow second-order kinetics), the hydroxide ion does not require 
deprotonation (Scheme 39 p.IIS), and is not as easily eliminated as the 
Me2NH.] The resulting enolate species III then undergoes ring cleavage 
in the rate-limiting step (III -+ rv) which involves the elimination of 
the resonance stabilised phenoxide ion in preference to Me2N-
(Figure 34 p.119). The formation of an intermediate addition product 
analogous to compound 165 (Scheme 39 p.IIS) has not been included in the 
proposed mechanism, since Zagorevskii et a1. 16 have reported an NMR 
study, in which they have demonstrated the absence of isotope exchange 
in the reactions of chromone with I-D-piperidine and of 3-D-chromone 
with piperidine. Consequently, in their proposed mechanism (Scheme 40 
p.119), amine-mediated ring-opening of chromones apparently proceeds via 
the dipolar species 166 without the formation of the addition product 
167. 
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Two substituent effects are expected to influence the experimentally 
determined rate constant (kobs ). The remote C-7 substituents may 
influence the electron density at C-2 and hence the equilibrium constant 
(Kl; Equation 8 p.116). However, as meta-substituents, they are also 
expected to significantly affect the relative stability of the phenoxide 
"leaving group" in the rate-determining step. Thus, electron-
withdrawing substituents should accelerate ring-opening. The 
experimentally determined rate constants (kobs; Table 10) decrease in 
the following order viz., k no2> kCl > kF > kH and, with the exception of 
the 7-methoxy analogue 130, this trend correlates with the reported 
order of the dissociation constants for meta-substituted phenols and 
benzoic acids,130 and 4-substituted 2-hydroxyacetophenones. 131 The 
methoxy analogue 130 was expected to produce a larger rate constant 
(kobs; Table 10) than the parent system 129, since the methoxy 
substituent constant is positive (am-MeO = +0.10) .132 This apparently 
anomalous smaller rate constant for the methoxy analogue 130 may be 
TABLE 10. Rate constants (kobs) for the ring-opening of 
N,N-dimethylchromone-2-carboxamides 129-133 
by dimethylamine at 30°C. 
R1 kobsa 
(dm6.mol-2.s-1 x 104 ) 
H 2.12 ± 0.08 
OMe 1.13 ± O. 05 
N02 648 ± 7 
F 18.5 ± 1.2 
Cl 40.8 ± 1.3 
a Mean value from duplicate runs. 
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rationalised by electron-releasing resonance effects, which either 
reduce electron density at C-l (Figure 35a p.119) and/or reduce the 
stability of the phenoxide ion. The phenoxide ion is stabilised by 
conjugation with the a-acyl function, and this effect may be opposed by 
competitive delocalization involving the electron-releasing m-methoxy 
substituent (Figure 35b p.119). 
The reaction constant (p; Equation 10) was determined from a linear plot 
(Figure 36) of log (kobs-xlkobs-II) against the corresponding meta-
substituent constants (0'm-x),132 applying the Hammett equation (9).I33 
{The x denotes the substituent RI.] The positive experimentally 
determined reaction constant (p = 4.48 ± 0.45) shows the development of 
a negative charge at the reaction centre for the rate-determining 
step,I33 consistent with the deprotonated intermediate species III in the 
proposed mechanism (Scheme 38 p.l08). 
3r---------------------------------, 
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FIGURE 36. Plot of log (kobs-xl kobs-II) 
0.8 
VB. (O'm-x> for the reaction of the 
N,N-dimethylchromone-2-carboxamides 129-133 
with dimethylamine at 30°C. 
(9) 
(10) 
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2.6 POTENTIOMETRIC DETERMINATION OF DISSOCIATION CONSTANTS OF 
CHROMONE-2-CARBOXYLIC ACIDS 
.While the acidity of anti-allergic compounds may be an important 
contributing feature for significant activity [Section 1.3.3 (i)], no 
120 
satisfactory correlations have been established. 40 The poor solubility 
of cromoglycic acid in aqueous solutions has been reported to have 
prevented the determination of its PKa. 119 The bischromone acids 
corresponding to the DSCG analogues (79) [discussed in Section 1.3.3 
(i)], however, have been reported to exhibit high acidity due to the 
delocalisation effects of the carbonyl ketone group and the oxygen of 
the pyran ring, with pKa values in the range of 1.3 to 2.0. 40 
Chromone-2-carboxylic acid (129) has reported pKa values of 2.96 
(determined by conductimetry at 25°C)134 and 2.8 (determined 
potentiometrically in 50% ethanol).135 In chromone-2-carboxylic acids, 
substitution at C-5 by an alkoxy group has been reported to increase the 
acidity, e.g. 5-(2-hydroxypropyloxy)chromone-2-carboxylic acid and 
5-(2-hydroxy-3-methoxypropyloxy)chromone-2-carboxylic acid have 
reported pKa values of 1.86 and 1.92 respectively.119 The acidity 
(pKa 2.8) of 2-(lH-tetrazol-5-yl)chromone (determined by potentiometry 
in 50% ethanol at 20 0 C)136 is comparable to chromone-2-carboxylic 
acid (129). 
In the present study, the pKa values (Table 11 p.121) for the chromone-
2-carboxylic acids 112-118 were determined in order to explore further 
substituent effects on chromones. The 7-substituted 
chromone-2-carboxylic acids (112-117; Table 11) were chosen to elucidate 
electronic effects, while 6-chlorochromone-2-carboxylic acid 118 
illustrates the effect of changing the substituent position. 
TABLE 11. Dissociations constants of the 
chromone-2-carboxylic acids 112-118 at 25°C. 
o 
R'~' 
-U"Jl. o COzH 
Compd. R1 pKaa 
112 7-H 2.69 ± 0.05b 
113 7-0Me 2.96 ± 0.02c 
114 7-N02 2.60 ± 0.03 
115 7-F 2.63 ± 0.01 
116 7-Cl 2.64 ± 0.04 
117 7-Br 2.64 ± 0.02 
118 6-Cl 2.62 ± 0.02 
a Potentiometric titration in O.Ol~-aqueous 
ethanol (50% v/v). b Lit. 143 ,135 2.8 by 
potentiometry in 50% EtOH and 2.96 by 
conductimetry at 25°C. c Potentiometric 
titration in 0.005~-aqueous ethanol (50% v/v). 
The pKa values (Table 11) for the chromone-2-carboxylic acids 112-118 
were determined by potentiometry in ethanol-water (50% v/v) at 25°C. 
O.Ol~-Aqueous ethanolic solutions of the acids were titrated with 
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O.Ol~-sodium hydroxide; although, in the case of the methoxy analogue 
113, 0.005~-acid and sodium hydroxide solutions were used. The 
recommended O.Ol~-acid concentrations were generally used, since 
activity effects at this concentration are usually small. 137 However, 
precipitation of 7-methoxychromone-2-carboxylic acid 113 from a 
O.Ol~-solution required the use of a 0.005~-solution in this case. 
The solvent ratio (ethanol-water; 50% v/v) was chosen to correspond to 
the reported135 ratio used to determine the pKa of the parent system 112. 
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In weak acids, the pKa is equivalent to the pH at half the equivalence 
point,138 and plots (e.g. Figure 37 p.123) of the first ~pH/aV) and 
second derivatives ~2pH/a V2) of the pH titration curve against volume 
(V) were used, in each case, to determine the equivalence point. 139 All 
determinations were duplicated using the same standard acid solutions 
(solution 1), and then repeated using a second standard acid solution 
(solution 2). 
In para-substituted benzoic acids, the reported130 gradation of pKa 
values is : OMe > H > F > Cl > Br > N02 and a similar trend was expected 
in the chromone-2-carboxylic acids 112-117. Electron-withdrawing 
substituents on chromone-2-carboxylic acids should decrease electron 
density at C-2 thus increasing the polarity of the O-H bond and 
stabilising the anion of the dissociated acid. Thus, electron 
withdrawing substituents should produce stronger acids (with lower pKa 
values) than the parent system 112. The pKa values (Table 11 p.121) of 
the 7-substituted acids 112-117 follow the expected, general trend 
(1.e. OMe > H > Cl, Br , F > N02) although the electronic effects of the 
7-halogeno substituents on the pKa appear to be very similar. The 
higher result (pKa = 2.96) for the methoxy analogue 113, relative to the 
parent analogue 112, may be rationalised by electron-releasing resonance 
effects which increase electron density at C-2 (Figure 38 p.124). [The 
pKa of the methoxy anologue 113 might have been expected to be lower 
than that of the parent system 112, if only inductive effects acting 
through the pyran oxygen were considered, as shown in the reported130 
gradation of pKa values in meta-substituted benzoic acids or phenols 
(H > OMe > F > Cl > Br > N02)'] 
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FIGURE 37. Curves for the titration of 
O.Ol~-chromone-2-carboxylic acid 112 against O.Ol~-NaOH. 
(a) Titration curve; 
(b) Plot of the first derivative (ApH/AV) VB. volume; 
(c) Plot of the second derivative (A2pH/AV2) VB. volume. 
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Changing the chloro substituent position from C-7 to C-6 results in a 
very small reduction in the pKa , although the values are nearly 
identical. This apparent reduction in pKa may be rationalised in terms 
of a larger net electron-withdrawing effect for the 6-chloro substituent 
compared to the 7-chloro substituent. Although the electron-withdrawing 
inductive effect of the 7-chloro substituent (Figure 39) may be expected 
to be stronger than that of 6-chloro substituent (since it acts over a 
shorter distance), mesomeric electron release is only possible with the 
7-chloro substituent (Figure 39). It should be noted, however, that the 
difference in the pKa values are very small and lie within the estimated 
experimental errors. Nevertheless, the estimated experimental errors 
are within the permitted scatter of ± 0.06. 140 reported for 
potentiometric determinations. The small, observed pKa differences 
suggest that the C-7 substituents do affect the electron density at C-2. 
It is not surprising that the differences in this effect are small in 
view of the distance between the 7-substituent and the carboxylic acid 
group. 
0-
O+H 
o 
FIGURE 38. 
0- 0-
CI 
O-+H O-+H 
o o 
FIGURE 39. 
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The pKa values were also determined in order to explore their 
relationship with the rate constants (kobs> for the ring-opening 
reactions described in the previous Section (2.5). In related kinetic 
studies of hydroxide ion induced ring-opening reactions of chromone 
derivatives (Scheme 39 p.115), Szabo et a1. 26 established a linear 
relationship (Equation 11) between the second-order rate constant (k) 
and the protonation constant (pKOII+) of the pyran carbonyl oxygen. They 
also suggested that this equation could be used to predict the 
reactivity of chromones towards other nucleophiles (e.g. nitrogen 
nucleophiles). In the present investigation, a linear relationship 
(Equation 12) was obtained from a plot (Figure 40) of log (kobs) against 
the corresponding dissociation constants (pKa) of the chromone-2-
carboxylic acids 112,114-116. This relationship is only possible 
provided the data for the methoxy anologue 113 is excluded. Since the 
pKa value of the methoxy analogue 113 follows the expected trend, this 
confirms that the rate constants for the ring-opening reaction do not 
effectively quantify the electron density at C-2 (i.e. C-2 
electrophilicity), but rather reflect stabilising meta-substituent 
effects on the phenoxide "leaving group", as discussed in the previous 
Section (2.5). 
log (k) ~ -1.55pKOII+ - 3.53 
log (kobs> III -25.91pKa + 65.90 
(11) 
(12) 
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2. 6 CONCLUSION 
In the chromone systems investigated, it is apparent that the C-7 
substituent influences the electron density at C-2, as shown in both the 
NMR conformational study and the pKa studies. Since the biological 
activity of anti-allergic chromones is apparently influenced by both 
conformation and acidity, such activity may, in turn, be related to the 
electron density at C-2. An involvement of ring-opening of the pyran 
ring in chromone pharmacology at a molecular level has been proposed. 
The ease of ring-opening of the chromone system may be an additional 
factor influencing biological activity. Future research will be 
concerned with verifying these proposals and is expected to involve the 
following. 
(i) Further NMR and IR analysis of the ring-opening of DSCG with 
various nitrogen nucleophiles. 
(ii) An extension of such analyses to include the interaction of DSCG 
and its analogues with proteinaceous material and mast cell 
extracts. 
(iii) The preparation of novel DSCG analogues with enhanced ring-opening 
capabilities (e.g. a 7,7' -dinitro DSCG analogue) and the 
determination of their biological activities. 
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3 • EXPERIMENTAL 
3 .1 GENERAL. 
Melting points were determined on a Kofler hot-stage apparatus or an 
automatic Mettler FPl melting point apparatus (m.p. > 230 0 C), and are 
uncorrected. NMR spectra were recorded on Bruker AM 300, AMX 400, and 
WM 500 MHz, or Varian Gemini 200 MHz NMR spectrometers, from CDC13 or 
DMSO-d6 solutions generally using TMS as internal standard. (In the 
absence of TMS, the chloroform peak was used as internal standard). The 
spectra of disodium salts were obtained from D20 solutions with 
3-(trimethylsilyl)-propionic acid-d6 sodium salt as internal standard 
for the 1H spectra, and acetone as internal standard for the 13C spectra. 
The 13C spectra were interpreted using either off resonance decoupled 
(ORD) spectra or DEPT spectra, which were obtained at the frequencies 
used to obtain the corresponding 13C spectra. Routine 1H NMR spectra 
were recorded on a Perkin-Elmer R12 60 MHz NMR spectrometer. IR spectra 
were recorded on a Perkin-Elmer 180 spectrophotometer using KBr discs, 
liquid films, or CHCl3 solutions. UV spectra were recorded on a 
Beckmann UV 5240 spectrophotometer from dry ethanol solutions. Quartz 
cuvettes with a 10 mm pathlength were used. Low resolution mass spectra 
were recorded on a Hewlett Packard 5988A mass spectrometer. High 
resolution mass spectra were recorded on a Varian Mat 212 spectrometer. 
The common nomenclature, viz. chromone, for the chromone structure is 
chosen, in preference to the 4-oxo-4H-chromene nomenclature, for 
simplicity. The ring-opened products (140-151 and 153) are all referred 
to as 2-amino-3-(2-hydroxybenzoyl)-N,N-dialkylacrylamides for 
continuity. The reported nomenclature40 of the 2-hydroxypropane 
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derivatives (155-156 and 158) was generally used. The atom numbering used 
to quote NMR signals for the different compounds generally agrees with 
the nomenclature. Standard atom numbering was used for the chromone 
structure. The benzoyl atoms of the acrylamides (140-151 and 153) are 
denoted by the Hdashed H notation (e.g. 5' -H). The bridging group atoms 
of the 2-hydroxypropane compounds (155-159) are referred to as CHOH or 
OCH2, with the appropriate atoms in italics. In 
bis(o-hydroxyacetophenone) (155) and the 1-(chromonyloxy)-3-(phenoxy)-
propane compound (157), the phenoxy atoms are also represented by the 
"dashed H notation, thereby differentiating them from the bridge atoms 
and chromonyloxy atoms in the latter compound. The "aromatic" nuclei in 
the ring-opened compound (159) are denoted by the "dashed" notation, 
thereby differentiating them from the acrylic acid atoms. 
Flash chromatography141 was performed on Merck Silica gel 60 [particle size 
0.040-0.063 mm (230-400 mesh)]. Preparative layer chromatography was 
achieved on Merck Silica gel 60 PF2M plates. Thin layer chromatography 
was performed on Merck Silica gel 60 F2S4 precoated plates. TLC plates 
were analysed by inspection under UV, using iodine, or using ninhydrin 
spray reagent. 
Solvents were dried using the following prodedures142 : 
(i) Benzene and ether were dried over sodium wire and then distilled 
under N2 over sodium wire using benzophenone as an indicator. 
(ii) 1,2-Dichloroethane was distilled over P20S. 
(iii) Dimethylformamide and acetone were dried over 4A molecular sieves. 
(iv) 1,2-Dioxan was dried over CaCl2 and 4A molecular sieves, 
and then filtered through a column of basic alumina. 
(v) Ethanol was distilled under N2 over magnesium ethoxide. 
(vi) Nitrobenzene was distilled under vacuum over P20S. 
(vii) Pyridine was dried over KOH overnight and distilled over fresh 
KOH. 
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All dry solvents were stored over 4A molecular sieves. The exact 
concentration of ethanolic/aqueous dimethylamine and ethanolic 
methylamine solutions was determined by titration with O.lM-HCI. The 
purity of the ethanolic amine solutions was determined by GLC analysis 
on a Hewlett Packard 5980A gas chromatograph, using flame ionisation 
detection with N2 carrier gas and H2/synthetic air feeder gases. The 
GLC trace of ethanolic dimethylamine (25% w/w) showed an extraneous peak 
with a retention time equivalent to that of ethanolic methylamine. HCI 
gas was generated from HCI-H2S04 using a standard literature 
procedure .143 
Computer modelling of structures was achieved using the Tripos 
Associates software package, ALCHEMY II, and a CW 16 AT microcomputer 
and Hewlett Packard colour Pro plotter. 
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3.2 PREPARATION OF CHROMONE DERIVATIVES. 
3-Nitrophenyl acetate (88) .103 AC20 (10.9 ml. 0.118 mol) was added 
dropwise to a stirred solution of 3-nitrophenol (10.0 g. 72 mmo1) and 
NaOH (4.6 g. 0.115 mol) in H20 (ca. 100 m1) at OOC, and the resulting 
mixture was stirred for 1 h. The mixture was extracted with EtOAc 
(3 x 50 m1) and the combined extracts were sequentially washed with 
5% aq. NaHC03 (2 x 50 ml) and H20 (1 x 50 m1). and then dried (anhyd. 
MgS04)' The solvent was evaporated to afford crude 3-nitrophenyl 
acetate (88) (12.9 g, 99%), m.p. 53-54°C (lit. ,144 55-56°C); 8H (60 MHz; 
CDC13) 2.40 (3H, s, Me) and 7.40 - 8.30 (4H, m, ArH); Vrnax (KBr)/cm-1 
1755 (CO). 
3-Fluorophenyl acetate (89) .103 AC20 (7.4 m1, 78 mmo1) was added 
dropwise to a stirred solution of 3-fluorophenol (5.0 g, 55 mmo1) and 
NaOH (3.1 g, 79 mmol) in H20 (ca. 50 ml) at OOC, and the resulting 
mixture was stirred for 1 h. The mixture was extracted with EtOAc 
(3 x 25 ml) and the combined extracts were sequentially washed with 5% 
aq. NaHC03 (2 x 25 m1) and saturated NaCl (1 x 50 ml), and then dried 
(anhyd. MgS04)' The solvent was evaporated to afford an oil which was 
distilled to give 3-fluoropheny1 acetate (89) (7.4 g, 87%), 
b.p. 183°C/760 mmHg (lit. ,145 77°C/16 mmHg); 8H (60 MHz; CDC13) 2.20 
(3H, s. Me) and 6.80 - 7.60 (4H, m, ArH); vrnax (KBr)/cm-1 1760 (CO). 
3-Chlorophenyl acetate (90) .103 The experimental procedure employed 
for the synthesis of 3-fluorophenyl acetate (89) was followed, using 
AC20 (10.4 m1, 0.110 mol), 3-chloropheno1 (10.0 g, 78 mmo1) , and NaOH 
(4.4 g, 0.110 mol) in H20 (ca. 75 m1). Work-up afforded an oil which 
was distilled to give 3-chloropheny1 acetate (90) (11.8 g, 89%), 
b.p. 49°C/0.01 mmHg (lit.,103 105-107°C/13 mmHg); 8H (60 MHz; CDC13) 2.20 
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(3H, s, Me) and 6.80 - 7.40 (4H, m, ArH); vrnax (KBr) /cm-1 1760 (CO). 
3-Bromophenyl acetate (91).lO3 The experimental procedure employed 
for the synthesis of 3-fluorophenyl acetate (89) was followed, using 
AC20 (8.7 ml, 93 mmol) , 3-bromophenol (10.0 g, 58 mmol) , and NaOH 
(3.7 g, 93 mmol) in H20 (ca. 70 ml). Work-up afforded an oil which was 
distilled to give 3-bromophenyl acetate (91) (10.8 g, 88%), 
b.p. 8l o C/l.5 mmHg (lit.,146 l49°C/40 mmHg); 6H (60 MHz; CDC13) 2.30 
(3H, s, Me) and 6.90 - 7.60 (4H, m, ArH); vrnax (KBr) /cm-1 1760 (CO). 
4-Chlorophenyl acetate (92). The experimental procedure employed for 
the synthesis of 3-fluorophenyl acetate (89) was followed, using AC20 
(10.4 ml, 0.110 mol), 4-chlorophenol (10.0 g, 78 mmol) , and NaOH 
(4.4 g, 0.110 mol) in H20 (ca. 75 ml). Work-up afforded an oil which 
was distilled to give 4-chlorophenyl acetate (92) (12.3 g, 93%), 
b.p. 69°C/0.3 mmHg (lit.,147 109°C/13 mmHg); 8H (60 MHz; CDC13) 2.25 
(3H, s, Me) and 6.90 - 7.60 (4H, m, ArH); Vrnax (liquid film) /cm-1 1755 
(CO). 
2-Hydroxy-4-methoxyacetophenone (93) .100 A mixture of resacetophenone 
(10.0 g, 66 mmol) , dry acetone (100 ml), and Me2S04 (4.8 ml, 50 mmol) 
was boiled under reflux over K2C03 (10.2 g, 74 mmol) for 6 h. The 
colour of the reaction mixture changed from a dark red to orange after 
ca. 1 h. The resulting solution was cooled and the acetone removed 
under reduced pressure. The excess Me2S04 was destroyed with a 25% 
ammonia-ice mixture (50 ml). The solution was then extracted with EtOAc 
(3 x 60 ml) and the combined organic solutions dried (anhyd. MgS04), 
evaporated, and distilled to afford 2-hydroxy-4-methoxyacetophenone (93) 
(9.5 g, 87%), b.p. 293°C/760 mmHg (lit.,IOO m.p. 48°C); 8H (60 MHz; 
CDC13) 2.50 (3H, s, COMe), 3.80 (3H, s, OMe) , 6.35 - 6.55 (2H, m , 3-H 
and 5-H), 7.65 (lH, d, J 9 Hz, 6-H) and 12.80 (lH, br s, OH); V~X 
(KBr) /cm-1 3400 - 2500 (OH) and 1625 (CO). 
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2-Hydroxy-4-nitroacetophenone (94).104 A mixture of 3-nitrophenyl 
acetate (88) (20.0 g, 0.110 mol), AICl3 (28.0 g, 0.210 mol), and dry, 
distilled nitrobenzene (100 ml) was heated at 140°C for 8 h. After 
cooling overnight, a mixture of ice (80 g) and conc. HCl (32 ml) was 
added and the resulting mixture was steam distilled. a The distillate 
was extracted with EtOAc and the combined organic solutions were 
extracted with 0.5~-NaOH. The combined aqueous solutions were 
acidified and extracted with EtOAc (3 x 80 ml). The combined organic 
solutions were dried (anhyd. MgS04) and evaporated to afford an oil 
which was distilled to give 2-hydroxy-4-nitroacetophenone (94) (7.6 g, 
38%), m.p. 60-61°C (from hexane) (lit. ,148 67-68°C); 8H (60 MHz; CDCI3) 
2.75 (3H, s, COMe), 7.60 - 8.20 (3H, m, ArH) and 12.40 (lH, br s, OH); 
V~X (KBr) /cm-1 3600 - 3300 (OH) and 1655 (CO). 
4-Fluoro-2-hydroxyacetophenone (95).101 A mixture of 3-fluorophenyl 
acetate (89) (6.2 g, 40 mmol) and AlCl3 (12.8 g, 96 mmol) was heated in 
an oil bath at 175-180 0 C for 1.5 h. The cooled mixture was treated with 
dil. HCI (ca. 110 ml) and then steam distilled. The distillate was 
extracted with CHCl3 (3 x 56 ml) and the combined extracts re-extracted 
with 0.5~-KOH (3 x 50 ml). The combined aqueous alkali solutions were 
washed with CHCl3 (2 x 56 ml), acidified, and extracted with CHCl3 
(3 x 56 ml). The CHCl3 solutions were then combined, dried (anhyd. 
MgS04), and evaporated to afford an oil which crystallised to give crude 
4-fluoro-2-hydroxyacetophenone (95) (4.9 g, 80%), m.p. 31-33°C 
a The bulk of the nitrobenzene was contained in the first two 400 ml 
fractions. 
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(from hexane) (lit. ,149 24°C); 8H (500 MHz; CDC13) 2.55 (3H, s, COMe), 
6.54 - 6.60 (2H, m, 3-H and 5-H), 7.71 (1H, dd, J 9 and 6 Hz, 6-H) and 
12.53 (1H, s, OH); vrnax (KBr) /cm-l 3500 - 2600 (OH) and 1645 (CO). 
4-Chloro-2-hydroxyacetophenone (96) ,101 The experimental procedure 
employed for the synthesis of 4-fluoro-2-hydroxyacetophenone (95) was 
followed, using 3-chlorophenyl acetate (90) (9.0 g, 53 romol) and AlC13 
(16.8 g, 0.126 mol). Work-up afforded an oil which was distilled to 
give 4-chloro-2-hydroxyacetophenone (96) (5.4 g, 60%), b.p. 77°C/1 mmHg 
(lit. ,101 121-124°C/15 mmHg); 8H (60 MHz; CDC13) 2.60 (3H, s, COMe), 
6.80 - 7.15 (2H, m, 3-H and 5-H), 7.70 (lH. d, J 8 Hz, 6-H) and 12.45 
(1H, br s, OH); vrnax (KBr) /cm-l 3500 - 2500 (OH) and 1645 (CO). 
4-Bromo-2-hydroxyacetophenone (97).101 The experimental procedure 
employed for the synthesis of 4-fluoro-2-hydroxyacetophenone (95) was 
followed, using 3-bromophenyl acetate (91) (10.0 g, 47 romol) and AlC13 
(20.3 g, 0.152 mol). In this case the reaction mixture was heated for 3 
h. Work-up afforded an oil which was distilled to give 4-bromo-2-
hydroxyacetophenone (97) (5.6g, 56%), m.p. 39-41°C (lit.,lOl 42-43°C); 8H 
(60 MHz; CDC13) 2.60 (3H, s, COMe), 6.95 - 7.30 (2H, m, 3-H and 5-H), 
7.65 (1H, d, J 8 Hz, 6-H) and 12.40 (lH, s. OH); vrnax (nujol mull) /cm-l 
3500 - 2500 (OH) and 1640 (CO). 
5-Chloro-2-hydroxyacetophenone (98). The experimental procedure 
employed for the synthesis of 4-fluoro-2-hydroxyacetophenone (95) was 
followed, using 4-chlorophenyl acetate (92) (11.0 g, 65 romol) and AlC13 
(20.5 g, 0.154 mol). Work-up afforded an oil which crystallised to 
afford 5-chloro-2-hydroxyacetophenone (98) (6.5 g, 59%), m.p. 51-53°C 
(lit.,150 52.5°C); &H (60 MHz; CDC13) 2.60 (3H, s, COMe), 6.80 - 7.80 
(3H, m, ArH) and 12.20 (1H, s, OH); vrnax (KBr) /cm-l 3600 - 2500 (OH) and 
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1650 (CO). 
Ethyl 4-(2-hydroxyphenyl)-2,4-dioxobutanoate (99).105 Diethyl oxalate 
(12.0 ml, 88 romol) and o-hydroxyacetophenone (7.2 ml, 60 romol) were 
added dropwise to a stirred ethanolic solution of NaOEt [generated in 
situ by adding Na metal (4.1 g, 0.180 mol) to dry EtOH (120 ml)]. The 
stirred, yellow mixture was gently boiled under reflux for 0.5 h 
becoming a thick, yellow slurry. After cooling, the mixture was poured 
into Et20 (450 ml) and allowed to stand for 0.5 h. The resulting 
yellow, sodium salt of (3a) was then filtered off, washed (Et20), and 
added to 2M-HCI (150 ml). The resulting semi-solid was extracted with 
Et20 (3 x 100 ml) and the combined organic solutions were dried (anhyd. 
MgS04) and evaporated to afford the diketone, ethyl 4-(2-hydroxyphenyl)-
2,4-dioxobutanoate (99) which was shown, by IH NMR spectroscopy, to be 
partially enolised and was used without further purification. 8H 
(60 MHz; DMSO-d6) 1.45 (3H, t, Me), 4.50 (2H, q, CH2Me) , 6.50 (lH, br s, 
OH), 7.10 (2H, s, COCH2) and 7.35 - 8.35 (4H, m, ArH). 
Ethyl 4-(2-hydroxy-4-methoxyphenyl)-2,4-dioxobutanoate (100) and ethyl 
2-hydroxy-7-methoxychromanone-2-carboxylate (IDS). The experimental 
procedure employed for the synthesis of ethyl 7-chloro-2-hydroxy-
chromanone-2-carboxylate (108) and ethyl 4-(4-chloro-2-hydroxyphenyl)-
2,4-dioxobutanoate (103) (p.137) was followed, using 2-hydroxy-
4-methoxyacetophenone (93) (8.0 g, 48 romol) , diethyl oxalate (9.7 ml, 
72 romol) , Na metal (1.7 g, 72 romol) , and dry EtOH (80 ml). In this case 
the reaction time was 70 min. Work-up afforded crude ethyl 
4-(2-hydroxy-4-methoxyphenyl)-2,4-dioxobutanoate (100) (8.7 g, 68%) 
[8H (60 MHz; CDCI3) 1.40 (3H, t, Me), 3.90 (3H, s, OMe) , 4.40 (2H, q, 
CH2Me) , 6.50 (lH, br s, OH), 7.10 (2H, s, COCH2) and 7.30 - 8.35 (3H, m, 
ArH»), which was used without further purification. During the 
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extraction (Et20, 3 x 67 ml), an insoluble interface was filtered off, 
dried under vacuum, acidified with 2~-HCl (50 ml), and extracted with 
EtOAc (3 x 67 ml). The combined organic solutions were dried (anhyd. 
MgS04) and evaporated to afford crude ethyl 2-hydroxy-7-
methoxychromanone-2-carboxylate (105) (1.6 g, 12%); BH (60 MHz; 
CDC13/DMSO-d6) 1.30 (3H, t, Me), 2.85 and 3.25 (2H, dd, J 17 Hz, COCH2), 
3.80 (3H, s, OMe) , 4.35 (2H, q, CH2Me) , 6.40 - 7.35 (3H, m, 6-H, 8-H and 
OH) and 7.90 (1H, d, J 8 Hz, 5-H). 
Ethyl 4-(2-hydroxy-4-nitrophenyl)-2,4-dioxobutanoate (lOl) and ethyl 
2-hydroxy-l-nitrochromanone-2-carboxylate (106) .105,106 A solution of 
2-hydroxy-4-nitroacetophenone (94) (6.0 g, 33 mmol) and diethyl oxalate 
(50.7 ml, 0.373 mol) was added dropwise to a stirred, ethanolic solution 
of NaOEt [generated in situ by adding Na metal (2.4 g, 0.105 mol) to dry 
EtOH (75 ml)]. The stirred, red solution was gently boiled under reflux 
for 45 min. becoming a red slurry. After cooling, the mixture was 
poured into Et20 (450 ml) and allowed to stand for 0.5 h. The red solid 
was filtered off, washed (Et20), and added to 2~-HCl (300 ml). The 
mixture was extracted with EtOAc (4 x 200 ml) and the combined organic 
solutions dried (anhyd. MgS04) and evaporated to afford a red solid 
shown, by IH NMR spectroscopy, to comprise a mixture of ethyl 
4-(2-hydroxy-4-nitrophenyl)-2,4-dioxobutanoate (101) (78%) [BH (60 MHz; 
DMSO-d6/CDC13) 1.35 (3H, t, Me), 4.35 (2H, m, CH2Me) , 7.20 (2H, s, 
COCH2), 7.60 - 8.60 (3H, m, ArH) and 9.15 (1H, br s, OH)] and ethyl 
2-hydroxy-7-nitrochromanone-2-carboxylate (106) (22%) [BH (60 MHz; 
DMSO-d6/CDC13) 1.35 (3H, t, Me), 3.00 and 3.40 (2H, dd, J 17 Hz, COCH2) 
4.50 (2H, m, CH2Me) , 7.60 - 8.60 (3H, m, ArH) and 9.15 (lH, br s, OH)], 
which was used without further purification. 
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Ethyl 4-(4-fluoro-2-hydroxyphenyl)-2,4-dioxobutanoate (102) and ethyl 
7-fluoro-2-hydroxychro~none-2-carboxylate (107). The experimental 
procedure employed for the synthesis of ethyl 7-chloro-2-hydroxy-
chromanone-2-carboxylate (108) and ethyl 4-(4-chloro-2-hydroxyphenyl)-
2,4-dioxobutanoate (103) was followed, using 4-fluoro-2-
hydroxyacetophenone (95) (2.0 g, 13 mmol) , diethyl oxalate (9.8 ml, 72 
mmol) , Na metal (1.2 g, 52 mmol) , and dry EtOH (30 ml). Work-up 
afforded a solid shown, by IH NMR spectroscopy, to comprise a mixture of 
ethyl 4-(4-fluoro-2-hydroxyphenyl)-2,4-dioxobutanoate (102) (62%) [8H 
(60 MHz; CDCI3) 1.00 - 1.65 (3H, m, Me), 4.15 - 4.75 (2H, m, CH2Me), 
6.35 (lH, br s, OH), 7.10 (2H, s, COCH2), 7.25 - 7.60 (2H, m, 6-H and 
8-H) and 8.30 (lH, dd, J 8 and 7 Hz, 5-H)] and ethyl 7-fluoro-2-
hydroxychromanone-2-carboxylate (107) (38%) [8H (60 MHz; CDCI3) 1.00 -
1.65 (3H, m, Me), 3.50 and 3.75 (2H, dd, J 7 Hz, CH2CO), 4.15 - 4.75 
(2H, m, CH2Me), 6.35 (lH, br s, OH), 7.25 - 7.60 (2H, m, 6-H and 8-H) 
and 8.30 (lH, dd, J 8 and 7 Hz, 5-H)], which was used without further 
purification. 
Ethyl 7-chloro-2-hydroxychromanone-2-carboxylate (108) and ethyl 
4-(4-chloro-2-hydroxyphenyl)-2,4-dioxobutanoate (103).103 A warm 
solution of 4-chloro-2-hydroxyacetophenone (96) (4.5 g, 26 mmol) and 
diethyl oxalate (19.9 ml, 0.147 mol) was added dropwise to a stirred 
ethanolic solution of NaOEt [generated in situ by adding Na metal (2.4 
g, 0.105 mol) to dry EtOH (44 ml)]. The stirred, yellow mixture was 
gently boiled under reflux for 40 min. becoming a thick, yellow slurry. 
After cooling, the mixture was poured into Et20 (108 ml) and allowed to 
stand for 0.5 h. The resulting yellow solid was filtered off, washed 
(Et20), and added to 2~-HCI (145 ml). The resulting semi-solid was 
extracted with Et20 (3 x 50 ml) and the combined organic solutions were 
dried (anhyd. MgS04) and evaporated to afford a solid shown, by IH NMR 
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spectroscopy, to comprise a mixture of ethyl 7-chloro-2-
hydroxychromanone-2-carboxylate (108) (63%) [8H (60 MHz; CDCI3/DMSO-d6) 
1.30 (3H, t, Me), 2.90 and 3.30 (2H, dd, J 16 Hz, COCH2), 4.35 (2H, q, 
CH2Me), 6.85 (1H, br s, OH), 7.00 - 7.25 (2H, m, 6-H and 8-H) and 7.85 
(lH, d, J 9 Hz, 5-H») and ethyl 4-(4-chloro-2-hydroxyphenyl)-2,4-
dioxobutanoate (103) (37%) [&H (60 MHz; CDCI3/DMSO-d6) 1.40 (3H, t, Me), 
4.35 (2H, q, CH2Me), 6.85 (IH, br s, OH), 7.00 - 7.25 (4H, m, COCH2' 6-H 
and 8-H) and 7.85 (lH, d, J 9 Hz, 5-H»), which was used without further 
purification. 
Ethyl 7-bromo-2-hydroxychro~none-2-carboxylate (109) and ethyl 
4-(4-bromo-2-hydroxyphenyl)-2,4-dioxobutanoate (104). The 
experimental procedure employed for the synthesis of ethyl 7-chloro-2-
hydroxychromanone-2-carboxylate (108) and ethyl 4-(4-chloro-2-
hydroxyphenyl)-2,4-dioxobutanoate (103) was followed, using 4-bromo-2-
hydroxyacetophenone (97) (4.5 g, 21 mmol) , diethyl oxalate (15.8 ml, 
0.116 mol), Na metal (2.3 g, 0.101 mol), and dry EtOH (71 ml). In this 
case EtOAc was used for the extraction. Work-up afforded a solid shown, 
by 1H NMR spectroscopy, to comprise a mixture of ethyl 7-bromo-2-
hydroxychromanone-2-carboxylate (109) (55%) [8H (60 MHz; CDCI3/DMSO-d6) 
1.35 (3H, t, Me), 2.90 and 3.30 (2H, dd, J 17 Hz, COCH2), 4.35 (2H, q, 
CH2Me) and 7.00 - 8.25 (4H, m, ArH and OH») and ethyl 4-(4-bromo-2-
hydroxyphenyl)-2,4-dioxobutanoate (104) (45%) [8H (60 MHz; CDCI3/DMSO-d6) 
1.35 (3H. t, Me), 4.35 (2H, q, CH2Me) and 7.00 - 8.25 (6H, m, COCH2' ArH 
and OH)], which was used without further purification. 
Ethyl chromone-2-carboxylate (110) .105 ,106 A mixture of crude ethyl 
4-(2-hydroxyphenyl}-2,4-dioxobutanoate (99), AcOH (60 ml), and cone. HCl 
(1 ml) was boiled under reflux for 40 min. After cooling, a mixture of 
ice and water (200 ml) was added and the resulting precipitate was 
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filtered and dissolved in EtOAc (100 ml). The solution was then washed 
with 5% aq. NaHC03 (3 x 50 ml), dried (anhyd. MgS04), and evaporated to 
afford crude ethyl chromone-2-carboxylate (110) (17.9 g, 69%),a m.p 72°C 
(from EtOH) (lit.,19 71-72°C); 8H (60 MHz; CDC13) 1.45 (3H, t, Me), 4.50 
(2H, q, CH2Me), 7.15 (lH, s, CH=C) , 7.30 - 8.00 (3H, m, 6-H, 7-H and 
8-H) and 8.25 (lH, d, J 8 Hz, 5-H); Vmax (KBr) /cm- l 1740 (CO.O) and 1650 
(CO) . 
Ethyl 7-ni trochromone-2-carboxylate (111) .105.106 A mixture (4:1) of 
crude ethyl 4-(2-hydroxy-4-nitrophenyl)-2,4-dioxobutanoate (101) and 
ethyl 2-hydroxy-7-nitrochromanone-2-carboxylate (106), AcOH (75 ml), and 
conc. HCl (trace, 5 drops) was boiled under reflux for 45 min. After 
cooling, a mixture of ice and water (150 ml) was added and the resulting 
precipitate was filtered and dissolved in EtOAc (500 ml). The solution 
was then washed with 5% aq. NaHC03 (4 x 80 ml), dried (anhyd. MgS04), 
and evaporated to afford crude ethyl 7-nitrochromone-2-carboxylate (111) 
(5.1 g, 58%),b m.p. 138°C (from EtOH) (lit. ,151 135-137°C); 8H (60 MHz; 
CDC13) 1.50 (3H, t, Me), 4.55 (2H, q, CH2Me), 7.25 (lH, s, CH=C) and 
8.20 - 8.75 (3H, m, ArH); vmax (KBr) /cm- l 1745 (CO.O) and 1660 (CO). 
Chromone-2-carboxylic acid (112) .105 
Method 1. A mixture of ethyl 4-(2-hydroxyphenyl)-2,4-dioxobutanoate 
(99), AcOH (30 ml), and conc. HCl (30 ml) was boiled under reflux for 1 
h. After cooling, the precipitated solid was filtered and 
recrystallized from AcOH to afford chromone-2-carboxylic acid (112) 
a Yield calculated on the basis of 2-hydroxyacetophenone. 
b Yield calculated on the basis of 2-hydroxy-4-nitroacetophenone (94). 
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(9.6 g, 84%),a m.p. 251°C (decomp.) (lit. ,105 250-25PC); 8H (60 MHz; 
DMSO-d6) 7.00 (lH, s, CH=C) , 7.35 - 8.25 (4H, m, ArH) and 8.90 (lH, br 
s, C02H); Vmax (KBr) /cm- l 3300 - 2100 (C02H), 1740 (C02H) and 1630 (CO). 
Method 2. 107 A mixture of ethyl chromone-2-carboxylate (110), AcOH 
(65 ml), 8N1-H2S04 (28 ml), and conc. HCl (15 ml) was boiled under reflux 
for 14 h. After cooling, H20 (110 m1) was added and the mixture was 
left to stand for 1 h. The precipitated solid was filtered off and 
recrystallised from AcOH to afford chromone-2-carboxy1ic acid (112) 
(9.9 g, 88%).a 
7-Methoxychromone-2-carboxylic acid (113). The experimental 
procedure employed for the synthesis of 7-chlorochromone-2-carboxylic 
acid (116) (p. 142) was followed, using crude ethyl 4-(4-methoxy-2-
hydroxypheny1)-2,4-dioxobutanoate (100) (8.7 g, 33 romo1) , AcOH (64 m1), 
and conc. HC1 (32 ml). In this case the reaction time was 1.5 h. Work-
up afforded crude 7-methoxychromone-2-carboxy1ic acid (113) (6.6 g, 
91%),b m. p . 266°C (decomp.) (from EtOH) [lit. ,152 270°C (decomp.)]; 8H 
(60 MHz; DMSO-d6) 3.95 (3H, s, OMe) , 6.90 (lH, s, CH=C) , 7.00 - 7.30 
(3H, m, 6-H , 8-H and OH) and 8.00 (lH, d, J 8Hz, 5-H); vmax (KBr) /cm- l 
3200 - 2100 (OH), 1735 (C02H) and 1625 (CO). 
7-Nitrochromone-2-carboxylic acid (114). 
Method 1. 107 A mixture of ethyl 7-nitrochromone-2-carboxy1ate (111) 
(0.9 g, 4 romol) , AcOH (4.0 m1), and 8N1-H2S04 (1.8 m1) was boiled under 
a Yield calculated on the basis of 2-hydroxyacetophenone. 
b Yield calculated on the basis of 2-hydroxy-4-methoxyacetophenone (93). 
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reflux for 12 h. After cooling, H20 (7 ml) was added and the resulting 
precipitate was filtered, dissolved in EtOAc (40 ml), and the solution 
was extracted with 5% aq. NaHC03 (3 x 50 ml). The combined aqueous 
solutions were acidified and extracted with EtOAc (3 x 40 ml). The 
organic solutions were combined, dried (anhyd. MgS04)' and evaporated to 
afford crude 7-nitrochromone-2-carboxylic acid (114) (0.5 g, 65%),a m.p. 
215°Cb (from EtOH); 8H (60 MHz; CD30D) 7.20 (lH, s, CH=C) and 8.30 -
8.70 (3H, m, ArH); vmax (KBr) /cm-1 3300 - 2100 (C02H), 1730 (C02H) and 
1640 (CO). 
Method 2. 106 A solution of ethyl 7-nitrochromone-2-carboxylate (111) (3.0 
g, 11 romol) and 45% HBr in AcOH (7.7 ml, 43 romol) was boiled under 
reflux for 1.5 h. After cooling, H20 (31 ml) was added and the 
resulting precipitate was filtered and shown, by 1H NMR spectroscopy, to 
comprise a mixture of ethyl 7-nitrochromone-2-carboxylate (111) (72%) 
and 7-nitrochromone-2-carboxylic acid (114) (27%). The solid was 
dissolved in EtOAc (50 ml) and extracted with 5% aq. NaHC03 (2 x 50 ml). 
The combined aqueous alkali solutions were then acidified and extracted 
with EtOAc (3 x 50 ml). The organic solutions were combined, dried 
(anhyd. MgS04), and evaporated, and the residue was recrystallised from 
EtOH to afford 7-nitrochromone-2-carboxylic acid (114) (0.9 g, 33%). 
7-Fluorochromone-2-carboxylic acid (115). The experimental procedure 
employed for the synthesis of 7-chlorochromone-2-carboxylic acid (116) 
(p.142) was followed, using a mixture (3:2) of crude ethyl 4-(4-fluoro-2-
hydroxyphenyl)-2,4-dioxobutanoate (102) and ethyl 7-fluoro-2-
a Yield calculated on the basis of 2-hydroxy-4-nitroacetophenone (94). 
b No melting point is given in the abstract106 describing the second 
procedure for the synthesis of 7-nitrochromone-2-carboxylic acid (114). 
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hydroxychromanone-2-carboxylate (107), AcOH (10.8 ml), and cone. HCl 
(5.5 ml). Work-up afforded crude 7-fluorochromone-2-carboxylic acid 
(115) (2.2 g, 81%),a m.p. 230°C (from EtOH); (Found: C, 57.4; H, 2.5. 
ClOH5F04 requires: C, 57.7; H, 2.4%); 8H (500 MHz; DMSO-d6) 6.B4 (lH, s, 
CH=C) , 7.32 - 7.36 (lH, m, 6-H), 7.60 (lH, dd, Jm 2 Hz and 3JHF 10 Hz, 
B-H), 8.03 (lH, dd, Jo 9 Hz and 4JHF 6 Hz, 5-H) and 8.9 (60 MHz; 1H, br 
s, C02H); Be (75 MHz; DMSO-d6) 105.60 (d, 2JCF 26 Hz, C-B), 113. 67 
(C-3), 114.69 (d, 2JCF 23 Hz, C-6), 120.92 (C-4a), 127.82 (d, 3JCF 11 Hz, 
C-5), 153.56 (C-2), 156.56 (d, 3JCF 14 Hz, C-Ba), 161.16 (C02H), 165.49 
(d, 1JCF 253 Hz, C-7) and 176.66 (C-4); vmax (KBr) /cm-l 3300 - 2700 
(C02H), 1740 (C02) and 1630 (CO); m/z 208 (}t, 100%). 
7-Chlorochromone-2-carboxylic acid (116) .103 A mixture (9:5) of crude 
ethyl 7-chloro-2-hydroxychromanone-2-carboxylate (108) and ethyl 
4-(4-chloro-2-hydroxyphenyl)-2,4-dioxobutanoate (103), AcOH (22 ml), and 
cone. HCI (11 ml) was boiled under reflux for 1.5 h. After cooling, H20 
(36 ml) was added and the resulting precipitated solid was filtered and 
recrystallised from EtOH to afford 7-chlorochromone-2-carboxylic acid 
(116) (3.5 g, 59%),b m.p. 236°C (decomp.) (lit. ,103 248-250 0 C); 8H (60 
MHz; DMSO-d6) 6.75 (lH, br s, C02H) , 7.00 (lH, s, CH=C) , 7.60 (lH, dd, J 
8 and 2 Hz, 6-H), 7.90 (lH, d, J 2 Hz, B-H) and B.10 (lH, d, J 8 Hz, 
5-H); vmax (KBr) /cm-l 3200 - 2300 (C02H), 1710 (C02H) and 1650 (CO). 
The crude product was sublimed to yield ethyl 
7-chlorochromone-2-carboxylate m.p. 106-108°C (lit.,5l 108-109°C); 8H 
(500 MHz; DMSO-d6) 1.42 (3H, t, Me), 4.45 (2H, q, CH2Me) , 7.09 (lH, s, 
CH=C) , 7.40 (lH, d, J 2 and 9 Hz, 6-H), 7.63 (lH, d, J 2 Hz, 8-H) and 
8.12 (lH, d, J 9 Hz, 5-H); vmax (KBr) /cm-l 1740 (C02H) and 1655 (CO); 
a Yield calculated on the basis of 4-fluoro-2-hydroxyacetophenone (95). 
b Yield calculated on the basis of 4-chloro-2-hydroxyacetophenone (96). 
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m/ z 252 (35CI, 11'", 100%). 
7-Bromochromone-2-carboxylic acid (117).51 The experimental 
procedure employed for the synthesis of 7-chlorochromone-2-carboxylic 
acid (116) was followed, using a mixture (11:9) of crude ethyl 7-bromo-
2-hydroxychromanone-2-carboxylate (109), and ethyl 4-(4-bromo-2-
hydroxyphenyl)-2,4-dioxobutanoate (104) AcOH (16.4 ml), and conc. HCI 
(8.7 ml). Work-up afforded crude 7-bromochromone-2-carboxylic acid 
(117) (2.2 g, 81%) ,a m.p. 247°C (decamp.) (from EtOH) (lit. ,51 252-
253°C); &H (60 MHz; DMSO-d6), 7.00 (lH, s, CH=C) , 7.60 - 8.20 (3H, m, 
ArH) and 9.05 (lH, br s, C02H); vrnax (KBr) /cm-1 3200 - 2100 (C02H), 1720 
(C02H) and 1630 (CO). 
6-Chlorochromone-2-carboxylic acid (118). The experimental procedure 
employed for the synthesis of ethyl 7-chloro-2-hydroxychromanone-2-
carboxylate (108) and ethyl 4-(4-chloro-2-hydroxyphenyl)-2,4-
dioxobutanoate (103) was followed, using 5-chloro-2-hydroxyacetophenone 
(98) (4.5 g, 26 mmol) , diethyl oxalate (19.9 ml, 0.147 mol), Na metal 
(2.4 g, 0.105 mol), and dry EtOH (44 ml). Work-up afforded a solid 
which was used without further purification. The experimental procedure 
employed for the synthesis of 7-chlorochromone-2-carboxylic acid (116) 
was then followed using the crude solid, AcOH (22 ml), and cone. HCI 
(11 ml). Work-up afforded a solid which was recrystallised from EtOH to 
afford 6-chlorochromone-2-carboxylic acid (118) (3.0 g, 51%),b m.p. 
253°C (decomp.) (from EtOH) (lit. ,150,153 275°C, 267-269°C and 262°C); &H 
(60 MHz; DMSO-d6) 5.65 (lH, br s, C02H) , 7.00 (lH, s, CH=C) , 7.75 - 7.95 
(2H, m, 7-H and 8-H) and 8.05 (lH, d, J 1 Hz, 5-H); vrnax (KBr) /cm-1 3300 
a Yield calculated on the basis of 4-bromo-2-hydroxyacetophenone (97). 
b Yield calculated on the basis of 5-chloro-2-hydroxyacetophenone (98). 
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- 2000 (C02H), 1735 (C02H) and 1630 (CO). 
Ethyl 3-methylchromone-2-carboxylate (119).107 A mixture of 
o-hydroxypropiophenone (10.0g, 67 mmol) and diethyl oxalate (27.1 ml, 
0.200 mol) was cooled in an ice-bath. NaH (50% dispersion in oil; 
9.6 g, 0.200 mol) was then added portionwise to the vigorously stirred 
mixture. The ice-bath was removed occasionally to allow the reaction to 
proceed and dry Et20 (100 ml) was then added to disperse the NaH within 
the slurry. After the addition of the NaH, the mixture was stirred at 
ca. DOC for 30 min. and at room temperature for 48 h. The solid 
material was filtered and added portionwise to a stirred mixture of AcOH 
(16 ml), H20 (50 ml), and ice (40 g). After stirring for 2h, the 
mixture was extracted with Et20 (3 x 50 ml). The combined ethereal 
extracts were washed with H20 (2 x 50 ml), dried (anhyd. MgS04), and 
evaporated. The residue was then dissolved in AcOH (20 ml) and conc. 
HCl (2 ml), and the resulting mixture was boiled under reflux for 0.5 h. 
After cooling, H20 (20 ml) was added and the mixture was cooled in an 
ice-bath. The resultant precipitate was filtered, dissolved in Et20 
(125 ml), and the solution was sequentially washed with 5% aq. NaHC03 
(2 x 50 ml) and H20 (50 ml), and dried (anhyd. MgS04)' The solvent was 
evaporated to afford crude ethyl 3-methylchromone-2-carboxylate (119) 
(7.9 g, 51%). The oil present in the filtrate was similarly extracted 
to afford additional crude ethyl 3-methylchromone-2-carboxylate (119) 
(1.0 g, 7%, overall 59%), m.p. 91-92°C (from EtOH) (lit.,107 89-90 0 C); 8H 
(60 MHz; CDC13) 1.45 (3H, t, CH2Me) , 2.35 (3H, s, CMe=C), 4.50 (2H, q, 
CH2Me) and 7.30 - 8.40 (4H, m, ArH); vrnax (KBr) /cm-1 1730 (CO.O) and 
1645 (CO). 
3-Methylchromone-2-carboxylic acid (120).107 A solution of ethyl 3-
methylchromone-2-carboxylate (119) (6.5 g, 28 mmol) , AcOH (26 ml), and 
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7~-H2S04 (22 ml) was boiled under reflux for 12 h. After cooling, H20 
(52 ml) was added and the resultant solid was filtered, dried, and 
recrystallised from EtOH to afford 3-methylchromone-2-carboxylic acid 
(120) (2.7 g, 49%), m.p. 230°C (lit.,I07 233-234°C); 8H (60 MHz; 
DMSO-d6/CDCI3) 2.30 (3H, s, Me), 7.30 - 8.30 (4H, m, ArH) and 10.55 (lH, 
br s, C02H); vmax (KBr) /cm- l 3400 - 2300 (C02H), 1730 (C02H) and 1615 
(CO). 
Ghromone-2-carbonyl chloride (121).64 
Method 1. SOCl2 (0.88 ml, 12 mmol) was added to a suspension of 
chromone-2-carboxylic acid (112) (1.8 g, 9 mmol) in dry 
1,2-dichloroethane (11 ml) and N,N-dimethylformamide (0.18 ml, 2.3 
mmol). The mixture was boiled under reflux for 1 h, cooled, and then 
concentrated under reduced pressure. Additional 1,2-dichloroethane 
(12 ml) was added to the concentrate and the resulting solution was 
evaporated to afford crude yellow chromone-2-carbonyl chloride (121) 
[m.p 92-93°C (sublimed) (lit.,I54 104-108°C); 8H (60 MHz; CDCI3) 7.30 
(lH, s, CH=C) and 7.40 - 8.40 (4H, m, ArH); vmax (KBr) /cm-1 1730 (CO.Cl) 
and 1625 (CO)], which was used without further purification. 
Attempted Preparation. 154 PCl5 (6.0 g, 29 mmol) was added to a stirred 
slurry of chromone-2-carboxylic acid (112) (5.0 g, 26 mmol) in 
cyclohexane (70 ml), and the resulting mixture was boiled under reflux 
for 1h. The solution was maintained at ca. 1°C for 15 h and the solvent 
was then evaporated to afford a solid residue shown, by IH NMR 
spectroscopy, to be starting material. 
7-Methoxychromone-2-carbonyl chloride (122). The experimental 
procedure employed for the synthesis of chromone-2-carbonyl chloride 
(121) was followed, using 7-methoxychromone-2-carboxylic acid (113) 
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(1.8 g, 8 mmol) , dry 1,2-dichloroethane (12 ml), N,N-dimethylformamide 
(0.16 ml, 2.0 mmol) , and SOCl2 (0.77 ml, 10.6 mmol). In this case the 
reaction time was 2 h. Work-up afforded crude green crystalline 
7-methoxychromone-2-carbonyl chloride (122) [8H (60 MHz; DMSO-d6/CDCI3) 
3.95 (3H, s, OMe), 6.95 (lH, s, CH=C) , 7.00 - 7.30 (2H, m, 6-H and 8-H) 
and 8.05 (lH, d, J 8 Hz, 5-H); vrnax (1,2-dichloroethane) /cm-1 1740 
(CO.CI) and 1620 (CO)], which was used without further purification. 
7-Nitrochromone-2-carbonyl chloride (123). SOCl2 (0.91 ml, 12.5 
mmol) was added to a suspension of 7-nitrochromone-2-carboxylic acid 
(114) (2.3 g, 10 mmol) in dry dioxan (13 ml) and N,N-dimethylformamide 
(0.18 ml, 2.3 mmol). The mixture was boiled under reflux for 2 h, 
cooled, and then concentrated under reduced pressure. Additional dry 
dioxan (10 ml) was added to the concentrate and the resulting solution 
was evaporated and dried under vacuum for 1h at 50°C to afford a brown 
solid shown, by IH NMR spectroscopy, to comprise a mixture of 
7-nitrochromone-2-carbonyl chloride (123) (81%) [8H (60 MHz; CDCI 3) 7.40 
(lH, s, CH=C) and 8.35 - 8.70 (3H, m, ArH)] and 7-nitrochromone-2-
carboxylic acid (6c) (19%) [(60 MHz; CDCI3) 7.40 (lH, s, CH=C) , 8.35 -
8.70 (3H, m, ArH) and 11.65 (lH, br s, OH)], which was used without 
further purification. 
7-Fluorochromone-2-carbonyl chloride (124). The experimental 
procedure employed for the synthesis of chromone-2-carbonyl chloride 
(121) was followed, using 7-fluorochromone-2-carboxylic acid (115) (1.2 
g, 6 mmol) , dry 1,2-dichloroethane (7 ml), N,N-dimethylformamide (0.11 
ml, 1.4 mmol) , and SOCl2 (0.55 ml, 7.6 mmol). In this case the reaction 
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time was 1.5 h. Work-up afforded crude brown crystalline 
7-fluorochromone-2-carbonyl chloride (U4) [m.p 113-115°C (sublimed); BH 
(60 MHz; CDCI3/1,2-dichloroethane) 7.25 - 7.40 (2H, m, 6-H and 8-H), 
7.50 (lH, s, CH=C) and 8.15 - 8.50 (lH, m, 5-H); vmax (KBr) /cm-1 1765 
(CO.CI) and 1650 (CO)], which was used without further purification. 
7-Chlorochromone-2-carbonyl chloride (US). The experimental 
procedure employed for the synthesis of chromone-2-carbonyl chloride 
(U1) was followed, using 7-chlorochromone-2-carboxylic acid (116) 
(1.8 g, 8 mmol) , dry 1,2-dichloroethane (13 ml), N,N-dimethylformamide 
(0.15 ml, 2.0 mmol) , and SOCl2 (0.76 ml, 10.4 mmol). In this case the 
reaction time was 1.5 h. Work-up afforded crude brown crystalline 
7-chlorochromone-2-carbonyl chloride (125) [m.p 179-182°C (sublimed); BH 
(60 MHz; CDCI3) 7.35 (lH, s, CH=C) , 7.55 (lH, dd, J 2 and 9 Hz, 6-H), 
7.70 (lH, d, J 2 Hz, 8-H) and 8.20 (lH, d, J 9 Hz, 5-H); vmax (KBr) /cm-1 
1760 (CO.CI) and 1650 (CO)], which was used without further 
purification. 
7-Bromochromone-2-carbonyl chloride (U6). The experimental 
procedure employed for the synthesis of chromone-2-carbonyl chloride 
(121) was followed, using 7-bromochromone-2-carboxylic acid (117) (1.8 g, 
7 mmol) , dry 1,2-dichloroethane (8 ml), N,N-dimethylformamide (0.13 ml, 
1.7 mmol) , and SOCl2 (0.65 ml, 8.9 mmol). In this case the reaction 
time was 1.5 h. Work-up afforded crude red crystalline 7-bromochromone-
2-carbonyl chloride (U6) [BH (60 MHz; CDCI3) 7.35 (lH, s, CH=C) , 7.65 (lH, 
dd, J 2 and 8 Hz, 6-H), 7.90 (lH, d, J 2 Hz, 8-H) and 8.15 (lH, d, J 9 
Hz, 5-H); Vmax (KBr) /cm-1 1740 (CO.Cl) and 1640 (CO)], which was used 
without further purification. 
3-Methylchromone-2-carbonyl chloride (127). The experimental 
procedure employed for the synthesis of chromone-2-carbonyl chloride 
(121) was followed, using 3-methylchromone-2-carboxylic acid (120) 
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(0.9 g, 4 mmol) , dry l,2-dichloroethane (5 ml), N,N-dimethylformamide 
(0.08 ml, 1.1 mmol) , and SOCl2 (0.41 ml, 5.6 mmol). In this case the 
reaction time was 2 h. Work-up afforded crude yellow crystalline 
3-methylchromone-2-carbonyl chloride (127) [BH (60 MHz; CDC13/1,2-
dichloroethane) 2.35 (3H, s, CMe=C), 7.35 - 8.40 (4H, m, ArH); Vrnax 
(KBr) /cm-1 1760 (CO.CI) and 1640 (CO)], which was used without further 
purification. 
Dimethylammonium chloride (128). HCI gas was bubbled through a 
stirred solution of ethanolic Me2NH (25% w/w; 18 ml, 77 mmol) and dry 
EtOH (40 ml) for 2 h at ca. OOC. The solvent was evaporated and the 
white crystalline slurry was dried under vacuum for 1h. Dry Et20 (ca. 
40 ml) was added and the mixture was cooled to ca. OOC. The solvent was 
decanted off and the crystals dried under vacuum for 1h. The crystals 
were then washed with Et20 (6 x 10 ml) by filtration under N2 and vacuum 
dried for 1 h to afford crude dimethylammonium chloride (128) (6.4 g, 
102%), m.p. 142-143°C (lit.,155 157°C); 8H (CDCI3) 2.80 (6H, t, Me) and 
9.45 (lH, br s, NH). 
N,N-Dimethylchromone-2-carboxamide (129). 
Method 1. 110 A slurry of dimethylammonium chloride (128) 
(1.5 g, 18 mmol) in dry pyridine (5 ml) was added slowly to a precooled 
(-SOC), stirred suspension of chromone-2-carbonyl chloride (121) (1.9 g, 
9 mmol) in dry pyridine (15 ml), ensuring that the temperature of the 
resulting black mixture did not exceed ~OC. The reaction mixture was 
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stirred at OOC for 2 h and at room temperature for 20 h, and was then 
poured into 2~-HCI (200 ml), allowed to stand for 0.5 h, and extracted 
with EtOAc (4 x 70 ml). The organic extracts were combined, 
sequentially washed with 5% aq. NaHC03 (2 x 50 ml) and saturated aqueous 
NaCI (1 x 50 ml), dried (anhyd. MgS04), and evaporated to afford 
N,N-dimethylchromone-2-carboxamide (129) (1.5 g, 76%).a,b The crude 
solid was chromatographed [flash chromatography on silica gel; elution 
with EtOAc] to afford N,N-dimethylchromone-2-carboxamide (129) (1.2 g, 
62%) ,a m.p. 115-116°C (from EtOAc) (lit. ,17 115-116°C); BH (300 MHz; 
CDCI3) 3.10 (6H, br s, NMe2) , 6.49 (lH, s, CH=C) , 7.37 - 7.47 (2H, m, 
6-H and B-H), 7.64 - 7.70 (lH, m, 7-H) and B.15 (lH, dd, J 2 and 8 Hz, 
5-H); Be (75 MHz; CDCI3) 35.41 and 38.27 (NMe2) , 111.58 (C-3), 118.13 
(C-B), 124.20 (C-4a), 125.73 (C-5 and C-6), 134.25 (C-7), 155.66 (C-8a), 
158.20 (C-2), 162.27 (CO.N) and 177.42 (C-4); vmax (KBr) /cm-1 3060 (CH), 
1645 and 1640 (CO); Amax (EtOH) fnm 215 (E /dm3 mol-1 cm-1 16 929), 226 
(19 907) and 301 (8 710). 
Method 2. 64 Chromone-2-carbonyl chloride (121) (1.9 g, 9 mmol) was 
cautiously added to a precooled (OOC), stirred solution of aqueous Me2NH 
(43% w/w; 1.14 ml, 9.6 mmol) and NaHC03 (1.3 g, 15 mmol) in ice-cold H20 
(11 ml). The mixture was stirred at ca. OOC for 1h and the resulting 
precipitate was filtered and washed (5% aq. NaHC03)' The crude solid 
(0.7 g) was shown, by IH NMR spectroscopy, to comprise a mixture (1:3) 
of chromone-2-carboxylic acid (112) and N,N-dimethylchromone-2-
carboxamide (129). The mixture was dissolved in CHCl3 (40 ml) and the 
solution was sequentially washed with 5% aq. NaHC03 (2 x 30 ml) and 
a Yield calculated on the basis of chromone-2-carboxylic acid (112). 
b Optimised reaction; yields using 1 and 1.5 molar equivalents of 
dimethylammonium chloride (128) were 65% and 71% respectively. 
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saturated aqueous NaCI (1 x 30 ml), and then dried (anhyd. MgS04). The 
solvent was evaporated and the residue recrystallised from EtOAc to 
afford N,N-dimethylchromone-2-carboxamide (129) (0.2 g, 10%).a The 
crude mother liquors were chromatographed [flash chromatography on silica 
gel; elution with EtOAc] to afford additional N,N-dimethylchromone-2-
carboxamide (129) (0.1 g, 5%).a 
Method 3. The first experimental procedure employed for the synthesis 
of N,N-dimethylchromone-2-carboxamide (129) was followed, using 
chromone-2-carbonyl chloride (121) (1.9 g, 9 mmol) , ethanolic Me2NH 
(33% w/w; 1.75 ml, 9.6 mmol) , and dry pyridine (19 ml). In this case 
the reaction time at room temperature was 15 h. Work-up afforded a 
solid (1.7 g) shown, by IH NMR spectroscopy, to comprise a mixture (1:2) 
of N,N-dimethylchromone-2-carboxamide (129) (0.6 g, ca. 28%) and ethyl 
chromone-2-carboxylate (110) (1.1 g, ca. 56%). 
Attempted preparation. 17 A solution of ethyl chromone-2-carboxylate 
(110) (2.0 g, 9 mmol) , ethanolic Me2NH (33% w/w; 1.26 m1, 7.0 mmol) , and 
dry EtOH (50 ml) was stirred at room temperature for 2 days and 21 h, 
and then boiled under reflux for 9 h. After cooling. the solution was 
evaporated to afford starting material (2.0 g). 
The first 7-Methoxy-N,N-dimethylchromone-2-carboxan.dde (130). 
experimental procedure employed for the synthesis of 
N,N-dimethylchromone-2-carboxamide (129) was followed, using 
7-methoxychromone-2-carbonyl chloride (122) (1.9 g, 8 mmol) , 
dimethylammonium chloride (128) (1.3 g. 16 mmol). and dry pyridine 
(20 ml). In this case the reaction time at room temperature was 24.5 h. 
a Yield calculated on the basis of chromone-2-carboxylic acid (112). 
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Work-up afforded crude 7-methoxy-N,N-dimethylchromone-2-csrboxao.Ude 
(130) (1.8 g, 92%)a which was chromatographed [flash chromatography on 
silica gel; elution with EtOAc] to afford 7-methoxy-N,N-
dimethylchromone-2-carboxao.Ude (130) (1.7 g, 83%),a m.p. 120-122°C (from 
EtOAc); (Found: C, 63.0; H, 5.1; N, 5.7. C13H13N04 requires: C, 63.15; 
H, 5.3; N, 5.7%); 8H (300 MHz; CDC13) 3.10 and 3.11 (6H, 2 x s, NMe2) , 
3.89 (3H, s, OMe) , 6.45 (lH, s, CH=C) , 6.85 (lH, d, J 2 Hz, 8-H), 6.98 
(lH, dd, J 2 and 8 Hz, 6-H) and 8.10 (lH, d, J 8 Hz, 5-H); 8 e (75 MHz; 
CDCl3) 35.53 and 38.50 (NMe2) , 55.91 COMe), 100.39 (C-8), 111.68 (C-3), 
115.00 (C-6), 118.05 (C-4a), 127.13 (C-5), 157.43 (C-8a), 157.50 (C-2), 
162.32 (CO.N), 164.41 (C-7) and 176.69 (C-4); vmax (KBr) /cm-1 2995 (CH), 
1660 and 1650 (CO); Amax (EtOH) /nm 217 (8 /dm3 mol-1 cm-1 25 769), 229 
(21 300) and 298 (12 277); m/z 247 (If, 100%). 
N ,N-Dimethyl-7-nitrochromone-2-csrboxso.Ude (131). The first 
experimental procedure employed for the synthesis of 
N,N-dimethylchromone-2-carboxamide (129) was followed, using a mixture 
(4:1; 2.6 g) of crude 7-nitrochromone-2-carbonyl chloride (123) (8 mmol) 
and 7-nitrochromone-2-carboxylic acid (114), dimethylammonium chloride 
(128) (1.3 g, 16 mmol) , and pyridine (20 ml). In this case the reaction 
time at room temperature was 13 h. Work-up afforded crude brown 
N,N-dimethyl-7-nitrochromone-2-csrboxso.Ude (131) (1.7 g, 68%)b which was 
chromatographed (flash chromatography on silica gel; elution with EtOAc] 
to afford N,N-dimethyl-7-nitrochromone-2-csrboxso.Ude (131) (1.7 g, 
66%),b m.p. 152-153°C (from EtOAc); (Found: C, 55.4; H, 3.8; N, 10.6. 
a Yield calculated on the basis of 7-methoxychromone-2-carboxylic acid 
(113) • 
b Yield calculated on the basis of 7-nitrochromone-2-carboxylic acid 
(114) • 
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and 3.15 (6H, 2 x s, NMe2) , 6.61 (lH, s, CH=C) , 8.23 (lH, dd, J 2 and 8 
Hz, 6-H) and 8.33 - 8.40 (2H, m, 5-H and 8-H): Be (75 MHz; CDCI3) 35.65 
and 38.40 (NMe2) , 112.41 (C-3), 114.55 (C-8), 119.97 (C-6), 127.86 
(C-5), 150.83 (C-7), 154.99 (C-8a), 159.28 (C-2), 161.33 (CO.N) and 
175.81 (C-4); vmax (KBr) /cm-1 1670 and 1655 (CO); Amax (EtOH) /nm 212 
(E Idm3 mol-1 cm-1 19 846),252 (20 137) and 322 (5 712); mlz 262 (M", 
73%) and 72 (100%). 
l-Fluoro-N,N-dimethylchromone-2-carboxanrlde (132). 
Method 1. The first experimental procedure employed for the synthesis 
of N,N-dimethylchromone-2-carboxamide (129) was followed, using 
7-fluorochromone-2-carbonyl chloride (115) (1.3 g, 6 mmol) , 
dimethylammonium chloride (128) (1.0 g, 12 mmol) , and dry pyridine 
(14 ml). Work-up afforded crude brown 7-fluoro-N,N-dimethylchromone-2-
carboxanrlde (132) (1.0 g, 76%)a which was chromatographed [flash 
chromatography on silica gel; elution with EtOAc] to afford 7-fluoro-
N,N-dimethylchromone-2-carboxanrlde (132) (0.9 g, 64%).a 
Method 2. The second experimental procedure employed for the synthesis 
of N,N-dimethylchromone-2-carboxamide (U9) was followed, using 
7-fluorochromone-2-carbonyl chloride (U4) (1.9 g, 9 mmol) , aqueous 
Me2NH (43% w/w; 1.20 ml, 10.1 mmol) , NaHC03 (1.2 g, 14 mmol) , and H20 
• 
(10 ml). Work-up afforded a solid (1.1 g) shown, by TLC, to comprise a 
mixture of two components. The mixture was chromatographed [flash 
a Yield calculated on the basis of 7-fluorochromone-2-carboxylic acid 
(115) • 
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chromatography on silica gel; elution with EtOAc] to afford a solid 
(0.9 g, 43%)a which was recrystallized from EtOAc to give 7-fluoro-N,N-
dimethylchromone-2-carboxan.llde (n2) (0.5 g, 25%),a m.p. 144-146°C; 
(Found: C, 61.85; H, 4.3; N, 6.1. C12HIOFN03 requires: C, 61.3; H, 4.3; 
N, 6.0%); BH (300 MHz; CDCI3) 3.11 (6H, s, NMe2) , 6.50 (lH, s, CH=C) , 
7.10 - 7.20 (2H, m, 6-H and 8-H) and 8.16 - 8.24 (lH, m, 5-H); Be (125 
MHz; CDCI3) 35.30 and 38.14 (NMe2) , 104.77 (d, 2JCF 26 Hz, C-8), 111.58 
(C-3), 114.39 (d, 2JCF 23 Hz, C-6), 120.92 (C-4a), 128.14 (d, 3JCF 11 Hz, 
C-5) 156.47 (d, 3JCF 14 Hz, C-8a), 158.25 (C-2), 161.72 (CO.N), 165.66 
(d, IJCF 256 Hz, C-7) and 176.15 (C-4); vmax (KBr) /cm-1 1660 and 1648 
(CO); "'max (EtOH) /nm 223 (8 Idm3 mol-1 cm-1 18 558), 263 (8 687) and 296 
(8 782); m/z 235 (}t, 100%) and 72 (100%). 
7-Chloro-N,N-dimethylchromone-2-carboxsn.llde (133). 
Method 1. The first experimental procedure employed for the synthesis 
of N,N-dimethylchromone-2-carboxamide (U9) was followed, using 
7-chlorochromone-2-carbonyl chloride (125) (2.0 g, 8 mmol) , 
dimethylammonium chloride (US) (1.3 g, 16 mmol) , and dry pyridine 
(20 ml). In this case the reaction time at DOC was 2.5 h, and at room 
temperature was 19.5 h. Work-up afforded crude brown 7-chloro-N,N-
dimethylchromone-2-csrboxsn.llde (n3) (1.6 g, 80%)b which was 
chromatographed [flash chromatography on silica gel; elution with EtOAc] 
a Yield calculated on the basis of 7-fluorochromone-2-carboxylic acid 
(115) • 
b Yield calculated on the basis of 7-chlorochromone-2-carboxylic 
acid (116). 
to afford 7-chloro-N,N-dimethylchromone-2-csrboxsndde (133) 
(1. 4 g, 72%). a 
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Method 2. The second experimental procedure employed for the synthesis 
OL N,N-dimethylchromone-2-carboxamide (129) was followed, using 
7-chlorochromone-2-carbonyl chloride (125) (1.9 g, 8 mmol) , aqueous 
Me2NH (43% w/w; 0.99 ml, 8 mmol) , NaHC03 (1.2 g, 14 mmol) , and H20 
(10 ml). Work-up afforded a solid (1.2 g) shown, by TLC, to comprise a 
mixture of two components, which was chromatographed [flash 
chromatography on silica gel; elution with EtOAc] to afford a solid 
(0.8 g, 38%)a which was recrystallised from EtOAc to give 7-chloro-N,N-
dimethylchromone-2-csrboxamide (133) (0.4 g, 22%),a m.p. 146-147°C; 
(Found : C, 57.3; H, 3. 7; N, 5.5. C12HlOCIN03 require s : C, 57.3; H, 4.0; 
N, 5.6%); BH (500 MHz; CDCI3) 3.09 (6H, s, NMe2) , 6.49 (lH, s, CH=C) , 
7.37 (lH, dd, J 2 and 9 Hz, 6-H), 7.47 (lH, d, J 2 Hz, 8-H) and 8.10 
(lH, d, J 9 Hz, 5-H); Be (75 MHz; CDCI3) 35.48 and 38.27 (NMe2) , 111.95 
(C-3), 118.23 (C-8), 122.76 (C-4a), 126.67 and 127.17 (C-5 and C-6), 
140.40 (C-7), 155.75 (C-8a), 158.23 (C-2), 161.91 (CO.N) and 176.55 
(C-4); Vmax (KBr) fcm-1 1658 and 1650 (CO); Amax (EtOH) fnm 224 
(10 fdm3 mol-1 cm-1 19 810),274 (9 390) and 304 (9 310); m/z 251 (35CI, 
}t, 54%) and 123 (100%). 
7-Bromo-N,N-dimethylchromone-2-csrboxsndde (134). 
Method 1. The first experimental procedure employed for the synthesis 
of N,N-dimethylchromone-2-carboxamide (129) was followed, using 
a Yield calculated on the basis of 7-chlorochromone-2-carboxylic acid 
(116) • 
7-bromochromone-2-carbonyl chloride (126) (1.9 g, 7 mmol) , 
dimethylammonium chloride (128) (1.1 g, 14 mmol) , and dry pyridine 
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(20 ml). In this case the reaction time at room temperature was 14 h. 
Work-up afforded crude 7-bromo-N,N-dimethylchromone-2-csrboxsnUde (04) 
(1.9 g, 96%)a which was chromatographed [flash chromatography on silica 
gel; elution with EtOAc] to afford 7-bromo-N,N-dimethylchramone-2-
csrboxsnUde (134) (1.5 g, 77%).a 
Method 2. The second experimental procedure employed for the synthesis 
of N,N-dimethylchromone-2-carboxamide (129) was followed, using 
7-bromochromone-2-carbonyl chloride (126) (1.9 g, 7 mmol) , aqueous Me2NH 
(43% w/w; 0.96 ml, 8.1 mmol) , NaHC03 (1.0 g, 11 mmol) , and H20 (8 ml). 
Work-up afforded a solid (0.6 g) shown, by TLC, to comprise a mixture of 
two components, which was chromatographed [flash chromatography on 
silica gel; elution with EtOAc] to afford a crude 7-bromo-N,N-
dimethylchramone-2-csrboxsnUde (134) (0.4 g, 21%),a m.p. 143-145°C (from 
EtOAc); (Found: C, 48.8; H, 3.45; N, 4.8. C12HIOBrN03 requires: 
C, 48.7; H, 3.4; N, 4.7%); 8H (500 MHz; CDCI3) 3.07 and 3.08 (6H, 2 x s, 
NMe2) , 6.47 (lH, s, CH=C) , 7.50 (lH, dd, J 2 and 9 Hz, 6-H), 7.63 (lH, 
d, J 2 Hz, 8-H) and 7.99 (lH, d, J 9 Hz, 5-H); 8 c (125 MHz; CDCI3) 35.48 
and 38.26 (NMe2) , 111.93 (C-3), 121.23 (C-8), 123.06 (C-4a), 127.12 and 
129.39 (C-5 and C-6), 128.51 (C-7), 155.61 (C-8a), 158.17 (C-2), 161.62 
(CO.N) and 176.58 (C-4); vmax (KBr) /cm-1 1655 and 1635 (CO); Amax (EtOH) 
/nm 228 (E /dm3 mol-1 cm-1 19 667),272 (10 245) and 297 (8 947); m/z 295 
(79Br, ~, 35%) and 72 (100%). 
a Yield calculated on the basis of 7-bromochromone-2-carboxylic acid 
(117). 
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N,N-Dimethyl-3-methylchromone-2-csrboxsnride (135). 
Method 1. The first experimental procedure employed for the synthesis 
of N,N-dimethylchromone-2-carboxamide (129) was followed, using 
3-methylchromone-2-carbonyl chloride (127) (1.0 g, 4 mmol) , 
dimethylammonium chloride (128) (0.7 g, 9 mmol) , and dry pyridine 
(10 ml). In this case the reaction time at room temperature was 14 h. 
Work-up afforded crude N,N-dimethyl-3-methylchromone-2-csrboxBnride (135) 
(0.8 g, 84%)a which was chromatographed [flash chromatography on silica 
gel; elution with EtOAc] to afford N,N-dimethyl-3-methylchromone-2-
csrboxsnride (135) (0.7 g 71%).a 
Method 2. The second experimental procedure for the synthesis of 
N,N-dimethylchromone-2-carboxamide (129) was followed, using 
3-methylchromone-2-carbonyl chloride (127) (1.9 g, 9 mmol) , aqueous 
Me2NH (43% w/w; 1.22 ml, 10.2 mmol) , NaHC03 (1.2 g, 15 mmol) , and H20 
(7 ml). In this case the mixture was stirred at cs. ODC for 2h. Work-
up afforded a crude solid (1.7 g) shown, by IH NMR spectroscopy, to 
comprise a mixture (cs. 1:4) of 3-methylchromone-2-carboxylic acid (120) 
and N,N-dimethyl-3-methylchromone-2-csrboxsnride (135). The mixture was 
dissolved in EtOAc (60 ml), and the solution was sequentially washed 
with 5% aq. NaHC03 (2 x 30 ml) and saturated aqueous NaCI (1 x 30 ml), 
and then dried (anhyd. MgS04). The solvent was evaporated to give an 
oil which crystallized to afford crude N,N-dimethyl-3-methylchromone-2-
csrboxsnride (135) (1.0 g, 52%).a Recrystallization from EtOAc afforded 
N,N-dimethyl-3-methylchromone-2-csrboxsnride (135) (0.1 g, 6%).a The 
crude motherliquours were chromatographed [flash chromatography on 
a Yield calculated on the basis of 3-methylchromone-2-carboxylic acid 
(120). 
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silica gel; elution with EtOAc] to afford additional N,N-dimethyl-3-
methylchromone-2-carboxamide (135) (0.5 g, 24%),a m.p. 74-76°C (from 
EtOAc); [m/z Found: 231.090 (}f, 100%). C13H13N03 requires: 231.090]; 
8H (500 MHz; CDCI3) 1.96 (3H, s, 3-Me) , 2.95 and 3.07 (6H, 2 x s, NMe2) , 
7.31 - 7.35 (2H. m, 6-H and 8-H). 7.56 - 7.60 (lH. m. 7-H) and 8.11 (lH, 
ddt J 2 and 8 Hz, 5-H); 8 e (75 MHz; CDC13) 9.98 (3-Me), 34.56 and 37.63 
(NMe2) , 117.36 (C-3), 117.88 (C-8), 122.89 (C-4a), 125.24 and 125.78 
(C-5 and C-6), 133.72 (C-7), 154.39 (C-8a). 155.61 (C-2). 162.40 (CO.N) 
and 177.82 (C-4); Vmax (KBr) /cm-1 1640 and 1635 (CO); m/z 231 
(}f. 100%). 
N .N-Diisopropylchromone-2-carboxamide (136). 
Method 1. 64 Diisopropylamine (1.06 mI. 7.6 mmol) was added to a 
solution of chromone-2-carbony1 chloride (121) (1.5 g. 7 mmol) in dry 
pyridine (20 ml) and the resulting solution was warmed on a steam bath 
for 3h. After cooling, the solution was poured into 2~-HCI (200 ml) 
and the resulting mixture was extracted with EtOAc (3 x 50 ml). The 
organic extracts were combined. dried (anhyd. MgS04)' and evaporated to 
afford a yellow oil (1.2 g) which was chromatographed [flash 
chromatography on silica gel; elution with EtOAc-hexane (1:1») to afford 
an oil (0.8 g; 40%)b which crystallised on standing. Recrysta1lisation 
from EtOAc gave N.N-diisopropylchromone-2-carboxamide (136) (0.3 g, 
15%).b m.p. 95-96°C (from EtOAc); (Found: C 70.65; H 7.3; N, 5.3. 
C16H19N03 requires: C 70.3; H. 7.0; N, 5.1%); 8H (500 MHz; CDCI3) 
a Yield calculated on the basis of 3-methylchromone-2-carboxylic acid 
(120) . 
b Yield calculated on the basis of chromone-2-carboxylic acid (112). 
1.29 (6H, br s, CHMe2), 1.55 (6H, br s, CHMe2), 3.60 (lH, br s, NCH), 
3.91 (lH, br s, NCH), 6.49 (lH, s, CH=C) , 7.49 - 7.55 and 7.76 - 7.83 
(2H, 2 x m, 6-H and 7-H), 7.57 (lH, d, J 8 Hz, 8-H) and 8.23 (lH d, 
J 7 Hz, 5-H); Be (125 MHz; CDCl3) 19.94 (CHMe2), 20.57 (CHMe2), 46.28 
(NCH) , 51.12 (NCH) , 109.50 (C-3), 117.96 (C-8), 124.06 (C-4a), 125.45 
and 125.48 (C-5 and C-6), 133.98 (C-7), 155.46 (C-8a), 159.83 (C-2), 
161.33 (CO.N) and 177.37 (C-4); V~X /cm-1 1655 and 1640 (CO); m/z 273 
(}f, 24%), 216 (100%). 
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Method 2. The second experimental procedure for the synthesis of 
N,N-dimethylchromone-2-carboxamide (129) was followed, using chromone-2-
carbonyl chloride (121) (1.5 g, 7 mmol) , diisopropylamine (1.23 ml, 
8.8 mmol) , NaHC03 (1.2 g, 15 mmol) , and H20 (11 ml). The precipitated 
solid was filtered off and shown, by IH NMR spectroscopy, to be starting 
material (0.2 g). The filtrate was extracted with EtOAc, dried (anhyd. 
MgS04), and evaporated to afford crude N,N-diisopropylchromone-2-
carboxamide (136) (0.1 g, 6%).a 
1-[(Chromon-2-yl)-carbonylJ-pyrrolidine (137). The second 
experimental procedure for the synthesis of N,N-dimethylchromone-2-
carboxamide (129) was followed, using chromone-2-carbonyl chloride (121) 
(1.7 g, 8 mmol) , pyrrolidine (0.746 ml, 9.0 mmol) , NaHC03 (1.2 g, 
14 mmol) , and H20 (10 ml). In this case, the mixture was stirred at ca. 
OOC for 1.5 h. Work-up afforded a crude solid (0.9 g) shown, by TLC, to 
comprise a mixture of three components. The mixture was chromatographed 
[flash chromatography on silica gel; elution with EtOAc] to afford crude 
1-[(chromon-2-yl)-carbonylJ-pyrrolidine (07) (0.4 g, 22%),a 
m.p.103-105°C (from EtOAc); [m/z Found: 243.089 (}f, 100%). C14H13N03 
a Yield calculated on the basis of chromone-2-carboxylic acid (112). 
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requires: 243.090]; 8H (500 MHz; CDC13) 1.83 - 1.89 [4H, m, 
CH-C), 7.27 - 7.30 and 7.56 - 7.60 (2H, 2 x m, 6-H and 7-H), 7.36 
(lH, d, J 8 Hz, 8-H) and 8.03 (lH. dd, J 2 and 8 Hz, 5-H); 8 e (125 MHz; 
117.87 (C-8), 123.94 (C-4a), 125.35 and 125.47 (C-5 and C-6), 134.06 
(C-7), 155.16 (C-8a), 157.86 (C-2), 159.60 (CO.N) and 177.48 (C-4); vmax 
(KBr) /cm-1 1640 and 1630 (CO); m/z 243 (~, 100%). 
1-[(Chromon-2-yl)-carbonylj-piperidine (138). The first 
experimental procedure for the synthesis of N,N-diisopropylchromone-2-
carboxamide (136) was followed, using piperidine (0.80 ml, 8.1 mmol) , 
chromone-2-carbonyl chloride (Ul) (1.6 g, 8 mmol), and dry pyridine 
(20 ml). Work-up afforded a red oil (1.6 g) which was chromatographed 
[flash chromatography on silica gel; elution with EtOAc-hexane (3:1)] to 
afford an oil (1.5 g). The oil was chromatographed [flash 
chromatography on alumina; elution with EtOAc-hexane (2:3)] to afford an 
oil which crystallized on standing to afford 1-[(chromon-2-yl)-
carbonyl]-piperidine (~) (1.5 g, 75%),a m.p. 66-67°C (from EtOAc) 
(lit.,17 90.5-92°C); (Found: C, 70.5; H 5.9; N, 5.6. Calc for C15H15N03 
: C, 70.0; H, 5.-9; N 5.4%); 8H (500 MHz; CDC13) 1.57 - 1.66 [6H, m, 
(lH, s, CHaC), 7.34 - 7.37 and 7.61 - 7.65 (2H, 2 x m, 6-H and 7-H), 
7.41 (lH, d, J 9 Hz, 8-H) and 8.11 (lH", dd, J 2 and 8 Hz, 5-H); 8 e (125 
. , 
MHz; CDC13) 24.17, 25.21, and 26.34 (NCHZCH2CHZCHZCH2), 43.21 (NCHZ)' 
48.03 (NCHZ)' 110.96 (C-3), 118.09 (C-8), 124.09 (C-4a), 125.57 
(C-5 and C-6), 134.09 (C-7), 155.61 (C-8a), 158.42 (C-2), 160.67 (CO.N) 
a Yield calculated on the basis of chromone-2-carboxylic acid (lU). 
I" 
1 I, 
! 
1,1 
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and 177.26 (C-4); vmax (KBr) /cm-1 1655 and 1650 (CO); m/z 257 (M', 35%) 
and 89 (100%). 
Chromone-2-carboxamide (139). 
Method 1. The second experimental procedure for the synthesis of 
N,N-dimethy1chromone-2-carboxamide (129) was followed, using chromone-2-
carbonyl chloride (121) (1.2 g, 11 mmol) and aqueous NH3 (25% w/v; 
8.4 ml, 0.123 mol). In this case work-up, which excluded the 
extraction, afforded crude chromone-2-carboxamide (139) (1.5 g, 74%)a 
which was recrystallised from a mixture of EtOH, DMF and H20 to afford 
chromone-2-carboxamide (139) (0.8 g, 41%),a m.p. 254°C (from EtOH) 
(lit.,l7 150-151°C); 8H (500 MHz; DMSO-d6/CDC13) 2.06 (3H, s, impurity), 
3.32 (lH, br s, CONH2), 6.83 (lH, s, CH=C) , 7.44 - 7.47 and 7.78 - 7.82 
(2H, 2 x m, 6-H and 7-H), 7.68 (lH, dd, J 1 and 8 Hz, 8-H), 8.01 (lH, 
dd, J 2 and 8 Hz, 5-H) and 8.10 and 8.45 (2B, 2 x br s, impurities); 
8 e (125 MHz; DMSO-d6/CDC13) 30.45 (Me impurity), 110.42 (C-3), 118.61 
(C-8), 123.51 (C-4a), 124.72 and 125.58 (C-5 and C-6), 134.49 (C-7), 
155.00 (C-8a), 155.62 (C-2), 160.62 (CO.N) and 177.25 (C-4); vmax 
(KBr) /cm-1 3360 (NH), 3160 (CH), 1715 (CO.N) and 1673 and 1628 (CO). 
Impurities in the IH and 13C NMR specra could not be eliminated by 
repeated recrystallisation from EtOH; or by purifying recrystallised 
material (200 mg) by chromatography [flash chromatography on alumina; 
elution with EtOAC and EtOH]. 
Method 2. The first experimental procedure for the synthesis of 
N,N-dimethylchromone-2-carboxamide (129) was followed, using chromone-2-
a Yield calculated on the basis of chromone-2-carboxylic acid (112). 
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carbonyl chloride (121) (2.2 g, 11 romol) , NH4Cl (1.1 g, 21 romol) , and 
dry pyridine (20 ml). In this case the acidic mixture was filtered to 
afford a solid (0.3 g) and the extracted filtrate afforded a solid 
(0.9 g). Both solids were shown, by TLC, to comprise a mixture of three 
components. The combined material (1.2 g) was chromatographed [flash 
chromatography on silica gel; elution with EtOAc-hexane (50:1)] to 
afford crude chromone-2-carboxamide (139) (0.3 g, 17%).a 
(E)-2-(Dimethylamdno}-3-(2-hydroxybenzoyl}-N,N-dimethyla cryl amdde (140). 
Method 1. 17 ,126 Ethanolic Me2NH (25% w/w; 3.14 ml, 13.2 romol) was added 
to a solution of N,N-dimethylchromone-2-carboxamide (129) (0.500 g, 
2.3 romol) in dry EtOH (17 ml) and the solution was stirred at room 
temperature for 20 h. The solution was evaporated under reduced 
pressure to afford a crude solid (0.53 g) which was chromatographed 
[flash chromatography on silica gel; elution with EtOAc] to afford 
(E)-2-(dimethylamino)-3-(2-hydroxybenzoyl)-N,N-dimethylacrylamide (140) 
(0.374 g, 62%). 
Method 2. Crude chromone-2-carbonyl chloride (121) (1.8 g, 9 romol) was 
cautiously added to precooled (DOC), stirred aqueous Me2NH (43% w/w; 
2.13 ml, 17.9 romol) , and cold water (10 ml) was then added. The mixture 
was stirred for 1 h at ca. OOC and the resulting precipitate was 
filtered and washed (H20) to afford crude (E)-2-(dimethylamino)-3-
(2-hydroxybenzoyl)-N,N-dimethylacrylamide (140) (0.7 g, 32%),a m.p. 
165-166°C (from EtOH) (lit.,17 166-167°C); 8H (500 MHz; CDC13) 2.89 and 
3.09 (6H, 2 x s, CONMe2)' 3.06 (6H, s, NMe2), 5.75 (lH, s, CH=C) , 6.75 -
a Yield calculated on the basis of chromone-2-carboxylic acid (112). 
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6.79 and 7.29 - 7.33 (2H, 2 x m, 4' -H and 5' -H), 6.88 (1H, dd, J 1 and 8 
Hz, 3' -H), 7.67 (lH, dd, J 2 and 8 Hz, 6' -H) and 13.60 (60 MHz; 1H, s, 
OH); Be (75 MHz; CDC13) 34.06 and 36.84 (CONMe2), 39.38 and 40.11 (NMe2) , 
88.81 (C-3), 117.78 and 117.88 (C-3' and C-5'), 120.18 (C-1'), 128.03 
(C-6'), 133.75 (C-4'), 158.76 (C-2), 162.53 (C-2'), 166.44 (CO.N) and 
189.74 (C-4); vmax (KBr) /cm-1 2920 and 1648; vmax (CHC13) /cm-1 2970 and 
1650; Amax (EtOH) /nm 216 (8 Idm3 mo1-1 cm-1 16 719), 257 (7 783) and 357 
(29 647); m/z 263 (~, 6%) and 72 (100%). 
N-[3-(2-Hydroxybenzoyl)-2-pyrrolidinoacryloyljpyrrolidine (141). The 
second experimental procedure for the synthesis of 
(E)-2-(dimethy1amino)-3-(2-hydroxybenzoy1)-N,N-dimethy1acry1amide (140) 
was followed, using chromone-2-carbony1 chloride (121) (1.7 g, 8 mmo1) , 
pyrrolidine (1.40 m1, 16.9 mmo1) , and H20 (10 m1). Work-up afforded an 
oily solid which was dissolved in Et20 (25 ml), and the solution was 
washed with H20 (20 m1). The aqueous layer was then extracted with Et02 
(2 x 25 m1). Yellow crystals formed during the extraction and in the 
combined ethereal layers which were left to stand overnight. The 
ethereal solution was then filtered to afford crude 
N-[3-(2-hydroxybenzoyl)-2-pyrrolidinoacryloyljpyrrolidine(141) (0.2 g, 
9%) ,a m.p. 161-162°C (from EtOH) (lit. ,19 182°C); BH (500 MHz; CDC13) 
1.77 - 1.96 [8H, m, 2 x CH2(CH2)2CH2], 3.06 - 3.10, 3.41 - 3.45, 3.60 -
3.61 and 3.67 - 3.69 14H, 4 x m, CON(CH2)2], 3.22 - 3.31 [4H, m, 
N( CH2)2], 5.57 (lH, s, CH=C) , 6.68 - 6.79 and 7.20 - 7.24 (2H, 2 x m, 
4' -H and 5' -H), 6.79 (lH, dd, J 1 and 8 Hz, 3' -H), 7.61 (lH, dd, J 1 
and 8 Hz, 6' -H) and 13.61 (lH, s, OH); Be (75 MHz; CDC13) 24.09, 24.41, 
24.99 and 25.44 [CH2(CH2)2CH2], 44.96, 46.82, 48.11 and 48.42 (2 x 
CH2NCH2), 88.53 (C-3), 117.68 and 117.81 (C_3' and C-5'), 120.14 (C-1'), 
a Yield calculated on the basis of chromone-2-carboxy1ic acid (112). 
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123.00 (C-6'), 133.55 (C-4'), 156.78 (C-2), 162.56 (C-2'), 164.99 (CO.N) 
and 189.49 (C-4); vmax (KBr) /cm-1 1960, 1875, 1650 and 1643; m/z 314 
(}f, 2%) and 121 (100%). 
(E)-2-(Dimethylsn.Uno)-3-(2-hydroxy-4-methoxybenzoyl)-N, N-
dimethylscrylsn.Ude (142). The first experimental procedure employed 
for the synthesis of (E)-2-(dimethylamino)-3-(2-hydroxybenzoyl)-N,N-
dimethylacrylamide (140) was followed, using 7-methoxy-N,N-
dimethylchromone-2-carboxamide (130) (0.500 g, 2.0 mmol) , dry EtOH 
(15 ml), and ethanolic Me2NH (25% w/w; 2.82 ml, 11.9 mmol). In this 
case the reaction solution was maintained at 35°C for 27 h. Work-up 
afforded a crude yellow oil (0.577 g) which was chromatographed [flash 
chromatography on silica gel; elution with EtOAc) to give a solid which 
was recrystallized from EtOAc to afford (E)-2-(dimethylsn.Uno)-3-(2-
hydroxy-4-methoxybenzoyl)-N,N-dimethylscrylsmide (142) (0.212 g, 36%), 
m.p. 154-156°C (from EtOAc); [m/z Found: 292.141 (}f, 10%). C15H20N204 
requires: 292.142]; 8H (300 MHz; CDCl3) 2.90 and 3.09 (5H, 2 x s, 
CONMe2), 3.04 (6H, br s, NMe2) , 3.78 (3H, s, OMe) , 5.65 (lH, s, CH=C) , 
6.31 - 6.37 (2H, m, 3' -H and 5' -H), 7.58 (lH, d, J 9 Hz, 6' -H) and 14.10 
(50 MHz; 1H, s, OH); Be (75 MHz; CDCl3) 34.48 and 37.30 (CONMe2), 39.47 
and 40.09 (NMe2) , 55.37 (OMe) , 89.12 (C-3), 101.02 and 106.43 (C-3' and 
C-5'), 113.95 (C-1'), 129.53 (C-6'), 157.89 (C-2), 154.26 (C-4'), 165.33 
(C-2' ), 166.93 (CO.N) and 189.01 (C-4); vmax (KBr) /cm-1 2930, 1660 and 
1650; vmax (CHCl3) /cm-1 2970 and 1650; Amax (EtOH) /nm 221 (t /dm3 mol-1 
cm-1 16 250), 280 (8 020) and 361 (39 240); m/z 292 (}f, 10%) and 220 
(100%). 
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(E)-2-(Dimethylsnrlno)-3-(2-hydroxy-4-nitrobenzoyl)-N,N-
dlmethylscrylsnrlde (143) and 3-(2-hydroxy-4-nitrobenzoyl)-N,N-dimethyl-
2-methylsnrlnoscrylsnrlde (147). The first experimental procedure 
employed for the synthesis of (E)-2-(dimethylamino)-3-(2-
hydroxybenzoyl)-N,N-dimethylacrylamide (140) was followed, using 
N,N-dimethyl-7-nitrochromone-2-carboxamide (131) (0.500 g, 1.9 mmol) , 
dry EtOH (55 ml), and ethanolic Me2NH (25% w/w; 2.60 ml, 11.0 mmol). In 
this case, the solution, which rapidly turned red, was maintained at 
35°C for 25 h. Work-up afforded a crude red oil (0.545 g) which was 
chromatographed [preparative layer chromatography; elution with EtOAc] 
to afford 2 crude components, viz., 
(i) (E)-2-(dimethylsnrlno)-3-(2-hydroxy-4-nitrobenzoyl)-N,N-
dlmethylscrylsnrlde (143) (0.305 g, 52%), m.p. 160-1610C (from EtOAc); 
(Found: C, 54.8; H, 5.7; N, 13.5. C14H17N305 requires: C, 54.7; H, 
5.6; N, 13.7%); &H (300 MHz; CDCl3) 2.92 and 3.11 (6H, 2 x s, CONMe2), 
3.07 and 3.19 (6H, 2 x s, NMe2) , 5.71 (lH, s, CH=C) , 7.58 (lH, dd, J 2 
and 9 Hz, 5' -H), 7.69 (lH, d, J 2 Hz, 3' -H), 7.79 (lH, d, J 9 Hz, 6' -H) 
and 13.85 (60 MHz; 1H, s, OH); &e (75 MHz; CDCI3) 34.50 and 37.14 
(CONMe2) , 39.90 and 40.93 (NMe2) , 89.04 (C-3), 112.28 and 113.52 (C-3' 
and C-5'), 124.82 (C-1'), 128.87 (C-6'), 150.53 (C-4'), 160.30 (C-2), 
163.09 (C-2' ), 165.92 (CO.N) and 188.02 (C-4); Vrnax (KBr) /cm-1 2920 and 
1645; Vrnax (CHCl3) /cm-1 2930 and 1650; Arnax (EtOH) /nm 215 
(e /dm3 mol-1 cm-1 21 425), 279 (15 379) and 388 (21 087); m/z 307 
(}f, 11%) and 72 (100%); and 
(ii) 3-(2-hydroxy-4-nitrobenzoyl)-N,N-dimethyl-2-methylsnrlnoscrylsnrlde 
(147) (0.041g, 7%), m.p. 222-225°C (from EtOAc); [m/z Found: 293.100 
(}f, 13%). C13H15N305 requires: 293.101]; &H (200 MHz; CDCl3) 3.07 and 
3.08 (3H, 2 x s, NMe), 3.12 (6H, s, CONMe2), 5.76 (lH, s, CH=C) , 7.58 -
7.79 (3H, m, ArH), 10.56 (lH, br s, NH) and 13.52 (lH, s, OH); &e (50 
MHz; CDC13) 31.02 and 31.84 (NHMe) , 34.27 and 37.88 (CONMe2), 88.18 
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(C-3), 113.13 and 113.81 (C-3' and C-5' ), 125.26 (C-1' ), 129.21 (C-6' ), 
151.20 (C-4' ), 153.20 (C-2), 163.11 (C-2'), 164.07 (CO.N) and 191.18 
(C-4); vmax (KBr) /cm-1 3235 (NH), 2930 and 1655; Amax (EtOH) /nm 212 (8 
/dm3 mol-1 cm-1 11 815), 274 (13 606) and 388 (20 043); m/z 293 (~, 13%) 
and 221 (100%). 
(E)-2-(Dimethylsmdno)-3-(4-fluoro-2-hydroxybenzoyl)-N,N-
dimethylscrylsmdde (144) and 3-(4-fluoro-2-hydroxybenzoyl)-N,N-dimethyl-
2-methylsmdnoscrylsmdde (148). The first experimental procedure 
employed for the synthesis of (E)-2-(dimethylamino)-3-(2-
hydroxybenzoyl)-N,N-dimethylacrylamide (140) was followed, using 
7-fluoro-N,N-dimethylchromone-2-carboxamide (132) (0.500 g, 2.1 mmol) , 
dry EtOH (16 ml), and ethanolic Me2NH (25% w/w; 2.90 ml, 12.2 mmol). In 
this case, the reaction solution was maintained at 35°C for 26 h. Work-
up afforded a crude yellow oil (0.711 g) which was recrystallized from 
EtOAc (0.361 g) and chromatographed [preparative layer chromatography; 
elution with EtOAc] to give 2 components, viz., 
(i) a solid which was recrystallized from EtOAc to afford (E)-2-
(dimethylsmdno)-3-(4-fluoro-2-hydroxybenzoyl)-N.N-dimethylscrylsmdde 
(144) (0.228 g, 39%), m.p. 164-166°C (from EtOAc); (Found: C, 59.7; H, 
6.3; N. 10.0. C14H17N203F requires: C, 60.0; H, 6.1; N, 10.0%); 6H 
(300 MHz; CDC13) 2.89 and 3.08 (6H, 2 x s, CONMe2), 3.06 (6H, br s, 
NMe2). 5.63 (lH. s, CH=C). 6.44 - 6.58 (2H, m, 3' -H and 5' -H), 7.65 
(lH, dd, J 7 and 9 Hz, 6' -H) and 14.00 (60 MHz; 1H, s, OH); Be (75 MHz; 
CDC13) 34.39 and 37.15 (CONMe2), 39.59 and 40.40 (NMe2) , 88.96 (C-3), 
104.73 and 105.81 (2 x d, 2JCF 23 Hz and 2JCF 24 Hz, C-3' and C-5'), 
117.25 (d, 4JCF 3 Hz, C-1'), 130.18 (d, 3JCF 11 Hz, C-6'), 159.03 (C-2), 
165.27 Cd, 3JCF 15 Hz, C-2' ), 166.10 (d, IJCF 254 Hz, C-4' ), 166.62 
(CO.N) and 189.10 (C-4); vmax (KBr) /cm-1 2910 and 1660; vmax (CHC13) /cm-1 
2960,2920 and 1655; Amax (EtOH) /nm 220 (8 /dm3 mol-1 cm-1 17 631),258 
166 
(7 561) and 353 (32 027); m/z 280 (Jt, 9%) and 208 (100%); and 
(ii) crude 3-(4-fluoro-2-hydroxybenzoyl)-N,N-dimethyl-2-
methylaminoacrylamide (148) (0.039 g, 7%), m.p. 163-165°C (from EtOAc); 
[m/ z Found : 266.105 (Jt, 11%). C13H15N203F requires : 266.106]; 8 H 
(200 MHz; CDCI3) 2.90 and 3.02 (3H, 2 x s, NMe), 3.09 (6H, s, CONMe2), 
5.62 (lH, s, CH=C) , 6.47 - 6.63 (2H, m, 3' -H and 5' -H), 7.58 (lH, dd, J 
7 and 9 Hz, 6' -H), 10.10 (lH, br s, NH) and 13.57 (lH, s, OH); 8C (50 
MHz; CDCI3) 31.46 (NHMe) , 34.24 and 37.90 (CONMe2), 87.43 (C-3), 105.07 
and 106.61 (2 x d, 2JCF 23 Hz and 2JCF 23 Hz, C-3' and C-5' ), 117.28 
(C-1'), 130.27 (d, 3JCF 11 Hz, C-6' ), 161.36 (C-2), 164.74 Cd, 3JCF 12 
Hz, C-2' ), 165.13 (CO.N), 166.64 (d, IJCF 254 Hz, C-4' ) and 192.57 
(C-4); vmax (KBr) /cm-1 3230 (NH), 2930 and 1650; Amax (EtOH) /nm 215 
(8 /dm3 mol-1 cm-1 17 067),256 (6 117) and 253 (27 967); m/z 266 (Jt, 
11%) and 139 (100%). 
(E)-3-(4-Chloro-2-hydroxybenzoyl)-2-(dimethylamino)-N,N-
dimethylacrylamide (145) and 3-(4-chloro-2-hydroxybenzoyl)-N,N-dlmethyl-
2-methylaminoacrylamide (149). The first experimental procedure 
employed for the synthesis of (E)-2-(dimethylamino)-3-(2-
hydroxybenzoyl)-N,N-dimethylacrylamide (140) was followed, using 
7-chloro-N,N-dimethylchromone-2-carboxamide (133) (0.500 g, 2.0 mmol) , 
dry EtOH (20 ml), and ethanolic Me2NH (25% w/w; 2.71 ml, 11.4 mmol). In 
this case the reaction solution was maintained at 35°C for 24 h. Work-
up afforded a crude yellow oil (0.555 g) which was chromatographed 
[preparative layer chromatography; elution with EtOAc] to give 2 crude 
components, viz., 
(i) (E)-3-(4-chloro-2-hydroxybenzoyl)-2-(dimethylamino)-N,N-
dimethylacrylamide (145) (0.327 g, 55%), m.p. 124-125°C (from EtOAc); 
[m/z Found: 296.092 (35CI, Jt, 12%). C14H17N203CI requires: 296.093]; 
8H (300 MHz; CDCI3) 2.89 and 3.09 (6H, 2 x s, CONMe2), 3.07 (6H, br s, 
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NMe2) , 5.66 (lH, s, CH=C) , 6.74 (lH, dd, J 2 and 9 Hz, 5' -H), 6.89 (lH, 
d, J 2 Hz, 3' -H), 7.57 (lH, d, J 9 Hz, 6' -H) and 13.85 (60 MHz; 1H, s, 
OH); &e (75 MHz; CDC13) 34.48 and 37.07 (CONMe2) , 39.70 and 40.60 (NMe2) , 
88.88 (C-3), 118.24 and 118.39 (C-3' and C-5' ), 118.85 (C-1' ), 129.10 
(C-6'), 139.32 (C-4'), 159.09 (C-2), 163.52 (C-2'), 166.45 (CO.N) and 
188.99 (C-4); vrnax (KBr) /cm-1 2920 and 1660; vrnax (CHC13) /cm-1 2970, 2930 
and 1650; Arnax (EtOH) /nm 213 (e /dm3 mol-1 cm-1 17 236),264 (10209) and 
358 (34 077); m/z 296 (35Cl, ~, 12%) and 224 (100%); and 
(ii) crude 3-(4-chloro-2-hydroxybenzoyl}-N,N-dimethyl-2-
methylaminoacrylamide (149) (0.032 g, 6%), m.p. 166-168°C (from EtOAc); 
[m/ z Found : 282.076 (35Cl, M+, 11%). C13H15N203Cl requires : 282.077); 
&H (200 MHz; CDC13) 2.99 and 3.02 (3H, 2 x s, NMe), 3.09 and 3.10 (6H, 2 
x s, CONMe2), 5.65 (lH, s, CH=C) , 6.77 (lH, dd, J 2 and 9 Hz. 5' -H), 
6.93 (lH, d, J 2 Hz, 3' -H), 7.51 (lH, d, J 9 Hz, 6' -H), 10.30 (lH, br s, 
NH) and 13.41 (lH, s, OH); &e (50 MHz; CDC13) 31.51 (NHMe) , 34.25 and 
37.89 (CONMe2) , 87.52 (C-3), 118.61 and 119.24 (C-3' and C-5' ), 119.01 
(C-1' ), 129.25 (C-6' ), 139.88 (C-4' ), 161.61(C-2). 163.41 (C-2' ), 164.50 
(CO.N) and 192.55 (C-4); vrnax (KBr) /cm-1 3200 (NH), 2920 and 1640; Arnax 
(EtOH) /nm 207 (e /dm3 mol-1 cm-1 17 367), 266 (8 283) and 358 (29 367); 
m/z 282 (C135, M+, 11%) and 210 (100%). 
(E)-3-(4-bromo-2-hydroxybenzoyl}-2-(dimethylamino}-N,N-
dimethylacrylamide (146) and 3-(4-bromo-2-hydroxybenzoyl}-N,N-dimethyl-
2-methylaminoacrylamide (150). The first experimental procedure 
employed for the synthesis of (E)-2-(dimethylamino)-3-(2-
hydroxybenzoyl}-N,N-dimethylacrylamide (140) was followed, using 7-
bromo-N,N-dimethylchromone-2-carboxamide (134) (0.500 g, 1.7 mmol) , dry 
EtOH (28 ml), and ethanolic Me2NH (25% w/w; 2.31 ml, 9.7 mmol). In this 
case the reaction was maintained at 35°C for 24 h. Work-up afforded a 
crude red oil (0.711 g) which was chromatographed [preparative layer 
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chromatography; elution with EtOAc] to give 2 crude components, viz., 
(i) an oil which crystallized and was filtered to afford (E)-3-(4-bramo-
2-hydroxybenzoyl)-2-(dimethylso.Uno)-N,N-dimethylscrylso.Ude (146) (0.265 
g, 46%), m.p. 124-125°C (from EtOAc); (Found: C, 49.2; H, 5.1; N, 8.4. 
C14H17N203Br requires: C, 49.3; H, 5.0; N, 8.2%); BH (300 MHz; CDC13) 
2.89 and 3.08 (6H, 2 x s, CONMe2), 3.06 (6H, 2 x s, NMe2) , 5.65 (lH, s, 
CH=C) , 6.89 (lH, dd, J 2 and 9 Hz, 5' -H), 7.06 (lH, d, J 2 Hz, 3' -H), 
7.50 (lH, d, J 9 Hz, 6' -H) and 13.80 (60 MHz; IH, s, OH); Be (75 MHz; 
CDC13) 34.40 and 37.11 (CONMe2), 39.74 and 40.52 (NMe2) , 88.88 (C-3), 
119.30 (C-l' ), 121.28 and 121.40 (C-3' and C-5'), 127.63 (C-4' ), 129.21 
(C-6'), 159.33 (C-2), 163.56 (C-2'), 166.49 (CO.N) and 189.28 (C-4); 
vmax (KBr) /cm-1 2920 and 1660; vmax (CHC13) /cm-1 2970, 2930 and 1655; 
Amax (EtOH) /nm 212 (£ /dm3 mol-1 cm-1 14 521), 267 (10 203) and 360 
(33 131); m/z 340 (79Br, ~, 6%) and 72 (100%); and 
(ii) 3-(4-bromo-2-hydroxybenzoyl)-N,N-dimethyl-2-methylso.Unoscrylso.Ude 
(150) (0.028 g, 5%), m.p. 153-155°C (from EtOAc); [m/z Found: 326.025 
(Br79 , ~,12%). C13H15N203Br requires: 326.027]; BH (200 MHz; CDC13) 
2.99 and 3.02 (3H, 2 x s, NMe), 3.08 and 3.09 (6H, 2 x s, CONMe2), 5.65 
(lH, s, CH=C) , 6.92 (lH, dd, J 2 and 9 Hz, 5' -H), 7.11 (lH, d, J 2 Hz, 
3' -H), 7.44 (lH, d, J 9 Hz, 6' -H), 10.30 (lH, br s, NH) and 13.36 (lH, 
s, OH); Be (50MHz; CDC13) 31.52 (NHMe) , 34.26 and 37.89 (CONMe2), 87.52 
(C-3), 119.38 (C-l' ), 121.73 and 122.11 (C-3' and C-5' ), 128.29 (C-4' ), 
129.29 (C-6' ), 161.66 (C-2), 163.31 (C-2' ), 164.48 (CO.N) and 192.66 
(C-4); Vmax (KBr) /cm-1 3200 (NH), 2920 and 1640; Amax (EtOH) /nm 207 (£ 
/dm3 mol-1 cm-1 18 550), 267 (9 767) and 360 (3 200); m/z 326 (Br79 , ~, 
12%) and 256 (100%). 
3-(4-Bromo-2-hydroxybenzoyl)-N,N-dimethyl-2-methylso.Unoscrylso.Ude (150). 
The first experimental procedure employed for the synthesis of 
(E)-2-{dimethylamino)-3-{2-hydroxybenzoyl)-N,N-dimethylacrylamide (140) 
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was followed, using 7-bromo-N,N-dimethylchromone-2-carboxamide (134) 
(0.502 g, 1.7 romol) , dry EtOH (25 ml), and ethanolic MeNH2 (4.8% w/w; 
5.44 ml, 8.4 romol). In this case the reaction solution was maintained 
at 35°C for 19.5 h. Work-up afforded a crude solid (0.565 g) which was 
chromatographed [flash chromatography on silica gel; elution with EtOAc) 
to afford crude 3-(4-bromo-2-hydroxybenzoyl)-N,N-dimethyl-2-
methylao.Unoacrylao.Ude (150) (0.470 g. 85%), 157-158°C (from EtOAc); 8H 
(400 MHz; CDC13) 2.96 and 3.01 (3H, 2 x s, NMe), 3.08 and 3.09 (6H, 2 x 
s, CONMe2), 5.64 (lH, s, CH=C) , 6.92 (lH, dd, J 2 and 9 Hz, 5' -H), 7.10 
(lH, d, J 2 Hz, 3' -H), 7.43 (lH, d, J 9 Hz, 6' -H), 10.28 (lH, br s, NH) 
and 13.37 (lH, s, OH); 8e (100MHz; CDC13) 31.37 (NHMe) , 34.10 and 37.72 
(CONMe2), 87.24 (C-3), 119.02 (C-1'), 121.33 and 121.70 (C_31 and C_51 ), 
127.86 (C-4' ), 128.87 (C_61 ), 161.17 (C-2), 162.81 (C-2' ), 163.96 (CO.N) 
and 192.06 (C-4); vmax (KBr) /cm-1 3210 (NH), 2925 and 1640; m/z 326 
(Br79 , K, 1%) and 72 (100%). 
(E)-3-(2-Hydroxybenzoyl)-N,N-dimethyl-2-pyrrolidinoacrylao.Ude (151). 
The first experimental procedure employed for the synthesis of 
(E)-2-(dimethylamino)-3-(2-hydroxybenzoyl)-N,N-dimethylacrylamide (140) 
was followed, using N,N-dimethylchromone-2-carboxamide (129) (0.500 g, 
2.3 romol) , dry EtOH (10 ml), and pyrrolidine (0.95 ml, 11.5 romol). In 
this case the reaction solution was maintained at 35°C for 6.5 h. Work-
up afforded a crude solid (0.669 g) which was chromatographed [flash 
chromatography on silica gel; elution with EtOAc] to afford 
(E)-3-(2-hydroxybenzoyl)-N,N-dimethyl-2-pyrrolidinoacrylamide (151) 
(0.594 g, 90%), m.p. 183-184°C (from EtOH); (Found: C, 66.3; H, 7.05; 
N, 9.2. C16H20N203 requires: C, 66.65; H, 7.0; N. 9.7%); 8H (200 MHz, 
NMe2) , 3.36 - 3.45 and 3.65 - 3.72 [3H and 1H, 2 x m, N(CH2)2), 5.72 
(lH, s, CH=C) , 6.76 - 6.93 (2H, m, 41 -H and 51 -H), 7.28 - 7.37 (lH, m, 
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3' -H), 7.69 (lH, dd, J 2 and 8 Hz, 6' -H) and 13.70 (60 MHz; IH, s, OH); 
8 e (50 MHz, CDC13) 24.82 and 25.39 [CH2(CH2}2CH2], 34.41 and 37.24 
(NMe2) , 48.57 and 48.78 [N(CH2)2], 89.84 (C-3), 118.30 and 118.61 (C-3' 
and C-5'), 120.70 (C-l'), 128.62 (C-6'), 134.35 (C-4'), 156.74 (C-2), 
163.31 (C-2'), 167.65 (CO.N) and 190.44 (C-4); Vrnax (KBr) /cm-1 2930, 
2870 and 1650; m/z 288 (P.r, 2%) and 121 (100%). 
Glycine ethyl ester hydrochloride (152) .156 HC1 gas was bubbled 
through a ~ixture of glycine (7.5 g, 10 mmo1) and EtOH (40 m1) on a 
boiling water bath until all the glycine was dissolved (ca. 1 h) and 
then for an additional 5 min. After cooling, the solution rapidly 
crystallised and was cooled on an ice bath. The crystals were filtered, 
washed (cold EtOH) , and dried under vacuum for 1 h to afford crude 
glycine ethyl ester hydrochloride (152) (13.0 g, 93%) m.p. 141-143°C 
(lit. ,156 143-144°C); 8H (60 MHz, CDC13) 1.30 (3H, t, CH2Me) , 3.80 
(2H, br s. CH2CO). 4.30 (2H, q, CH2Me) and 8.80 (3H, br s, NH3+)' 
2-(N-CarbethoxymethylanUno)-3-(2-hydroxybenzoyl)-N,N-dime thyla cryl anU de 
(153). Ethano1ic glycine ethyl ester (2.5 mmo1) [generated by adding 
a solution of KOH (0.14 g, 2 mmo1) in dry EtOH (2 m1) dropwise to a 
solution of glycine ethyl ester hydrochloride (152) (0.35 g. 2.5 mmo1) 
in dry EtOH (5 m1)] was added dropwise to a solution of 
N,N-dimethy1chromone-2-carboxamide (129) (0.50 g, 2.3 mmo1) in dry EtOH 
(10 m1). The resulting mixture was warmed at 35°C for 24 h. Additional 
glycine ethyl ester (9.2 mmo1) [generated by adding a solution of KOH 
(0.60 g, 11 mmo1) in dry EtOH (4 m1) dropwise to a solution of glycine 
ethyl ester hydrochloride () (1.29 g, 9.2 mmo1) in dry EtOH (5 m1)] was 
added and the mixture was warmed at 35°C for 4 days, and at room 
temperature for 23 days. After cooling, the mixture was filtered and 
the filtrate was evaporated to give a red oil (1.53 g) which was 
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chromatographed [flash chromatography on silica gel; elution with EtOAc) 
to afford 3 fractions, viz., 
i) an oil (0.28 g, 37%) which crystallized and was recrystallized from 
EtOAc to afford 2-(N-carbethoxymethylan.dno)-3-(2-hydroxybenzoyl)-N,N-
dimethylacrylan.dde (153) (0.19 g, 25%), m.p. 134-135°C (from EtOH); 
(Found: C, 59.8; H, 6.2; N. 8.6. C16H20N205 requires: C, 60.0; H, 6.3; 
N, 8.7%); 8H (400 MHz; CDC13) 1.30 (3H, t, CH2Me) , 3.05 and 3.12 (6H, 
2 x s, NMe2) , 4.07 (2H, d, J 6 Hz, CH2NH), 4.24 (2H, q, CH2Me) , 5.80 
(lH, s, CH=C). 6.81 (lH, t, J 7 Hz, 5' -H), 6.93 (lH, d, J 8 Hz, 3' -H), 
7.36 (lH, t, J 8 Hz, 4' -H), 7.61 (lH, d, J 8 Hz, 6' -H), 10.50 (lH, br s, 
NH) and 13.01 (lH, s, OH); Be (100 MHz; CDCI3) 14.10 (CH2Me), 34.36 and 
38.51 (NMe2) , 45.82 (NHCH2), 61.86 ( CH2Me ), 89.20 (C-3), 118.37 and 
118.40 (C-3' and C-5'), 120.09 (C-1'), 128.04 (C-6'), 134.46 (C-4'), 
158.15 (C-2), 162.35 (C-2'), 164.13 (CO.N), 168.82 (CO.O) and 193.62 
(C-4); vrnax (KBr) /cm-1 3230 (NH), 2990 (CH), 1743 (CO.O) and 1640 (CO); 
m/z 320 (~, 24%) and 248 (100%); 
ii) starting material (0.03 g); and 
iii) an oil (0.11 g). 
l,3-Bis(2-acetyl-3-hydroxyphenoxy)-2-hydroxypropane (155).40 - A 
solution of KOH (85% pellets; 2.3 g, 35 mmol) , i-PrOH (25 ml), and H20 
(ca. 1 ml) was added to a stirred solution of 2,6-dihydroxyacetophenone 
(9.7 g, 64 mmol) , epichlorohydrin (2.75 ml, 35 mmol) , and i-PrOH 
(250 ml). The mixture was then boiled under reflux for 96 h, and 
stirred for 2 days. Half the i-PrOH was distilled off and H20 (50 ml) 
was then added. After cooling, the precipitated solid was filtered off, 
washed (i-PrOH and Et20) , and recrystallized from i-PrOH to afford 
1,3-bis(2-acetyl-3-hydroxyphenoxy)-2-hydroxypropane (155) (4.6 g, 40%), 
m.p. 167-169°C (lit.,40 165-166°C); 8H (400 MHz; CDCI3) 1.57 (3H, s, 
impurity), 2.73 (6H, s, COMe), 4.23 - 4.33 (5H, sept, CBOH and 2 x 
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OCH2) , 4.55 - 4.62 (lH, ses, CHOH) , 6.40 and 6.63 (4H, 2 x d, J 8 Hz, 2 
X 4' -H and 6' -H), 7.35 (2H, t, J 8 Hz, 2 X 5' -H) and 13.17 (2H, s, 2 x 
ArOH); Be (100 MHz; CDCI3) 33.92 (COMe), 68.73 (CHOH), 70.02 (2 X OCH2) , 
101.80 and 111.80 (C-4' and C-6' ), 111.45 (C-2' ), 136.13 (C-5' ), 159.92 
(C-3'), 164.78 (C-1') and 204.37 (CO); Vrnax (KBr) /cm-1 3600 - 3400 (OH) 
and 1618 (CO). 
l,3-Bis(2-ethoxycarbonylchromon-5-yloxy)-2-hydroxypropane (156) and 3-
(2-acetyl-3-hydroxyphenoxy)-1-(2-ethoxycarbonylchromon-5-yloxy)-2-
hydroxypropane (157).40 An ethanolic solution of NaOEt was generated 
in situ by adding Na metal (1.1 g, 48 mmol) to dry EtOH (14 ml) with 
stirring and heating under reflux. After cooling, Et20 (28 ml) was 
added. A warm solution of 1,3-bis(2-acetyl-3-hydroxyphenoxy)-2-
hydroxypropane (155) (4.0 g, 11 mmol) , diethyl oxalate (6.94 ml, 
51 mmol) , dry EtOH (14 ml), and dry benzene (14 ml) was then added, and 
the resulting yellow mixture was boiled under reflux overnight (ca. 
16 h). After cooling, dry Et20 (56 ml) was added and the resulting 
precipitate was filtered off, washed (Et20, 28 ml), and dried. The 
solid was then added to H20 (67 ml) with stirring, and the mixture was 
acidified with conc. HCI. The H20 was decanted off, and the remaining 
syrupy solid was dissolved in dry EtOH (14 ml) and dry benzene (14 ml). 
The solvent was evaporated off to azeotrope off any H20. Cone. HCI 
(0.14 ml), dry EtOH (5 ml), and dry benzene (5 ml) was added to the red 
oil, and the mixture was boiled under reflux for 5 min. Since no 
precipitation occurred, the mixture was azeotroped with additional dry 
EtOH-benzene (1:1; 28 ml). The resulting oil was dissolved in dry EtOH-
benzene (1:1; 10 ml) and conc. HCI (0.28 ml), and boiled under reflux 
for 5 min. After cooling, the solution was evaporated and azeotroped 
with dry EtOH-benzene (1:1; 40 ml) to afford a red oil (3.4 g), half of 
which was repeatedly chromatographed [flash chromatography on silica 
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gel; elution with EtOAc-hexane (2:1)] to afford three components, viz., 
i) starting material (0.22 g) m.p. 171-172°C; 
ii) a solid which was recrystallised from EtOH to afford 1,3-bis(2-
ethoxycarbonylchromon-5-yloxy)-2-hydroxypropane (156) (0.151 g), 
m.p 186-188°C (lit.,40 180-182°C); BH (400 MHz; CDCl3) 1.42 (6H, t, 2 x 
CH2Me) , 4.34 - 4.38 and 4.49 - 4.59 (5H, 2 x m, CEDH and 2 x OCH2) , 4.45 
(4H, q, 2 x CH2Me) , 4.86 (lH, d, J 6 Hz, CHOH) , 6.96 (2H, s, 2 x CH=C) , 
6.97 and 7.16 (4H, 2 x d, J 8 Hz, 2 x 6-H and 8-H) and 7.60 (2H, t, J 
8Hz, 2 x 7-H); 8e (100 MHz; CDCl3) 14.06 (CH2Me ) , 62.89 ( CH2Me ), 67.76 
(CHOH), 70.36 (2 X OCH2) , 109.64 and 111.13 (C-6 and C-8), 115.66 
(C-4a), 116.21 (C-3), 134.88 (C-7), 150.66 (C-2), 157.69 (C-8a), 158.83 
(C-5), 160.46 (CO.O) and 178.19 (C-4); Vrnax (KBr) /cm-1 3600 - 3200 (OH), 
1748 (CO.O) 1666 and 1650 (CO); and 
iii) a mixture (0.73 g), shown, by TLC, to comprise two components, of 
which 70 mg was chromatographed [preparative layer chromatography; 
elution with EtOAc-hexane (2:1)] to afford 3-(2-acetyl-3-
hydroxyphenoxy)-1-(2-ethoxycarbonylchromon-5-yloxy)-2-hydroxypropane 
(157) (0.038 g), m.p. 140-142°C (from EtOH);a 8H (400 MHz; CDCl3) 1.43 
(3H, t, CH2Me) , 2.72 (3H, s, COMe), 4.26 - 4.33 and 4.36 - 4.39 (4H, 2 x 
m, 2 x OCH2) , 4.46 (3H, q, CEDH and CH2Me) , 4.83 (lH, d, J 6 Hz, CHOH) , 
6.44 and 6.57 (2H, 2 x d, J 8 Hz, 4' - and 6' -H), 6.90 and 7.25 (2H, 2 x 
d, J 8 and 9 Hz, 6-H and 8-H), 6.99 (lH, s, CH=C) , 7.32 (lH, t, J 8 Hz, 
5' -H), 7.64 (lH, t, J 8Hz, 7-H) and 13.18 (lH, s, ArOH); Be (100 MHz; 
CDCl3) 14.06 (CH2Me ) , 33.96 (COMe), 63.03 ( CH2Me ), 68.03 (CHOH), 69.32 
( CH20Ph ), 72.25 (CH20Chromonyl), 102.03 and 111.14 (C-4' and C-6'), 
110.59 and 112.07 (C-6 and C-8), 111.40 (C-2'), 115.99 (C-4a), 116.13 
(C-3), 134.96 (C-7), 136.09 (C-5' ), 150.99 (C-2), 157.64 (C-8a), 158.79 
(C-5), 160.25 and 160.32 (C-3' and CO.O), 164.62 (C-1'), 178.55 (C-4) 
a No melting point is given in the abstract. 157 
and 204.88 (CO); Vmax (KBr) /cm-1 3600 - 3300 (OH), 1725 (CO.O), 1660 
(CO) and 1625 (COMe). 
1,3-Bis(2-carboxychromon-5-yloxy)-2-hydroxypropane disodium salt 
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[disodium cromoglycate (DSCG)] (158).40 2N-NaOH (0.233 ml, 0.8 mmol) 
was added dropwise to a stirred suspension of 
1,3-bis(2-ethoxycarbonylchromon-5-yloxy)-2-hydroxypropane (156) 
(0.122 g, 0.2 mmol) in absolute EtOH (0.58 ml). Three drops of H20 was 
added to the yellow/red paste and the mixture was boiled under reflux 
for 1 h. The solid dissolved after ca. 5 min. After cooling, EtOH 
(1.16 ml) was added and the precipitate was filtered, washed (absolute 
EtOH) , and dried under vacuum at 50°C for 3 h to afford crude 1,3-bis(2-
carboxychromon-5-yloxy)-2-hydroxypropane disodium salt (158) (0.109 g, 
91%);a 8H (400 MHz; D20/acetone) 4.17 - 4.32 (5H, m, CEOH and 2 x OCH2) , 
4.55 - 4.71 (10H, m, HDO) , 6.37 (2H, s, 2 x CH=C) , 6.71 and 6.80 (4H, 2 
x d, J 7 Hz, 2 x 6-H and 8-H) and 7.14 (2H, t, J 7Hz, 2 x 7-H); 8e (100 
MHz; D20) 67.92 (CHOH), 70.89 (2 X OCH2) , 109.56 and 111.21 (C-6 and 
C-8), 112.70 (C-3), 113.74 (C-4a), 135.98 (C-7), 156.87 (C-2), 157.49 
(C-8a), 158.25 (C-5), 165.63 (CO.ONa) and 181.58 (C-4); vmax (KBr) /cm-1 
3700 - 2800 (OH and H20 of crystallisation) and 1635 (CO). 
Ring-opening of 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane 
disodium salt [disodium cromoglycate (DSCG)] (158). - A solution of 
1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane disodium salt (158) 
(0.031 g, 0.05 mmol) in D20 (0.7 ml) was added to aqueous Me2NH (43% 
w/w, 74 ~l, 0.62 mmol) in an NMR tube. After 0.5 h, the resulting red 
solution was examined by NMR spectroscopy and showed no evidence of 
a Yield calculated of the basis of the unhydrated product. 
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starting material. as illustrated in Figures 25 and 26 (p.105 and 106).a 
[Both IH and 13C spectra of the reaction mixture correspond essentially 
with the ring-opened disodium 1.3-bis{2-(3-carboxy-3-
dimethylan.Unoacryloyl;-3-hydroxyphenoxy]-2-hydroxypropane (159).] After 
24 h, the spectra of the reaction solution were essentially the same. 
After 32 h, the red solution was poured into a round bottomed flask, and 
dry benzene (5 ml) was added. b The solution was warmed under vacuum to 
azeotrope off the H20. This process was repeated several times in an 
attempt to reduce the volume of H20, and the resulting solution was 
dried under vacuum for 2h at ca. 70°C to afford crude starting material 
(0.033 g, 100%). 
a The IH and 13C spectra of DSCG (158) were calibrated against acetone. 
The spectra of the reaction mixture were calibrated against the HDO 
signal at 4.5 - 4.7 ppm for the IH spectrum, and by the Me2NH N-methyl 
signal at ca. 36.9 ppm in the 13C spectrum. [The Me2NH chemical shift 
was calibrated from a reference solution of aqueous Me2NH (40% w/w) in 
D20 using acetone as reference material.] 
b The isolation procedure did not involve acidification, since this may 
have resulted in formation of the dimethylammonium salt. 
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3.3 NMR CONFORMATIONAL STUDIES. 
Variable-temperature IH spectra were recorded on a Bruker AM 300 MHz NMR 
spectrometer, from CDCl3 solutions of the chromone-2-carboxamides, and 
temperature errors are estimated at ±lK. The n.O.e difference spectra 
were recorded on a Bruker AM 300 MHz NMR spectrometer, from a CDCl3 
solution at 298K. 
The coalescence temperatures (Te) were obtained from the variable-
temperature spectra (Figure 41) with an estimated ±2K accuracy. The 
estimated error of the Te values, viz., ± 3K is the sum of this error and 
the accuracy of the NMR spectrometer temperature, viz., ±lK. The IH NMR 
frequency separations measured at slow site-exchange ~vo) are either 
maximum frequency separations ~vo) or separations corresponding to the 
minimum temperature below which precipitation of material precluded 
further measurement. The frequency differences at coalescence ~ve) 
were obtained from the variable-temperature spectra by extrapolation of 
linear plots of the frequency separations ~v) against temperature (T). 
Extrapolation data and plots are included after the variable temperature 
spectra (Figure 41). The estimated error of the AVe values is the sum 
of the measurement error [± 0.5 mm (for 1 mm = 1 Hz) and ± 0.3 mm (for 
2 mm = 1 Hz)] and the linear extrapolation error. The latter error was 
calculated by substituting Te±3K into the respective linear equation. 
The rotational energy barriers ~G*) were calculated from the 
coalescence temperatures (Te) and the frequencies at coalescence ~v c) . 
The estimated errors of the AG* data were calculated from the separate 
effects of the errors in Tc and Av c' and the maximum scatter 
incorporating both effects was quoted. 
315 K A 296 K i 296 K 1 305 K A 285 K 296 K 290 K ! 
300 K 275 K 1 285 K 285 K JL 
296 K 270 K ~ 275 K 275 K Jl 
285 K ~ 265 K A 265 K 265 K 1L 
275 K 1 255 K A 255 K 1 255 K A 
3.3 3.0 3.2 3.1 3.2 3.1 6 3.2 3.3 
131 132 133 ·134 
296 K A 
285 K A 325 K 
275 K A 
1 270 K 
265 K 1 345 K U 
255 K A 296 K U 296 K 
3.2 3.1 6 3.3 2.9 6 4.1 
129 135 136 
FIGURE 41. Variable temperature IH NMR spectra showing N-alkyl 
signals for selected chromone-2-carboxamides 129-138. 
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3.3 6 
178 
130 
No. Tc/K dV/Hz Y(CALC) 4.2 
1 275 4.0 3.9 
2 285 3.1 3.4 4 
3 296 3.0 2.8 3.8 
4 300 2.6 2.6 3.6 
Regression Output: ~ 3.4 Constant 17.39826 3.2 Std Err of Y Est 0.2472/,9 
R Squared 0.88328 3 
No. of Observations 4 2.8 Degrees of Freedom 2 
2.6 
X Coefficient(s) -0.0492154 2'~70 Std Err of Coef. 0.0126.503729 275 280 285 290 295 JOO J05 
Tell< 
131 
No. Tc/K dV/Hz Y(CALC) 3.2 
1 275 3.0 2.9 3 2 285 2.5 2.6 
3 296 2.0 2.1 2.8 4 300 2.1 2.0 
~ 2.6 Regression Output: 
Constant 13.67263 ~ 2.4 
Std Err of Y Est 0.139323 
R Squared 0.937384 2.2 
No. of Observations 4 
Degrees of Freedom 2 2 
X Coefficient(s) -0.03900562 
Std Err of Coef. 0.007128402.52 
1270 275 280 285 290 295 JOO 305 
Tcll< 
132 
No. Tc/K dV/Hz Y(CALC) 2 
1 255 1. 75 1.75 
2 265 1.25 1.25 1.8 
3 270 1.00 1.00 
1.6 
Regression Output: 
Constanl: 14.5 ~ 
Std Err of Y Est 1.11E-06 ~ 1.4 
R Squared 1 
No. of Observations 3 1.2 
Degrees of Freedom 1 
X Coefficientls) -0.0500 
Std Err of Coef. 0.0000 0'~50 255 260 265 270 275 
Tcll< 
134 
No. Tc/K dV/Hz Y(CALC) 1.1 
1 265 1.0 1.0 
2 27.5 1.0 1.0 1.05 
3 280 1.0 1.0 ~ 4 285 1.0 1.0 5 290 0.9 0.9 ~ 0.95 
Regression Output: ~ 
Constant 1.80946 0.9 .. Std Err of Y Est 0.03971 
R Squared 0.40878 
No. of Observations 5 0.85 
Degrees of Freedom 3 
X Coefficient(s) -0.0029729730 0·960 265 270 275 280 285 290 295 
Std Err of Cod. 0.00206422329 Tcll< 
129 
No. Te/X dV/Hz 
1 255 1.00 
2 265 1.00 
3 270 0.75 
Regression Output: 
Constant 
Std Err of Y Est 
R Squared 
No. of Observations 
Degrees of Freedom 
X Coefficient(s) -0.01428571 
Std Err of Coe!. 0.0124 
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No. Te/X dV/Hz 
1 296 98 
2 305 93 
3 310 90 
Regression Output: 
Constant 
Std Err of Y Est 
R Squared 
No. of Observations 
Degrees of Freedom 
X Coefficient(s) -0.5695365 
S td Err of Coe!. 0.0115 
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No. Tc/X dV/Hz 
1 296 21 
2 305 19 
3 315 17 
4 325 15 
5 330 14 
Regression Output: 
Constant 
Std Err of Y Est 
R Squared 
No. of Observations 
Degrees of Freedom 
X Coefficient ( s) -0.20464997 
Std Err of Coe£. 0.00253355 
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No. Te/X dV/Hz 
1 296 71 
2 305 70 
3 315 65 
4 320 63 
Regression Output: 
Constant 
Std Err of Y Est 
R Squared 
No. of Observations 
Degrees of Freedom 
X Coefficient(s) -0.3508772 
Std Err of Coef. 0.062181785 
Y(CALC) 
1.04 
0.89 
0.82 
4.678571 
0.133631 
0.571429 
3 
1 
Y(CALC) 
98 
93 
90 
266.6159 
0.115087 
0.999595 
3 
1 
Y(CALC) 
21 
19 
17 
15 
14 
81.50103 
0.070885 
0.99954 
5 
3 
Y(CALC) 
72 
69 
65 
63 
175.6711 
1.149943 
0.9409 
4 
2 
1.2 
1.1 
~ 
~ 
0.9 
0.8 
0·3::AJ 
100 
98 
96 
~ 94 
~ 92 
90 
88 
~90 
22 
20 
~ 18 
~ 
16 
14 
'~90 
76 
74 
72 
70 
~ 68 
66 
64 
62 
6990 
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255 260 265 270 275 
Tell< 
295 .300 J05 310 315 
Tell< 
.300 310 320 3JO 340 
Tell< 
295 .300 305 310 315 320 325 
Tell< 
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Calculation of the percentage n.O.e. 
The percentage n.O.e for each interaction was calculated using equation 
13. where As. Bs. CSt and Ds represent the height. in mm. of a particular 
peak in a trace divided by the scale for the trace of the spectra A. B. 
C. and D respectively (figure 42). 
% n.O.e = (As/Bs) x 100 x (Ds/Cs ) (13) 
Calculations: a) Irradiation at vI: Ds 
Peak 2 As .9375. Bs = 150, % n.O.e 
Peak 3 .3125. 
b) Irradiation at v2 : 
Peak 1 As 1.5625, 
Peak 3 .59375, 
Bs = 144. % n.O.e 
144. Cs = 110 
144. % n.O.e 
144, % n.O.e 
c) Irradiation at v3: Ds = 144, Cs = 104 
144, Cs 
.87 
.30 
1.42 
.54 
Peak 1 As = .390625, Bs = 144, % n.O.e = .38 
Peak 2 As .76565. Bs = 150. % n.O.e .71 
104 
60 nm. 20 nm. 
a) 
1 x 64 
50 nm. 
b) 
2 x 32 
c) 
25 nm.1 
~)h· 
49 nm. 33 nm. 
3 x 64 
A) Observed n.O.e Specta. 
72 nm. 75 nm. 72 nm. 
Vl V2 V3 
I I • -.---- .-------,----------,--, , , ItS 
S. Z 3.1 3.' Z. g z. a Z.7 Z.6 Z. S Z. J Z.3 Z.2 Z.1 2..' 
x 0.5 PPM 
B) Reference Spec tum of A. 
FIGURE 42 
72 nm. 72 nm. 72 nm. 
Vl V2 V3 
3:: 3:1 3!8 Z~g 1:8 1:' 2:6 2.:5 -i;J------z;3 Z:i--2:1 1:' 
x 0.5 PPM 
O} Reference Spec tum of C. 
3 x 0.5 
2 x 0.5 ,,..-
1 x 0.5 ~rr--~r-------------------------------------1---
52 nm. 55 nm. 52 nm. 
C) Negative Specta of A. 
~ 
CD 
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3.4 CRYSTAL STRUCTURE DETERMINATION OF 2-DIMETHYLAMIN0-3-(2-
HYDROXYBENZOYL)-N. J.t.DIMETHYLACRYLAMIDE. 
Collection and reduction of intensity data. 
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The crystal used for data collection was grown from 95% ethanol. 
Preliminary investigation was carried out using a Stoe reciprocal 
lattice explorer. The absence of symmetry in the oscillation photograph 
and the de Jong-Bouman photograph of the reciprocal lattice plane hkO 
indicated that the crystal was triclinic with the space group P1 or pI. 
Crystal density calculation indicated that there were two molecules per 
unit cell. suggesting pi as the correct group. The structure was 
successfully refined in Pi which confirmed this assignment. X-ray 
intensity data were measured on an Enraf-Nonius CAD4 diffractometer at 
298K using graphite-monochromated Mo K a radiation (A = 0.70930 A). The 
data were corrected for Lorenz and polarization effects and for 
absorption. 
Structure solution and refinement. 
Automatic centrosymmetric direct methods were used to determine the 
positions of the non-hydrogen atoms. The structure was refined using 
full matrix least-squares; 190 parameters were refined using 3260 
observed (I > cr(I» reflections. All the non-hydrogen atoms were 
assigned anisotropic temperature factors. Hydrogen atoms [with the 
exception of the hydroxy hydrogen H(O)] were placed at calculated 
positions based on the corresponding carbon atoms and refined with 
common isotropic temperature factors. The position of H(O) was 
determined from the difference Fourier map and refined in subsequent 
cycles. H(O) is involved in an intramolecular hydrogen bond: 
O(l)-H(O) 0.87(3)A; O(2) •.. H(0) 1.69(3)A; and O(1)-H(O) .•. O(2) 
150.0(2)°. The final refinement converged to an R factor of 0.069 with 
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unit weights for the reflection data. SHELX 158 was used for the 
structure solution and refinement. 
Structure Analysis. 
The crystal data are summarised in tables 12-23 (Appendix 5.2). The 
program XANADU 159 was used to calculate dihedral angles of the amide and 
enamine functionalities (table 17) and the hydrogen bond (table 18), 
mean planes through various groups of atoms (tables 19-22) and the 
angles between the normals of the planes (table 23). The plotting 
program PLUTO 160 was used to obtain the molecular structure (figure 21 
p.97) and packing diagram (figure 22 p.98) viewed in the direction of 
minimum overlap. Crystal data are summarised in table 12, the atomic 
co-ordinates and equivalent isotropic temperature factors for the non-
hydrogen atoms and the atomic co-ordinates and isotropic temperature 
factor for H(O) in table 13, the atomic co-ordinates and isotropic 
temperature factors for the hydrogen atoms in table 16, bond lengths and 
angles for non-hydrogen atoms and H(O) in table 14, and the anisotropic 
temperature factors for non-hydrogen atoms in table 15. Observed and 
calculated structure factors are available from the Department of 
Chemistry and Biochemistry, Rhodes University, Grahamstown, South 
\ 
Africa. 
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3 . 5 KINETIC STUDIES. 
Standard ethanolic chromone-2-carboxamide solutions were prepared by the 
following illustrative procedure : N,N-dimethylchromone-2-carboxamide 
129 (5.0 mg, 23.0 mmol) was dissolved in dry EtOH (10 ml) in a 10 ml 
volumetric flask and the resulting solution (0.46 ml, 1.05 x 10-3 mmol) 
was diluted in a 10 ml volumetric flask. This solution (1.00 ml, 1.05 x 
10-3 mmol) was then diluted in a 3 ml reaction volumetric flask to the 
required initial concentration. The volumes and corresponding 
dimethylamine concentrations used are summarised in Table 24. 
Dilution and triggering of the reaction were carried out in a 3 ml 
volumetric flask [for the chromone-2-carboxamides (129,130,132, and 133) 
standard amide solutions (1.00 ml) were added to the volumetric flask 
containing the required ethanolic dimethylamine (33% w/w; 0.22 - 1.43 
ml); while ethanolic dimethylamine (33% w/w; 32.54 - 54.23 ~l) was added 
to the flask containing N,N-dimethyl-7-nitro-chromone-2-carboxamide 131 
(1.00 ml)]. The stopwatch was started after combining the reagents and 
mixing was achieved by inverting the flask five times. The reaction was 
then transferred to the curvette and initial readings were taken after 
1 - 2 min. 
Concentrations and corresponding absorptions required for the Beer's Law 
determinations of the acrylamides (140,142-143) were calculated using 
molar absorption coefficients [e.g. for the parent acrylamide (140), A~x 
357 (8 29 647 dm3 mol-I cm-I )]. Standard ethanolic acrylamide solutions 
were prepared by the following procedure: (E)-2-(dimethylamino)-3-(2-
hydroxybenzoyl)-N,N-dimethylacrylamide (140) (5.35 mg, 20.4 mmol) was 
dissolved in dry EtOH (10 ml) in a 10 ml volumetric flask and the 
resulting solution (0.50 ml, 1.02 x 10-4 mmol) was diluted in a 10 ml 
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volumetric flask. This solution was then diluted in a 3 ml volumetric 
flask. The volumes used for the final dilution, and the concentrations, 
calculated absorptions (Ae), and measured absorptions (Am) are 
summarised in table 25 p.186. The linear regression data is summarised 
below Table 25. 
TABLE 24. Ethanolic dimethylamine concentrations. 
Volumea 
(ml) 
H 0.55 
0.66 
0.77 
0.88 
OMe 0.99 
1.10 
1.21 
1. 32 
1.43 
F 0.22 
0.27 
0.33 
0.38 
0.44 
CI 0.11 
0.17 
0.22 
0.27 
0.33 
a± 0.1 mL b± 
[Me 2NH ] 
(moLI-1) 
1.00 
1.20 
1.40 
1.60 
1.80 
2.00 
2.20 
2.40 
2.60 
0.40 
0.50 
0.60 
0.70 
0.80 
0.20 
0.30 
0.40 
0.50 
0.60 
0.41-'-1. 
N02 
Volumeb 
32.54 
37.96 
43.38 
48.81 
54.23 
[Me2NH ] 
(10- 2mol.l-1 ) 
5.9 
6.9 
7.9 
8.9 
9.9 
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TABLE 25. Beer's Law data for 2-(dimethylamino)-3-
(2-hydroxybenzoyl)-N,N-dimethylacrylamide 140. 
[acrylamide] volume Ac Am 
(10- 5 mol.I-1 ) (ml) 
0.7 0.20 0.2 0.233 
1.4 0.40 0.4 0.440 
2.0 0.59 0.6 0.639 
2.7 0.79 0.8 0.858 
3.4 0.99 1.0 1.083 
4.0 1.19 1.2 1.305 
The linear regression data are summarised below 
(i) determinations of Beer's law p.187-189; 
(ii) determinations of the pseudo first order rate constants (ka) 
p.190-214; 
(iii) determinations of the observed rate constants (kobs) p. 215-217. 
(iv) Hammett plot p.217. 
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(i) Determinations of Beer's law. 
140 R-H 
No. Ca/l0-5 Absorbance Y(calc) 
1 0.68 0.233 0.224 
2 1.35 0.440 0.438 
3 2.02 0.639 0.651 
4 2.70 0.858 0.867 
5 3.37 1.083 1.081 
J 6 4.05 1.305 1.297 Regression Output: 
Constant 0.00799 
Std Err of Y Est 0.00972 
R Squared 0.99953 
No. of Observations 6 
Degrees of Freedom 4 
X Coefficient{s) 0.31828 2 3 4 5 
Std Err of CoeL 0.00345 Co/,o-5 moll-' 
R-H 
No. Call0-5 Absorbance Y(calc) 
1 0.68 0.235 0.222 
2 1.35 0.432 0.437 
3 2.02 0.6/11 0.651 
4 2.70 0.862 0.868 
5 3.37 1.080 1.083 j 6 4.05 1.311 1.300 
Regression Output: 
Constant 0.00478 
Std Err of Y Est 0.01055 
R Squared 0.99945 
No. of Observations 6 
Degrees of Freedom 4 
2 :3 4 5 
X Coefficient ( s) 0.31985 
Std Err of Coof. 0.00374 CoI,o-5 mell"" 
142 R-OMe 
1.2 
No. Ca/l0-5 Absorbance Y(calc) 
1 0.51 0.207 0.216 
2 1.02 0.416 0.408 
3 1.53 0.599 0.599 
4 2.04 0.802 0.791 0.8 
5 2.56 0.978 0.986 j 6 3.06 1.171 1.173 
Regression Output: 
Constant 0.02513 
Std Err of Y Est 0.00937 
R Squared 0.99945 
No. of Observations 6 
Degrees of Freedom 4 
0.5 1.5 2 2.5 :3 3.5 
X Coefficient(s) 0.37521 
Std Err of Coof. 0.00439 Co/1o-5 mc:tJ-l 
R-OMe 
1.4 
No. Ca/l0-5 Absorbance Y(calc) 
1 0.51 0.221 0.227 
2 1.02 0.429 0.424 
3 1.53 0.626 0.621 
4 2.04 0.821 0.819 
5 2.56 1.011 1.020 
J 6 3.06 1.216 1.213 Regression Output: 
Constant 0.02962 
Std Err of Y Est 0.00652 
R Squared 0.99975 
No. of Observations 6 
Degrees of Freedom 4 
0.38678 0.5 1.5 2 2.5 :3 3.5 X Coefficient(s) 
Std Err of Coof. 0.00305 CoI,o-5 rrdJ...l 
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143 R-N02 
No. Call0-5 Absorbance Y(calc) 
1 0.95 0.224 0.206 
2 1.90 0.419 0.423 
3 2.85 0.620 0.640 
4 3.79 0.848 0.855 
5 4.74 1.072 1.072 j 6 5.69 1.302 1.289 
Regression Output: 
Constant -0.01110 
Std Err of Y Est 0.01550 
R Squared 0.99883 
No. of Observations 6 
Degrees of lreedom 4 
X Coefficient(s) 0.22849 
-0.20 2 J 4 S 6 
Std Err of Coef. 0.00391 Co/ID-S mcil-I. 
R-N02 
No. Ca/10-5 Absorbance Y(calc) 
1 0.95 0.215 0.201 
2 1.90 0.420 0.417 
3 2.85 0.612 0.634 
4 3.79 0.840 0.847 
5 4.74 1.062 1.064 j 6 5.69 1.294 1.280 
Regression Output: 
Constant -0.01530 
Std Err of Y Est 0.01518 
R Squared 0.99887 
No. of Observations 6 
Degrees of Freedom 4 
0.22765 
-0.2
0 2 J 4 S 6 X Coefficient(s) 
Std Err of Coef. 0.00383 Co/1D-S mdl-I 
144 R-F 
1.4 
No. Call0-5 Absorbance Y(calc) 
1 0.62 0.221 0.229 
2 1.25 0.426 0.431 
3 1.87 0.651 0.631 
4 2.50 0.835 0.835 
5 3.12 1.033 1.035 J 6 3.75 1.233 1.238 
Regression Output: 
Constant 0.02712 
Std Err of Y Est 0.01129 
R Squared 0.99929 
No. of Observations 6 
Degrees of Freedom 4 
2 J 4 
X Coefficient(s) 0.32303 
Std Err of Coef. 0.00432 Co/ID-5 mdl-l 
R-F 
1.4 
No. Ca/l0-5 Absorbanca Y(cale) 
1 0.62 0.231 0.225 
2 1.25 0.423 0.426 
3 1.87 0.624 0.625 
4 2.50 0.818 0.828 
5 3.12 1.033 1.027 
J 6 3.75 1.232 1.230 Regression Output: 
Constant 0.02437 
Std Err of Y Est 0.00682 
R Squared 0.99974 
No. of Observations 6 
Degrees of Freedom 4 
2 J 4 
X Coefficient(s) 0.32139 
Std Err of Coef. 0.00261 Co/ID-S mdl-I 
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145 R-Cl 
14 
No. Ca/l0-5 Absorbance Ylcalc) 
1 0.59 0.207 0.210 1.2 2 1.17 0.406 0.401 
3 1. 76 0.600 0.596 
4 2.35 0.783 0.790 
5 2.93 0.978 0.981 j 6 3.52 1.179 1.175 
Regression Outputl 
Constant 0.01584 
Std Err of Y Est 0.00554 
R Squared 0.99981 .-
No. of Observations 6 
Degrees of Freedom 4 
X Coefficient(s) 0.32938 35 4 
Std Err of Coef. 0.00226 Co/I0-5 mdl-I 
R-Cl 
1.4 
No. Ca/l0-5 Absorbance Ylcalc) 
1 0.59 0.214 0.221 1.2 
2 1.17 0.427 0.414 
3 1.76 0.613 0.611 
4 2.35 0.801 0.808 
5 2.93 0.994 1.002 
J 6 3.52 1.206 1.199 Regression Outputl 
Constant 0.02384 
Std Err of Y Est 0.00967 
R Squared 0.99944 
No. of Observations 6 
Degrees of Freedom 4 
X Coefficientls) 0.33376 2 2.5 3 35 4 
Std Err of Coef. 0.00394 Co/I0-5 mdl-I 
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( ii) Determinations of pseudo first order rate constants (ka). 
129 
RUN 1 R-H Ca-3.5 Cb-1.0 A-1.163 %R-83 
No. time Absorbance A-At In(A-At) Ylcalc) 
1 1.58 0.050 1.113 0.107 0.092 
2 5.02 0.106 1.057 0.055 0.042 
3 7.50 0.146 1.017 0.017 0.006 
4 10.00 0.185 0.978 -0.022 -0.030 
5 15.00 0.255 0.908 -0.097 -0.102 
6 20.00 0.322 0.841 -0.173 -0.174 
7 25.00 0.383 0.780 -0.248 -0.246 
8 30.00 0.439 0.724 -0.323 -0.318 
9 35.00 0.491 0.672 -0.397 -0.390 
10 40.00 0.539 0.624 -0.472 -0.462 
11 45.02 0.583 0.580 -0.545 -0.535 
12 50.00 0.624 0.539 -0.618 -0.607 
13 55.00 0.662 0.501 -0.691 -0.679 
14 60.00 0.697 0.466 -0.764 -0.751 
15 70.00 0.759 0.404 -0.906 -0.895 
16 80.03 0.812 0.351 -1.047 -1.040 
17 90.00 0.858 0.305 -1.187 -1.184 
18 100.02 0.897 0.266 -1.324 -1.328 
19 110.00 0.930 0.233 -1.457 -1.472 
20 120.00 0.960 0.203 -1.595 -1.616 
Regression Output: 
Constant 0.1147 
Std Err of Y Est 0.0111 
R Squared 0.9996 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.014/, 
Std Err of Coef. 0.0001 
RUN 2 R-H Ca-3.5 Cb-1.0 A-1.156 %R-82 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.15 0.043 1.113 0.107 0.099 
2 5.00 0.101 1.055 0.054 0.044 
3 7.50 0.140 1.016 0.016 0.008 
4 10.00 0.178 0.978 -0.022 -0.028 
5 15.00 0.248 0.908 -0.091 -0.099 
6 20.00 0.313 0.843 -0.171 -0.171 
7 25.00 0.372 0.784 -0.243 -0.242 
8 30.00 0.428 0.728 -0.317 -0.314 
9 35.00 0.479 0.677 -0.390 -0.385 :;' 
10 40.00 0.527 0.629 -0.464 -0.457 1 <t 
-D.B 
11 45.00 0.570 0.586 -0.534 -0.528 ~ 
12 50.00 0.611 0.545 -0.607 -0.600 - -1 
13 55.00 0.61,9 0.507 -0.679 -0.671 -1.2 
14 60.00 0.684 0.472 -0.751 -0.743 
15 70.00 0.71,7 0.409 -0.891, -0.886 -1.4 
16 80.00 0.801 0.355 -1. 036 -1.029 -1.6 
17 90.00 0.847 0.309 -1.174 -1.172 
-1.B
O 18 100.02 0.887 0.269 -1.313 -1.315 20 40 60 eo 100 120 140 
19 110.00 0.921 0.235 -1.41,8 -1.1,58 
20 120.02 0.951 0.205 -1.585 -1.601 l;""\m., 
Regression Output: 
Constant 0.1152 
Std Err of Y Est 0.0076 
R Squared 0.9998 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0143 
Std Err of Coef. 0.0000 
191 
RUN 1 R-H Ca-3.5 Cb-1.2 A-l.163 %R-85 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.77 0.068 1.095 0.091 0.083 
2 3.97 0.118 1.045 0.044 0.036 
3 5.00 0.143 1.020 0.020 0.014 
4 7.50 0.198 0.965 -0.036 -0.040 
5 10.00 0.255 0.908 -0.097 -0.094 
6 12.50 0.299 0.864 -0.146 -0.148 
7 15.00 0.344 0.819 -0.200 -0.201 
8 17.50 0.389 0.774 -0.256 -0.255 
9 20.02 0.430 0.733 -0.311 -0.309 :r I 
10 25.00 0.506 0.657 -0.420 -0.417 .. 
11 30.00 0.573 0.590 -0.528 -0.524 
.: 
12 35.00 0.634 0.529 -0.637 -0.632 
13 40.00 0.689 0.474 -0.747 -0.739 
14 45.00 0.738 0.425 -0.856 -0.847 
15 50.02 0.781 0.382 -0.962 -0.955 
16 55.00 0.819 0.344 -1. 067 -1.062 
17 60.00 0.855 0.301r -1.178 -1.170 
18 70.00 0.913 0.250 -1.386 -1.385 20 40 00 SO leo 
19 80.00 0.960 0.203 -1.595 -1,"600 
20 90.00 0.997 0.166 -1. 796 -1.815 Im..\mn 
Regression Output: 
Constant 0.1213 
Std Err of Y Est 0.0072 
R Squared 0.9999 
No. of Observations 20 
Degrees of Preedom 18 
X Coefficient(s) -0.0215 
Std Err of Coef. 0.0001 
RUN 2 R-H Ca-3.5 Cb-1.2 A-l.146 %a-83 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.40 0.056 1.090 0.086 0.072 
2 3.40 0.099 1.047 0.046 0.033 
3 5.00 0.133 1.013 0.013 0.001 
4 7.50 0.185 0.961 -0.040 -0.048 
5 10.00 0.234 0.912 -0.092 -0.098 
6 12.50 0.280 0.866 -0.144 -0.147 
7 15.00 0.324 0.822 -0.196 -0.197 
8 17.50 0.365 0.781 -0.247 -0.246 
9 20.00 0.404 0.742 -0.298 -0.296 
10 22.50 - 0.441 0.705 -0.350 -0.345 ;( 
11 25.00 0.476 0.670 -0.400 -0.395 - I .. 
12 27.50 0.509 0.637 -0.451 -0.444 
" 13 30.00 - 0.541 0.605 -0.503 -0.494 - -1 
14 35.00 0.602 0.544 -0.609 -0.593 -1.2 
15 40.00 0.653 0.493 -0.707 -0.692 
16 45.00 0.699 0.447 -0.805 -0.791 -1.4 
17 50.00 0.741 0.405 -0.904 -0.890 
18 60.00 0.811 0.335 -1.094 -1.088 
19 70.00 0.871 0.275 -1.291 -1.286 20 40 00 SO leo 
20 80.00 0.917 0.229 -1.474 -1.484 
21 90.00 0.954 0.192 -1.650 -1.682 tine\tnii 
Regression Output: 
Constant 0.1002 
Std Err of Y Est 0.0122 
R Squared 0.9995 
No. of Observations 21 
Degrees of Preedom 19 
X Coefficient(s) -0.0198 
Std Err of Coef. 0.0001 
192 
RUN 1 R-H Cb-3.5 Cb-1.4 A-l.170 %a-85 
No. time Absorbance A-At 1n(A-At) Y(ca1c) 
1 1.38 0.066 1.104 0.099 0.072 
2 3.17 0.127 1.043 0.042 0.024 
3 5.00 0.177 0.993 -0.007 -0.026 
4 7.15 0.238 0.932 -0.070 -0.085 
5 10.00 0.312 0.858 -0.153 -0.163 
6 12.38 0.370 0.800 -0.223 -0.228 
7 15.03 0.430 0.740 -0.301 -0.300 
8 17.50 0.481 0.689 -0.373 -0.368 
9 20.00 0.528 0.642 -0.443 -0.436 < 
10 22.50 0.573 0.597 -0.516 -0.504 I .. 
11 25.00 0.613 0.557 -0.585 -0.572 ~ e 
12 28.00 0.660 0.510 -0.673 -0.654 -
13 30.00 0.688 0.482 -0.730 -0.709 
14 32.52 0.720 0.450 -0.799 -0.778 
15 35.00 0.750 0.420 -0.868 -0.845 
16 40.02 0.803 0.367. -1.002 -0.982 
17 45.02 0.849 0.321 -1.136 -1.119 
-2
0 18 50.00 0.887 0.283 -1.262 -1.255 10 20 JO 4() 50 so 70 so 
19 60.02 0.949 0.221 -1.510 -1.528 
20 70.13 0.996 0.17l, -1.7l,9 
-1.804 trne'mn 
Regression Output: 
Constant 0.1102 
Std Err of Y Est 0.0212 
R Squared 0.9985 
No. of Observations 20 
Degrees of Freedom 18 
X Coeffic:l.ent (s) -0.0273 
Std Err of CoeL 0.0003 
RUN 2 R-H Ca-3.5 Cb-1.l, A-1.190 U-80 
No. time Absorbance A-At 1n(A-At) Y(c:a1c) 
1 1.55 0.063 1.127 0.120 0.117 
2 3.00 0.105 1.085 0.082 0.077 
3 5.02 0.163 1.027 0.027 0.023 
4 8.20 0.2l,9 0.941 -0.061 -0.063 
5 10.02 0.295 0.895 -0.111 -0.112 
6 lIt.98 0.410 0.780 -0.248 -0.246 
7 17.18 0.455 0.735 -0.308 -0.305 :i I 8 20.03 0.510 0.680 -0.386 -0.382 .. 
9 25.15 0.599 0.591 -0.526 -0.520 
.: 10 30.67 0.680 0.510 -0.673 -0.669 
11 35.67 0.744 0.l,l,6 -0.807 -0.804 
12 40.02 0.793 0.397 -0.924 -0.922 
13 45.02 0.842 0.348 -1.056 -1.056 
14 50.02 0.885 0.305 -1.187 -1.191 
15 60.06 0.957 0.233 -1.457 -1.462 
10 20 JO 4() 50 so 70 
Regression Output: 
lme\mn Constant 0.1584 
Std Err of Y Est 0.0038 
R Squared 0.9999 
No. of Observations 15 
Degrees of Freedom 13 
X Coefficient(s) -0.0270 
Std El·r of Coef. 0.0001 
193 
RUN 1 R-H Ca-3.5 Cb-1.6 A-l.16 %R-82 
No. time Absorbance A-At In(A-At) Ylcatc) 
1 1.38 0.079 1.081 0.078 0.067 
2 3.25 0.153 1.007 0.007 -0.003 
3 5.00 0.220 0.940 -0.062 -0.069 
" 
7.32 0.302 0.858 -0.153 -0.156 
5 8.82 0.350 0.810 -0.211 -0.212 
6 10.00 0.387 0.713 -0.257 -0.257 
7 12.25 0.450 0.710 -0.342 -0.341 
8 14.22 0.503 0.657 -0.420 -0.415 
9 15.00 0.522 0.638 -0.449 -0.445 ;; 
10 17.50 0.581 0.579 -0.546 -0.539 1 ... 
11 20.00 0.633 0.527 -0.641 -0.633 c 12 22.53 0.681 0.479 -0.736 -0.728 -
13 25.00 0.723 0.437 -0.828 -0.820 -1 
14 27.50 0.762 0.398 -0.921 -0.914 
15 30.00 0.798 0.362 -1.016 -1.008 
16 32.50 0.829 0.331 . -1.106 -1.102 
17 35.00 0.858 1).302 -1.197 -1.196 
18 37.50 0.884 0.276 -1.287 -1.290 41) 50 
19 40.00 0.908 0.252 -1.378 -1.384 
20 45.00 0.948 0.212 -1.551 -1.572 trne\mn 
Constant 
Regression Output: 
0.1190 
Std Err of Y Est 0.0081 
R Squared 0.9997 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0376 
Std Err of Coef. 0.0001 
RUN 2 R-H Ca-3.5 Cb-1.6 A-I. 180 %R-81 
No. time Absorbance A-At InIA-At) Ylcalc) 
1 1.42 0.084 1.096 0.092 0.067 
2 3.38 0.154 1.026 0.026 0.002 
3 5.00 0.213 0.967 -0.034 -0.051 
4 7.13 0.286 0.894 -0.112 -0.122 
5 8.23 0.321 0.859 -0.152 -0.158 
6 10.00 0.373 0.807 -0.214 -0.217 
7 12.50 0.442 0.738 -0.304 -0.299 
8 15.00 0.505 0.675 -0.393 -0.382 
9 17.50 0.560 0.620 -0.478 -0.465 ::;: 1 
10 20.00 0.612 0.568 -0.566 -0.547 ... 
11 22.50 0.658 0.522 -0.650 -0.630 
.= 12 25.00 0.699 0.481 -0.732 -0.713 
13 27.50 0.737 0.443 -0.814 -0.795 
14 30.00 0.772 0.408 -0.896 -0.878 
15 32.50 0.803 0.377 -0.976 -0.961 
16 35.00 0.833 0.347 -1.058 -1.044 
17 37.50 0.858 0.322 -1.133 -1.126 10 20 JO 40 50 18 40.00 0.881 0.299 -1. 207 -1.209 
19 45.00 0.921 0.259 -1.351 -1.374 li'ne\mn 20 50.00 0.954 0.226 -1.487 -1.540 
Regression Output: 
Constant 0.1143 
Std Err of Y Est 0.0204 
R Squared 0.9983 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0331 
Std Err of Coef. 0.0003 
194 
RUN 1 R-II Ca-3.5 Cb-1.8 A-1.193 %R-82 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1. 78 0.104 1.089 0.085 0.078 
2 3.85 0.195 0.998 -0.002 -0.011 
3 5.00 0.245 0.948 -0.053 -0.061 0.2 
4 7.12 0.330 0.863 -0.147 -0.153 
5 8.55 0.385 0.808 -0.213 -0.215 0 
6 10.00 0.435 0.758 -0.277 -0.277 -02 
7 12.13 0.503 0.690 -0.371 -0.369 
8 13.72 0.550 0.643 -0.442 -0.438 
9 15.00 0.586 0.607 -0.499 -0.494 =< 
10 17.32 0.645 0.548 -0.601 -0.594 I .. 
11 18.68 0.676 0.517 -0.660 -0.653 e 
12 20.00 0.705 0.488 -0.717 -0.710 -
-1 13 22.18 0.750 0.443 -0.814 -0.804 
14 25.02 0.800 0.393 -0.934 -0.927 
15 27.53 0.840 0.353 -1.0ltl -1.036 
16 30.02 0.876 0.317 -1.149 -l.llt4 
17 32.53 0.907 0.286 -1.252 -1.252 
18 35.00 0.935 0.258 -1.355 -1.359 
19 37.85 0.961t 0.229 -1.471t -1.483 
20 40.00 0.983 0.210 -1.561 -1.576 lrne\rnn 
Constant 
Regression Output: 
0.1555 
Std Err of Y Est 0.0072 
R Squared 0.9998 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0433 
Std Err of Coef. 0.0001 
RUN 2 R-II Ca-3.5 Cb-1.8 A-I. 151 %R-81 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.23 0.082 1.069 0.067 0.046 
2 3.00 0.161 0.990 -0.010 -0.028 
3 3.90 0.200 0.951 -0.050 -0.065 
4 5.00 0.246 0.905 -0.100 -0.111 
5 7.00 0.324 0.827 -0.190 -0.195 
6 8.00 0.360 0.791 -0.234 -0.237 
7 9.98 0.427 0.724 -0.323 -0.320 
8 12.12 0.492 0.659 -0.417 -0.409 
9 13.87 0.540 0.611 -0.493 -0.483 
=< 10 15.02 0.570 0.581 -0.543 -0.531 I .. 
11 17.05 0.619 0.532 -0.631 -0.616 
c: 12 18.50 0.651 0.500 -0.693 -0.677 -
13 20.00 0.681 0.470 -0.755 -0.739 
14 22.48 0.727 0.424 -0.858 -0.843 
15 25.00 0.769 0.382 -0.962 -0.949 
16 27.55 0.809 0.342 -1.073 -1.055 
17 30.00 0.840 0.311 -1.168 -1.158 
18 32.50 0.869 0.282 -1.266 -1.263 
19 35.00 0.894 0.257 -1.359 -1.367 
20 40.00 0.932 0.219 -1.519 -1.577 lrne\mn 
Regression Output: 
Constant 0.0979 
Std Err of Y Est 0.0189 
R Squared 0.9985 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0419 
Std Err of Coef. 0.0004 
195 
130 
RUN 1 R-OMe Ca-3.0 Cb-l.8 A-I. 152 %R-82 
No. I:ime Absorbance A-At lnCA-AI:.) Y(calc) 
1 1.22 0.060 1.092 0.088 0.080 
2 3.00 0.107 1.045 0.044 0.037 
3 5.00 0.157 0.995 -0.005 -0.011 
4 7.00 0.204 0.948 -0.053 -0.059 
5 8.00 0.228 0.924 -0.079 -0.084 
6 10.00 0.272 0.880 -0.128 -0.132 
7 12.50 0.326 0.826 -0.191 -0.192 
8 15.00 0.376 0.776 -0.254 -0.252 
9 17.70 0.426 0.726 -0.320 -0.318 
10 20.00 0.465 0.687 -0.375 -0.373 
11 22.50 0.506 0.646 -0.437 -0.433 :t 
12 25.00 0.545 0.607 -0.499 -0.494 I ..: 
13 27.50 0.581 0.571 -0.560 -0.554 
.: 14 30.00 0.615 0.537 -0.622 -0.614 
15 32.50 0.646 0.506 -0.681 -0.675 
16 35.00 0.676 0.476 -0.742 -0.735 
17 40.00 0.730 0.422 . -0.863 -0.856 
18 45.00 0.778 0.374 -0.983 -0.976 
19 50.00 0.820 0.332 -1.103 -1.097 
20 55.00 0.858 0.294 -1.224 -1.218 60 70 
21 65.00 0.916 0.236 -1.444 -1.459 
22 70.00 0.942 0.210 -1.561 -1.579 It-ne\mn 
Regression OutPUI:: 
Constanl: 0.1095 
Sl:d Err of Y Est 0.0078 
R Squared 0.9998 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0241 
Sl:d Err of Cae!. 0.0001 
RUN 2 R-OMe Ca-3.0 Cb-l.8 A-l.166 %R-81 
No. I:ime Absorbance A-AI: In(A-At) YCcalc) 
1 1.03 0.052 1.114 0.108 0.098 
2 3.00 0.103 1.063 0.061 0.052 
3 5.00 0.153 1.013 0.013 0.005 
4 7.00 0.202 0.964 -0.037 -0.042 
5 8.50 0.236 0.930 -0.073 -0.078 
6 10.00 0.270 0.896 -0.110 -0.113 
7 12.50 0.323 0.843 -0.171 -0.171 
8 15.00 0.372 0.794 -0.231 -0.230 
9 17.52 0.419 0.747 -0.292 -0.289 
10 20.00 0.463 0.703 -0.352 -0.347 
11 22.50 0.504 0.662 -0.412 -0.406 :t 
12 25.00 0.542 0.624 -0.472 -0.465 I .. 
13 27.50 0.578 0.588 -0.531 -0.523 
" 14 30.00 0.612 0.554 -0.591 -0.582 -
15 32.50 0.644 0.522 -0.650 -0.641 -1 
16 35.00 0.674 0.492 -0.709 -0.699 
-1.2 
17 40.00 0.728 0.438 -0.826 -0.817 
18 45.00 0.775 0.391 -0.939 -0.934 
19 50.00 0.818 0.348 -1.056 -1.051 
20 55.00 0.855 0.311 -1.168 -1.169 40 50 60 70 21 60.00 0.888 0.218 -1.280 -1.286 \ 22 70.00 0.942 0.224 -1.496 -1.521 lm..\mn 
Regression OuI:PUI:: 
Constant 0.1219 
Std Err of Y Est 0.0087 
R Squared 0.9997 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient ( s) -0.0235 
Sl:d Err of Cae!. 0.0001 
196 
RUN 1 R-OMe Ca-3.0 Cb-2.0 A-1.182 %&-82 
No. time Absorbance A-At lnIA-At) Ylcalc) 
1 1.32 0.072 1.110 0.104 0.098 
2 2.50 0.112 1.010 0.068 0.062 
3 5.00 0.194 0.988 -0.012 -0.016 
4 7.00 0.255 0.927 -0.076 -0.079 
5 9.00 0.313 0.869 -0.140 -0.141 
6 10.00 0.340 0.842 -0.172 -0.172 
7 12.58 0.406 0.776 -0.254 -0.253 
8 15.00 0.463 0.719 -0.330 -0.329 
9 17.52 0.518 0.66 /, -0.409 -0.407 ;; 
10 20.00 0.568 0.614 -0.488 -0.485 I .., 
11 22.50 0.615 0.567 -0.567 -0.563 c -08 12 25.00 0.658 0.524 -0.646 -0.641 -
13 27.50 0.697 0.485 -0.724 -0.719 -I 
14 30.00 0.733 0.449 -0.801 -0.797 
-12 
15 32.50 0.767 0.415 -0.879 -0.875 
16 35.00 0.798 0.384 . -0.957 -0.953 -1.4 
17 40.00 0.853 0.329 -1.112 -1.109 
18 45.00 0.900 0.282 -1.266 -1.265 
19 50.02 0.939 0.243 -1.415 -1.422 60 
20 55.02 0.973 0.209 -1.565 -1.578 li're\mn 
Regression Output: 
Constant 0.1397 
Std Err of Y Est 0.0051 
R Squared 0.9999 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0312 
Std Err of Coef. 0.0001 
RUN 2 R-OMe Ca-3.0 Cb-2.0 A-1.195 %&-80 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.58 0.086 1.109 0.103 0.097 
2 2.50 0.114 1.081 0.078 0.071 
3 5.00 0.191 1.004 0.004 -0.001 
4 7.00 0.248 0.947 -0.054 -0.058 
5 8.00 0.216 0.919 -0.084 -0.087 
6 10.00 0.328 0.867 -0.143 -0.144 
7 12.50 0.389 0.806 -0.216 -0.215 
8 15.00 0.446 0.749 -0.289 -0.287 
9 17.50 0.499 0.696 -0.362 -0.358 ;; 
10 20.00 0.547 0.648 -0.434 -0.429 I ... 
11 22.50 0.592 0.603 -0.506 -0.501 :. 12 25.00 0.634 0.561 -0.518 -0.572 
-I 
13 27.50 0.673 0.522 -0.650 -0.644 
14 30.02 0.709 0.486 -0.122 -0.716 
15 32.50 0.742 0.453 -0.792 -0.781 
16 35.00 0.173 0.422 -0.863 -0.858 -1.4 
11 40.00 0.829 0.366 -1.005 -1.001 
-1.6
0 18 45.00 0.876 0.319 -1.143 -1.144 10 20 JO 40 50 60 
19 50.00 0.911 0.278 -1.280 -1.287 
20 55.00 0.952 0.243 -1.415 -1.430 liTe\rnn 
Regression Output: 
Constant 0.1420 
Std Err of Y Est 0.0060 
R Squared 0.9998 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0286 
Std Err of Coef. 0.0001 
197 
RUN 1 R-OMe Ca-3.0 Cb-2.2 A-l.227 %R-83 
No. time Absorbance A-At In(A-At) Ylcalc) 
1 1.42 0.100 1.127 0.120 0.113 
2 2.50 0.142 1.085 0.082 0.074 
3 4.02 0.201 1.026 0.026 0.020 
4 5.00 0.237 0.990 -0.010 -0.014 
5 6.62 0.292 0.935 -0.067 -0.072 
6 7.50 0.322 0.905 -0.100 -0.103 
7 9.00 0.371 0.856 -0.155 -0.157 
8 10.05 0.403 0.824 -0.194 -0.194 
9 12.02 0.460 0.767 -0.265 -0.264 
10 13.00 0.487 0.740 -0.301 -0.299 
11 15.00 0.538 0.689 -0.373 -0.370 ;;( 
12 17.00 0.586 0.641 -0.445 -0.441 1 .. 
13 19.00 0.631 0.596 -0.518 -0.512 
c II, 20.00 0.652 0.575 -0.553 -0.547 -
15 22.52 0.702 0.525 -0.644 -0.637 
16 25.00 0.747 0.480. -0.734 -0.725 
17 27.50 0.787 0.440 -0.821 -0.814 
18 30.00 0.824 0.403 -0.909 -0.902 
19 35.00 0.889 0.338 -1. 085 -1.080 
20 40.00 0.943 0.284 -1.259 -1.258 -1.80 10 20 :JO 40 50 
21 45.00 0.987 0.240 -l.il27 -1.435 
22 50.00 1.024 0.203 -1.595 -1.613 ti'ne\rnn 
Regression Output: 
Constant 0.1631 
Std Err of Y Est 0.0069 
R Squared 0.9998 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficientls) -0.0355 
Std Err of Coef. 0.0001 
RUN 2 R-OMe Ca-3.0 Cb-2.2 A-l.191 XR-81 
No. time Absorbance A-At lnIA-At) Ylcalc) 
1 1.il5 0.095 1.096 0.092 0.079 
2 2.50 0.134 1.057 0.055 0.044 
3 4.00 0.188 1.003 0.003 -0.006 
iI 5.00 0.222 0.969 -0.031 -O.OilO 
5 6.92 0.285 0.906 -0.099 -0.104 
6 7.50 0.303 0.888 -0.119 -0.123 
7 9.02 0.349 0.842 -0.172 -0.174 
8 10.00 0.378 0.813 -0.207 -0.206 
9 12.02 0.432 0.759 -0.276 -0.274 
10 13.00 0.458 0.733 -0.311 -0.306 
11 15.00 0.507 0.684 -0.380 -0.373 ;;( 
12 17.00 0.552 0.639 -0.448 -0.440 1 .. 
13 19.00 0.594 0.597 -0.516 -0.506 -o.B 
14 20.00 0.614 0.577 -0.550 -0.5i10 .= 
15 22.50 0.660 0.531 -0.633 -0.623 -1 
16 25.00 0.703 0.488 -0.717 -0.706 -1.2 
17 27.50 0.7i12 0.il49 -0.801 -0.790 
18 30.00 0.778 0.413 -0.884 -0.873 -1.4 
19 35.00 0.840 0.351 -1.047 -1.040 
20 40.01 0.892 0.299 -1. 207 -1.206 50 
21 45.00 0.935 0.256 -1.363 -1.373 
22 50.00 0.970 0.221 -1.510 -1.539 lint\mn 
Regression Output: 
Constant 0.1269 
Std Err of Y Est 0.0109 
R Squared 0.9995 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0333 
Std Err of Coef. 0.0002 
198 
RUN 1 R-OMe Ca-3.0 Cb-2.4 A-lo225 lR-82 
No. time Abeorbance A-At in(A-At) Y(caic) 
1 1.05 0.083 1.142 0.133 0.126 
2 2.50 0.151 1.074 0.071 0.065 
3 4.00 0.219 1.006 0.006 0.001 
4 5.00 0.262 0.963 -0.038 -0.042 
5 6.70 0.330 0.895 -0.111 -0.114 
6 7.50 0.361 0.864 -0.146 -0.148 
7 9.00 0.416 0.809 -0.212 -0.212 
8 10.00 0.450 0.775 -0.255 -0.255 
9 11.78 0.508 0.717 -0.333 -0.331 
10 12.50 0.530 0.695 -0.364 -0.361 
11 14.00 0.574 0.651 -0.429 -0.425 ;;: 
12 15.00 0.602 0.623 -0.473 -0.468 I « 
13 11.00 0.653 0.572 -0.559 -0.553 c 14 19.00 0.700 0.525 -0.644 -0.638 -
15 20.00 0.722 0.503 -0.687 -0.680 -1 
16 22.50 0.773 0.452 -0.794 -0.787 
17 25.00 0.818 0.407 -0.899 -0.893 
18 27.50 0.858 0.367 -1.002 -1.000 
19 30.00 0.895 0.330 -1.109 -1.106 
20 35.00 0.957 0.268 -1.317 -1.319 
21 37.52 0.983 0.242 -1.419 -1.426 
22 40.00 1.006 0.219 -1.519 -1.532 \me\m" 
Regression Output: 
Constant 0.1710 
Std Err of Y Est 0.0058 
R Squared 0.9999 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0426 
Std Err of Cod. 0.0001 
RUN 2 R-OMe Ca-3.0 Cb-2.4 A-l.191 %R-82 
No. time Absorbance A-At in (A-At) Y(caic) 
1 1.35 0.097 1.094 0.090 0.080 
2 2.50 0.147 1.044 0.043 0.034 
3 4.00 0.209 0.982 -0.018 -0.025 
4 5.00 0.249 0.942 -0.060 -0.065 
5 6.78 0.314 0.877 -0.131 -0.136 
6 7.50 0.339 0.852 -0.160 -0.164 
7 9.00 0.390 0.801 -0.222 -0.224 
8 10.00 0.423 0.768 -0.264 -0.263 
9 11.98 0.484 0.707 -0.347 -0.342 
10 14.00 0.539 0.652 -0.428 -0.422 
11 15.02 0.566 0.625 -0.470 -0.463 ;;: 
12 18.12 0.639 0.552 -0.594 -0.586 ..I: 
13 20.00 0.680 0.511 -0.671 -0.660 ! 14 22.50 0.728 0.463 -0.770 -0.759 
15 25.00 0.771 0.420 -0.868 -0.858 -1 
16 ·27.50 0.811 0.380 -0.968 -0.958 
17 30.00 0.846 0.345 -1.064 -1.057 
18 32.77 0.881 0.310 -1.171 . -1.167 
19 35.00 0.906 0.285 -1.255 -1.255 
20 37.52 0.932 0.259 -1.351 -1.355 10 20 :lO 40 50 
21 40.00 0.954 0.237 -1.440 -1.454 
22 42.50 0.975 0.216 -1.532 -1.553 \me\mn 
Regression Output: 
Constant 0.1334 
Std Err of Y Est 0.0090 
R Squared 0.9997 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0397 
Std Err of Cod. 0.0001 
199 
RUN 1 R-OMe Ca-3.0 Cb-2.6 A-1.197 U-81 
No. time Absorbance A-At inCA-At) YCcaic) 
1 1.18 0.100 1.097 0.093 0.080 
2 2.50 0.168 1.029 0.029 0.018 
3 4.00 0.242 0.955 -0.046 -0.053 
4 5.00 0.287 0.910 -0.094 -0.100 
5 6.00 0.330 0.867 -0.143 -0.147 
6 7.00 0.372 0.825 -0.192 -0.194 
7 8.00 0.412 0.785 -0.242 -0.242 
8 9.00 0.449 0.748 -0.290 -0.289 
9 10.00 0.486 0.711 -0.341 -0.336 :i I 10 12.00 0.552 0.645 -0.439 -0.430 .. 
11 13.00 0.582 0.615 -0.486 -0.477 
" 12 15.00 0.638 0.559 -0.582 -0.571 -
13 17.00 0.690 0.507 -0.679 -0.666 -1 
14 20.02 0.756 0.441 -0.819 -0.808 
15 22.50 0.805 0.392 -0.936 -0.925 
16 25.00 0.847 0.350. -1.050 -1.043 
17 27.50 0.885 0.312 -1.165 -1.161 
18 30.00 0.918 0.279 -1.277 -1.278 5 10 15 20 25 30 35 
19 32.50 0.946 0.251 -1.382 -1.396 
20 35.00 0.972 0.225 -1.492 -1.514 lrne\mn 
Regression Output: 
Constant 0.1354 
Std Err of Y Est 0.0102 
R Squared 0.9996 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0471 
Std Err of Coef. 0.0002 
RUN 2 R-OMe Ca-3.0 Cb-2.6 A-1.198 %R-82 
No. time Absorbance A-At inCA-At) Y(caic) 
1 1.35 0.l12 1.086 0.083 0.071 
2 2.50 0.172 1.026 0.026 0.015 
3 4.00 0.246 0.952 -0.049 -0.058 
4 5.03 0.296 0.902 -0.103 -0.108 
5 6.00 0.340 0.858 -0.153 -0.156 
6 7.00 0.382 0.816 -0.203 -0.205 
7 8.00 0.422 0.776 -0.254 -0.253 
8 9.00 0.461 0.737 -0.305 -0.302 
9 10.00 0.498 0.700 -0.357 -0.351 :i 10 12.00 0.564 0.634 -0.456 -0.449 I .. 
l1 13.00 0.595 0.603 -0.506 -0.497 
.: 12 15.00 0.652 0.546 -0.605 -0.595 
13' 17.50 0.715 0.483 -0.728 -0.717 
14 20.00 0.771 0.427 -0.851 -0.839 
15 22.50 0.819 0.379 -0.970 -0.961 
16 25.00 0.861 0.337 -1.088 -1.083 
17 27.50 0.899 0.299 -1.207 -1.205 
18 30.00 0.932 0.266 -1.324 -1.327 
19 32.50 0.961 0.237 -1.440 -1.449 
20 35.00 0.986 0.212 -1.551 -1.571 I;".,,,,,n 
Regression Output: 
Constant 0.1371 
Std Err of Y Est 0.0091 
R Squared 0.9997 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0488 
Std Err of Coef. 0.0002 
200 
131 
RUN 1 R-N02 Ca-5.5 Cb-0.059 A-1.160 lR-65 
No. time Absorbance A-At lnIA-At) Ylcalc) 
1 1.18 0.069 1.091 0.087 0.082 
2 5.00 0.129 1.031 0.031 0.027 0.2 
3 7.65 0.169 0.991 -0.009 -0.012 
4 10.02 0.203 0.957 -0.044 -0.046 
5 12.75 0.241 0.919 -0.084 -0.086 
6 15.00 0.272 0.888 -0.1l9 -0.118 
7 17.65 0.307 0.853 -0.159 -0.157 
8 20.00 0.337 0.823 -0.195 -0.191 :; 
9 25.02 0.395 0.765 -0.268 -0.264 I of 
10 30.02 0.448 0.712 -0.340 -0.336 
11 35.00 0.497 0.663 -0.411 -0.408 
12 40.00 0.543 0.617 -0.483 -0.481 
13 45.00 0.585 0.575 -0.553 -0.553 
14 50.02 0.629 0.531 -0.633 -0.626 
15 60.00 0.697 0.463 -0.770 -0.770 
16 70.02 0.755 0.405· -0.904 -0.915 
10 20 JO 40 so 60 70 60 
Regression Output: 
Constant 0.0990 
Std Err of Y Est 0.0047 
R Squared 0.9998 
No. of Observation9 16 
Degrees of Freed~ 14 
X Coefficient(s) -0.0145 
Std Err of Coof. 0.0001 
RUN 2 R-N02 Ca-5.5 Cb-0.059 A-1.208 lR-73 
No. time Absorbance A-At In(A-At) Ylcalc) 
1 1.25 0.066 1.142 0.133 0.136 
2 3.28 0.100 1.108 0.103 0.104 
3 5.00 0.130 1.078 0.075 0.076 
4 7.85 0.176 1.032 0.031 0.031 
5 10.00 0.210 0.998 -0.002 -0.003 
6 12.82 0.253 0.955 -0.046 -0.047 
7 15.00 0.285 0.923 -0.080 -0.082 
8 17 .67 0.323 0.885 -0.122 -0.124 
9 20.00 0.357 0.851 -0.161 -0.161 
10 22.77 0.393 0.815 -0.205 -0.205 :;: 
11 25.00 0.421 0.787 -0.240 -0.240 I .. 
12 30.00 0.481 0.727 -0.319 -0.319 
.: 13 35.00 0.536. 0.672 -0.397 -0.398 
14 40.00 0.587 0.621 -0.476 -0.471 
15 45.00 0.635 0.573 -0.557 -0.556 
16 50.00 .0.678 0.530 -0.635 -0.635 
-1 17 55.00 0.718 0.490 -0.713 -0.714 
18 60.00 0.754 0.454 -0.790 -0.793 
19 65.00 0.790 0.418 -0.872 -0.872 40 60 eo 
20 70.00 0.822 0.386 -0.952 -0.951 
21 80.00 0.879 0.329 -1.112 -1.109 I ..... \lnn 
Regression Output: 
Constant 0.1554 
Std Err of Y Est 0.0014 
R Squared 1.0000 
No. of Observations 21 
Degrees of Freedom 19 
X Coefficientls) -0.0158 
Std Err of Coef. 0.0000 
201 
RUN 1 R-N02 Ca-5.5 Cb-0.069 A-l.087 %R-76 
No. time Absorbance A-At In(A-At) Y(cdc) 
1 1.33 0.082 1.005 0.005 -0.012 
2 5.00 0.157 0.930 -0.073 -0.084 0.2 
3 7.50 0.203 0.884 -0.123 -0.134 
4 10.00 0.247 0.840 -0.174 -0.183 
5 12.68 0.292 0.795 -0.229 -0.236 
6 15.00 0.333 0.754 -0.282 -0.282 
7 17 .67 0.373 0.714 -0.337 -0.335 
8 20.00 0.407 0.680 -0.386 -0.381 ;.: I 
9 22.75 0.444 0.643 -0.442 -0.435 « 
10 25.12 0.475 0.612 -0.491 -0.482 .. 
-11 27.77 0.505 0.582 -0.541 -0.534 
12 30.00 0.530 0.557 -0.585 -0.578 
-1 13 35.00 0.589 0.498 -0.697 -0.677 
14 40.00 0.635 0.452 -0.794 -0.776 
-1.2 
15 45.00 0.677 0.410 -0.892 -0.875 
16 50.02 0.713 0.374 -0.983 -0.974 
17 55.02 0.746 0.341 . -1.076 -1.073 
18 60.03 0.775 0.312 -1.165 -1.172 
19 70.00 0.822 0.265 -1.328 -1.369 ti"ne\mn 
Regression Output: 
Constant 0.0147 
Std Err of Y Est 0.0148 
R Squared 0.9987 
No. of Observations 19 
Degrees of Freedom 17 
X CoefficientCs) -0.0198 
Std Err of Coef. 0.0002 
RUN 2 R-N02 Ca-5.5 Cb-0.069 A-1.042 %R-77 
No. time Absorbance A-At lnCA-At) Y(calc) 
1 '1.22 0.076 0.966 -0.035 -0.043 
2 5.00 0.148 0.894 -0.112 -0.121 Q2 
3 7.62 0.196 0.846 -0.167 -0.174 
4 10.00 0.239 0.803 -0.219 -0.223 
5 12.60 0.284 0.758 -0.277 -0.276 
6 15.00 0.322 0.720 -0.329 -0.325 
7 17.62 0.360 0.682 -0.383 -0.378 
8 20.00 0.389 0.653 -0.426 -0.427 ;.: 
9 22.67 0.425 0.617 -0.483 -0.481 I .. 
10 25.00 0.455 0.587 -0.533 -0.529 
.: 11 27.65 0.487 0.555 -0.589 -0.583 
12 30.00 0.512 0.530 -0.635 -0.631 -1 
13 35.00 0.567 0.475 -0.744 -0.733 
-1.2 
14 40.00 0.611 0.431 -0.842 -0.835 
15 45.00 0.652 0.390 -0.942 -0.937 -1,4 
16 50.00 0.688 0.354 -1.038 -1.039 
17 55.00 0.721 0.321 -1.136 -1.142 10 20 :.10. 40 50 so 70 so 
18 60.00 0.755 0.287 -1.248 -1.244 
19 70.02 0.803 0.239 -1.431 -1.448 lme'\rnn 
Regression Output: 
Constant -0.0184 
Std Err of Y Est 0.0070 
R Squared 0.9997 
No. of Observations 19 
Degrees of Freedom 17 
X Coefficient(s) -0.0204 
Std Err of Coef. 0.0001 
202 
RUN 1 R-N02 Ca-5.5 Cb-0.079 A-1.135 %R-67 
No. time Absorbance A-At 1n(A-At) Y(ca1c) 
1 1.65 0.117 1.018 0.018 0.005 
2 2.83 0.151 0.984 -0.016 -0.027 0.2 
3 5.00 0.210 0.925 -0.078 ';0.084 
4 7.77 0.278 0.857 -0.154 -0.158 
5 10.00 0.330 0.805 -0.217 -0.217 
6 12.77 0.389 0.746 -0.293 -0.291 
7 15.00 0.437 0.698 -0.360 -0.350 
8 17.70 0.486 0.649 -0.432 -0.421 =< 
9 20.00 0.525 0.610 -0.494 -0.483 ~ 
10 22.70 0.567 0.568 -0.566 -0.554 
.: 11 25.00 0.600 0.535 -0.625 -0.615 
12 27.73 0.636 0.499 -0.695 -0.688 
13 30.00 0.663 0.472 -0.751 -0.748 
14 32.65 0.694 0.441 -0.819 -0.819 
-I 
15 35.00 0.717 0.418 -0.872 -0.881 
16 40.00 0.763 0.372 -0.989 -1.014 
-1.2
0 '0 20 40 
Regression Output: 
Constant 0.0486 line,,";' 
Std Err of Y Est 0.0109 
R Squared 0.9989 
No. of Observations 16 
Degrees of Freedom 14 
X Coefficient(s) -0.0266 
Std Err of Coef. 0.0002 
RUN 2 R-N02 Ca-5.5 Cb-0.079 A-l.232 U-78 
No. time Absorbance A-At 1n(A-At) Y(ea1e) 
1 1.52 0.097 1.135 0.127 0.119 
2 2.50 0.128 1.104 0.099 0.094 
3 3.88 0.165 1.067 0.065 0.059 
4 5.00 0.197 1.035 0.034 0.031 
5 7.70 0.268 0.964 -0.037 -0.038 
6 10.00 0.324 0.908 -0.097 -0.096 
7 12.82 0.387 0.845 -0.168 -0.168 
8 15.00 0.435 0.797 -0.227 -0.223 
9 17.87 0.491 0.7111 -0.300 -0.296 ::i 
10 20.00 0.531 0.701 -0.355 -0.350 I <C 
11 22.92 0.581 0.651 . -0.429 -0.424 c 12 25.00 0.615 0.617 -0.483 -0.477 -
13 27.72 0.656 0.576 -0.552 -0.546 
14 30.00 0.688 0.544 -0.609 -0.603 
15 32.87 0.725 0.507 -0.679 -0.676 
16 35.02 0.753 0.479 -0.736 -0.731 -, 
17 37.77 0.783 0.449 -0.801 -0.801 
18 40.00 0.808 0.424 -0.858 -0.857 
19 45.00 0.856 0.376 -0.978 -0.984 
20 50.00 0.897 0.335 -1.094 -1.111 line,,";' 
Regression Output: 
Constant 0.1574 
Std Err of Y Est 0.0062 
R Squared 0.9997 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0254 
Std Err of CoeL 0.0001 
203 
RUN 1 R-N02 Ca-5.5 Cb-0.089 A-l.013 %R-75 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.13 0.096 0.917 -0.087 -0.100 
2 2.50 0.139 0.874 -0.135 -0.145 
3 3.50 0.169 0.844 -0.170 -0.178 0.2 
4 5.00 0.212 0.801 -0.222 -0.228 
5 7.47 0.277 0.736 -0.307 -0.309 0 
6 8.50 0.303 0.710 -0.342 -0.343 
7 10.00 0.339 0.674 -0.395 -0.392 
8 12.57 0.395 0.618 -0.481 -0.477 
9 14.00 0.424 0.589 -0.529 -0.524 :;r 
10 15.00 0.444 0.569 -0.564 -0.557 I .. 
11 17.55 0.490 0.523 -0.648 -0.641 c 
12 20.00 0.535 0.478 -0.738 -0.722 -
13 22.75 0.575 0.438 -0.826 -0.812 
14 25.00 0.606 0.407 -0.899 -0.886 
15 27.57 0.640 0.373 -0.986 -0.971 
16 30.32 0.669 0.344 -1.067 -1.062 
17 32.95 0.696 0.317 -1.149 -1.148 
18 35.00 0.714 0.299 -1.207 -1.216 
19 37.57 0.736 0.277 -1.284 -1.300 
20 40.00 0.756 0.257 -1.359 -1.380 I"","";' 
Regression Output: 
Constant -0.0630 
Std Err of Y Est 0.0112 
R Squared 0.9993 
No. of Observations 20 
Degrees of Preedom 18 
X Coefficient(s) -0.0329 
Std Err of Coe!. 0.0002 
RUN 2 R-N02 Ca-5.5 Cb-0.089 A-1.016 %R-76 
No. time Absorbance A-At InCA-At) YCeale) 
1 1.13 0.098 0.918 -0.086 -0.098 
2 2.50 0.143 0.873 -0.136 -0.146 0.2 
3 3.50 0.174 0.842 -0.172 -0.181 
4 5.00 0.220 0.796 -0.228 -0.233 0 
5 7.47 0.289 0.727 -0.319 -0.320 
6 8.50 0.316 0.700 -0.357 -0.356 
7 10.02 0.353 0.663 -0.411 -0.409 
8 12.62 0.413 0.603 -0.506 -0.500 :;r 9 13.50 0.433 0.583 -0.540 -0.531 I .. 
10 15.00 0.462 0.554 -0.591 -0.584 
11 17.62 0.511 0.505 -0.683 -0.676 ~ 
12 20.00 0.552 0.464 -0.768 -0.759 
13 22.58 0.591 0.425 -0.856 -0.849 
14 25.00 0.630 0.386 -0.952 -0.934 
15 27.53 0.658 0.358 -1.027 -1.023 
16 30.00 0.687 0.329 -1.112 -1.110 
17 32.52 0.714 0.302 -1.197 -1.198 
18 35.00 0.737 0.279 -1.277 -1.285 
19 40.00 0.778 0.238 -1.435 -1.460 I"","";' 
Regression Output: 
Constant -0.0580 
Std Err of Y Est 0.0099 
R Squared 0.9995 
No. of Observations 19 
Degrees of Preedom 17 
X Coefficient(s) -0.0350 
Std Err of Coe!. 0.0002 
204 
RUN 1 R-N02 Ca-5.5 Cb-0.099 A-1.037 %R-71 
No. time Absorbance A-At In(A-At) Y(calC) 
1 1.40 0.120 0.917 -0.087 -0.104 0.2 
2 3.00 0.181 0.856 -0.155 -0.167 
3 4.00 0.216 0.821 -0.197 -0.206 0. 
4 5.00 0.250 0.787 -0.240 -0.245 
5 6.00 0.282 0.755 -0.281 -0.284 
6 1.00 0.313 0.724 -0.323 -0.323 
7 8.00 0.343 0.694 -0.365 -0.362 ::;; 
8 9.00 0.370 0.667 -0.405 -0.402 I .. 
9 10.00 0.397 0.640 -0.446 -0.441 
10 12.00 0.450 0.587 -0.533 -0.519 ! 
-C.B 
11 14.02 0.495 0.542 -0.612 -0.598 
12 15.00 0.516 0.521 -0.652 -0.636 -1 
13 17.48 0.564 0.473 -0.749 -0.733 
14 20.00 0.606 0.431 -0.842 -0.832 -1.2 
15 22.52 0.645 0.392 -0.936 -0.930 
16 25.00 0.678 0.359 -1.024 -1.027 -1.40. 5 10. 15 20 25 30 17 27.50 0.708 0.329 
-1.112 -1.125 
18 30.00 0.735 0.302 -1.197 -1.223 lme""h 
Regression Output: 
Constant 
-0.0496 
Std Err of Y Est 0.0125 
R Squared 0.9988 
No. of Observations 18 
Degrees of Freedom 16 
X Coefficient(s) -0.0391 
Std Err of Coef. 0.0003 
RUN 2 R-N02 Ca-5.5 Cb-0.099 A-1.042 %R-73 
No. time Absorbance A-At In(A-At) Y(ca1c) 0..2 1 1.77 0.139 0.903 -0.102 -0.119 
2 3.02 0.187 0.855 -0.157 -0.167 0. 3 4.07 0.222 0.820 -0.198 -0.208 
4 5.00 0.254 0.788 -0.238 -0.244 
-0.2 5 6.00 0.286 0.756 -0.280 -0.283 
6 7.00 0.317 0.725 -0.322 -0.322 -0.4 
7 9.00 0.374 0.668 -0.403 -0.400 ::;; I 8 10.00 0.400 0.642 -0.443 -0.438 ... -0.6 
9 12.65 0.465 0.577 -0.550 -0.541 ! 10 14.02 0.495 0.547 -0.603 -0.595 -o.B 
11 15.02 0.516 0.526 -0.642 -0.634 
-1 12 17.00 0.560 0:482 -0.730 -0.710 
13 20.00 0.613 0.429 -0.846 -0.827 
-1.2 14 22.52 0.650 0.392 -0.936 -0.925 
15 25.00 0.684 0.358 -1.027 -1.021 
16 27.50 0.715 0.327 -1.118 -1.119 5 10. 15 20 25 30 :35 
17 30.00 0.741 0.301 -1.201 -1.216 
18 32.50 0.765 0.277 -1.284 -1.313 tme\n"ln 
Regression Output: 
Constant -0.0498 
Std Err of Y Est 0.0132 
R Squared 0.9989 
No. of Observations 18 
Degrees of Freedom 16 
X Coefficient(s) -0.0389 
Std Err of Coef. 0.0003 
205 
132 
RUN 1 R-F Ca-3.0 Cb-0.4 A-l.168 %R-76 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.38 0.053 1.115 0.109 0.097 
2 3.52 0.102 1.066 0.064 0.053 
3 5.02 0.136 1.032 0.031 0.023 
4 7.50 0.188 0.980 -0.020 -0.027 
5 10.00 0.239 0.929 -0.074 -0.078 
6 12.52 0.288 0.880 -0.128 -0.129 
7 15.02 0.334 0.834 -0.182 -0.179 
8 17.50 0.376 0.792 -0.233 -0.229 
9 20.00 0.416 . 0.752 
-0.285 -0.280 :0 
10 22.52 0.453 0.715 -0.335 -0.331 I of 
11 25.00 0.489 0.679 -0.387 -0.381 
12 27.73 0.526 0.642 -0.443 -0.436 
13 30.00 0.555 0.613 -0.489 -0.482 
14 32.52 0.586 0.582 -0.541 -0.533 ·1 
15 35.00 0.615 0.553 -0.592 -0.583 
16 40.00 0.668 0.500 -0.693 -0.684 .1.2 
17 45.00 0.715 :>.453 . -0.792 -0.785 
18 50.00 0.757 J.411 -0.889 -0.886 .1.40 10 20 30 40 50 60 70 19 60.00 0.829 0.339 -1.082 -1.088 
20 70.00 0.886 0.282 -1. 266 -1.290 lme\rn;, 
Regressicn Output: 
Constant 0.1245 
Std Err of Y Est 0.0093 
R Squared 0.9994 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0202 
Std Err of CoeL 0.0001 
RUN 2 R-F Ca-3.0 Cb-0.4 A-1.058 %R-75 
No. time Absorbance A-At In(A-At) YCcalc) 
1 1.25 0.046 1.012 0.012 0.001 
2 3.50 0.091 0.967 -0.034 -0.043 
3 5.00 0.121 0.937 -0.065 -0.073 
4 7.50 0.168 0.890 -0.117 -0.122 
5 10.00 0.213 0.845 -0.168 -0.172 0.2 
6 12.50 0.255 0.803 -0.219 -0.221 
7 15.00 0.295 0.763 -0.270 -0.270 
8 17.50 0.333 0.725 -0.322 -0.320 
9 20.00 0.370 0.688 -0.374 -0.369 
10 22.50 0.403 0.655 -0.423 -0.418 
11 25.00 0.436 0.622 -0.475 -0.468 <i 12 27.50 0.466 0.592 -0.524 -0.517 I of 
13 30.00 0.495 0.563 -0.574 -0.566 
14 32.50 0.522 0.536 -0.624 -0.616 .: 
15 35.00 0.548 0.510 -0.673 -0.665 
16 40.00 0.597 0.461 -0.774 -0.764 
17 45.00 0.638 0.420 -0.868 -0.862 
18 50.00 0.671 0.381 -0.965 -0.961 
19 55.00 0.711 0.347 -1.058 -1.060 
20 60.00 0.741 0.317 -1.149 -1.158 10 20 30 40 50 60 70 
21 65.00 0.771 0.287 -1.248 -1.257 
22 70.00 0.797 0.261 -1.343 -1.356 tine,,"n 
Regression Output: 
Constant 0.0258 
Std Err of Y Est 0.0076 
R Squared 0.9997 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0197 
Std Err of Coef. 0.0001 
206 
RUN 1 R-F Ca-3.0 Cb-0.5 A-I. 156 IR-83 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.25 0.066 1.090 0.086 0.072 
2 3.00 0.122 1.034 0.033 0.021 
3 5.00 0.184 0.972 -0.028 -0.038 
4 7.00 0.243 0.913 -0.091 -0.097 
5 8.00 0.270 0.886 -0.121 -0.126 
6 10.00 0.324 0.832 -0.184 -0.185 
7 12.02 0.373 0.783 -0.245 -0.245 
8 13.00 0.397 0.759 -0.276 -0.274 
9 15.00 0.442 0.714 -0.337 -0.332 
10 17.50 0.495 0.661 -0.414 -0.406 <i 11 20.00 0.542 0.614 -0.488 -0.480 I 
"" 12 22.50 0.586 0.570 -0.562 -0.553 
13 25.00 0.627 0.529 -0.637 -0.627 .: 
14 27.50 0.666 0.490 -0.713 -0.701 
15 30.00 0.700 0.456 -0.785 -0.774 
16 32.50 0.732 0.424. -0.858 -0.848 
17 35.00 0.762 0.394 -0.931 -0.921 
18 40.00 0.814 0.342 -1.073 -1.069 
19 45.00 0.859 0.297 -1.214 -1.216 10 20 :lO 40 50 60 
20 50.00 0.897 0.259 -1.351 -1.363 
21 55.00 0.929 0.227 -1.483 -1.510 line\rn;, 
Regression Output: 
Constant 0.1092 
Std Err of Y Est 0.0109 
R Squared 0.9995 
No. of Observations 21 
Degrees of Freedom 19 
X Coefficient(s) -0.0294 
Std Err of Coef. 0.0002 
RUN 2 R-F Ca-3.0 Cb-0.5 A-1.077 lR-83 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.37 0.066 1.011 0.011 -0.011 
2 3.17 0.118 0.959 -0.042 -0.059 
3 5.00 0.168 0.909 -0.095 -0.109 
4 7.00 0.219 0.858 -0.153 -0.163 0.2 5 8.00 0.243 0.834 -0.182 -0.189 
6 10.00 0.290 0.787 -0.240 -0.243 
7 12.00 0.337 0.740 -0.301 -0.297 
8 13.00 0.355 0.722 -0.326 -0.324 
9 15.00 0.395 0.682 -0.383 -0.378 
10 17.50 0.442 0.635 -0.454 -0.446 
11 20.00 0.484 0.593 -0.523 -0.513 <i I 
12 22.50 0.524 0.553 -0.592 -0.580 .. 
13 25.00 0.561 0.516 -0.662 -0.648 .: 
14 27.50 0.595 0.482 -0.730 -0.715 
-1 
15 30.00 0.627 0.450 -0.799 -0.782 
16 32.50 0.656 0.421 -0.865 -0.850 
17 35.00 0.683 0.394 -0.931 -0.917 
18 40.00 0.732 0.345 -1.064 -1.052 
19 45.00 0.774 0.303 -1.194 -1.187 
20 50.00 0.809 0.268 -1.317 -1.321 
21 55.00 0.839 0.238 -1.435 -1.456 
22 60.00 0.866 0.211 -1.556 -1.591 li'ne\mn 
Regression Output: 
Constant 0.0261 
Std Err of Y Est 0.0149 
R Squared 0.9990 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0270 
Std Err of Coef. 0.0002 
207 
RUN 1 R-F Ca-3.0 Cb-0.6 A-1.167 %R-81 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.25 0.090 1.077 0.074 0.064 
2 2.50 0.154 1.013 0.013 0.004 
3 4.00 0.226 0.941 -0.061 -0.067 
4 5.00 0.211 0.896 -0.110 -0.115 
5 6.77 0.345 0.822 -0.196 -0.199 
6 7.50 0.374 0.793 -0.232 -0.234 
7 9.02 0.431 0.736 -0.307 -0.306 
8 10.00 0.466 0.701 -0.355 -0.353 
9 12.00 0.531 0.636 -0.453 -0.448 
10 13.07 0.564 0.603 -0.506 -0.499 
11 14.00 0.590 0.577 -0.550 -0.544 :( I 
12 15.00 0.617 0.550 -0.598 -0.591 '" 
-13 17.00 0.667 0.500 -0.693 -0.687 c 
-H 18.00 0.691 0.476 -0.142 -0.734 
-1 
15 20.00 0.734 0.433 -0.831 -0.829 
16 22.00 0.774 0.393· -0.934 -0.925 -,.2 
17 24.00 0.809 1).358 -1.027 -1.020 
-',4 18 25.00 0.825 0.342 -1.073 -1.068 
19 27.50 0.862 0.305 -1.187 -1.187 
20 30.02 0.894 0.273 -1.298 -1.307 
21 32.50 0.924 0.243 -1.415 -1.425 
22 35.00 0.950 0.217 -1.528 -1.544 tme\mn 
Regression Output: 
Constant 0.1232 
Std Err of Y Est 0.0076 
R Squared 0.9998 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0476 
Std Err of Coef. 0.0002 
RUN 2 R-F Ca-3.0 Cb-0.6 A-1.104 %R-75 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.35 0.081 1.023 0.023 0.005 
2 2.50 0.130 0.974 -0.026 -0.040 
3 4.00 0.188 0.916 -0.088 -0.098 
4 5.00 0.227 0.877 -0.131 -0.137 
5 6.88 0.292 0.812 -0.208 -0.211 0.2 
6 7.50 0.312 0.792 -0.233 -0.235 
7 9.00 0.360 0.744 -0.296 -0.294 
8 10.00 0.390 0.714 -0.337 -0.333 
9 12.08 0.448 0.656 -0.422 -0.4H 
10 13.00 0.471 0.633 -0.457 -0.450 
11 14.00 0.495 0.609 -0.496 -0.489 ::t 
12 15.00 0.519 0.585 -0.536 -0.528 I .. 
13 17.00 0.564 0.540 -0.616 -0.606 -c 
14 18.00 0.584 0.520 -0.654 -0.645 -
15 20.00 0.623 0.481 -0.732 -0.723 
16 22.00 0.662 0.442 -0.816 -0.802 -, 
17 24.00 0.695 0.409 -0.894 -0.880 
18 25.00 0.110 0.394 -0.931 -0.919 
19 27.50 0.743 0.361 -1.019 -1.016 
20 30.00 0.773 0.331 -1.106 -1.114 5 '0 ,5 20 25 :lO 35 
21 32.50 0.801 0.303 -1.194 -1.212 
22 35.00 0.826 0.278 -1.280 -1.309 1,.",,"";' 
Regression Outputl 
Constant 0.0579 
Std Err of Y Est 0.0122 
R Squared 0.9991 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0391 
Std Err of Coef. 0.0003 
208 
RUN 1 R-P Ca-3.0 Cb-0.7 A-1.056 %R-85 
No. time Absorbance A-At lnIA-At) Ylcalc) 
1 1.37 0.121 0.935 -0.067 -0.012 
2 2.00 0.156 0.900 -0.105 -0.108 
3 3.00 0.205 0.851 -0.161 -0.166 
4 4.00 0.254 0.802 -0.221 -0.224 
5 5.00 0.300 0.756 -0.280 -0.282 0.2 
6 6.00 0.343 0.713 -0.338 -0.340 0 
7 7.00 0.384 0.672 -0.397 -0.398 
8 8.00 0.423 0.633 -0.457 -0.456 
9 9.00 0.458 0.598 
-0.514 -0.513 
10 10.00 0.493 0.563 -0.574 -0.571 
11 11.00 0.525 0.531 -0.633 -0.629 :t 
12 12.00 0.555 0.501 -0.691 -0.687 .\: 
13 13.00 0.584 0.472 
-0.751 -0.745 -I c 
14 15.00 0.635 0.421 -0.865 -0.861 - -1.2 
15 17.00 0.681 0.375 -0.981 -0.977 
-1.4 16 18.00 0.702 0.354 . -1.038 -1.034 
17 20.00 0.740 0.316 -1.152 -1.150 -1.6 
18 22.50 0.782 0.274 -1.295 -1.295 -I.a 
19 25.00 0.818 0.238 -1.435 -1.440 
20 27.50 0.849 0.207 -1.575 -1.584 25 JO .3S 
21 30.00 0.879 0.177 -1.732 -1.129 
22 32.50 0.902 0.154 -1.871 -1.874 lme\mil 
Regression Output: 
Constant 0.0076 
Std Err of Y Est 0.0040 
R Squared 0.9999 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0579 
Std Err of Coef. 0.0001 
RUN 2 R-F Ca-3.0 Cb-0.7 A-l.080 IR-77 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.40 0.112 0.968 -0.033 -0.048 
2 2.00 0.143 0.937 -0.065 -0.080 
3 3.00 0.193 0.887 -0.120 -0.132 
4 4.00 0.242 0.838 -0.177 -0.184 
5 5.00 0.287 0.793 -0.232 -0.236 
6 6.00 0.330 0.750 -0.288 -0.289 0.2 
7 7.00 0.370 0.710 -0.342 -0.341 
8 8.00 0.408 0.672 -0.397 -0.393 0 
9 9.00 0.U4 0.636 -0.453 -0.445 
-0.2 10 10.00 0.478 0.602 -0.507 -0.497 
11 11.00 0~509 0.571 -0.560 -0.550 -0.4 
12 12.00 0.539 0.541 -0.614 -0.602 :t 
-0.6 13 13.00 0.567 0.513 -0.667 -0.654 I .. 
14 15.00 0.618 0.462 -0.772 -0.758 c -o.a 15 17.00 0.663 0.417 -0.875 -0.863 -
16 18.00 0.683 0.397 -0.924 -0.915 -I 
17 20.00 0.721 0.359 -1.024 -1.019 
-1.2 18 22.50 0.763 0.317 -1.149 -1.150 
19 25.00 0.798 0.282 -1.266 -1.280 -1.4 
20 27.50 0.829 0.251 -1.382 -1.411 
-1.6
0 5 10 15 20 25 JO Regression Output: 
Constant 0.0247 lme\mil 
Std Err of Y Est 0.0125 
R Squared 0.9991 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0522 
Std Err of Coef. 0.0004 
209 
RUN 1 R-F Ca-3.0 Cb-0.8 A-1.123 %R-83 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.48 0.160 0.963 -0.038 -0.047 
2 2.02 0.201 0.922 -0.081 -0.088 
3 2.50 0.236 0.887 -0.120 -0.125 
4 3.00 0.271 0.852 -0.160 -0.164 
5 4.00 0.335 0.788 -0.238 -0.241 0.2 
6 5.00 0.395 0.728 -0.317 -0.318 0 7 6.00 0.450 0.673 -0.396 -0.395 
8 7.00 0.501 0.622 -0.475 -0.472 -0.2 
9 8.02 0.548 0.575 -0.553 -0.551 
-D.4 
10 9.00 0.591 0.532 -0.631 -0.626 
11 10.00 0.632 0.491 -0.711 -0.704 :; -D.6 
12 11.00 0.668 0.455 -0.787 -0.781 I ... -D8 
13 12.00 0.703 0.420 -0.868 -0.858 c 
-I 14 13.00 0.733 0.390 -0.942 -0.935 -
15 14.C2 0.763 0.360 -1.022 -1.013 -1.2 
16 15.00 0.788 0.335. -1.094 -1.089 
-1.4 17 16.00 0.813 0.310 -1.171 -1.166 
18 17.00 0.835 0.288 -1.245 -1.243 -1.6 
19 18.00 0.855 0.268 -1.317 -1.320 
-1.8
0 20 19.00 0.875 0.248 -1.394 -1.397 10 15 20 25 21 20.00 0.892 0.231 -1.465 -1.474 
22 22.50 0.931 0.192 -1.650 -1.667 ti're\rnn 
Regression Output: 
Constant 0.0672 
Std Err of Y Est 0.0070 
R Squared 0.9998 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient!s) -0.0771 
Std Err of Coef. 0.0002 
RUN 2 R-F Ca-3.0 Cb-0.8 A-l.10S %R-74 
No. time Absorbance A-At In(A-At) yecalc) 
1 1.38 0.137 0.968 -0.033 -0.047 
2 2.00 0.181 0.924 -0.079 -0.090 
3 2.50 0.213 0.892 -0.114 -0.124 0.2 
4 3.00 0.246 0.859 -0.152 -0.159 
5 4.00 0.307 0.798 -0.226 -0.228 0 
6 5.02 0.364 0.741 -0.300 -0.299 
-D.2 7 6.00 0.416 0.689 -0.373 -0.367 
8 7.02 0.464 0.641 -0.445 -0.438 
-0.4 
9 8.00 0.508 0.597 -0.516 -0.506 :; 
10 9.02 0.549 0.556 -0.587 -0.577 I ... 
-0.6 
11 10.00 0.587 0.518 -0.658 -0.645 ! 12 11.00 0.621 0.484 -0.726 -0.714 -0.8 
13 12.00 0.653 0.452 -0.794 -0.783 
14 13.00 .0.683 0.422 -0.863 -0.853 -1 
15 14.00 0.710 0.395 -0.929 -0.922 
-1.2 16 15.00 0.735 0.370 -0.994 -0.991 
17 16.00 0.759 0.346 -1.061 -1.061 
-1.4
0 18 17.00 0.779 0.326 -1.121 -1.130 5 10 15 20 
19 18.00 0.799 0.306 -1.184 -1.200 
20 19.00 0.818 0.287 -1.248 -1.269 lme,,"" 
Regression Output: 
Constant 0.0492 
Std Err of Y Est 0.0108 
R Squared 0.9993 
No. of Observations 20 
Degrees of Freedom 18 
X Coefficient(s) -0.0694 
S td Err of Coef. 0.0004 
210 
133 
RUN 1 R-Cl Ca-3.5 Cb-0.2 A-l.H4 %R-82 
No. time Absorbance A-At In(A-At) YCcalc) 
1 1.18 0.039 1.135 0.127 0.119 
2 5.00 0.097 1.077 0.074 0.068 
3 7.50 0.133 1. Ot.l 0.040 0.035 
4 10.00 0.168 1.006 0.006 0.001 
5 12.50 0.202 0.972 -0.028 -0.032 
6 15.00 0.235 0.939 -0.063 -0.065 
7 17.53 0.266 0.908 -0.097 -0.099 
8 20.00 0.297 0.877 -0.131 -0.132 
9 25.00 0.355 0.819 -0.200 -0.198 ::t 
10 30.00 0.408 0.766 -0.267 -0.265 I .. 
11 35.00 0.458 0.716 -0.334 -0.331 
.= 12 40.00 0.505 0.669 -0.402 -0.397 
13 45.02 0.549 0.625 -0.470 -0.464 -1 
14 50.02 0.590 0.584 -0.538 -0.531 
15 55.00 0.627 0.547 -0.603 -0.597 
16 60.00 0.663 0.511 . -0.671 -0.663 
17 70.00 0.727 0.447 -0.805 -0.796 
18 80.00 0.782 0.392 -0.936 -0.929 120 14t; 
19 90.00 0.829 0.345 -1.064 -1.062 
20 100.00 0.872 0.302 -1.197 -1.195 liT'le\rn;, 
21 110.00 0.908 0.266 -1.324 -1.328 
22 120.00 0.940 0.234 -1.452 -1.461 
23 130.00 0.968 0.206 -1.580 -1.594 
Regression Output: 
Constant 0.1342 
Std Err of Y Est 0.0063 
R Squared 0.9999 
No. of Observations 23 
Degrees of Freedom 21 
X Coefficient(s) -0.0133 
Std Err of Cod. 0.0000 
RUN 2 R-Cl Ca-3.5 Cb-0.2 A-l.130 %R-82 
No. time Absorbance A-At lnCA-At) YCealc) 
1 1.48 0.042 1.088 0.084 0.072 
2 5.00 0.094 1.036 0.035 0.026 
3 7.52 0.130 1.000 -0.000 -0.008 
4 10.00 0.163 0.967 -0.034 -0.041 
5 12.50 0.196 0.934 -0.068 -0.074 
6 15.00 0.229. 0.901 -0.104 -0.107 
7 17.50 0.259 0.871 -0.138 -0.140 
8 20.00 0.288 0.842 -0.172 -0.173 
9 25.00 0 •. 344 0.786 -0.241 -0.239 ::t I 
10 30.00 0.396 0.734 -0.309 -0.306 .. 
11 35.00 0.4114 0.686 -0.377 -0.372 c 
-1 12 40.00 0.489 0.641 -0.445 -0.438 -
13 45.00 0.531 0.599 -0.512 -0.504 
14 50.00 0.570 0.560 -0.580 -0.571 
15 55.00 0.606 0.524 -0.646 -0.637 
16 60.00 0.640 0.490 -0.713 -0.703 
H 70.00 0.702 0.428 -0.849 -0.835 
-l.B
O 18 80.00 0.754 0.376 -0.978 -0.968 20 40 EO eo 100 120 140 
19 90.00 0.800 0.330 -1.109 -1.100 
20 100.00 0.839 0.291 -1.234 -1.233 til"e\rnn 
21 110.10 0.874 0.256 -1.363 -1.367 
22 120.00 0.904 0.226 -1.487 -1.498 
.. 23 130.23 0.930 0.200 -1.609 -1.633 
Regression Outputl 
Constant 0.0917 
Std Err of Y Est 0.0095 
R Squared 0.9997 
No. of Observations 23 
Degrees of Freedom 21 
X Coefficient! s) -0.0132 
Std Err of Coef. 0.0001 
211 
RUN 1 R-Cl Ca-3.5 Cb-0.3 A-1.208 %R-82 
No. time Absorbance A-At lnIA-At) Ylcall:) 
1 1.40 0.080 1.128 0.120 0.112 
2 3.50 0.147 1.061 0.059 0.052 
3 5.00 0.193 1.015 0.015 0.009 
4 7.00 0.250 0.958 -0.043 -0.048 
5 9.00 0.305 0.903 -0.102 -0.105 
6 10.00 0.332 0.876 -0.132 -0.134 
7 12.50 0.393 0.815 -0.205 -0.205 
8 15.00 0.451 0.757 -0.278 -0.277 ;( 9 17.50 0.504 0.704 -0.351 -0.348 I 
10 20.00 0.553 0.655 -0.423 -0.419 .. 
11 22.50 0.599 0.609 -0.496 -0.491 .. 
-12 25.00 0.642 0.566 -0.569 -0.562 -1 
13 27.50 0.681 0.527 -0.641 -0.634 
14 30.00 0.717 0.491 -0.711 -0.705 
15 32.50 0.752 0.456 -0.785 -0.777 
16 35.00 0.782 0.426 . -0.853 -0.848 
17 40.00 0.838 0.370 -0.994 -0.991 
:30 40 50 60 18 42.53 0.864 0.344 -1.067 -1.063 
19 45.00 0.887 0.321 -1.136 -1.134 line\m" 20 50.00 0.930 0.278 -1.280 -1.276 
21 55.00 0.965 0.243 -1.415 -1.419 
22 60.00 0.993 0.215 -1.537 -1.562 
Regression Output: 
Constant 0.1519 
Std Err of Y Est 0.0077 
R Squared 0.9998 
No. of Observations 22 
Degrees of Preedom 20 
X Coefficient(s) -0.0286 
Std Err of Coef. 0.0001 
RUN 2 R-Cl Ca-3.5 Cb-0.3 A-1.138 %R-82 
No. time Absorbance A-At lnIA-At) Y(eale) 
1 1.28 0.069 1.069 0.067 0.058 
2 3.50 0.134 1.004 0.004 -0.004 
3 5.00 0.178 0.960 -0.041 -0.047 
4 7.07 0.234 0.904 -0.101 -0.105 
5 8.50 0.271 0.867 -0.143 -0.146 
6 10.00 0.309 0.829 -0.188 -0.188 
7 12.50 0.366 0.772 -0.259 -0.259 
8 15.00 0.420 0.718 -0.331 . -0.329 ;;( 9 17.50 0.470 0.668 -0.403 -0.400 I .. 10 20.00 0.516 0.622 -0.475 -0.471 
11 22.50 0.559 0.579 -0.546 -0.541 ! -1 
12 25.00 0.599 0.539 -0.618 -0.612 
13 27.50 0.636 0.502 -0.689 -0.683 
14 30.00 0.671 0.467 -0.761 -0.753 -1.4 
15 32.50 0.702 0.436 -0.830 -0.824 -1.6 
16 35.00 0.732 0.406 -0.901 -0.895 
-1.B
o 17 40.00 0.785 0.353 -1.041 -1.036 10 20 :30 40 50 60 18 42.50 0.808 0.330 -1.109 -1.107 
19 45.02 0.830 0.308 -1.178 -1.178 tn-e\mh 
20 50.00 0.870 0.268 -1.317 -1.319 
21 55.00 0.904 0.234 -1.452 -1.460 
22 60.00 0.933 0.205 -1.585 -1.601 
Regression Output: 
Constant 0.0946 
Std Err of Y Est 0.0065 
R Squared 0.9998 
No. of Observations 22 
Degrees of Preedom 20 
X Coefficientls) -0.0283 
Std Err of Coef. 0.0001 
212 
RUN 1 R-Cl Ca-3.5 Cb-0.4 A-I. 195 %R-80 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.37 0.104 1.091 0.087 0.069 
2 2.50 0.155 1.040 0.039 0.024 
3 3.50 0.198 0.997 -0.003 -0.015 
4 5.00 0.260 0.935 -0.067 -0.075 
5 7.02 0.336 0.859 -0.152 -0.155 
6 8.00 0.371 0.824 -0.194 -0.194 
7 9.00 0.405 0.790 -0.236 -0.234 ;;; 8 10.00 0.438 0.757 -0.278 -0.274 I 
'" 9 11.98 0.497 0.698 -0.360 -0.353 
10 13.02 0.527 0.668 -0.403 -0.394 c 
-
1! 15.00 0.578 0.617 -0.483 -0.473 -, 
12 17.50 0.639 0.556 -0.587 -0.572 
-',2 13 20.00 0.692 0.503 -0.687 -0.672 
14 22.50 0.739 0.456 -0.785 -0.771 
-'4 15 25.00 0.782 0.413 -0.884 -0.871 
16 27.50 0.821 0.374 -0.983 -0.970 -'.6 0 '0 20 17 30.00 0.854 0.341 -1.076 -1.070 
18 32.50 0.885 0.310 -1.171 -1.169 tmeVnn 
19 35.00 0.912 0.283 -1. 262 -1.269 
20 37.50 0.936 0.259 -1.351 -1.368 
21 40.00 0.958 0.237 -1.440 -1.468 
Regression Output: 
Constant 0.1240 
Std Err of Y Est 0.0129 
R Squared 0.9993 
No. of Observations 21 
Degrees of Freedom 19 
X Coefficient(s) -0.0398 
Std Err of CoeL 0.0002 
RUN 2 R-Cl Ca-3.5 Cb-0.4 A-I. 148 %R-87 
No. time Absorbance A-At In(A-At) YCcalc) 
1 1.58 0.127 1.021 0.021 0.008 
2 2.57 0.172 0.976 -0.024 -0.036 
3 3.50 0.213 0.935 -0.067 -0.078 
4 5.00 0.278 0.870 -0.139 -0.145 
5 7.00 0.354 0.794 -0.231 -0.235 
6 8.00 0.390 0.758 -0.277 -0.279 
7 9.00 0.424 0.724 -0.323 -0.324 
8 10.00 0.457 0.691 -0.370 -0.369 :< I 9 12.07 0.520 0.628 -0.465 -0.461 
"'" 10 13.00 0.546 0.602 -0.507 -0.503 -, 
11 15.02 0.599 0.549 -0.600 -0.593 .: 
12 17.50 0.658 0.490 -0.713 -0.704 
13 20.00 0.711 0.437 -0.828 -0.816 
14 22.50 0.757 0.391 -0.939 -0.927 
15 25.00 0.799 0.349 -1.053 -1.039 
16 27.50 0.836 0.312 -1.165 -1.151 
17 30.00 0.868 0.280 -1.273 -1.263 10 20 .:10 40 50 
18 32.50 0.897 0.251 -1.382 -1.374 
19 35.00 0.922 0.226 -1.487 -1.486 li'ne\mn 
20 37.50 0.944 0.204 -1.590 -1.598 
21 40.00 0.965 0.183 -1.698 -1.710 
22 45.00 0.999 0.149 -1.904 -1.933 
Regression Output: 
Constant 0.0784 
Std Err of Y Est 0.0113 
R Squared 0.9997 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0447 
Std Err of Coef. 0.0002 
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RUN 1 R-Cl Ca-3.5 Cb-0.5 A-l.141 %R-85 
No. time Absorbance A-At lnIA-At) Y(calc) 
1 1.48 0.148 0.993 -0.007 -0.017 0.2 2 2.00 0.184 0.957 -0.044 -0.051 
3 3.00 0.246 0.895 -0.111 -0.118 0 
4 4.00 0.306 0.835 -0.180 -0.184 
-0.2 5 5.00 0.361 0.780 -0.248 -0.251 
6 7.00 0.460 0.681 -0.384 -0.384 -0.4 
7 8.00 0.506 0.635 -0.454 -0.451 
-0.6 8 9.00 0.547 0.594 -0.521 -0.518 <i I 9 10.00 0.586 0.555 -0.589 -0.584 .. -0.8 
10 12.00 0.657 0.484 
-0.726 -0.718 c 
-1 
-11 13.01 0.688 0.453 -0.792 -0.785 
12 14.00 0.717 0.424 -0.858 -0.851 -1.2 
13 15.00 0.745 0.396 -0.926 -0.918 -1.4 
14 17.10 0.796 0.345 -1.064 -1.058 
-1.6 15 18.00 0.817 0.324 -1.127 -1.118 
16 19.00 0.837 0.304 -1.191 -1.184 
17 20.00 0.856 0.285 -1.255 -1.251 ;J() 
18 22.02 0.890 0.251 -1.382 -1.386 1iT1e\rnn 19 23.02 0.906 0.235 -1.448 -1.452 
20 24.00 0.920 0.221 -1.510 -1.518 
21 25.00 0.933 0.208 -1.570 -1.584 
22 27.50 0.966 0.175 -1.743 -1.751 
Regression Outputs 
Constant 0.0821 
Std Err of Y Est 0.0072 
R Squared 0.9998 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0667 
Std Err of Coef. 0.0002 
RUN 2 R-Cl Ca-3.5 Cb-0.5 A-1.157 %R-82 
No. time Absorbance A-At In(A-At) Y(calc) 
1 1.38 0.131 1.026 0.026 0.017 
2 2.00 0.171 0.986 -0.014 -0.022 
3 3.00 0.231 0.926 -0.077 -0.084 
4 4.00 0.288 0.869 -0.140 -0.146 
5 5.00 0.342 0.815 -0.205 -0.208 
6 6.00 0.393 0.764 -0.269 -0.269 
7 7.00 0.440 0.717 -0.333 -0.331 
"1 8 8.00 0.484 0.673 -0.396 -0.393 
9 9.00 0.525 0.632 -0.459 -0.455 ... 
10 10.00 0.564 0.593 -0.523 -0.517 . c 
-11 11.00 0.599 0.558 -0.583 -0.579 
12 12.00 0.633 0.524 -0.646 -0.641 
13 13.00 0.6M 0.493 -0.707 -0.703 
14 14.00 0.695 0.462 -0.772 -0.765 
15 15.00 0.722 0.435 -0.832 -0.827 
16 16.00 0.749 0.408 -0.896 -0.889 -1.8
0 17 17.00 0.772 0.385 -0.955 -0.951 5 10 15 20 25 ;J() 
18 18.00 0.795 0.362 -1.016 -1.013 
19 20.00 0.837 0.320 -1.139 -1.136 1iT1e\rnn 
20 22.50 0.882 0.275 -1.291 -1.291 
21 25.00 0.919 0.238 -1.435 -1.446 
22 27.50 0.952 0.205 -1.585 -1.601 
Regression Output: 
Constant 0.1021 
Std Err of Y Est 0.0067 
R Squared 0.9998 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficient(s) -0.0619 
Std Err of Coef. 0.0002 
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RUN 1 R-C1 Ca-3.5 Cb-0.6 A-1.154 %R-82 
No. time Absorbance A-At 1nCA-At) 1(ca1c) 
1 1./.5 0.203 0.951 -0.050 -0.066 
2 2.00 0.250 0.904 -0.101 -0.115 0.2 
3 2.50 0.292 0.862 -0.149 -0.160 0 4 3.00 0.332 0.822 -0.196 -0.204 
5 3.50 0.369 0.785 -0.242 -0.249 -0.2 
6 4.00 0.406 0.748 -0.290 -0.294 
-04 
7 4.50 0.439 0.715 -0.335 -0.338 
8 5.00 0.473 0.681 -0.384 -0.383 -:t -os I 9 5.50 0.504 0.650 -0.431 -0.428 .. -D.S 
10 6.00 0.534 0.620 -0.478 -0.472 
.: 
-1 11 6.50 0.563 0.591 -0.526 -0.517 
12 7.00 0.589 0.565 -0.571 -0.562 -1.2 
13 8.00 0.638 0.516 -0.662 -0.651 
-1.4 14 9.00 0.684 0.470 -0.755 -0.740 
15 10.00 0.724 0.430 -0.844 -0.830 -1.S 
16 11.00 0.759 0.395· -0.929 -0.919 
-1.S 17 12.00 0.794 0.360 -1.022 -1.008 0 5 10 15 20 18 13.00 0.824 0.330 -1.109 -1.097 
19 14.00 0.851 0.303 -1.194 -1.187 In,.,\mi1 
20 15.00 0.875 0.279 -1.277 -1.276 
21 17.00 0.918 0.236 -1.444 -1.455 
22 19.00 0.951 0.203 -1.595 -1.633 
Regression Output: 
Constant 0.0637 
Std Err of 1 Est 0.0133 
R Squared 0.9992 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficientls) -0.0893 
Std Err of Coef. 0.0006 
RUN 2 R-C1 Ca-3.5 Cb-0.6 A-1.ll0 ZR-85 
No. time Absorbance A-At 1nCA-At) 1lca1c) 
1 1.33 0.179 0.931 -0.071 -0.079 
2 2.00 0.238 0.812 -0.137 -0.144 0.2 
3 2.50 0.280 0.830 -0.186 -0.193 0 4 3.00 0.321 0.789 -0.237 -0.242 
5 3.50 0.359 0.751 -0.286 -0.290 -D.2 
6 4.00 0.395 0.715 -0.335 -0.339 
-04 7 4.52 0.430 0.680 -0.386 -0.389 
8 5.00 0.463 0.647 -0.435 -0.436 ::( -D.6 
9 5.50 0.495 0.615 -0.486 -0.484 ..I: 
-os 10 6.00 0.525 0.585 -0.536 -0.533 
.: 11 6.50 0.554 0.556 -0.587 -0.581 -1 
12 7.00 0.580 0.530 -0.635 -0.630 
-1.2 
13 8.00 0.630 0.480 -0.734 -0.727 
14 9.00 0.675 0.435 -0.832 -0.824 -1.4 
15 10.00 0.715 0.395 -0.929 -0.921 -1.6 
16 11.00 0.752 0.358 -1.021 -1.018 
-1.S
0 17 12.00 0.185 0.325 -1.124 -1.116 20 18 13.00 0.815 0.295 -1.221 -1.213 
19 14.00 0.841 0.269 -1.313 -1.310 tine\rn" 
20 15.00 0.865 0.245 -1.406 -1.407 
21 17.00 0.907 0.203 -1.595 -1.601 
22 19.00 0.940 0.170 -1.772 -1.795 
Regression Output: 
Constant 0.0498 
Std Err of 1 Est 0.0080 
R Squared 0.9998 
No. of Observations 22 
Degrees of Freedom 20 
X Coefficientls) -0.0971 
Std Err of Coe£. 0.0003 
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(iii) Determinations of the observed rate constants (kobs)' 
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RUN 1 R-H 4.5 
No. Cb (Cb)2 ka Y(calc) 4 
1 1.00 1.00 1.43 1.45 
2 1.20 1.44 1.98 1.99 3.5 
3 1.40 1.96 2.70 2.62 
4 1.60 2.56 3.31 3.36 ]; J 5 1.80 3.24 4.19 4.19 
Regression Output: ~ 2.5 
Constant 0.230 2 
Std Err of Y Est 0.053 
R Squared 0.998 1.5 No. of Observations 5 
Degrees of Freedom 3 b.s 1.5 2 2.5 J 3.5 
X Coefficient(s) 1.22 
Std Err of Coef. 0.03 (Cb)2/md2.1-2 
RUN 2 R-H 5 
No. Cb (Cb)2 ka Y(calc) 4.5 
1 1.00 1.00 1.44 1.52 
2 1.20 1.44 2.15 2.09 4 
3 1.40 1.96 2.73 2.78 3.5 
4 1.60 2.56 3.76 3.56 1 5 1.80 3.24 4.33 4.46 J ] 
Regression Output: 2.5 
Constant 0.205 
Std Err of Y Est 0.148 2 
R Squared 0.988 
No. of Observations 5 1.5 • 
Degrees of Freedom 3 b.5 1.5 2 2.5 J 3.5 
X Coefficient(s) 1.31 
Std Err of Coef. 0.08 Cb2/moI2.I-2 
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RUN 1 R-OMe 5 
No. Cb (Cb)2 ka Y(calc) 4.5 
1 1.80 3.24 2.41 2.52 
2 2.00 4.00 3.12 3.01 
3 2.20 4.84 3.55 3.56 4 
4 2.40 5.76 4.26 4.16 ]; 5 2.60 6.76 4.71 4.80 ~ 3.5 
Regression Outputl 
Constant 0.416 3. 
Std Err of Y Est 0.120 
R Squared 0.987 2.5 
No. of Observations 5 • 
Degrees of Freedom 3 2J 3.5 4 4.5 5 55 6 6.5 7 
X Coefficient(s) 0.65 
Std Err of Coef. 0.04 (Cb}2/rn:l2.1-2 
RUN2 a-OMe 5 
No. Cb (Cb)2 ka Y(calc) 
1 1.80 3.24 2.35 2.30 4.5 
2 2.00 4.00 2.86 2.83 
3 2.20 4.84 3.33 3.42 4 
4 2.40 5.76 3.97 4.07 1 5 2.60 6.76 4.88 4.77 J5 ] 
Regression Output: 
3. Constant 0.014 
Std Err of Y Est 0.106 
R Squared 0.991 25 
No. of Observations 5 
Degrees of Fresdom 3 2J 3.5 • 4.5 5 55 6 6.5 7 X Coefficient ( s) 0.70 
Std Err of Coef. 0.04 (Cb)2/mC12.1-2 
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RUN 1 R-N02 45 
No. Cb (Cb)2 k.a Y(calc) 4 
1 0.059 0.003 1.450 1.496 
2 0.069 0.005 1.980 1.998 
.3.5 
3 0.079 0.006 2.660 2.579 
4 0.089 0.008 3.290 3.239 1 3 5 0.099 0.010 3.910 3.977 
Regression Output: ~ 2.5 
Constant 0.129 
Std Err of Y Est 0.073 2 
R Squared 0.996 
No. of Observations 5 1.5 
Degrees of lreedom 3 , 
0..003 0.004 D.COS 0.006 0..007 0..00II 0..009 0.01 X Coefficient(s) 392.6 
Std Err of CoeL 14.6 (Cbl2/mcl2J-2 
RUN 2 R-N02 4.5 
No. Cb (Cb)2 k.a Y(calc) 4 
1 0.059 0.003 1.580 1.574 
2 0.069 0.005 2.040 2.066 3.5 
3 0.079 0.006 2.540 2.635 
4 0.089 0.008 3.510 3.281 
.. 3 5 0.099 O.OlD 3.890 4.004 .~ 
~ 2.5 -
Regression Output: 
Constant 0.235 2 
Std Err of Y Est 0.158 
R Squared 0.980 1.5 
No. of Observations 5 
Degrees of lreedom 3 I 
0..003 0.004 o.COS 0.00II 0.007 0.00II 0.009 0.01 
X Coefficient(s) 384.5 
Std Err cf Cod. 31.6 (Cb)21mc12J-2 
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RUN 1 R-l 8 
No. Cb (Cb)2 k.a Y(Calc) 7 
1 0.40 0.16 2.02 2.04 
2 0.50 0.25 2.94 3.11 6 
3 0.60 0.36 4.76 4.41 
4 0.70 0.49 5.79 5.95 1 5 5 0.80 0.64 7.71 7.72 ~ 4 
Regression Output: 
Constant 0.150 3 Std Err of Y Est 0.243 
R Squared 0.991 2 No. of Observaticns 5 
Degrees of lreedcm 3 I 0..1 0.2 0.3 0.4 0..5 0..6 0.7 
X Coefficient(s) 11.83 
Std Err of Coef. 0.64 (Cbl2/rrci2.1-2 
RUN 2 R-l 8 
No.. Cb (Cb)2 k.a Y(calc) 7 
1 0.40 0.16 1.97 1.85 
2 0.50 0.25 2.70 2.79 6 
3 0.60 0.36 3.91 3.94 
4 0.70 0.49 5.22 5.29 I 5 5 0.80 0.64 6.94 6.86 ~ 4 
Regression Output: 
Constant 0.186 3 Std Err of Y Est 0.108 
R Squared 0.998 2 No. of Observations 5 
Degrees of lreedom 3 , 
0..1 0.2 0.3 0..4 0..5 0..6 0.7 
X Ccefficient(s) 10.43 
Std Err cf Coef. 0.28 (Cbl2/rrci2.1-2 
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RUN 1 R-Cl 
No. Cb (Cb)2 ka Ylcalc) 
1 0.20 0.04 1.33 1.1,3 
2 0.30 0.09 2.86 2.62 
3 0.40 0.16 3.98 4.28 
4 0.50 0.25 6.67 6.41 
5 0.60 0.36 8.93 9.02 
Regression Outputl 
Constant 0.485 
Std Err of Y Est 0.278 
R Squared 0.994 
No. of Observations 5 
Degrees of Preedom 3 
X Coefficientls) 23.72 
Std Err of Coef. 1.09 
RUN 2 R-Cl 
No. Cb ICb)2 ka Y(calc) 
1 0.20 0.04 1.32 1.37 
2 0.30 0.09 2.83 2.63 
3 0.40 0.16 4.47 4.40 
4 0.50 0.25 6.19 6.67 
5 0.60 0.36 9.71 9.45 
Regression Outputl 
Constant 0.357 
Std Err of Y Est 0.340 
R Squared 0.992 
No. of Observations 5 
Degrees of Preedom 3 
X Coefficient(s) 25.26 
Std Err of Coef. 1.33 
( i V) Hammett plot. 
R 
OM. 
H02 
P 
Cl 
sigma k(obs) log(kx/kh) Y(eale) 
0.10 0.000113 -0.273 -0.14 
0.71 0.064800 2.485 2.59 
0.34 0.001850 0.941 0.93 
0.37 0.004080 1.284 1.06 
Regreesion Output. 
Conetant 
Std Err of Y Est 
r 
No. of Obsarvations 
Degrees of Preedom 
X Coeffieient(s) 
Std Err of Coef. 
4.48 
0.45 
-0.59 
0.19 
0.98 
4.00 
2.00 
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"j 
.C j 
0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 
(Cb)2/md2.1-2 
1 j 
0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 
(Cb)2.fmd2.l-2 
J~---------------------------------------~ 
D.8 
3.6 POTENTIOMETRIC DETERMINATION OF DISSOCIATION CONSTANTS. 
Aqueous ethanolic chromone-2-carboxylic acid standard solutions (50% 
v/v; 0.01~ and 0.005~) were obtained by dissolving the appropriate 
masses (me) in 95% ethanol (half the volume of the volumetric flask 
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used) with heating and stirring, and on cooling, diluting with water to 
the required volume (Table 26). Aqueous benzoic acid and salicylic acid 
standard solutions (0.01~) were obtained by respectively dissolving 
benzoic acid (0.12230 g, 1.00 mmol) and salicylic acid (0.13833 g, 1.00 
mmol) in water (100 ml). Standard NaOH solutions (0.01~ and 0.005~) 
were obtained by diluting standard O.l~-NaOH. The pH buffers 2, 4, and 
6, were obtained using commercial vials or tablets with dilution to the 
appropriate volumes. A British Drug House (B.D.H) pH buffer 3.1, 
devised by Prideaux and Ward,16I was also obtained by dilution in the 
appropria~e volume. 
Table 26. Standard chromone-2-carboxylic acid solutions. 
R1 Volume mass(mc ) 
(ml) (g) 
H 250 0.4754 
50 0.0474 
OMe 50 0.05505 
N02 25 0.05879 
F 25 0.05204 
Cl 25 0.05615 
Br 25 0.06726 
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The pH was measured using a Knick Digital-pH-meter 646 and an Ingold 
combined electrode; and the pH meter was calibrated with pH buffers 4 
and 7 using standard procedures. 162 Once calibrated, the pH region of 
the expected pKa (ca. pH 2.7) was checked using pH buffers 2 and 3.1, 
which consistently gave readings of 2.01 and 3.16 respectively. It was 
then assumed that the meter would read accurately in the pH range 2-4. 
The 0.01~-chromone-2-carboxylic acid solutions (5ml) were maintained at 
25 (±0.2)OC, using a waterbath, and titrated with O.Ol~-NaOH (ca. 10 
ml). The titrations were done slowly to ensure that the temperature was 
maintained throughout the titration. In the case of the methoxy 
analogue 113, 0.005~-acid and NaOH solutions were used. Magnetic 
stirring was stopped while the pH readings were taken. 
This procedure was also validated by initially determining the pKa 
values of benzoic acid (pKa = 4.21 ± 0.02 cf lit.,163 4.19 at 25°C) 
and salicylic acid (pKa = 3.07 ± 0.01 cf lit.,163 2.97 at 19°C), by 
potentiometry in O.Ol~-aqueous solutions of the appropriate acids at 
25°C. 
In each case, the determination was duplicated using the same standard 
solution (solution 1), and then repeated using a second standard acid 
solution (solution 2). The pKa values are summarised in table 27. The 
reported pKa value, in each case, is the logarithm of the mean of the 
dissociation constants obtained using solution 1 (average of two 
determinations) and the dissociation constant obtained using solution 2. 
Linear regression data for the plots of pKa against log (kobs ) and sample 
titration curves for each acid are summarised after Table 27 p.220. 
TABLE 27. Dissociations constants of the 
chromone-2-carboxylic acids 112-118 at 25°C. 
COfl1ld. Solution 1 
pKaa 
Solution 2 Mean value 
112 7-H 2.74 2.74 2.64 2.69± 0.05 
113 7-0Meb 2.96 2.99 2.94 2.96± 0.02 
114 7-N02 2.65 2.59 2.57 2.60± 0.03 
115 7-F 2.62 2.62 2.64 2.63± 0.01 
116 7-Cl 2.67 2.67 2.60 2.64± 0.04 
117 7-Br 2.65 2.67 2.63 2.64± 0.02 
118 6-Cl 2.65 2.55 2.63 2.62± 0.02 
a Potentiometric titration in O.Ol~-aqueous ethanol (50% v/v). 
b Potentiometric titration in 0.005~-aqueous ethanol (50% v/v). 
Determination of the relationship between pKa and log(kobs)' 
R pKa !t(obs) log(!tobs) Y(calc) -1 
H 2.69 0.000212 -3.674 -3.79 
N02 2.60 0.064800 -1.188 -1.46 -1.5 
F 2.63 0.001850 -2.733 -2.24 
Cl 2.64 0.004080 -2.389 -2.50 -2 
Regression Outputl :I 
-2.5 
Constant 65.90 .B' 
Std Err of Y Est 0.42 
-3 R Squared 0.89 
No. of Obeervations 4.00 
Degrees of Freedom 2.00 -3.5 
X Coefficient(s) -25.91 ~5S 
Std Err of Coei. 6.41 2.6 2.64 
-1 R pKa !t(obs) log(!tobs) Y(calc) .. 
H 2.69 0.000212 -3.674 -2.71 
-1.5 
OMe 2.96 0.000113 -3.947 -4.21 
N02 2.60 0.064800 -1.188 -2.21 
-2 
F 2.63 0.001850 -2.733 -2.37 
Cl 2.64 0.004080 -2.389 -2.43 :I -2.5 
Regression Output: .B' -3 
Constant 12.29 
Std Err of Y Est 0.85 -3.5 
R Squared 0.55 
No. of Observations 5.00 -. 
Degrees of Freedom 3.00 
-4~.5 2.6 2.7 
X Coefficient(s) -5.58 
Std Err of Coei. 2.90 
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2.66 2.7 2.68 2.72 
~a 
2.B 2.9 3 
~a 
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112 12 
R-H 10 
No. Vol/ml pH Vl(Ave) d(pH)/dV V21Ave) d[dlpH)/dV]V 8 
1 0.000 2.47 'Ii 
2 0.520 2.49 0.260 0.038 6 
3 1.005 2.55 0.762 0.124 0.511 0.170 
4 1.485 2.62 1.245 0.146 1.004 0.01,6 4 
5 2.000 2.71 1. 71,2 0.175 1.494 0.058 
-
-6 2.185 2.74 2.093 0.162 1.917 -0.036 2 
7 2.255 2.76 2.220 0.286 2.156 0.969 
8 2.330 2.78 2.292 0.267 2.256 -0.263 00 2 4 6 8 10 9 2.357 2.79 2.344 0.370 2.318 2.033 
10 2.395 2.79 2.376 0.000 2.360 -11.396 
.olm 
11 2.435 2.80 2.415 0.250 2.396 6.410 
12 2.475 2.82 2.455 0.500 2.435 6.250 
13 2.510 2.82 2.493 0.000 2.474 -13.333 60 
14 2.555 2.84 2.533 0.444 2.513 11.111 
15 2.590 2.85 2.573 0.286 2.553 -3.968 50 
16 2.775 2.90· 2.683 0.270 2.628 -0.140 
17 3.035 2.99 2.905 0.346 2.794 0.341 40 
18 3.575 3.28 3.305 0.537 3.105 0.477 
19 4.045 4.06 3.810 1.660 3.557 2.223 ! .:lO 20 1,.085 4.23 4.065 4.250 3.938 10.159 
21 4.125 4.46 4.105 5.750 4.085 37.500 i 20 22 4.205 5.23 4.165 9.625 4.135 64.583 
23 4.240 5.69 4.223 13.143 4.194 61.180 10 24 4.280 6.17 4.260 12.000 4.241 -30.476 
25 4.325 6.60 4.302 9.556 4.281 -57.516 
26 4.355 7.03 4.340 14.333 4.321 127.407 0 
27 4.394 7.72 4.375 17.692 4.357 97.362 
28 4.425 9.23 4.410 48.710 4.392 886.211 -IO~ :15 4 4.5 5 5.5 6 
29 4.460 9.75 4.443 14.857 4.426 -1025.834 
30 4.495 10.01 4.478 7.429 4.460 -212.245 .otm 
31 4.534 10.16 4.514 3.846 4.496 -96.822 
32 4.575 10.29 4.554 3.171 4.534 -16.886 
33 4.605 10.39 4.590 3.333 4.572 4.580 1000 
34 4.680 10.58 4.643 2.533 4.616 -15.238 BOO 
35 4.800 10.77 4.740 1.583 4.691 -9.744 600 36 4.905 10.89 1,.853 1.143 4.796 -3~915 
37 5.025 10.99 4.965 0.833 4.909 -2.751 400 
38 5.215 11.11 5.120 0.632 5.043 -1.302 200 
39 5.405 11.20 5.310 0.474 5.215 -0.831 .. ..,... 
40 5.680 11.29 5.542 0.327 5.426 -0.630 ~ 0 f 41 5.970 11.36 5.825 0.241 5.684 -0.304 .i -20('1 
42 6.485 11.45 6.228 0.175 6.026 -0.166 'e 
--400 
43 7.074 11.52 6.779 0.119 6.503 -0.101 
44 7.497 11.55 7.285 0.071 7.032 -0.095 -600 
45 7.995 11.59 7.746 0.080 7.516 0.020 -BOO 
46 8.975 11.64 8.485 0.051 8.115 -0.040 
-1000 
47 9.975 11.68 9.475 0.040 8.980 -0.011 
-12003 :15 
" 
45 5 5.5 6 
.olm 
222 
,. 
113 12 
R-OMe 10 
No. Vol/ml pH Vl(Ave) d(pH)/dV V2(Ave) d[d(pH)/dV]V B 
1 0.000 2.68 :a 
2 0.519 2.71 0.260 0.058 6 
3 1.044 2.75 0.782 0.076 0.520 0.035 
4 1.514 2.80 1.279 0.106 1.030 0.061 4 
5 2.019 2.87 1. 767 0.139 1.523 0.066 
6 2.244 2.91 2.131 0.178 1.91,9 0.107 2 
7 2.278 2.92 2.261 0.294 2.196 0.898 
8 2.318 2.92 2.298 0.000 2.280 -7.949 00 2 4 6 9 2.401 2.94 2.360 0.241 2.329 3.918 B 10 12 
10 2.464 2.95 2.433 0.159 2.396 -1.126 
vc//rrl 11 2.509 2.96 2.487 0.222 2.460 1.176 
12 2.558 2.96 2.534 0.000 2.510 -4.728 
13 2.599 2.97 2.579 0.21,4 2.556 5.420 25 II, 2.674 2.99 2.637 0.267 2.607 0.392 
15 2.859 3.03 2.767 0.216 2.702 -0.388 
16 3.080 3.09 2.970 0.271 2.868 0.272 20 
17 3.549 3.24 3.315 0.320 3.11,2 0.140 
18 3.999 3.45 3.774 0.467 3.544 0.320 15 
19 4.219 3.63 4.109 0.818 3.942 1.049 
20 4.299 3.72 4.259 1.125 I, .181, 2.045 ! 10 21 4.351 3.76 4.325 0.769 4.292 -5.390 ~ 22 4.379 3.80 1,.365 1.1,29 1,.345 16.484 
23 4.464 3.92 4.421 1.412 4.393 -0.297 5 
24 4.584 1,.14 4.524 1.833 4.473 " .113 
25 4.719 4.46 1,.652 2.370 4.588 1,.212 0 26 4.799 4.72 4.759 3-.250 1,.705 8.183 
27 4.900 5.02 4.850 2.970 4.804 -3.091 
28 1,.940 5.18 4.920 4.000 1,.885 11,.606 -5 4 4.5 5 5.5 6 6.5 7 29 5.024 5.60 4.982 5.000 1,.951 16.129 
30 5.077 5.86 5.050 1,.906 5.016 -1.377 
-31 5.119 6.14 5.098 6.667 5.074 37.074 32 5.161 6.43 5.140 6.905 5.119 5.669 
33 5.199 6.70 5.180 7.105 5.160 5.013 200 
34 5.240 6.98 5.220 6.829 5.200 -6.987 
35 5.284 7.28 5.262 6.818 5.21,1 -0.261 150 
36 5.324 7.85 5.304 14.250 5.283 176.948 
37 5.369 8.80 5.346 21.111 5.325 161.438 100 
38 5.404 9.35 5.386 15.714 5.367 -134.921 50 
""-.i .. -----~ 39 5.454 9.62 5.429 5.400 5.408 -242.689 '" 40 5.1,79 9.74 5.466 4.800 5.448 -16.000 ?, 0 i~ ~ 41 5.511 9.83 5.495 2.812 5.481 -69.737 t -50 42 5.589 10.05 5.550 2.821 5.523 0.146 
43 5.664 10.22 5.627 2.267 5.588 -7.240 -100 I-
44 5.751 10.34 5.708 1.379 5.667 -10.955 
45 5.879 10.49 5.815 1.172 5.761 -1.930 -150 
46 6.001 10.61 5.940 0.984 5.878 -1.506 
-200 
47 6.518 10.91 6.260 0.580 6.100 -1.262 
48 6.994 11.03 6.756 0.252 6.508 -0.661 -250 
49 7.494 11.13 7.244 0.200 7.000 -0.107 4 4.5 5 5.5 6 6.5 7 
50 8.000 11.18 7.747 0.099 7.495 -0.201 
vc//rrl 51 9.039 11.28 8.520 0.096 8.133 -0.003 
52 10.019 11.32 9.529 0.041 9.024 -0.055 
223 
14 
12 
114 
R-N02 10 
No. Vol/ml pH Vl(Ave) d(pH)/dV V2(Ave) d(d(pH)/dV]V B 
1 0.000 2.36 'Ii 
2 0.515 2.38 0.258 0.039 6 
3 1.000 2.43 0.758 0.103 0.508 0.129 
4 1.630 2.51 1.315 0.127 1.036 0.043 4 
5 2.001 2.57 1.815 O. i62 L565 0.069 
6 2.099 2.59 2.050 0.204 1.933 0.181 2 
7 2.180 2.60 2.139 0.123 2.095 -0.901 
8 2.265 2.62 2.223 0.235 2.181 1.347 00 2 4 6 B 10 9 2.359 2.64 2.312 0.213 2.267 -0.252 
10 2.400 2.65 2.380 0.244 2.346 0.461 
.aIm 
11 2.440 2.66 2.420 0.250 2.400 0.151 
12 2.480 2.67 2.460 0.250 2.440 -0.000 
13 2.522 2.67 2.501 0.000 2.481 -6.098 30 
14 2.565 2.68 2.543 0.233 2.522 5.472 
15 2.615 2.69 2.590 0.200 2.567 -0.700 25 
16 2.700 2.71 2.658 0.235 2.624 0.523 
17 3.010 2.79 2.855 0.258 2.756 0.115 20 
18 3.475 2.95 3.243 0.344 3.049 0.222 
19 3.778 3.11 3.627 0.528 3.434 0.479 ~ 15 20 3.995 3.28 3.886 0.783 3.156 0.982 
21 4.080 3.36 4.037 0.941 3.962 1.045 $ 10 22 4.115 3.46 4.128 L053 4.082 1.238 
23 4.260 3.58 4.218 1.412 4.173 3.990 5 24 4.341 3.76 4.300 2.222 4.259 9.765 
25 4.430 4.02 4.385 2.921 4.343 8.225 
26 4.520 4.52 - 4.475 5.556 4.430 29.432 0 
27 4.565 4.95 1,.542 9.556 4.509 59.259 
28 4.605 5.41 4.585 11.500 4.564 45.752 -5 4 4.5 5 5.5 6 
29 4.645 5.97 4.625 14.000 4.605 62.500 
30 4.685 6.49 4.665 13.000 4.645 -25.000 .aIm 
31 4.730 7.08 4.708 13.111 4.686 2.614 
32 4.775 8.00 4.753 20.444 4.730 162.963 
33 4.820 9.17 4.798 26.000 4.775 123.457 200 
34 4.861 9.50 4.841 8.049 4.819 -417.470 
35 4.915 9.84 4.888 6.296 4.864 -36.894 100 
36 4.950 10.03 4.932 5.429 4.910 -19.499 
37 5.021 10.29 4.986 3.662 4.959 -33.332 0 -.... • 38 5.118 10.51 5.070 2.268 5.027 -16.594 
39 5.202 10.65 5.160 1.667 5.115 -6.645 ~ 
-100 
40 5.282 10.76 5.242 1.375 5.201 -3.557 ! 
41 5.385 10.85 5.333 0.871, 5.288 -5.478 i -200 42 5.479 10.93 5.432 0.851 5.383 -0.231 
43 5.555 10.96 5.517 0.395 5.474 -5.369 
-300 44 5.800 11. 11 5.678 0.612 5.597 1.355 
45 6.021 11.20 5.911 0.407 5.794 -0.880 
-400 46 6.525 11.35 6.273 0.298 6.092 -0.302 
47 7.119 11.45 6.822 0.168 6.548 -0.235 
48 7.558 11.50 7.338 0.114 7.080 -0.105 -500 4 45 5 5.5 6 
49 8.125 11.55 7.841 0.088 7.590 -0.051 
50 9.020 11.58 8.572 0.034 8.207 -0.075 vcJltTi 
51 9.975 11 .61 9.497 0.031 9.035 -0.002 
224 
14 
115 12 
R-F 10 
No. Vol/ml pH VlIAvel d(pHI/dV V2(Ave) d[d(pH)/dV]V 8 
1 0.000 2.39 'Ii 
2 0.540 2.39 0.270 0.000 5 
3 0.980 2.41 0.760 0.045 0.515 0.093 
4 1.501 2.47 1. 240 0.115 1.000 0.145 4 
5 1.980 2.53 1. 740 0.125 1.490 0.020 
6 2.115 2.56 2.047 0.222 1.894 0.316 2 
7 2.255 2.59 2.185 0.214 2.116 -0.058 
8 2.345 2.61 2.300 0.222 2.242 0.069 00 9 2.440 2.62 2.393 0.105 2.346 -1.264 2 4 5 8 10 
10 2.490 2.63 2.465 0.200 2.429 1.307 
11 2.530 2.64 2.510 0.250 2.487 1.111 vd/rrl 
12 2.570 2.65 2.550 0.250 2.530 -0.000 
13 2.610 2.66 2.590 0.250 2.570 0.000 JO 14 2.660 2.67 2.635 0.200 2.612 -1.111 
15 2.750 2.69 2.705 0.222 2.670 0.317 
16 2.941 2.74 2.846 0.262 2.775 0.282 
17 3.490 2.93 3.216 0.346 3.030 0.228 
18 3.980 3.21 3.735 0.571 3.475 0.434 
19 4.122 3.33 4.051 0.845 3.893 0.866 
20 4.261 3.50 4.191 1.223 4.121 2.690 ! 
21 4.401 3.77 4.331 1.929 4.261 5.058 ~ 22 4.530 4.22 4.465 3.488 4.398 11.597 
23 4.677 5.52 4.603 8.844 4.534 38.806 
24 4.760 6.66 4.718 13.735 4.661 42.534 
25 4.805 7.23 4.782 12.667 4.750 -16.692 ........ 
26 4.855 8.51 4.830 25.600 4.806 272.281 
27 4.900 9.43 4.878 20.444 4.854 -108.538 
28 4.940 9.78 4.920 8.750 4.899 -275.163 -5 4 4.5 5 55 6 29 4.989 9.98 4.965 4.082 4.942 -104.907 
30 5.041 10.05 5.015 1.346 4.990 -54.168 vdIm 
31 5.078 10.19 5.059 3.784 5.037 54.778 
32 5.160 10.45 5.119 3.171 5.089 -10.303 
33 5.259 10.64 5.210 1.919 5.164 -13.829 JOO 34 5.398 10.82 5.329 1.295 5.269 -5.246 
35 I 5.480 10.91 5.439 1.098 5.384 -1. 786 
36 5.621 11.02 5.551 0.780 5.495 -2.847 200 
37 5.859 11.18 5.740 0.672 5.645 -0.569 
38 6.000 11.24 5.929 0.426 5.835 -1.302 100 
39 6.499 11.40 6.250 0.321 6.090 -0.328 .. 
40 7.030 11.51 6.764 0.207 6.507 -0.220 i 41 7.505 11.55 7.267 0.084 7.016 -0.244 0 42 8.142 11.61 7.823 0.094 7.545 0.018 
43 8.860 11.64 8.501 0.042 8.162 -0.077 
-100 
44 9.882 11. 72 9.371 0.078 8.936 0.042 
-200 
-JOO 
4 4.5 55 6 
vd/m 
225 
'4 
12 
116 10 
R-Cl 
B 
No. Vol/ml pH Vl(Ave) d(pH)/dV V2(Ave) dld(pH)/dV1V 'Ii 
1 0.000 2.37 6 
2 0.522 2.40 0.261 0.057 
3 1.002 2.43 0.762 0.063 0.511 0.010 .. 
4 1.490 2.47 1.246 0.082 1.004 0.040 
5 2.030 2.52 1.760 0.093 1.503 0.021 2 6 2.160 2.58 2.095 0.462 1.927 1.101 
7 2.295 2.61 2.228 0.222 2.161 -1.806 00 8 2.380 2.62 2.337 0.118 2.282 -0.951 2 .. 6 8 ,0 
9 2.460 2.64 2.420 0.250 2.379 1.604 
10 2.500 2.66 2.480 0.500 2.450 4.167 vd/m 
11 2.550 2.67 2.525 0.200 2.502 -6.667 
12 2.598 2.68 2.574 0.208 2.550 0.170 
:lO 13 2.640 2.69 2.619 0.238 2.596 0.661 
14 2.760 2.71 2.700 0.167 2.659 -0.882 
15 3.050 2.78 2.905 0.241 2.803 - 0.364 25 
16 3.502 2.94 3.276 0.354 3.091 0.304 
17 4.123 3.32 3.813 0.612 3.544 0.481 20 
18 4.270 3.48 4.196 1.088 4.005 1.241 
19 4.405 3.70 4.337 1.630 4.267 3.838 i '5 20 4.540 4.07 4.472 2.741 4.405 8.230 i 21 4.630 4.47 4.585 4.444 4.529 15.144 '0 
22 4.680 4.74 4.655 5.400 4.620 13.651 
23 4.720 5.00 4.700 6.500 4.678 24.444 5 
24 4.802 5.61 4.761 7.439 4.731 15.394 
25 4.851 5.99 4.827 7.755 4.794 4.826 0 
26 4.899 6.37 4.875 7.917 4.851 3.331 
27 4.940 6.75 4.919 9.268 4.897 30.374 
-5 
5 5.2 5.4 5.6 5.B 28 4.981 7.09 4.960 8.293 4.940 
-23.795 4.4 4.6 4.8 
29 5.030 7.70 5.005 12.449 4.983 92.362 
..aIm 30 5.065 8.59 5.047 25.429 5.026 309.038 
31 5.120 9.22 5.092 11. 455 5.070 -310.534 
32 5.160 9.51 5.140 7.250 5.116 -88.517 
33 5.199 9.74 5.179 5.897 5.160 -34.242 400 
34 5.240 9.89 5.220 3.659 5.200 -55.972 :lOO 35 5.330 10.15 5.285 2.889 5.252 -11.750 
36 5.400 10.33 5.365 2.571 5.325 -3.968 200 
37 5.502 10.49 5.451 1.569 5.408 -11.660 
38 5.741 10.81 5.622 1.339 5.536 -1.347 ~ '00 39 6.000 11.01 5.870 0.772 5.746 
-2.276 ! 40 6.521 11.25 6.261 0.461 6.066 -0.799 i 0 41 7.050 11.40 6.786 0.284 6.523 -0.337 
-'00 42 7.492 11.47 7.271 0.158 7.028 -0.258 
43 8.002 11.54 7.7117 0.137 7.509 -0.044 
-200 44 8.915 11.63 8.459 0.099 8.103 -0.054 
45 9.919 11.68 9.U7 0.050 8.938 -0.051 -:lOO 
-400 4.4 4.6 4.B 5 5.2 5.4 5.6 5.8 
..aIm 
226 
14 
12 
117 
R-Br 10 
No. Vol/ml pH Vl(Ave) dCpll)/dV V2(Ave) dld(pll)/dVjV B 
I 0.000 2.36 'li 
2 0.636 2.40 0.318 0.063 6 
3 1.023 2.42 0.829 0.052 0.574 -0.022 
4 1.468 2.48 1. 245 o. :35 1.037 0.200 4 
5 2.062 2.55 1.765 0.:18 1.505 -0.033 
6 2.193 2.60 2.127 0.382 1.946 0.728 2 
7 2.303 2.62 2.248 0.182 2.188 -1.659 
8 2.345 2.63 2.324 0.238 2.286 0.740 00 9 2.442 2.65 2.393 0.206 2.359 -0.459 2 4 6 B 10 
10 2.483 2.66 2.462 0.244 2.428 0.547 
-d/rrl 11 2.528 2.67 2.505 0.222 2.484 -0.504 
12 2.573 2.68 2.550 0.222 2.528 0.000 
13 2.673 2.70 2.623 0.200 2.587 -0.307 35 14 2.805 2.71 2.739 0.076 2.681 -1.071 
15 3.043 2.79 2.924 0.336 2.832 1.407 :lO 
16 3.493 2.94 3.268 0.333 3.096 -0.008 
17 4.021 3.24 3.757 0.568 3.512 0.480 25 
18 4.203 3.43 4.112 1.044 3.934 1.340 
19 4.384 3.71 4.293 1.547 4.203 2.771 20 
20 4.553 4.16 4.468 2.663 4.381 6.376 ! 
21 4.688 5.02 4.620 6.370 4.544 24.392 ~ 15 
22 4.784 5.79 4.736 8.021 4.678 14.290 10 
23 4.885 6.57 4.835 7.723 4.785 -3.026 
24 4.938 6.95 4.912 7.170 4.873 -7.181 5 
25 4.984 7.42 4.961 10.217 4.936 61.567 
26 5.024 8.62 5.004 30.000 4.982 460.061 0 
27 5.082 9.31 5.053 11.897 5.028 -369.458 
28 5.123 9.63 5.102 7.805 5.078 -82.660 -~.2 4.4 4.6 4.8 5 5.2 5.4 5.6 5.8 
29 5.164 9.83 5.143 4.878 5.123 -71.386 
30 5.265 10.18 5.214 3.465 5.179 -19.897 vd/rrl 
31 5.413 10.51 5.339 2.230 5.277 -9.925 
32 5.558 10.71 5.486 1.379 5.412 -5.805 
33 5.728 10.93 5.643 1.294 5.564 -0.541 500 34 6.025 11.14 5.877 0.707 5.760 -2.514 
35 6.528 11.33 6.276 0.378 6.076 -0.823 400 
36 7.018 11.46 6.773 0.265 6.525 ;::0.226 
37 7.563 11.54 7.290 0.11,7 7.032 -0.229 :lOO 
38 8.103 11.59 7.833 0.093 7.562 -0.100 200 
39 9.003 11.66 8.553 0.078 8.193 -0.021 ;?! 
1,0 9.983 11.70 9.493 0.041 9.023 -0.039 ! 100 
'li 
~ 0 --.. ,-6 
-100 r -200 
-:lOO 
-400 4.2 44 46 4.8 5 5.2 5.4 5.6 5.B 
-d/rrl 
227 
118 " 
R-6-Cl R-6-Cl 12 
No. Vol/ml pH Vl(Ave) d(pH)/dV V2(Ave) d[d(pH)/dV]V 10 
1 0.000 2.31 8 2 0.480 2.35 0.240 0.083 1i 
3 0.975 2.39 0.728 0.081 0.484 -0.005 6 
4 1.505 2.46 1.240 0.132 0.984 0.100 
5 1.980 2.53 1.743 0.147 1.491 0.030 
6 2.195 2.57 2.088 0.J86 1.915 0.112 
7 2.315 2.59 2.255 0.167 2.171 -0.116 2 
8 2.405 2.61 2.360 0.222 2.308 0.529 
9 2.480 2.62 2.442 0.133 2.401 -1.077 00 2 .. 6 8 10 10 2.575 2.64 2.527 0.211 2.485 0.908 
11 2.656 2.66 2.615 0.247 2.571 0.413 va""" 12 2.735 2.68 2.696 0.253 2.655 0.078 
13 3.000 2.75 2.867 0.264 2.781 0.064 
14 3.285 2.84 3.143 0.316 3.005 0.188 25 
15 3.515 2.92 3.400 0.348 3.271 0.124 
16 3.735 3.03 3.625 0.500 3.513 0.676 20 17 3.994 3.19 3.865 0.618 3.745 0.492 
18 4.117 3.30 4.056 0.894 3.960 1.448 
19 4.295 3.52 4.206 1.236 4.131 2.270 '5 
20 4.465 3.86 4.380 2.000 4.293 4.391 i 21 4.575 4.18 4.520 2.909 4.450 6.494 ~ 10 22 4.745 5.88 4.660 10.000 4.590 50.649 
23 4.790 6.17 4.768 6.444 4.714 -33.075 5 
24 4.820 6.38 4.805 7.000 4.786 14.815 
25 ·4.910 6.84 4.865 5.111 4.835 -31.481 0 
26 4.995 7.55 4.952 8.353 4.909 -37.049-
27 5.040 7.83 5.018 6.222 4.985 -32.780 -~ 28 5.115 9.49 5.077 22.133 5.047 265.185 .. ".5 5 55 6 6.5 
29 5.170 9.61 5.143 2.182 5.110 -306.946 
30 5.280 10.14 5.225 4.818 5.184 31.956 vd/"" 
31 5.445 10.60 5.362 2.788 5.294 -14.766 
32 5.645 10.93 5.545 1.650 5.454 -6.235 
33 5.820 11.07 5.732 0.800 5.639 -4.533 JOO 
34 5.990 11. 21 5.905 0.824 5.819 0.136 
35 6.290 11.37 6.140 0.533 6.022 -1.235 200 
36 6.545 11.45 6.418 0.314 6.279 -0.791 
37 6.795 11.52 6.670 0.280 6.544 -0.134 ,00 
38 6.993 11.55 6.894 0.152 6.782 -0.574 I ~ 1\ 39 7.545 11.66 7.269 0.199 7.082 0.127 0 -40 8.015 11. 71 7.180 0.106 7.524 -0.182 ! -,00 41 8.985 11.80 8.500 0.093 8.140 -0.019 
42 9.995 11.85 9.490 0.050 8.995 -0.044 
-200 
-JOOI-
-~5 .. ".5 5 55 6 6.5 
va/"" 
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5.2 CRYSTALLOGRAPHIC DATA. 
Table 12. Crystal data for (E)-2-(dimethylamino)-3-(2-hydroxybenzoyl)-
N,N-dimethylacrylamide 140.a 
Formula 
Molar mass 
Crystal system 
Space group 
a(A) 
b(A) 
c(A) 
f3 ( ° ) 
'Y ( ° ) 
V(A3) 
Z 
De(g·cm- I ) 
F(OOO) 
J.L (em-I) 
Number of reflections 
(2 < 6< 30°) 
Observed reflections 
[1> 0' (1)] 
R(unit weights) 
Nparameters 
C14HlSN203 
262.31 
triclinic 
pI 
6.8745(6) 
9.353(1) 
10.872(1) 
94.536(8) 
99.245(8) 
91. 223 (8) 
698.38(21) 
2 
1.2637(4) 
280 
0.71 
4195 
3260 
0.069 
190 
a Estimated standard deviations in parentheses. 
Table 13. Fractional coordinates (x104) and equivalent isotropic 
temperature factors (A2, x103) for (E)-2-(dimethylamino)-
3- (2-hydroxybenzoyl) -N, N-dimethylacrylamide 140. a,b 
atom x/a y/b z/c 
C(l) 3746(3) 2544(2) 7544(2) 
C(2) 4446(3) 1354 (2) 8181(2) 
C(3) 3164(4) 227(3) 8319(3) 
C(4) 1200(4) 271 (3) 7832(3) 
C(5) 472(4) 1427(3) 7209(3) 
C(6) 1730(3) 2549(3) 7066(3) 
0(1) 6362(3) 1258(2) 8686(2) 
H(O) 6934(51) 2084(37) 8613(32) 
0(2) 6909(2) 3670(2) 7972(2) 
C(7) 5145(3) 3749(2) 7440(2) 
C(8) 4480(3) 4935(2) 6764(2) 
C(9) 5709(3) 6084(2) 6666(2) 
C(lO) 7921(3) 6067(2) 7141(2) 
N(l) 5105(3) 7253(2) 6094(2) 
C(ll) 3046(4) 7375(3) 5518(3) 
C(12) 6442(4) 8452(3) 5964(3) 
0(3) 8996(2) 5627(2) 6412(2) 
N(2) 8558(3) 6626(2) 8313(2) 
C(13) 10644(4) 6488(3) 8826(3) 
C(14) 7234(5) 7056(4) 9187(3) 
* isotropic temperature factor 
/ * * Ueq = 1 3 l: i l: j U ij a i a j (a i . a j) 
a For atom labelling see figure 21 p.97 (Section 2.3). 
b Estimated standard deviations in parentheses. 
40(1) 
44(1) 
54(1) 
60(1) 
62(1) 
53(1) 
66(1) 
98(12)* 
61(1) 
42(1) 
43(1) 
40(1) 
42(1) 
47(1) 
57(1) 
60(1) 
56(1) 
50(1) 
71( 1) 
76(1) 
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TabJe14. Bond lengths (A) and angles (0) for (E)-2-(dimethylamino)-
3- (2-hydroxybenzoyl) -N, N-dimethylacrylamide 140. a,b,c 
C(1)-C(2) 1.410(3) C(1)-C(6) 1.400(3) 
C(l)-C(7) 1.489(3) C(2)-C(3) 1.392(3) 
C(2)-0(1) 1. 351 (3) C(3)-C(4) 1.371(3) 
C(4)-C{5) 1.381(4) C(5)-C{6) 1.380(3) 
O(l)-H(O) 0.87(3) o (2) -C (7) 1.263(2) 
C(7 )-C (8) 1.422(3) C(8)-C(9) 1.374(3) 
C(9)-C{10) 1. 526( 3) C(9)-N(1) 1. 340 (3) 
C(10)-0(3) 1. 222(3) C(10)-N(2) 1. 339 (3) 
N(l)-C(ll) 1.464(3) N(1)-C(12) 1.465(3) 
N(2)-C(13) 1.465(3) N(2)-C(14) 1.458(3) 
C(2)-C(1)-C(6) 117.7(2) C(2)-C(1)-C(7) 
C(6)-C(1)-C(7) 123.0(2) C(l)-C(2)-C(3) 
C(1)-C(2)-0(1) 122.1(2) C(3)-C(2)-O(l) 
C(2)-C(3)-C(4) 119.9(2) C(3)-C(4)-C(5) 
C(4)-C(5)-C(6) 119.9(2) C (l~) -C ( 6) -C (5) 
C(2)-O(1)-H(0) 106.0(2) C(1)-C(7)-0(2) 
C(1)-C(7)-C(8) 120.1(2) D(2)-C(7)-C(8) 
C(7)-C(8)-C(9) 122.1(2) C(8)-C(9)-C(10) 
C(8)-C(9)-N(1) 123.6(2) C(10)-C(9)-N(1) 
C(9)-C(10)-O(3) 118.2(2) C(9)-C(10)-N(2) 
D(3)-C(10)-N(2) 124.5(2) C(9)-N(1)-C(11) 
C(9)-N(1)-C(12) 123.0(2) C(11)-N(1)-C(12) 
C(10)-N(2)-C(13) 117.8(2) C(10)-N(2)-C(14) 
C(13)-N(2)-C(14) 117.5(2) 
a For atom labelling see figure 21 p.97 (Section 2.3). 
b Estimated standard deviations in parentheses. 
119.3(2) 
120.6(2) 
117.3(2) 
120.8(2) 
121. 2(2) 
117.6(2) 
122.3(2) 
121.3(2) 
115.0(2) 
117.1(2) 
121.1 (2) 
115.9(2) 
123.1(2) 
C Bond Lengths and angles inyolving hydrogen atoms, excepting the phenolic 
hydrogen, are not listed as their positions were calculated and not refined. 
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Table 15. Anisotropic temperature factors (A2, x103) for (E)-2-
(dimethylamino)-3-(2-hydroxybenzoyl)-N,N-dimethylacrylamide 140. a,b 
atom U(l1) U(22) U(33) U(23) 
C(l) 37(1) 39(1) 42(1) 4(1) 
C(2) 42(1) 42(1) 47(1) 5(1) 
C(3) 53(1) 40(1) 68(2) 12(1) 
C(4) 52(1) 48(1) 80(2) 11(1) 
C(5) 40(1) 58(2) 85(2) 17(1) 
C(6) 40(1) 49(1) 69(2) 15(1) 
0(1) 44(1) 59(1) 93(2) 31(1) 
0(2) 40(1) 55(1) 84(1) 24(1) 
C(7) 37(1) 41(1) 47(1) 5(1) 
C(8) 37(1) 43(1) 50(1) 9(1) 
C(9) 40(1) 41(1) 38(1) 3(1) 
C(10) 41(1) 36(1) 47(1) 4(1) 
N(l) 47(1) 41(1) 51(1) 9(1) 
C(ll) 52(1) 51(1) 63(2) 12U) 
C(12) 66(2) 45(1) 69(2) 16(1) 
0(3) 45(1) 63(1) 59(1) -1(1) 
N(2) 50(1) 48(1) 46(1) 1(1) 
C(13) 55(2) 77(2) 72(2) 15(2) 
C(14) 84(2) 89(2) 51(2) -11(1) 
a For atom labelling see figure 21 p.97 (Section 2.3). 
b Estimated standard deviations in parentheses. 
U(13) U(12) 
6(1) 2(1) 
2(1) 3(1) 
2(1) 0(1) 
5(1) -11(1) 
-1(1) -6(1) 
1(1) 2(1) 
-10(1) 0(1) 
-8(1) -4(1) 
4(1) 0(1) 
2(1) 1(1) 
3(1) 1(1) 
3(1) -2(1) 
-1(1) -1(1) 
-7(1) 6(1) 
4(1) -10(1) 
15(1) -1(1) 
.. 4(1) 
-3(1) 
-19(1) -10(1) 
8(1) 17(2) 
Table 16. Fractional coordinates (x104) for hydrogen atoms for 
(E)-2-(dimethylamino)-3-(2-hydroxybenzloyl)-
N, N-dimethylacrylamide 140. a,b 
x/a y/b z/c 
H(3) 3715(4) -679(3) 8809(3) 
H(4) 212(4) -607(3) 7938(3) 
H(5) -1079(4) 1451(3) 6834(3) 
H(6) 1149(3) 3448(3) 6577(3) 
H(O) 6934(51) 2084 (37) 8613(32) 
H(8) 2961(3) 4932(2) 6312(2) 
H( llA) 2818(4) 8447(3) 5231(3) 
H(llB) 2095(4) 7161(3) 6187(3) 
H (l1C) 2704(4) 6607(3) 4711(3) 
H(12A) 5614(4) 9168(3) 5362(3) 
H(12B) 7712(4) 8105(3) 5565(3) 
H(12C) 6924(4) 9005(3) 6876(3) 
H(13A) 10942(4) 7148(3) 9700£3) 
H( 13B) 11647(4) 6801(3) 8219(3) 
H(13C) 10840(4) 5376(3) 9001(3) 
H(14A) 8074(5) 7683(4) 9980(3) 
H(14B) 6618(5) 6102(4) 9496(3) 
H(14C) 6056(5) 7685(4) 8753(3) 
a For atom labelling see figure 21 p.97 (Section 2.3). 
b Estimated standard deviations in parentheses. 
u 
82(4) 
82(4) 
82(4) 
82(4) 
98(12) 
82(4) 
176(6) 
176(6) 
82(4) 
176(6) 
176(6) 
176(6) 
176(6) 
176(6) 
176(6) 
176(6) 
176(6) 
176(6) 
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Table 17. Torsion angles (0) of the amide and 
~-amino-vinyl ketone functionalities. a 
03 CI0 N2 C13 -10.55 
03 C10 N2 C14 -175.88 
C9 CI0 N2 C13 173.99 
C9 C10 N2 C14 B.65 
N1 C9 C10 N2 90.65 
N1 C9 CI0 03 -B5.11 
CB C9 C10 N2 -92.96 
CB C9 C10 03 91.29 
CB C9 N1 Cll 0.00 
CB C9' N1 C12 -17B.ll 
CI0 C9 N1 Cll 175.93 
C10 C9 N1 C12 -1.B1 
Table 18. Torsion angles (0) in the vi'Cinity of the 
intra-molecular hydrogen-bond. a 
C6 C1 C7 CB -4.10 
C6 Cl C7 02 175.75 
C2 Cl C7 CB 177.77 
C2 C1 C7 02 -2.37 
C7 C1 C2 01 -1.07 
C7 Cl C2 C3 178.44 
C6 C1 C2 01 1BO.00 
C6 C1 C2 C3 0.00 
C1 C2 01 HO 7.16 
C3 C2 01 HO -172.37 
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a For atom labelling see figure 21 p.97 (Section 2.3). 
Table 19. Deviations from the mean plane 1 
defined by CI-CI2, HO, Nl, 01, and 02.a 
Cl -0.0219 02 0.0576 
C2 -0.0229 C7 -0.0031 
C3 -0.007S CS -0.0496 
C4 0.0077 C9 -0.0058 
C5 0.0146 C10 -0.0796 
C6 -0.0004 Nl 0.0263 
01 -0.0287 Cll 0.0082 
HO 0.0732 C12 0.0323 
Table 20. Deviations from the mean plane 2 of 
the amide functionality defined by 
C9, C10, 03, N2, and C14. a 
C9 
CI0 
-0.0192 
-0.0065 
03 0.0025 
N2 
C14 
0:0820 
-0.0399 
Table 21. Deviations from the mean plane 3 of the 
p-amino-vinyl ketone functionality 
defined by CS, C9, Nl, Cll and C12. a 
CS 
C9 
-0.0087 
0.0066 
Nl 0.0141 
Cll 
C12 
-0.0019 
-0.0101 
255 
a For atom labelling see figure 21 p.97 (Section 2.3). 
Table 22. Deviations from the mean plane 4 ot 
the hydrogen-bond chelation defined 
by ~1, C2, 01, HO, 02, and C7. a 
Cl 
C2 
01 
0.0110 
0.0094 
-0.0401 
HO 
02 
C7 
0.0375 
0.0013 
-0.0191 
256 
a For atom labelling see figure 21 p.97 (Section 2.3). 
Table 23. The angles (0) between the 
normals to the planes. 
1 and 2 
1 and 3 
1 and 4 
2 and 3 
85.14 
1.28 
2.17 
86.40 
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5.2 PUBLICATIONS. 
Manuscript as published in Synth. Cammun., 1990, 20, 727, by courtesy of 
Marcel Dekker, Inc. 
CHROMONE STUDIES. PART 2.1 AN EFFICIENT SYNTHESIS 
OF ll,H-DIMETHYLCHROMONE-2-CARBOXAMIDES 
Deborah N. Davidson and Perry T. Kaye* 
Department of Chemistry, Rhodes University 
P.O. Box 94, Grahamstown, 6140, 
Republic of South Africa 
ABSTRACT: Chromone-2-carboxylic acids are efficiently transformed 
into the li,li-dimethylcarboxamides, without concomitant formation 
of unwanted products, by reacting the corresponding acid chlorides 
with dimethylammonium chloride in pyridine. 
The potential of chromone derivatives in asthma therapy is 
well illustrated by the established action of compounds such as 
khellin, a naturally-occuring furochromone, and the widely used 
synthetic drug, disodium cromoglycate. 2 Certain chromone 
carboxamides have also been shown to exhibit some antiallergic 
activity.3 In order to explore the conformational properties. of 
such compounds, we required a range of model carboxamides, 
including the li,li-dimethylchromone-2-carboxamides[3(a~); Scheme]. 
However, the preparation of these (latter) compounds, from the 
corresponding acid chlorides (2), was complicated by:-
*To whom correspondence should be addressed. 
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i) competitive formation of the ethyl carboxylate analogues, 
when using ethanolic dimethylamine;4 
ii) heterogeneous reaction mixtures with hydrolytic potential, 
when using aqueous dimethylamine;s 
iii) the susceptibility of chromones to nucleophilic attack at 
C-2 by excess dimethylamine and consequent ring opening to 
afford products such as (4);6 
iv) the difficulties associated with handling and metering pure 
dimethylamine (b.p.7°C);7 and 
v) unacceptably low yields.4~ 
o 
~ Ii_ 
RNloACOCI 
1 2 3 
R 
o CONMe2 
H a ~NM.2 b OMe ~ OH 
c NOz 
4 d F 
SCHEME e CI 
f Br 
Reagents i) SOClz• DHF. C1CIIZCII2CI: 
it) HeZHllzCl,pyridlne, O°C. 
The foregoing difficulties were obviated by the simple but 
effective expedient of generating dimethylamine in situ from 
the amine salt, dimethylammonium chloride, in pyridine. The 
pyridine thus serves as reaction solvent; as base, releasing 
nucleophilic dimethylamine from its hydrochloride salt and 
neutralising the HCI liberated during acyl substitution; and, 
presumably, as nucleophilic catalyst, enhancing acyl 
substitution. 8 Previous applications involving ammonium salts 
include the acid catalysed ammonolysis of' ethyl benzoate;9 
the acylation of amines by carboxamides;10 and, recently, 
Schotten-Baumann acylation of 1,3,5-tris(aminomethyl)benzene 
trihydrochloride. 11 
In our method, the acid chlorides (2) were reacted with two 
equivalents of dimethylammonium chloride in pyridine, at ca. DoC, 
to afford the corresponding chromone-2-carboxamides (3) in 
overall yields ranging from moderate to excellent (Table). The 
general procedure is illustrated by the following example. 
A slurry of dimethylammonium chloride12 (1.50g, 18.4 mmol) 
in dry pyridine (5 ml) was added slowly to a pre-cooled 
(- 5DC), stirred solution of chromone-2-carbonyl chloride 
(2a)[generated3 from the acid (1a)(1.75 g, 9.2 mmol)] in 
dry pyridine (15 ml), ensuring that the temperature of the 
resulting mixture did not exceed DoC. After stirring for 
2 h at DoC and then for a further 20 h at room 
temperature, the black mixture was poured into 2~-HCI 
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~ 
MoJlcoNMe2 R 
Co~. R 
3a H 
3b OMe 
3c N02 
3d F 
3e CI 
3f Br 
Crude 
Yield8 
(%) 
76 
92 
68 
76 
80 
96 
TABLE Data for ,M,N-dimethylaminochromone-2-carboxamides(3) 
ChrolOOtographed 
Yieldb 
(%) 
62 
83 
66 
64 
72 
77 
Melting 
Point 
(DC) 
U5-U6c 
120-122d 
152-153d 
144-146d 
146-147d 
143-145d 
C 
63.0 
55.4 
61.85 
57.3 
48.8 
Found 
" 
5.1 
3.8 
4.3 
3.7 
3.45 
Microanalytical Data (%) 
H 
5.7 
10.6 
6.1 
5.5 
4.8 
Molecular 
ForlllJla 
C13"13H04 
C12"10N205 
C12"10FN03 
C12"1OC1H03 
C12"lOBrH03 
Requires 
C " 
63.15 5.3 
55.0 3.8 
61.3 4.3 
57.3 4.0 
48.7 3.4 
8 Overall yield from the corresponding acids (1): the crude material was essentially clean by 1" NMR spectroscopy. 
b Overall yield from acid (1) after flash chromatography. c Llt.6 115-116°C. d New compound which gave 
satisfactory spectroscopic (1" and 13C NMR, IR, and MS) analyses. 
".{., 
',<. 
~)--
'/" 
H 
5.7 
10.7 
6.0 
5.6 
4.7 
N 
0\ 
o 
(200 ml). After standing for 0.5 h, the resulting mixture 
was extracted (EtOAc) and the organic extracts were washed 
(ca.5% aq. NaHCOJ and then satd.aq.NaCl), dried (anhyd. 
MgS04), and evaporated. The residue (1.51 g) was 
chromatographed (flash chromatography on silica gel; 
elution with EtOAc) to afford N,N-dimethylchromone-2-
carboxamide (3a) (1.24 g). 
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Chromone Studies. Part 3.' NMR Analysis of Rotational Isomerism in 4-0xo-4H-
chromene-2-carboxamides 
Deborah N. Davidson and Perry T. Kaye' 
Depilrlmenl 01 Chemislry. Rhodes University. P. O. Box 94. GralJamslowII. 6140. Republic 01 Soulh Africa 
Tnmpcralurn dnpendnnl splitting 01 N.alkyl 'H and "c NMR signnls in a sories 01 4·oxo·4H-
chrOlllcnn·2·carboxamirlos has boen analysed in Inrms 01 rOlalion 01 Ihe nmido group. Rolalionnl 
bnrrims have been calculaled from dynamic 'H NMR data and the conformational options have been 
explorcu. 
Vnrin"o 4·n~0.411.c.:hromcnc derivnlivC5 arr knnwn 10 nhihil 
nnli'allc'llic "l'li~iIY: Ihroc includc Ihe widely uscd synlhclic 
tllUll. di."di"l11 nnl1lo[llycnlC 2 And ccrlain 4.010·411·chl1lm-
t'nc l·nrhuI"mitic,.-\ In nn enrlier c:nmmt1Jlicnlion 4 we dc~c:rjhcd 
nn IR 'Indy nf IIllillinn,,1 i,mneri'lll in a serics "f 4,010·411· 
ch"""cllc·2·l·;lIh",ylnle e.lcrs. A. pari nf an inVC5li)!alinll illio 
clccl",";" IIl1d cllllfnrlllalinnni clTeels in chrnmone .yolcm" wilh 
Illedicinal I'<'lel1linl. \Ve now rcporl Ihe restllls "f NMR 51udic5 
nl rnlalinnal i,nlllcri.m in 0 !Crics "f 4·0.0·411·chromenc-2-
curhulalllide •. 
Ill'slIJls and J)i"l:lIs~lon 
Thc 4 .... ".411·"'HI'l1Icnc·2·carho."'''i,les (4) were ohlaincd hy 
rCllclin!! Ihc aci,1 chl"ritle~ (.1) wilh I he approprinl<: ~ecnndary 
aminc 0'. in Ihc casc of Ihe N.N.,lilllclhylcarhoxamides. wilh 
dimclhyhlmmonillm chlnridc in py,idine' (Scheme I). Sym-
0 
,O(:~ ~I 
A' ~ Off 
f A' Rt R' 
i • OM • H NM"2 0 b NOt H NMea ~R2 c F If NMea 
2 jO" I I . d CI H NM·a 
A' ~ 0 COaH • Bt If NM"a 
II I If M. NM.a 9 If If NM@a 
0 h If If NP,'z 
~nl If If () jO" I I 
If If {J 11' ~ 0 COCI 
-I 
~""m. I R.·")!,·,,,,· i. !;(}n, J)MF nCII,nl,CI; ii. Me,NII.('I· 
pyridine nr R'II "'I. N.IJll'U, IIr R 'JI'ry,itline 
mCl,ienlly ,"h.lillll,d amides werc 115cd io order If' Jimplify 
nnalysis e,f Ihe tlynnmic NMR tlala. while Ihe N,"lkyl and rinl! 
5"h.lillleIl15 wcre chosen 10 elucitlale elcclronic alld slerie 
crrecls "II Ihe ",Iumerit eqllilihria. 
In Ihc .1·u ... ·41/·chromene·2·embo.amitlc.~ [4 R' ~ R 
(Scheme 2)j. Ihe mnfnrnmlionol cncrgy minima a.sodalcd 
~o R'. jO" I I .~ R' ~ 0 b ty'A 
o 
II. 
lib' 
.' 
--
dYn'o 
R'A)J....OJly 
n.,oN"'R-
Ib JIb 
wilh simullnllcnus rolalion ahoul Ihe N .. CO allli C·2-CO 
bollds may be e,pccled 10 cnrrespolld 10 Iwo e'llIival(,1I1 pairs 
of qua,i'phlllor t cnnj"galed conformers (I_ 51 II. ond Ib I! IIh). 
In Iwo rccenl invesliga.inns _.1 nr syslem, elhihiling simul-
IlInenllS ",Iolioll alloul 5I:p."aIC hnnds. Ihe silc.cxchnnllc 
procc5l1CS were suflieiclI'ly slow for dynnmic NMR nnalysis III 
illdividual rolll.ionni barrie". In Ihe 4·oxo·411·chromene·2· 
corhoxamides (4). however. III amhicnl lempcrnlUre C·2-CO 
rolnlion is e.peclctl 10 be rapid. rclolive 10 II,,: NM R lime-
!!Cale.t and 10 reqllire analysis by an allcrnali~e let:illliqlle. The 
!Cnsilivity of IR corhollyl nbsluplion honds 10 COllformolionol 
chnll[le orten makes IR speclroscopy (wilh ilS vcry much 
shorler lime-scale) a 115dlll probe for 5111dyillg rapid rolalinlls 
involving cnrbnllyl IlrnllpS.4 lJnlorlllllalely. Ihe ami.le nlld 4· 
".0-411-chrolllcne IR L1"honyl ahsorl'li"n honds oflhe 4-n.,,-
411·chromcne-2·cnrho~amides 14) ovcrlnp eXlen.ivcly 'al rn. 
1650 cm-'). "recl"ding \I.e of IR ~I'eclrllscopy for allnly.illl! 
rolatinn Bhnul Ihc C-2-CO bond. Rololinn oholll Ihc N-CO 
"'md. "n Ihe olher hantl. 5ho"ld be slImeienlly inhihiled hy 
dcloc:alisalion CITCCI5 (Fig. 2). [i .... k •• .t •. <f kh• A~. (Schcme 2» 
10 permil analysi. by dynamic NMR nll:lhodl. The ob.ervc,1 
5"lilling of N-alkyl III (Fig. I and Tahle I) Hnd IJC NMR 
,illn"l. i. Ihll5 alJrih,,'cd 10 slow .ilc·Clchanllc of Ihe N'alkyl 
,uhslilucnl.§ and variahlc lempemlure 'II NMR spectroscopy 
h ... been ".cd 10 c'plore rulalion llbotlllhc N-CO hund in Ihe 
lillc COlli pounds (4). 
It shollid be nOlcd Ihal ",'olioll of Ihe amide grollp ill " 
f lil.ri.inlerarlinnA In anal .. go". ""n •• mi.leu"""nr 10 Inle,rer. ",ilh Ih. 
r"·,,IlIna,lIy nf 110. 8"'lIlnllc and ra,hflumid •• yolem •. ' 
1 Ev.n in sl.rk-.lly hind.red m,h"..",h,liluled ""nlAmid ••• C·I-CO 
",I.linn.I ho"i ... Ar.Ie~'lh.n f,() kJ mnl '." 
I f)ynamic rale ,,'ncC'ur~ in\'nJvinp; nUrnJlt'o inv(,f!lion and rin,. reve.s ... J 
are ("nsider.dlo "" significantly fUJler Ihan N· CO lOla lim,.' 
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Table I Dala from dynamic NMR sludy of 4·0,0-411-chromene-2-carboxamides (4)" 
J00c0 R2 '7 I I A':::'" 0 COR' 
4 
Compound R' R' R' 7~'/K A.:/Hz AG"/kJ mol-' k. 2Q1I ~/s~J 
4. OMe II NMe, 302 2.5 ± 0.7 69.7 ± 1.5 4 
4b NO, II NMe, 305 1.8 ± 0.6 71.2 ± 1.9 2 
4c F H NMe, 270 1.0 ± 0.5 64.1 ± 2.3 36 
4d n II NMe, <255' 
4c Rr II NMe, 290 1.0 ± 0.3 69.0 ± 1.6 
4f H Me NMe, > 345' > 72.3 ± 0.2 <I 
4~ II II NMe, 270 0.8 ± 0.3 64.6 ± 1.9 29 
4h II H NPr', 315 87.2 ± 2.2 63.5 ± 0.7 46 
4i II H {J 332 13.6 ± 1.1 72.2 ± 0.9 
4j II II NJ 325 61.6 ± 1.6 66.5 ± 0.9 14 
" Variable lem""mlure 300 Mllz 'II NMR s""clm recorded using solulions in CDCI,. • Coale.cence lem""mlure (± 3 K).' Frequency separalion al 
c".I.scence (geuderencc 12)' Free energy of "elivalion for N-CO mlalion; I\GI = R T. (22.96 + In T,/A,·,).· Firsl-nrderrale conslanl ul 298 K for 
N-CO rolalion; In k = In (k.1Yh) - AGI/RT.' No splillingofNMe, signal observed.' Nocoulescenceoflhe NMe signals observed; A.· .1345 K = 
36.5 ± 0.5 liz. 
3~ 
335K~3~3~ 
325K~3~3~ 
320K~3~3~ 
315Kf~3~2~ 
305K~30~2~ 
296K~29~2~ 
3.7 3.4 3.8 3.6 3.2 3_0 II 
4J 41 40 
Fill_ I Variablelem""ralure' II NMR speclr. showing N-alkyl signals 
for s.lecled 4-oxo-41f-chromene-2-carboxamidcs (4) 
Fig. 2 
symmelrically subsliluted benzamide, for example, effectively 
involves sile-exchange belween a pair of equivalent quasi-
plnnar conformers.! In Ihe 4-oxo-411-chromene-2-carbox-
amides (4), however, Ihe situation is complicated by the non-
equivalence of rota mer types (a) and (h) (Scheme 2) and Ihe 
measuret! mles of site-exchange must represenl some com-
binalion of the individual rates, k. [Ia] and k •. [Ib). '0 
The' H NMR frequency separations measured al slow sile 
exchange· (~vo) vary widely (1-99 Hz), the separations 
being smallest for Ihe N.N-dimcthylcarboxamides. For each 
compound examined Avo must reflecl the difference in Ihe 
average magnetic environment of the nuclei concerned and, 
more specifically, their average spatial orientalion relalive 10 
Ihe magnetically anisotropic 4-oxo-411-chromene and carbox-
amide' moieties. 
Factors which contribule to such orientation of the relevant 
nuclei undoubtedly';nclude: dipole-.tJipole and steric 3 interac-
tions; 'gear-meshing' II of the isopropyl groups in compound 
4h; and ring-conformational constraints in the helerocyclic 
analogues 4f and 4j. Thus, comparable deshielding of the N-
melhyl groups in Ihe N,N·dimethylcarboxamides (4a-c:. e and g) 
accounts for their remarkably small ~vo values; in fact, in Ihe 
case oflhe 8-chloro-N.N-dimethylcarboxamide (4d). splilling of 
Ihe N-melhyl 'II NMR signals could not be achieved within the 
accessible temperature range t-an observation which 
undoubtedly reflects the chemical shift equivalence of Ihese 
signals al slow site exchange rather than an unusually low 
rotalional barrier.~ 
Rotational energy barriers (~GI, 64-72 kJ mol-'; Table I), 
delermined for the 4-oxo-411-chromene-2-carboxamides 4 a·c:. 
e. g-j from Ihe coalescence data,12 lie within the typical amide 
range (50--100 kJ mol-I). More perlinent is the correspond-
ence belween these resulls and the ~GI data obtained for 
comparahle N,N-dialkylbenznmides."·14 The tendency to-
wards slighlly higher rotational barriers in the 4-oxo-411-
chromene analogues is consistent with Ihe expectation that 
the electron-withdrawing 4-oxo-411-chromene system should 
reduce compelitive delocalisation' and, hence. increase the 
• AI maximum separation ('\'0) or atth. minimum lemperature below 
which precipilalion of malerial precluded further measurement. 
t Malerial precipitated below 255 K. 
: Splilling of N-alkyl signals was ob.erved in Ihe ambient "c NMR 
spectra of an the 4-oxo-4lf-ehromene-2-carboxamides (4) examined, 
including 4d. 
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N·methyl 
groups 
(i) 
carboxamldo 
plane 
I 
(ii) 
_3-methyt 
group 
.Fj~. J Proposed conformation of compound 4r based on computer-
modelled slruelure; (i) 'wire·rrum. and (il) 'spacefill' representations 
It·charncler of the N-CO bond and the magnilude of the 
roWtionaJ barrier. Similar arguments, based on the net electron-
withdrawing properilies of substituent R I may well explain the 
gradation of fiG' values in the series of N,N·dimethylcarb-
oxamides R I = F (4c) < Br (4e) < NO, (4b)-a trend which 
parallels results obtained for the correspondingpara-substituted 
N,N·dimethyJhcnz:lmides. I J The anomaJous result for the 7-
methoxy analogue (4.). while possibly reflecting the influence of 
changing conformer populations on the overall rate of rotation. 
nevertheless emphasises the complexity of the rota me ric 
equilibria and the need for caution in interpreting the toGt data, 
particularly when toG I differences are comparable with the 
estimated errors. 
The influence of electron-releasing inductive effects on nitro-
gen lone· pair delocalisation (Fig. 2) appears to be illustrated 
by the higher rotational barrier (relative to compound 411) 
observed for the pyrrolidine derivative (4i) and, to a lesser 
extent, for the piperidine analogue (4j). The diITerence in toG I 
for enrboxamides 4i and 4j is consistent with the greater ease 
wilh which a pyrrolidine nitrogen i. expected to adopt the 
planar sp' "rrangement necessary for eITective lone·pair de-
localisalion. In spile of an electron-releasing inductive eITect, 
such dclocalisation may. of course. be inhibited by steric 
destabilisation of the carboxamide ground-state IS_a situation 
which presumably obtains in the case of N,N-diisopropyl.4-
oxo-411·chromene-2-carboxamide (4h). (Rotational barriers for 
benzamide analogues are reported to follow a similar pallern: 
N,N·diisopropylbenlamide .;; N.N·dimethylbenzamidc" ~ 1-
benzoyl piperidine. 16) 
In 4-oxo-411-chromene-2-carboxylate esters. bulky 3-sub-
stituent. appear to prevent co· planarity of the ester and 
chromene planes' and similar conformational constraints were 
expected to operate in the )·methyl-4-oxo-4H·chromene-2-
carboxamide (4f)-an expectation which is supported both by 
computer modelling and hy earlier studies of benzamide 
analogues.' I H NMR analysis of this compound (4f) reveals N-
metbyl signals which are well separated (37 Hz) and which. even 
al 345 K. show no sign of coalescence. These observations. 
which indicate significant inhibition of N·methyl site-exchange. 
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are accommodated by the proposed conformation (Fig. 3). in 
which: (I) the essentially planar N,N-dimethylcarboxamide 
group occupies an average position perpendicular. or quasi. 
perpendicular, to the chromone plane; (iI) the N·methyl groups 
are dinstereotopic; and (iii) there is significant steric hindrance 
to rotation about both the C-2-CO and N-CO bonds. 
Experimental 
The 4-oxo-411-chromene-2-carboxamides (4) were obtained by 
treating the acid chlorides (3)' [obtained from the correspond· 
ing carboxylic acids (2) 'J: with dimethylammonium chloride in 
pyridine I (4a'-2); with the appropriate amine in aq. NaHCO, 
(4i).1 or in pyridine (4hJ) . .1 
,,'C NMR spectra were edited with the aid of DEPT (75 
MHz) and ORD (125 MHz) techniques. All coupling constants 
are in Hz. Variable lemperature 'H NMR data were obtained 
from CDCI, solutions of the 4-oxo-411-chromene-2-carbox· 
amides (4) on a Rruker AM 300 NMR spectrometer and 
temperatures are judged to be correct within ± I K. Computer 
modellinl.! for compound 4f was eITected using the Tripos 
Associntes software pnckage, ALCHEMY II. 
Analytical datu for new compounds are as follows: 
7-Fllloro-4-oxo.411-chromeIlP-2-earboxylic aeM (2c) m.p. 
230 DC (EtOH) (Found: C. 57.4; H, 2.5. C,oHsFO, requires: C. 
57.7; H, 2.4%); .5,,(500 MHz; [2H.]DMSO) 6.84 (I H, s, 
CII=C), 7.32-7.36 (I H. m. 6-H), 7.60 (I H. dd.Jm 2 and )J". 10. 
8-H),8.03 (I H.dd.J.9 and 'J"F6,5-B)and R.9(60 MHz; I H.br 
s, CO,H); 15c (75 Mllz; [,H.]DMSO) 105.60 (d. 2JeF 26. C·S). 
113.67 (C-3), 114.fi9 (d. 'JeF 23. C-6), 12D.92 (C-4a). 127.R2 (d, 
'Jef II, C-5). 153.56 (C-2). 156.56 (d, 'JeF 14, C-8a). 161.16 
(CO,H). 165.49 (d. I I n 253, C-7) and 176.66 (C-4); "m.,(K Br) 
3300-2700 10H), 1740 (CO·Oll) and 1630 (CO) cm-
'
; III/z 208 
(M·.IOO%). 
N.N.3-metiJyl.4.o.YtJ-4H·ciJ",m"1If·-2-ct1rhoxomitl" (4f) m.p. 
74-76"C (EtOAc) (Found: M I 231.090. CIJIIIJNO.l requires 
M. 231.090); r5,,(500 Mllz; CDCI.,) 1.96 (3 II,s. 3-Me), 2.95 (3 H. 
s, NMe), 3.07 (3 II •• , NMe), 7.31-7.35 (2 H, m. 6-11 and 7-H). 
7.56-7.60(1 H.m.I!·U)andR.11 (I H,dd,J2andR,5.H):r),.(75 
MHz; CDCI,) 9.98 (3-Me), 34.56 (NMe), 37.63 (NMe). 117.36 
(C-3). 117.88 (C-8), 122.89 (C-4a). 125.24 and 125.78 (C·S and 
C-6). 133.72 (C-7), 154.39 (C-8a). 155.61 (C-2), 162.40 (CO·N) 
and 177.82 (C-4); "m .. (KBr) 1640 and 1635 (CO) cm· l; III/z 231 
(M+,I00'X,)· 
N. N- Diisopropyl-4-oxo-4 H ,(·"rOIlli'lIe· 2 'CClrhoxu/II ide (4h) 
m.p. 95-96"C (EtOAe) (Found: C, 70.65; H. 7.3; N. 5.3. 
C,.H .. NO) requires: C, 70.3; H, 7.0; N, 5.1%); 1\,,(500 Mlb~ 
CDCI.,) 1.29 (611, brs,CHMe,), 1.55 (6 H, brs. CHM<'2)' 3.60(1 
H. br s. NCII). 3.91 (I H. br s, NCII), 6.49 (I H, s, CH=C), 7.49-
7.55 and 7.76- 7.83 (2 11,2 x m, 6-H and 7-m. 7.57 (I II. d. J 8, 
8-1l) and 8.23 (I H. d J 7, 5-H); .5ct125 Mllz; CDCI,) 19.94 
((:IIM"2)' 20.57 (CIIM.·,). 46.28 (NCII). 51.12 (NCII). 109.50 
(C-3), 117.96 (C·S). 124.06 (C-4a). J25.45 and 125.48 (C-S and 
C-6). 133.98 (C-7), 155.46 (C-8a), 159.83 (C-2). 161.33 (CO-N) 
and 177.37 (C-4): "m .. 1655 and 1640 (CO) em-'; mI. 273 (M" 
24%),216 (100%). 
1-(4-0.H>-4H·c1rrIJmel1-2-ylcurb,lIIy/)pyrr"lidilll' (4i) m.p. 
103-IOS"C (EtOhc) (Found: M' 243.089. C,.H"NO) 
requires: M, 243.090); 15,,(500 MHz; CDCI) 1.83-1.89 ([4 Il. m, 
CH 2ICII,hCH,). 3.51 (2 H. t, NCH,), 3.63 (2 H.t, NCH 2), 6.62 
(I H,s, CH=C), 7.27-7.303nd 7.56-7.60(2 H, 2 x m.6-11 anti 7-
H), 7.36 (I H. d, J 8, 8-H) and 8.03 II H, dd. J 2 and 8. S·H); 
15,,(125 MII7.; COO» 23.49 (CH,). 26.09 (CII,). 46.92 (NCH,). 
48.08 (NCH,), 111.91 (C-3). 117.87 (C-S), 123.94 (C-4a), 125.35 
lind 125.47 (C-5 and C-6), 134.06 (C-7). 155.16 (C-8a). 157.86 
(C-2), 159.60 (CO·N) and 177.48 (C-4); l'm .. (KBr) 1640 and 
1630 (CO) cm-
'
; m/z 243 (M +,100"/0). 
1-(4-0xIJ-4 H -t'ilrrlmpl1.2.yl)·earbol1)'l)pip,·ridiIlP (4j) m. p. 65-
930 
66°C (EtOAc) (lil.," 90.5-92 oq (Found: C, 70.5; H, 5.9; N, 
5.6. C,.JI,.NO) requires: C, 70.0; H, 5.9; N, 5.4%); tS,,(500 
MHz; CDCI) .1.57-1.66 [6 H, m, (CH,l,], 3.39 (2 JI, br s, 
NCH,). 3.62 (2 II, br s, NClI,), 6.39 (I lI, s, CH=C), 7.34-7.37 
and 7.61-7.65 (2 H, 2 x m, 6-H and 7-11),7.41 (I H, d,J9, 8-H) 
and 8.11 (I II, dd, J 2 and 8, 5-H); tScCI25 MHz; CDCI) 24.17, 
25.21 and 26.34 (NCH,CH,CIl,C1I,C1I,), 43.21 (NCIl,), 
411.03 (NCH,). 110.96 (C-3). IIR09 (C-R). 124.09 (C-4a), 125.57 
(C-5 and C-6), 134.09 (C-7), 155.61 (C-Rn), 158.42 (C-2), 160.67 
(CO·N) and 177.26 (C-4); '", .. (KBr) 1655 and 1650 (CO) cm-'; 
m/z 257 (M +,35%) and 89 (100%). 
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Chromone Studies. Part 4.' Structural Analysis of Chromone-derived 2-Amino-
3- (2-hydroxybenzoyl }acrylamides 
Deborah N. Davidson. Robin B. English and Perry T. Kaye' 
Department of Chemistry. Rhodes University. PO Box 94. GrahamslOwn 6140. Republic of South Africa 
A combination of X-ray crystallographic. 'H. "C NMR and IR spectroscopic. and computer-
modelling techniques have been used to explore both configurational and conformational aspects of 
the structures of a series of substituted 2-amino-3- (2-hydroxybenzoyl)acrylamides. 
Chromone derivatives such as disodium cromoglycate (DSCO 
I).' and certain chromone-2-carboxamides] are known to 
exhibit anti-allergic activity. In fact, ))SCO I is widely used" in 
asthma therapy. its mode of action apparently involving. 
amongst other things, stabilisation of mast cells in the bronchial 
mucosa. '.' To our knowledge. however. the molecular basis for 
such action has yet to be established."" The susceptibility of 
chromones to ring ol"'ning, via C-2 allock by various nitrogen.! 
and oxygen nucleophiles,' has prompted us to explore the 
possible implication of ·this molecular process in chromone 
pharmacology. Thus, appropriate chromones may block or 
modify receptor interactions by binding covalently. through 
C-2, to biogenetic nUcleophiles such as mast-cell proteins or in-
flammatory mediators like histamine' o (Fig. I). Consequently, 
we have hegun a detailed examination of the reactions of 
chromone-2-carboxamides (2. Scheme I) with amines as models 
for in vivo nucleophiles. 
R' R' R' R2 R3 
• H Me Me 'N' b OMe Me Me 
e N02 Me Me ~~~ d F Me Me e Cl Me Me ~ I '<:c? f Br Me Me 
9 H -(CH2).- R':::"" O ... H 
5 
S<hem. I 
I n principle. ring opening of chromones may afford products 
having either E- or Z-double-bond configurations. Zagorevskii 
"/ ClI., I. in an earlier investigation of related systems. used I H 
NMR J •. ] vinyl coupling constants and IR spectroscopy to 
establish: the E-configuration of N.N-disubstituted J3-amino-
vinylketones 6; the Z-configuration of N-monosubstituted 
analogues 7; and the significance of intra-molecular hydrogen 
bonding in both ~eries. However. they were unable to determine 
the double-hond geometry in the products of reactions or 2-
substituted chromones with secondary amines. In this com-
Fig. J Putative inleraction of biogenetic nucleophiles (e.g. X = N, 0, S) 
with chromone systems 
6 
N~ 
H 
H 
7 
FiR. 2 X-Ray cryotal slructure of 2-(dimcthylamino)-J.(2-hydro~y­
benlUyl)-N.N-dimethylacrylamide (S.). showing th. crystallographic 
numbering 
munication we describe the use of X-ray crystallographic, 
spectroscopic and computer-modelling methods in elucidating 
the stereochemistry of such compounds 5. 
A definitive delermination of the solid-state structure of the 
parent system 5a was achieved by single crystal X-ray diffrac-
tion analysis. The crystal structure (Fig. 2) clearly indicates the 
E-geometry of the double bond in this compound. Other 
significant features of the solid state structure are: (i) intra-
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~ CON(CH,). 
R' 
III III 
I.M 
(a) (b) (e) 
Fit!. 3 (a) Favoured E-eonfiguration of compound. 500-1 illustrating delocalisation and hydrogen-bonded c~lation. (h~ Unfavourable s~eric 
inleraclion (see footnole • on p. 1183) in Ihe allernalive rotamer of the E-dia.lereoisomer. (e) Unfavourable stene Inleracllon (s .. footnole on 
p. 1183) in a planar conformation of the Z-diaslereoisomer. 
Table I Comrarati.e I Hand "c NM R chemical shifts for com-
pounds 500-1 (see Fig. 4) 
"c Nucleus ,ss. A,s" 
CONMr, 34.06 0.44 
36.84 0.46 
NMe, 39.38 0.52 
40.11 0.82 
C-I 166.44 0.52 
C-2 158.76 1.54 
C-3 88.81 0.31 
C-4 189.74 1.72 
3-H" 5.75 0.11 
" Maximum variation from value for compound 500 in the series 5Io-r. 
• I H nucleus. 
molecular hydrogen bonding between the phenolic hydroxy 
and the .,yn-orientated ketone carbonyl groups; (ii) the 
orthogonal (ca. 85°) arrangement of the planar· carboxamide 
moiety with respect to the rest of the molecule; and (iii) the 
remarkable co-planarity· of all of the remaining crystallo-
graphically determined atoms. The observed c?-planarit~ is 
consistent with significant delocalisation of the dimethyl ammo 
nitrogen lone pair into the extended conjugated system, an effect 
which is, undoubtedly, enhanced by the hydrogen-bonding 
chelation (Fig. 3). 
It is apparent, from IR and NMR spectroscopic data, that the 
solid-state (crystal) conformation of the parent system Sa is 
essentially maintained in solution (in chloroform at least) and 
it may also be argued that the same configurational and 
conformational features, in fact, characterise all of the 2-amino-
J-(2-hydroxybenzoyl)acrylamides Sa-« examined. Thus the 
NMR data. obtained for COCll solutions, provide compelling 
evidence for E-geometry in each of the 2-amino-3-(2-hydroxy-
benzoyl)acrylamides Sa-g. Filstly, the chemical shifts for the 
vinyl protons (3-H) and the non-aromatic carbons exhibit only 
marginal variations within the series (Table I; Fig_ 4), and the 3-
• Maximum devialion. from Ihe least-square planes were: 0.0820 A. 
(earboxamide moiety) and 0.0796 A. (rest of th. molecule)_ 
(a) 
5 
(b) (e) 
3.2 2.8 
Ii 
Fie.4 (a) Compounds 5 wilh numbering (see Table I for N~R dala); 
(h) parlial 'H NMR spectrum for 501 (R' - F); (e) partial C NMR 
spectrum for 501 (R' - F) 
H chemical shifts are closer 10 the calculated U value for the 
E-isomer (5.51 ppm) than for the Z-isomer (6.08 ppm)_ 
Secondly, in each of the compounds Sa-f, both the amino- and 
carboxamido "c N-methyl signals are split [in the 'H NMR 
spectra only the corresponding carboxamido signals are clearly 
split, the amino N-methyl signals typically appearing, .at 
ambienl temperalure, as broad, post-coalescence singlets (FIg. 
4)].t While slow site-cxchange of N-alkyl groups is typical of 
N,N-disubstituted carboxamides, the parallel splitting of the 
dimethylamino IlC signals is particularly significant, the i?,.pli-
cation being h~ndered rotation between resonance-stabilised 
t The assignment of 'H and "c NMR N-melhyl signals is based on 
comparisons between lhe relevant spectra of Ihe dimethylamino (s.-f) 
and pyrrolidino (Sg) analogues_ 
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planar conformers in which the N-mcthyl groups nrc dia-
stereotopic. Such an arrangement is only possihle if the 
acrylamides 5a-g adopt the E-conliguration illustrated in Fig. 
3(a), since molecular modelling studies' clearly indicate that in 
the Z-diastereoisomer [Fig. 3(c)], co-planarity of the dimethyl-
amino and vinyl ketone moieties is sterically prohibited. 
[Unfavourahle steric interactions' would also destabilise the 
alternative planar rolamer, Fig. 3(b), even when the carbox-
amide moiety is perpendicular to the rest of the molecule.] The 
significance of these steric constraints is further illustrated "y 
the orthogonal orientation of the carboxamide group in the 
crystal structure of the parent system Sa. This orientation, 
which is presumahly maintained in solution, ohviates un-
favourahle steric interaction with the vinyl ketone oxygen 
without inhihiting lone-pair delocalisation in the independently 
planar carhoxamide group. 
I R carbonyl absorption band frequencies tend to be sensitive 
to structural change and it is noteworthy that, in the solid (KRr 
disc) and solution (chloroform) spectra of compounds Sa-II, 
these bands exhibit minimal frequency variation (ra. ± 10 
cm-'). Moreover, the general superposition of both ketone and 
carboxamide carbonyl absorption bands at low (ca. 1650 cm-') 
frequencies relleds effective delocalisation and concomitant 
reduction in the double-hond character of both carbonyl 
groups. Such frequency shifts are characteristic of planar 
carboxamide moieties but, more pertinently in this instance, 
argue independently for the essential co-planarity of the 
dimethylamino and aryl vinyl ketone systems. Furthermore, in 
both the solid state and solution IR spectra of each compound 
5a-"II, the hydroxyl stretching hand is shifted below 3000 em-I. 
This observation [together with the low field resonance (ca. " 
14) of the phenolic proton in the 60 MHz IH NMR spectrum 
of each compound] is indicative I I of the strongly hydrogen-
bonded chelate conformation illustrated in Fig. 3. 
C-2 nucleophilic attack is, of course, equally likely at either 
face of the chromone-2-carboxamides (2, Scheme I) and ring-
opening (t'in racemic intermediates 4) to the corresponding (E)-
dimethylaminoacrylamides 5 may be attributed either to 
product development control or, in view of the reported JJ EIZ-
configurational lability of related systems. to predominance of 
the more stable diastereoisomer. Effective It-participation by the 
dimethylamino nitrogen lone pair is expected to account for 
stabilisation of the essentially planar, conjugated E-products 5, 
relative to the corresponding Z-isomers. In the mono-sub-
stitllted amino analogues 7 examined by Zagorevskii el 01., I I 
however, .'yn-orientated amino and vinyl ketone groups can 
achieve co-planarity without steric strain, and the configur-
ation which permits 'double hydrogen bonding' is apparently 
favoured. 
Experimental 
'H and "c NM R spectra were obtained from CDCI .. solutions 
on Rruker AM 300 and WM 500 MHz or Varian Gemini 200 
MHz spectrometers. Computer modelling was effected using 
Tripos Associates' software package, ALCHEMY II. The title 
compounds 5a-g were obtained by treating the corresponding 
chromone-2-carboxamides 2a-f" with ethanolic dimethyl-
amine as illustrated in the following example (all coupling 
constant values J are given in Hz). 
Dimethylamine (25% wlw solution in EtOH, 3.14 cm'; 13.2 
mmol) was added to a solution of N,N-dimethylchromone-2-
.. The required structures were modelled, and the resulting interatomic 
distance< measured, using the software package, ALCHEMY II. The 
planar nrrangemenl! were obtained by altering the relevant torsion 
angles of energy·nlinimised structure!. 
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carboxamide 2a (0.500 g, 2.3 mmol) in dry EtOH (17 cm'). 
After being stirred at room temperature (35'C for the pre-
paration of compounds 5b-Jl) for 20 h, the solution was cooled 
and evaporated under reduced pressure to afford a crude solid 
(0.53 g) which was chromatographedt on silica (elution with 
EtOAc) to afford 2-(dimethylamino)-3-(2-hydroxybenzoyl)-
N,N-dimethylacrylamide (Sa) (0.374 g, 62%). m.p. 165-166"C 
(from EtOIl) (lil.." 166-167 DC); ",,(500 Mill.; CDCI,) 2.89 
and 3.09 (6 H, 2 x s, CON Me,), 3.06 (6 II,s, NMe,), 5.75 (I II, 
s, CII:C), 6.75·-6.79 and 7.29-7.33 (2 H, 2 x m, 4'-H and 5'-H), 
6.88(1 H,dd,JJ and8,Y-H), 7.67(1 H,dd,J2 and 8,6'-11) and 
JJ.60 (60 MHz; I H, s, OH); "r(75 MHz; CDCI,) 34.06 and 
36.114 (CONUp,), 39J8 and 40.11 (NMe,), 88.81 (C-3), 117.78 
and I 17.88 (C-3' and C-5'), 120. I 8 (C- I '), 121!.O3 (C-6')'-133. 75 
(C-4'), 158.76 (C-2), 162.53 (C-2'), 166.44 (CO·N) and 189.74 
(C-4); vm,,(KRr)/cm-1 2920 and 1648. 
Analytical data for new compounds are as follows. 2-( Di-
metlrylamina)-3-{2-hJ,droxy-4-mPl/JOxyhmzoy/)-N,N-dimt'lhJ'1-
arrylamiclt' (Sh) (0.212 g, 36%), m.p. 154-156 DC (from EtOAc); 
[/II/z Found: 292.141 (M'. 10%). C"H,.N,O, requires: 
292.142]; ",,(300 MHz; CDCI,) 2.90 and 3.09 (6 H, 2 x s, 
CONMe,), 3.04 (6 II, br s, NMe,), 3.78 (3 1-1, S, OMe), 5.65 
(I H, s, CH:C), 6.31·-6.37 (2 H, m, 3'-H and 5'-H), 7.58 (I H, d, 
J 9, 6'-11) and 14.10 (60 MII7~ I H, s, OB); "d75 MH7~ 
CDCl3) 34.48 and 37.30 (CONMr,), 39.47 and 40.09 (NMe,), 
55.37 (OCII ,), 89. I 2 (C-3), 101.02 and 106.43 (C-3' and C-S'), 
113.95 (C-I'), 129.63 IC-6'), 157.89 (C-2), 164.26 (C-4'), 165.33 
(C-2'), 166.93 (CO·N) and 189.oJ (C-4); l'm,,(KBr)/cm- 1 
2930,1660 and 1650; mlz 292 (M·, 10"1.) and 220 (100%). 
2-{Di/llf?lhy/amino)-3-(2-/Jydm.ry-4-lIilrobenzoyl)-N,N-di-
mt'lhylacrylamicie (Sc) (0.305 g, 52%), m.p. 160-161 DC (from 
EtOAc) (Found: C, 54.8; II, 5.7; N, 13.5. C,oH I7N,O, requires: 
C, 54.7; H, 5.6; N. 13.7%); "11(300 MHZ; CDCI,) 2.92 and 3.11 
(6 11,2 x s, CONMc2), 3.07 and 3.19 (6 H, 2 x s, NMe,), 5.71 
(I II, s, CH:C), 7.58 (I H, dd, J 2 and 9, S'-H), 7.69 (I H, d, J 2, 
3'-11) 7.79 (I H, d, J 9, 6'-H) and 13.85 (60 MHz; I H, s, 
OB); ,sd75 MHz; CDCI,) 34.50 and 37.14 (CONMt',), 39.90 
and 40.93 (NMe2)' 89.04 (C-3), 112.28 and 113.52 (C-3' and C-
5'), 124.82 (C-I'), 128.87 (C-6'), 150.53 (C-4'), 160.30 (C-2), 
163.09 (C-2'), 165.92 (CO,N) and 188.02 (C-4); vm.,(KSr)! 
cm- I 2920 and 1645; mlz 307 (M .. II %) and 72 (100%). 
2-(Dimt'lhy/a/llino)-3-(4-j/lIoro-2-hydroxybellzoy/)-N,N-
dimt'lhylacrylamidt' (Sd) (0.228 g, 39%), m.p. 164-166 DC (from 
EtOAc) (Found: C, 59.7; H, 6.3; N, 10.0. C,oH I1N203F 
requires: C, 60.0; H, 6.1; N, 10.0%); ,sH(300 MHz; CDCI,) 2.89 
and 3.08 (6 H, 2 x s, CON Me,), 3.06 (6 II, br s. NMe,), 5.63 
(I H,s, CH:C), 6.44-6.58 (2 II, m, 3'-H and 5'-11), 7.65 (I H, dd, 
J 7 and 9, 6'-H) and 14.0 (60 MHz; I H, s, OH); "d75 MHz; 
CDCI,) 34.39 and 37.15 (CONMe,), 39.59 and 40.40 (NMe2), 
88.96 (C-3), 104.73 and 105.81'(2 x d, 'JrF 23 and 'JeF 24, C-3' 
and C-S'), 117.25 (d, 'JCF 3, C-I'), 130.18 (d, 'JCT- II, C-6'), 
159.03 (C-2), 165.27 (d, 3 JCF 15, C-2'), 166.10 (d, I JCF 254, C-4'), 
166.62 (CO·N) and 189.10 (C-4); vm,,(KBr)/cm-' 2910 and 
1660; mlz 280 (M" 9%) and 208 (100%). 
3-(4-Chioro-2-Irydroxyht'nzo)'/)-2-(climt'lhylamino)-N.N-
dimelhyiarryla/llicle 5e (0.327 g, 55%), m.p. 124-125 DC (from 
EtOAc); [mlz Found: 296.092 (M', 12%). C,.H I1N20,CI 
requires: 296.093]; "H(300 MHz; CDCI,) 2.89 and 3.09 (6 H, 
2 x s, CONMc,), 3.07 (6 H, br s, NMe3), 5.66 (I H, s, CH:C), 
6.74(1 H,dd,J2 and 9,5'-H),6.89 (I H,d,J2,3'-H), 7.57(111, 
d, J 9, 6'-H) and 13.85 (60 MHZ; 1 H, s, OH); "r<75 MHz; 
CDCI3) 34.48 and 37.07 (CONMe,), 39.70 and 40.60 (NMc,), 
8R.88 (C-3), 118.24 and 118.39 (C-3' and C-S'). 118.85 (C-I'), 
129.10 (C-6'), 139.32 (C-4'), 159.09 (C-2), 163.52 (C-2'), 166.45 
t Preparalive layer .hromatography w .. Iypi.ally employed 10 oblain 
analyti.al samples. 
• 
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T.hle 2 Fractional coordinates ()( 10") for 2.(dimethylamino)-3-(2. 
hydroxybenzoyl).N.N.dimethylacrylamide·" 
Atom .,10 ylh zle 
C(I) J 146(3) 2544(2) 1544(2) 
C(2) 4446(3) 1354(2) 8181(2) 
C(3) 3 164(4) 227(3) 8319(3) 
C(4) I 200(4) 211(3) 7832(3) 
C(~) 412(4) 1421(3) 1209(3) 
C(I\) I 130(3) 2549(3) 101i6(3) 
0(1) 6362(31 12511(2) 8686(2) 
H(O) 1\ 934(51) 2084(31) 8613(32) 
0(2) 6909(2) 3610(2) 1972(2) 
C(7) 5 145(3) 3149(2) 14411(2) 
C(8) 448(1(3) 4935(2) 6164(2) 
C(9) 5109(3) 6084(2) 6666(2) 
qlO) 1921(3) 6067(2) 1141(2) 
N(I) 5 105(3) 1253(2) 6094(2) 
C(II) 3046(4) 1315(3) 5518(3) 
C(12) 6442(4) 8452(3) 5964(3) 
0(3) 8996(2) 5621(2) 6412(2) 
N(2) 8558(3) 6626(2) 8313(2) 
C(13) 10644(4) 6488(3) 8826(3) 
("(141 1234(5) 1056(4) 9181(3) 
• For atom labelling. see FiB- 2. • Estimated standard deviations in paren· 
theses. 
T.hIe 3 Selected bond Iengths/A and anglesr for 2·(dimethylamino)-
3.(2.hydroxyhenzoyl).N.N-dimethylacrylamide··· 
C(1}--C(1) 1.489(3) C(2)--0(1) 1.351(3) 
O(I)--H(O) 0.81(3) 0(2}--C(1) 1.263(2) 
C(1)--C(8) 1.422(3) C(8)--C(9) 1.374(3) 
C(9)--C(HlI 1.~26(31 C(9)-N(I) 1.3411(3) 
C(10)-0(3) 1.222(3) C(10)--N(2) 1.339(3) 
N(I}--C(II) 1.464(3) N(I}--C(12) 1.465(3) 
Nm-C(13) 1.465(3) N(2}--C(14) 1.458(3) 
C(2}--C(I)--C(1) 119.3(21 C(6)--C(1}--C(1) 123.(1(2) 
C( I )--C(2)--O( I) 122.1(2) C( 3 )--C( 2)--0( I) 111.3(2) 
C(2)--0(I)--H(O) 106.(1(2) C( I }--C(1)--O(2) 111.6(2) 
C( I )--C(1)-C(8) 120.1(2) 0(2}--C(1)--C(8) 122.3(2) 
C(7)--C(8)--C(9) 122.1(2) C(8)-C(9)--C(l0) 121.3(2) 
C(8)--C(9)-N( I 1 123.6(2) C( 10)--C(9)--N( I) 115.(1(2) 
C(9)--C(10)--O(3) 118.2(2) C(9)-C( IO)--N(2) 111.1(2) 
0(3)--C(lO)-N(2) 124.5(2) C(9)-N(I}--C(II) 121.1(2) 
Cm-N(I)--C(l2) I 23.(l(2) qll)--N(I}--C(12) 115.9(2) 
C(10)--N(2)-C(13) 111.8(2) C(10)--N(2)--C(14) 123.1(2) 
C( I3)-N(2)-C(l4) 111.5(2) 
• Fur atom labelling. see Fig. 2. • Estimated standard deviations in 
parentheses. 
(CO·N) and 188.99 (C-4); vM •• (KDr)/cm-1 2920 and 1660; m/z 
296 ("CI, M +.12%) and 224 (U)(rl.). 
3·(4.Broma-2.hydmxyMnznyl)-2-(dimt'lhylamina)-N,N-
diml'lh),IQ('r),/"",i(le (Sf) (0.265 g. 46%), m.p. 124--125"C (from 
EtOAc) (Found: C,49.2; H, 5.1; N. 8.4. C,.H 17N,O,Dr requires: 
C, 49.3; H, 5.0; N, 8.2%); .5,,(300 MHZ; CDCI,) 2.89 and 3.08 (6 
H, 2 x s, CONM.,), 3.06 (6 H. 2 x s. NMe,). 5.65 (I H. s. 
CH=C). 6.89 (I H, dd. J 2 and 9. 5'-H), 7.06 (I H. d. J 2. 3'-H). 
7.SO (I H. d, J 9, 6'·H) and 13.80 (60 MHz; I H. s, 011); .5c(15 
Mllz; CDCI,) 34.40 and 37.11 (CONMe,), 39.74 and 40.52 
(NMe,). 88.88 (C-3). I 19.30 (C-I'). 121.28 and 121.40 (C-3' and 
C-S'). 127.63 (C-4'), 129.21 (C-6'), 159.33 (C-2). 163.56 (C-2'). 
166.49 (CO·N) and 189.28 (C-4); ..... (K8r)/cm-
' 
2920 and 
1660; mlz 340 (?ODr. M +.6%) and 72 (100"1.). 
3-(2- II.I'drox)'h""zn.l,/)-N.N-dimell,yl-2-pyrrnlidinnncryl-
amid" (Sit) (0.594 So 'Xr;~). m.p. 183-184"C (from EtOH) 
(Found: C, 66.3; H. 7.05; N, 9.2. C,.HznN,O, requires: C.66.65; 
H, 7.0; N. 9.7); .5,,(200 MHz; CDCI,) 1.86-2.11 [4 H. m. 
CHz(CllzIzCH,], 2.94 and 3.11 (6 H. 2 x s. CONMe,). 3.36-
270 
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3.45and3.65-3.72[3Hand I H.2)( m,N(CH,lz).5.72(1 H.s, 
CH=C).6.76-6.93 (2 H. m. 4'-H and,5'-H), 7.28-7.37 (I H. m. 3'-
H), 7.69 (I H, dd, J 2 and 8, 6'-H) and 13.70 (60 MHz; I H. s. 
OH); .5C<SO MHz; CDCI,) 24.82 and 25.39 [CH 1(CH zhCH z]. 
34.41 and 37.24 (2 x NMe), 48.57 and 48.78 [N(CH,h). 89.84 
(C-3), 118.30 and 118.61 (C-3' and C-5'). 120.70 (C-I'). 128.62 
(C·6'). 134.35 (C·4'), 156.74 (C-2). 163.31 (C-2'). 167.65 (CO·N) 
and 190.44 (C-4); v .... (KBr)/cm-
' 
2930.2870 and 16,50; mlz 288 
(M+, 2%) and 121 (100"1.). 
Cry.flal Dala.-C ,.H .. N 10" M = 262.31. Triclinic, a = 
6.8745(6). h = 9.353( I). c = 1O.872( I) A, II = 94.536(8). 
f/ = 99.245(8). Y = 91.223(8)". V = 687.4(1) A' (by least-
squares refinement on diffractometer angles for 25 aUIO-
matically centred reflections. ). - 0.7093 A), space group PI. 
Z = 2. D. = 1.264 g cm-J, yellow blocks. /1 = 0.71 em-I. 
Dala Cnlll'Cllnn and Prnc ...... inK.-CAD4 diffractometer, Or 
20 mode with (}) scan width = 0.5 + 0.35 tan (), variable (I) scan 
speed (max = 5.49· min-'). graphite-monochromated Mo·K .. 
radiation: 4195 renections measured (2 ~ 0 ~ 30", 10:9-9. 
k: D-I3,/:0-15). 3260 observed with I> a(/). No crystal decay 
observed . 
S/rllclurl' AIIOI.!' .. i.f and Rl'jint'm"nt.-Direct methods I. fol-
lowed by full·matrix least-squares refinement with all non-
hydrogen atoms anisotropic, and hydrogen atoms (with the 
exception of the phenolic hydrogen) in calculated positions with 
common isotropic temperature factors. The phenolic hydrogen 
[H(O») was located from a difference Fourier map and 
its position refined. H(O) is involved in an intramolecular 
hydrogen bond: 0( I )-H(O) 0.87(3) A; 0(2) ••• H(O) 1.69(3) A; 
and O(I)-H(O)··· 0(2) ISO.O(2)". Unit weights were used. The 
final R value was 0.069 (190 parameters). Final fractional 
atomic coordinates are given in Table 2. and some selected bond 
lengths and angles are presented in Table 3. A diagram of the 
molecule appears in Fig. 2. Full lists of bond lengths and bond 
angles. thermal parameters and hydrogen atom coordinates 
have been deposited at the Cambridge Crystallographic Data 
Centre (CCOC).· 
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Chromone Studies. Part 5.' Kinetics and Mechanism of the Reaction of 4-0xo-
4H-chromene-2-carboxamides with Dimethylamine 
Deborah N. Davidson and Perry T_ Kaye' 
Department of Chemistry, Rhodes University. P. O. Box 94. Grahamstown, 6140, South Africa 
The dimethylamine-mediated ring-opening of a series of N,N-dimethyl-4-oxo-4H-chromene-2-
carboxamides to the corresponding (E) -2- (N,N-dimethylamino) -3- (2-hydroxybenzoyl)acrylamides 
has been monitored by UV spectroscopy, and a mechanistic sequence which accommodates the 
observed third-order kinetics is presented_ 
In our invesliglilions of substituent eITects in chromone (4-oxo-
411-chromene) systems we have previously examined the 
inlernal rotation of 4-oxo-411-chromene-2-carboxylate esters 
by 1 R spectroscopy 2 and N-methyl site-exchange in 4-0.0-
411-chromene-2-carboxamides by DNMR techniques. 3 The 
susceptihility of chromone derivatives to ring-opening via 
nucleophilic allack at C-2 is well illustrated by the amine-
mediated formation of (E)-2-(N,N-dimethylamino)-3-(2-
hydroxybenzoyl)acrylamides 4 from 4-oxo-4H-chromene-2-
carboxamide precursors J, J and the possible implication ofsuch 
o 
~ R'~O.JlcO.H 
2 
R' 
• H 
b MeO 
c F 
d CI 
• NO. 
o 
~ 
R,A)loJlcoNMe. 
3 
4 
Sche",. I Rptl/lpnlJ: i. SOCl,-DMF-CICH,CH,CI; ii, Me,NH,CI-
pyridin.; iii, ethanolic Me,NH-F.IOH 
reactions in the molecular-level pharmacology of anti-aller~ic 
drugs such as disodium cromoglycate (DSCG, I) has prompted 
the present kinetic study of substituenl eITeets on the ring-
opening process. 
Experimental 
MtIIl'Tiol .• _-The N.N-dimethyl-4-oxo-411-chromene-2-carb-
oxamides J. ·e were prepared from the corresponding 4-0"0-
41/-chromene-2-carboxylic acids l.-e as described previously 4 
and the identity of the ring-opened products as (E)-2-(N,N-
0.8 
CD 
u 0.6 c 
IV 
-e 
\I 0.4 III 
.0 
0( 
0.2 
10 20 30 40 50 60 70 
lime/min 
Fig. I Plots of absorb""ce v.,. lime ror reaclion of N,N-dimethyl-4-o.o-
4H-chromene-2-carbo •• mide 3. with Me,NH al30 ·C. [Me,NH]/mot 
dm- l ; (a), 1.0; (b), 1.2; (e) 1.4; (J), 1.6; (e), 1.8. 
dimelhylamino)-3-(2-hydroxybenzoyl)acrylamides 4 has 
already been established.' The exact concentration of the 
ethanolic dimethylamine (supplied by Fluka as a 33% wlw 
solution) was determined by titration against 0.1 mol dm-
' 
lICf. 
Ethanol, used as a solvent for the reactions, was dried by 
distillation from magnesium ethoxide. ' 
Kinetic Procedurf'.-The formation of the aery lam ides 4 was 
followed on a Beckmann UV 5240 spectrophotometer, the 
absorbance changes being measured. in each case, at the 
wavelength corresponding to the absorption maximum of the 
particular acrylamide 4 (I'.g. Fig. I). In all cases, the absorption 
maxima of reactants and products were well separated. The 
wavelength, initial concentrations of 4-oxo-411-chromene-2-
carboxamide J and dimethylamine, and the duration of each 
reaction are summarised ill Table I. Quartz cuvelles with JO 
mm pathlength were used, and the cuvelle chamber, reaction 
flask, and reagent solutions were maintained at 30 ( ± 0.2) 'C. 
Initial 4-oxo-411-chromene-2-carbollamide J concentrations 
were chosen to produce maximum acrylamide 4 absorbances of 
ca. 1.1) ... 1.2 absorbance units and dimethylamine concentrations 
were chosen to ensure ca. 80"1. transformation within 1 ... 1.5 h 
(Table I). The final absorbance readings (Iim,->~A,) were taken 
after 15--24 h. All determinations were duplicated. The linear 
(Beer's Law) relationship between acrylamide 4 concentration 
and absorbance was confirmed over the corresponding ranges 
. used for each system. 
Use of large cxcesse.~ of dimethylamine {> 103 [J]} permilled 
pseudo-first-order analysis of the reactions, linear plots of 
In (A - A,) against time [eqn. (I») aITording pseudo-first-order 
rate constants [k.: eqn. (3)] at diITerent dimethylamine 
concent rations. The ring-opening reactions were shown to be 
third-order overall [cqn. (2)] and the rate constants (k ... ) were 
1510 
Table I Reactioll parameters 
Reaction 
"1../ [Amide]/IO' [M.,NII]/ Completion time 
R' nm mol dm ' mol dm-' (%) (min) 
II 357 
OM. J61 
NO, 388 
F 35J 
CI 358 
5 
4 
3.5 
3.0 
5.5 
3.5 
3.5 
1.0-1.8 
1.8··2.6 
0.059·0.099 
0.4-{1.8 
0.2-0.6 
80-85 
65-76 
SO··R2 
74-85 
SO-II? 
40-120 
32-80 
35-70 
19-70 
17.5-130 
OL-__ L-__ ~ __ ~ __ ~ __ ~ __ ~ __ ~ 
0.5 1.5 2 2.5 3 3.5 4 
[Dimethylamine]2/mol2 dm-a 
Fig.2 PI.,t .. f pseudo.fint.order rate constants k. 1'.'. [Me,NII)' f .. r 
the reaction of N.N·dimethyl.4-oxo.4H·chromene-2-c:arbolamide Ja 
with Me,NII at 30·C 
Tabl. 2 Pseudo·first·order rate constants (k.l for the ring.opening of 
N.N-dimothyl-4.010-4H.chromene-2-carbooamid.s 3 by dimethyl. 
amine at 30·C 
[Amide]/ 
ro'mol [Me,N})]/ 
R 1 dm-' mol dm-' k. '/10. ,-I 
II 3.5 1.00 2.40 ± 0.02 
1.20 3.45 ± 0.15 
1.40 4.53 ± 0.03 
1.60 5.90 ± 0.38 
1.80 7.10 ± 0.12 
OM. 3.0 1.80 3.97 ± 0.05 
2.00 4.98 ± 0.22 
2.10 5.73 ± 0.18 
2.40 6.87 ± 0.25 
2.60 7.97 ± 0.15 
NO, 5.5 0.059 2.53 ± 0.12 
0.069 3.35 ± 0.05 
0.079 4.33 ± 0.10 
0.089 5.67 ± 0.18 
0.099 6.50 ± 0.02 
F 3.5 0.40 3.33 ± 0.05 
O.SO 4.70 ± 0.20 
0.60 7.23 ± 0.72 
0.70 9.18 ± 0.48 
0.80 12.22 ± 0.65 
CI 3.5 0.20 2.22 ± 0.02 
0.30 4.75 ± 0.03 
0.40 7.05 ± 0.42 
O.SO 10.72 ± 0.40 
0.60 15.53 ± 0.65 
, Mean value from duplir.ate runs. 
determined from plols of pseudo-first·order mte constants (k.) 
against [Mc,NH]' (e.g. Fig. 2). The relevant data are 
summarised in Tables 2 and 3. Best straight line fits were 
obtained by linear regression analysis of the experimental data. 
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Tahl.3 Rat. constallt. (k • .,) fllr the ring·opening of N,N.dimethyl-4-
0.o-411-chromonc-2-carboxamides 3 by dimethylamin. al 30 ·C 
R' 
II 
OMe 
NO, 
I' 
CI 
2.12 ± 0.08 
1.13 ± 0.05 
6411 ± 7 
18.5 ± 1.2 
40.8 ± 1.3 
In (A - A,) '" -k.1 + In (A - Ao) 
where Ao '" initial absorbance, A, '" absorbance 
at lime. 1 and A '" Iim.-..,A, 
'" k. [3] 
where k. '" k .... [Me,NH]' 
Results and Discussion 
(I) 
(2) 
(3) 
In relaled kinetic studies, Szabo 1'1 01. have shown that 
hydroxide·ion·induced cleavage of the pyrone ring in 
chromone 6 and isollavonoid derivatives 7.8 follows second. 
order kinetics {Rale a: [substrale][OH-]}. They proposed a 
mechanislic sequence (Scheme 2) in which the first step (5-6), 
6 7 
II 
oj' ? R I R2 ~ 0 OH 
8 
Scheme 1 
involving hydroxide ion auack at C-2. is considered to be rate-
determining. and suggesled 6 thaI the measured rale conslanls 
rellecl the electron density at C-2 and. hence, Ihe susceptibility 
of chromone derivatives to C-2 nucleophilic auack. 
Consequently, we expected the reactions of N,N. 
dimelhyl-4-oxo-411-chromene-2-carboxamides 3 with 
dimelhylamine to follow second·order kinelics with C-2 auack 
by dimethylamine being rate·determiuing. In the event, our 
results clearly show that Ihese ring·opening reaclions follow 
IIIi,J·ort/,., (rather than second·order) kinetics overall and 
require formulation of the rate equation as indicated in eqn. (2). 
The mechanism which we are now proposing is delailed in 
Scheme 3 and is consistent with a rate expression [eqn. (4)] 
which, for kJK, K, '" k .... , is identical to the experimentally 
determined relationship [eqn. (2)], 
Rate'" kJK,K, [3] [Me,NH]2 (4) 
The proposed mechanism (Scheme 3) comprises two 
conseculive equilibria followed by a rale.delermining ring· 
opening step. In the first equilibrium, readily reversible 
nucleophilic allack by the amine al C-2 of the 4-oxo-4l1-
chromene-2-carbollamide 3 alTords Ihe dipolar species 9 in 
which loss of Ihe lIelllral amine (9->3; Fig. 3) occurs inore 
readily than ring.fission (9->1 I). The nexl step is simply an acid-
base equilibrium. the second molecule of amine now acting as a 
